0001213900-22-073520.txt : 20221117 0001213900-22-073520.hdr.sgml : 20221117 20221117170057 ACCESSION NUMBER: 0001213900-22-073520 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 55 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221117 DATE AS OF CHANGE: 20221117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Western Uranium & Vanadium Corp. CENTRAL INDEX KEY: 0001621906 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS METAL ORES [1090] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55626 FILM NUMBER: 221399259 BUSINESS ADDRESS: STREET 1: 330 BAY STREET, SUITE 1400 CITY: TORONTO STATE: A6 ZIP: M5H 2S8 BUSINESS PHONE: (970) 864-2125 MAIL ADDRESS: STREET 1: 330 BAY STREET, SUITE 1400 CITY: TORONTO STATE: A6 ZIP: M5H 2S8 FORMER COMPANY: FORMER CONFORMED NAME: Western Uranium Corp DATE OF NAME CHANGE: 20150220 FORMER COMPANY: FORMER CONFORMED NAME: HOMELAND URANIUM INC. DATE OF NAME CHANGE: 20141009 10-Q 1 f10q0922_westernuranium.htm QUARTERLY REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2022

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______________to ______________

 

Commission File Number 000-55626

 

WESTERN URANIUM & VANADIUM CORP.

(Exact Name of Registrant as Specified in Its Charter)

 

Ontario, Canada   98-1271843
(State or Other Jurisdiction of
Incorporation or Organization)
 

(I.R.S. Employer
Identification Number)

 

330 Bay Street, Suite 1400

Toronto, Ontario, Canada

  M5H 2S8
(Address of Principal Executive Offices)   (Zip Code)

 

(970) 864-2125

(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of exchange on which registered
N/A        

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirement for the past 90 days. Yes No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

 

As of November 15, 2022, 43,589,048 of the registrant’s no par value common shares were outstanding

 

 

 

 

 

 

WESTERN URANIUM & VANADIUM CORP.

FORM 10-Q

 

TABLE OF CONTENTS

 

PART I – FINANCIAL INFORMATION 1
Item 1. Financial Statements 1
  Condensed Consolidated Balance Sheets (Unaudited) 1
  Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) (Unaudited) 2
  Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) 3
  Condensed Consolidated Statements of Cash Flows (Unaudited) 4
  Notes to the Condensed Consolidated Financial Statements (Unaudited) 5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 17
Item 3. Quantitative and Qualitative Disclosures About Market Risk 29
Item 4. Controls and Procedures 29
     
PART II – OTHER INFORMATION 30
Item 1. Legal Proceedings 30
Item 1A. Risk Factors 30
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 44
Item 3. Defaults Upon Senior Securities 44
Item 4. Mine Safety Disclosures 44
Item 5. Other Information 44
Item 6. Exhibits 45
     
SIGNATURES 46

 

i

 

 

PART I . FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

WESTERN URANIUM & VANADIUM CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Stated in USD)

(Unaudited)

 

   As of 
   September 30,
2022
   December 31,
2021
 
Assets        
Current assets:        
Cash  $10,468,789   $880,821 
Restricted cash, current portion   75,057    75,057 
Prepaid uranium concentrate inventory   -    4,085,723 
Prepaid expenses   299,357    153,701 
Marketable securities   928    2,120 
Other current assets   45,251    264,039 
Total current assets   10,889,382    5,461,461 
           
Restricted cash, net of current portion   676,348    665,389 
Mineral properties and equipment, net   12,656,075    11,780,142 
Kinetic separation intellectual property   9,488,051    9,488,051 
           
Total assets  $33,709,856   $27,395,043 
           
Liabilities and Shareholders’ Equity          
           
Liabilities          
Current liabilities:          
Accounts payable and accrued liabilities  $572,930   $699,593 
Reclamation liability, current portion   75,057    75,057 
Subscription payable   -    146,177 
Deferred revenue, current portion   60,015    48,465 
Total current liabilities   708,002    969,292 
           
Reclamation liability, net of current portion   222,453    196,563 
Deferred tax liability   2,708,887    2,708,887 
Deferred contingent consideration   321,600    362,794 
Deferred revenue, net of current portion   -    60,015 
           
Total liabilities   3,960,942    4,297,551 
           
Commitments and Contingencies (Note 6)   
 
    
 
 
           
Shareholders’ Equity          
Common shares, no par value, unlimited authorized shares, 43,589,048 and 39,073,428 shares issued as of September 30, 2022 and December 31, 2021, respectively, and 43,588,742 and 39,073,122 shares outstanding as of September 30, 2022 and December 31, 2021, respectively   42,581,002    36,195,510 
Treasury shares, 306 shares held in treasury as of September 30, 2022 and December 31, 2021   -    - 
Accumulated deficit   (12,583,074)   (13,161,496)
Accumulated other comprehensive (loss) income   (249,014)   63,478 
Total shareholders’ equity   29,748,914    23,097,492 
Total liabilities and shareholders’ equity  $33,709,856   $27,395,043 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 

 

1

 

 

WESTERN URANIUM & VANADIUM CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS)

(Stated in USD)

(Unaudited)

 

   For the Three Months Ended
September 30,
   For the Nine Months Ended
September 30,
 
   2022   2021   2022   2021 
                 
Revenues  $108,547   $16,155   $7,611,419   $48,465 
Cost of revenues   -    -    4,044,083    - 
Gross profit   108,547    16,155    3,567,336    48,465 
                     
Expenses                    
Mining expenditures   204,520    335,028    616,146    422,921 
Professional fees   97,077    136,174    445,596    287,042 
General and administrative   351,928    361,301    1,870,747    835,281 
Consulting fees   18,346    12,801    78,165    16,810 
Total operating expenses   671,871    845,304    3,010,654    1,562,054 
                     
Operating profit/ (loss)   (563,324)   (829,149)   556,682    (1,513,589)
                     
Accretion and interest   (35,799)   1,344    (17,740)   4,687 
Other (income)/expense   -    -    (4,000)   
-
 
Settlement expense   -    -    -    78,441 
                     
Net income/(loss)   (527,525)   (830,493)   578,422    (1,596,717)
                     
Other comprehensive income/(loss)                    
Foreign exchange gain/(loss)   (148,365)   (46,363)   (312,492)   23,531 
                     
Comprehensive income/(loss)  $(675,890)  $(876,856)  $265,930   $(1,573,186)
                     
Net income/(loss) per share - basic  $(0.01)  $(0.02)  $0.01   $(0.04)
                     
Net income/(loss) per share - diluted  $(0.01)  $(0.02)  $0.01   $(0.04)
                     
Weighted average shares outstanding - basic   43,514,832    38,203,075    42,536,893    36,243,124 
                     
Weighted average shares outstanding - diluted   43,514,832    38,203,075    43,547,377    36,243,124 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

2

 

 

WESTERN URANIUM & VANADIUM CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

(Stated in USD)

(Unaudited)

 

    Common Shares    Treasury Shares    Accumulated    Accumulated
Other
Comprehensive
      
    Shares    Amount    Shares    Amount    Deficit    

Income (Loss)

    

Total

 
                                    
Balance as of January 1, 2022   39,073,122   $36,195,510    306   $-   $(13,161,496)  $63,478   $23,097,492 
                                    
Private placement - January 20, 2022   2,495,575    3,011,878    -    -    -    -    3,011,878 
Stock based compensation - stock options   -    502,145    -    -    -    -    502,145 
Proceeds from exercise of warrants   268,204    341,850    -    -    -    -    341,850 
Foreign exchange gain   -    -    -    -    -    56,661    56,661 
Net loss   -    -    -    -    (1,173,603)   -    (1,173,603)
                                    
Balance as of March 31, 2022   41,836,901   $40,051,383    306   $-   $(14,335,099)  $120,139   $25,836,423 
                                    
Proceeds from the exercise of warrants   1,477,743    1,989,427    -    -    -    -    1,989,427 
Stock based compensation - stock options   -    251,074    -    -    -    -    251,074 
Foreign exchange loss   -    -    -    -    -    (220,788)   (220,788)
Net income   -    -    -    -    2,279,550    -    2,279,550 
Balance as of June 30, 2022   43,314,644   $42,291,884    306   $-   $(12,055,549)  $(100,649)  $30,135,686 
                                    
Proceeds from the exercise of warrants   274,404    289,118    -    -    -    -    289,118 
Foreign exchange loss   -    -    -    -    -    (148,365)   (148,365)
Net loss   -    -    -    -    (527,525)   -    (527,525)
Balance as of September 30, 2022   43,589,048   $42,581,002    306   $-   $(12,583,074)  $(249,014)  $29,748,914 
                                    
Balance as of January 1, 2021   30,083,747   $29,886,367    306   $-   $(11,087,459)  $(25,542)  $18,773,366 
Private placement - February 16, 2021   3,250,000    1,950,509    -    -    -    -    1,950,509 
Private placement - March 1, 2021   3,125,000    1,918,797    -    -    -    -    1,918,797 
Foreign exchange gain   -    -    -    -    -    44,964    44,964 
Net loss   -    -    -    -    (291,614)   -    (291,614)
                                    
Balance as of March 31, 2021   36,458,747   $33,755,673    306   $-   $(11,379,073)  $19,422   $22,396,022 
                                    
Proceeds from the exercise of warrants   1,722,570    1,597,416    -    -    -    -    1,597,416 
Foreign exchange gain   -    -    -    -    -    24,930    24,930 
Net loss   -    -    -    -    (474,610)   -    (474,610)
                                    
Balance as of June 30, 2021   38,181,317   $35,353,089    306   $-   $(11,853,683)  $44,352   $23,543,758 
                                    
Proceeds from the exercise of warrants   40,000    52,615    -    -    -    -    52,615 
Foreign exchange gain   -    -    -    -    -    (46,363)   (46,363)
Net loss   -    -    -    -    (830,493)   -    (830,493)
                                    
Balance as of September 30, 2021   38,221,317   $35,405,704    306   $-   $(12,684,176)  $(2,011)  $22,719,517 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

3

 

 

WESTERN URANIUM & VANADIUM CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Stated in USD)

(Unaudited)

 

   For the Nine Months Ended
September 30,
 
   2022   2021 
Cash Flows From Operating Activities:          
Net income/(loss)  $578,422   $(1,596,717)
Reconciliation of net income (loss) to cash provided by (used in) operating activities:          
Depreciation   19,468    8,564 
Accretion of reclamation liability   25,890    5,983 
Stock based compensation   753,219    - 
Change in marketable securities   1,192    542 
Change in operating assets and liabilities:          
Prepaid uranium concentrate inventory   4,085,723    - 
Prepaid expenses and other current assets   73,132    (80,454)
Accounts payable and accrued liabilities   (126,664)   133,920 
Subscription payable   (146,177)   - 
Deferred revenue   (48,465)   (48,465)
Contingent consideration   (41,194)   - 
Net cash provided by (used in) operating activities   5,174,546    (1,576,627)
           
Cash Flows Used In Investing Activities          
Purchase of property and equipment   (895,400)   (65,000)
Net cash used in investing activities   (895,400)   (65,000)
           
Cash Flows From Financing Activities          
Proceeds from Private Placement - January 20, 2022   3,011,878    - 
Proceeds from warrant exercises   2,620,395    1,650,031 
Issuances of common shares, net of offering costs   -    3,869,306 
Net cash provided by financing activities   5,632,273    5,519,337 
           
Effect of foreign exchange rate on cash   (312,492)   (7,835)
           
Net increase in cash and restricted cash   9,598,927    3,869,875 
           
Cash and restricted cash - beginning   1,621,267    1,472,061 
           
Cash and restricted cash - ending  $11,220,194   $5,341,936 
           
Cash  $10,468,789   $4,445,103 
Restricted cash, current portion   75,057    75,057 
Restricted cash, noncurrent   676,348    821,776 
Total  $11,220,194   $5,341,936 
           
Supplemental disclosure of cash flow information:          
Cash paid during the period for:          
Interest  $-   $- 
Income taxes  $-   $- 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4

 

 

WESTERN URANIUM & VANADIUM CORP. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Stated in USD)

 

NOTE 1 – BUSINESS

 

Nature of operations

 

Western Uranium & Vanadium Corp. (“Western” or the “Company”) was incorporated in December 2006 under the Ontario Business Corporations Act. On November 20, 2014, the Company completed a listing process on the Canadian Securities Exchange (“CSE”). As part of that process, the Company acquired 100% of the members’ interests of Pinon Ridge Mining LLC (“PRM”), a Delaware limited liability company. The transaction constituted a reverse takeover (“RTO”) of Western by PRM. Subsequent to obtaining appropriate shareholder approvals, the Company reconstituted its Board of Directors and senior management team. Effective September 16, 2015, Western completed its acquisition of Black Range Minerals Limited (“Black Range”).

 

The Company’s registered office is located at 330 Bay Street, Suite 1400, Toronto, Ontario, Canada, M5H 2S8, and its common shares are listed on the CSE under the symbol “WUC.” On April 22, 2016, the Company’s common shares began trading on the OTC Pink Open Market, and on May 23, 2016, the Company’s common shares were approved for trading on the OTCQX Best Market. The Company’s principal business activity is the acquisition and development of uranium and vanadium resource properties in the states of Utah and Colorado in the United States of America (“United States”).

 

On June 28, 2016, the Company’s registration statement became effective and Western became a United States reporting issuer. Thereafter, the Company was approved for Depository Trust Company eligibility through the Depository Trust and Clearing Corporation, which facilitates electronic book-entry delivery, settlement, and depository services for shares in the United States.

 

Note 2 – Liquidity and going concern

 

With the exception of the quarter ending June 30, 2022, the Company had incurred losses from our operations. During the three months ended September 30, 2022, the Company generated a net loss of $527,525. The Company expects to generate operating losses for the foreseeable future as it incurs expenses to bring its mining operations online. As of September 30, 2022, the Company had an accumulated deficit of $12,583,074 and working capital of $10,181,380.

 

Since inception, the Company has met its liquidity requirements principally through the issuance of notes and the sale of its common shares. On January 20, 2022, the Company closed a non-brokered private placement of 2,495,575 units at a price of CAD $1.60 per unit. The aggregate gross proceeds raised in the private placement amounted to CAD $3,992,920 (USD $3,011,878 in net proceeds). During the nine months ended September 30, 2022, the Company received $2,620,395 in proceeds from the exercise of warrants.

 

The Company’s ability to continue its planned operations and to pay its obligations when they become due is contingent upon the Company obtaining additional financing. Management’s plans include seeking to procure additional funds through debt and equity financing, to secure regulatory approval to fully utilize its kinetic separation (“Kinetic Separation”) technology, and to initiate the processing of ore to generate operating cash flows.

 

There are no assurances that the Company will be able to raise capital on terms acceptable to the Company or at all, or that cash flows generated from its operations will be sufficient to meet its current operating costs. If the Company is unable to obtain sufficient amounts of additional capital, it may be required to reduce the scope of its planned product development, which could harm its financial condition and operating results, or it may not be able to continue to fund its ongoing operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern to sustain operations for at least one year from the issuance of these condensed consolidated financial statements. The accompanying condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

5

 

 

WESTERN URANIUM & VANADIUM CORP. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Stated in USD)

 

Note 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Principles of Consolidation

 

The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10 of Regulation S–X. Accordingly, they do not include all of the information and notes required U.S. GAAP. However, in the opinion of management of the Company, all adjustments necessary for a fair presentation of the financial position and operating results have been included in these condensed consolidated financial statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10–K for the fiscal year ended December 31, 2021, as filed with the SEC on April 15, 2022. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for any subsequent quarters or for the year ending December 31, 2022.

 

The accompanying condensed consolidated financial statements include the accounts of Western and its wholly-owned subsidiaries, Western Uranium Corp. (Utah), PRM, Black Range, Black Range Copper Inc., Ranger Resources Inc., Black Range Minerals Inc., Black Range Minerals Colorado LLC, Black Range Minerals Wyoming LLC, Haggerty Resources LLC, Ranger Alaska LLC, Black Range Minerals Utah LLC, Black Range Minerals Ablation Holdings Inc., and Black Range Development Utah LLC. All inter-company transactions and balances have been eliminated upon consolidation.

 

The Company has established the existence of mineralized materials for certain uranium projects. The Company has not established proven or probable reserves, as defined by the United States Securities and Exchange Commission (the “SEC”), through the completion of a “final” or “bankable” feasibility study for any of its uranium projects.

 

Exploration Stage and Mineral Properties

 

In accordance with U.S. GAAP, expenditures relating to the acquisition of mineral rights are initially capitalized as incurred while exploration and pre-extraction expenditures are expensed as incurred until such time the Company exits the exploration stage by establishing proven or probable reserves. Expenditures relating to exploration activities, such as drill programs to search for additional mineralized materials, are expensed as incurred. Expenditures relating to pre-extraction activities, such as the construction of mine wellfields, ion exchange facilities, disposal wells, and mine development, are expensed as incurred until such time proven or probable reserves are established for that uranium project, after which subsequent expenditures relating to development activities for that particular project are capitalized as incurred. Expenditures relating to mining and ore production while the Company is in the exploration stage and while the ore is stockpiled underground are expensed as incurred.

 

Production stage issuers, as defined in subpart 1300 of Regulation S-K, having engaged in material extraction of established mineral reserves on at least one material property, typically capitalize expenditures relating to ongoing development activities, with corresponding depletion calculated over proven and probable reserves using the units-of-production method and allocated to future reporting periods to inventory and, as that inventory is sold, to cost of goods sold. The Company is an exploration stage issuer, which has resulted in the Company reporting larger losses than if it had been in the production stage due to the expensing, instead of capitalizing, of expenditures relating to ongoing mine development and extraction activities. Additionally, there would be no corresponding amortization allocated to future reporting periods of the Company since those costs would have been expensed previously, resulting in both lower inventory costs and cost of goods sold and results of operations with higher gross profits and lower losses than if the Company had been in the production stage. Any capitalized costs, such as expenditures relating to the acquisition of mineral rights, are depleted over the estimated extraction life using the straight-line method. As a result, the Company’s condensed consolidated financial statements may not be directly comparable to the financial statements of companies in the production stage. Western will not be eligible to become a production stage issuer, and will remain an exploration stage issuer, until such time as mineral reserves are established on at least one material property.

 

6

 

 

WESTERN URANIUM & VANADIUM CORP. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Stated in USD)

 

Note 3 – SUMMARY OF Significant Accounting Policies, CONTINUED

 

Use of Estimates

 

The preparation of these condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and revenues and expenses during the periods reported. By their nature, these estimates are subject to measurement uncertainty, and the effects on the condensed consolidated financial statements of changes in such estimates in future periods could be significant. Significant areas requiring management’s estimates and assumptions include the determination of the fair value of transactions involving common shares, assessment of the useful life and evaluation for impairment of Kinetic Separation intellectual property, valuation and impairment assessments of mineral properties and equipment, valuation of deferred contingent consideration, valuation of the reclamation liability, valuation of stock-based compensation, and valuation of available-for-sale securities. Other areas requiring estimates include allocations of expenditures, depletion, and amortization of mineral rights and properties. Actual results could differ from those estimates.

 

Foreign Currency Translation

 

The reporting currency of the Company, including its subsidiaries, is the United States dollar. The financial statements of subsidiaries located outside of the U.S. are measured in their functional currency, which is the local currency. The functional currency of the parent (Western Uranium & Vanadium Corp. (Ontario)) is the Canadian dollar. Monetary assets and liabilities of these subsidiaries are translated at the exchange rates at the balance sheet date. Transactions denominated in currencies other than the functional currency are recorded based on the exchange rates at the time of the transaction. Income and expense items are translated using average monthly exchange rates. Non-monetary assets are translated at their historical exchange rates. Translation adjustments are included in “Accumulated other comprehensive income” in the condensed consolidated balance sheets.

 

Revenue Recognition

 

The Company purchased prepaid uranium concentrate contracts for future delivery of uranium concentrate pursuant to a supply agreement. The Company recognizes revenue upon the delivery of the uranium contract to the counterparty and charges to cost of revenues the purchase cost of the uranium concentrate contract upon such delivery. 

 

The Company leases certain of its mineral properties for the exploration and production of oil and gas reserves. The Company accounts for lease revenue in accordance with the FASB ASC 842, Leases. Lease payments received in advance are deferred and recognized on a straight-line basis over the related lease term associated with the prepayment. Royalty payments are recognized as revenues based upon production.

 

Fair Values of Financial Instruments

 

The carrying amounts of cash, restricted cash, accounts payable, subscription payable, reclamation liability, contingent consideration and accrued liabilities approximate their fair value due to the short-term nature of these instruments. Marketable securities are adjusted to fair value at each balance sheet date based on quoted prices which are considered level 1 inputs. The Company’s operating and financing activities are conducted primarily in United States dollars, and as a result, the Company is not subject to significant exposure to market risks from changes in foreign currency rates. The Company is exposed to credit risk through its cash and restricted cash but mitigates this risk by keeping these deposits at major financial institutions.

 

The FASB ASC 820, Fair Value Measurements and Disclosures, provides the framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements).

 

7

 

 

WESTERN URANIUM & VANADIUM CORP. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Stated in USD)

 

Note 3 – SUMMARY OF Significant Accounting Policies, continued

 

Fair Values of Financial Instruments (continued)

 

Fair value is defined as an exit price, representing the amount that would be received upon the sale of an asset or payment to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows:

 

Level 1 - Quoted prices in active markets for identical assets or liabilities.

 

Level 2 - Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly.

 

Level 3 - Significant unobservable inputs that cannot be corroborated by market data and inputs that are derived principally from or corroborated by observable market data or correlation by other means.

 

The fair value of the Company’s financial instruments are as follows:

 

   Quoted Prices
in Active
Markets for
Identical
Assets or
Liabilities
(Level 1)
   Quoted Prices
for Similar
Assets or
Liabilities in
Active
Markets
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Marketable securities as of September 30, 2022  $928   $       -   $        - 
                
Marketable securities as of December 31, 2021  $2,120   $-   $- 

 

Stock-Based Compensation

 

The Company follows the FASB ASC 718, Compensation - Stock Compensation, which addresses the accounting for stock-based payment transactions, requiring such transactions to be accounted for using the fair value method. Awards of shares for property or services are recorded at the fair value of the stock or the fair value of the service, whichever is more readily measurable. The Company uses the Black-Scholes option-pricing model to determine the grant date fair value of stock-based awards under ASC 718. The fair value is charged to earnings depending on the terms and conditions of the award, and the nature of the relationship of the recipient of the award to the Company. The Company records the grant date fair value in line with the period over which it was earned. For employees and consultants, this is typically considered to be the vesting period of the award. The Company recognizes forfeitures at the time forfeitures occur.

 

8

 

 

WESTERN URANIUM & VANADIUM CORP. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Stated in USD)

 

Note 3 – SUMMARY OF Significant Accounting Policies, continued

 

Net Income (Loss) per Share

 

Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share are computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and warrants (using the treasury stock method). The following is a reconciliation of the numerator and denominator used to calculate basic earnings per share and diluted earnings per share for the three and nine months ended September 30, 2022 and 2021. The computation of net income (loss) per share for each of the three and nine months ended September 30, 2021 is the same for both basic and fully diluted.

 

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2022   2021   2022   2021 
Numerator:                
Net (loss) income  $(527,525)  $(830,493)  $578,422   $(1,596,717)
                     
Denominator:                    
Weighted average shares outstanding, basic   43,514,832    38,203,075    42,536,893    36,243,124 
                     
Dilutive effect of options and warrants   -    -    1,010,484    - 
                     
Weighted average shares outstanding, diluted   43,514,832    38,203,075    43,547,377    36,243,124 
                     
Net (loss) income per share, basic  $(0.01)  $(0.02)  $0.01   $(0.04)
                     
Net (loss) income per share, diluted  $(0.01)  $(0.02)  $0.01   $(0.04)

 

Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net income (loss) per share because the effect of their inclusion would have been anti-dilutive.

 

   For the Three Months
Ended September 30,
   For the Nine Months
Ended September 30,
 
   2022   2021   2022   2021 
Warrants to purchase common shares   9,362,076    10,715,873    2,970,826    10,715,873 
Options to purchase common shares   3,108,000    2,808,000    983,000    2,808,000 
Total potentially dilutive securities   12,470,076    13,523,873    3,953,826    13,523,873 

 

Recent Accounting Standards

 

Management does not believe that any recently issued, but not yet effective accounting standards, when adopted, will have a material effect on the accompanying condensed consolidated financial statements.

 

9

 

 

WESTERN URANIUM & VANADIUM CORP. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Stated in USD)

 

NOTE 4 – MINERAL ASSETS equipment, Kinetic separation INTELLECTUAL PROPERTY, AND OTHER PROPERTY 

 

The Company’s mining properties acquired on August 18, 2014 that the Company retains as of September 30, 2022 include: The San Rafael Uranium Project located in Emery County, Utah; The Sunday Mine Complex located in western San Miguel County, Colorado; The Van 4 Mine located in western Montrose County, Colorado; The Sage Mine located in San Juan County, Utah, and San Miguel County, Colorado. These mining properties include leased land in the states of Colorado and Utah. None of these mining properties were operational at the date of acquisition.

 

The Company’s mining properties acquired on September 16, 2015 that the Company retains as of September 30, 2022 include Hansen, North Hansen and Hansen Picnic Tree located in Fremont and Teller Counties, Colorado. The Company also acquired the Keota project located in Weld County, Colorado and the Ferris Haggerty project located in Carbon County Wyoming. These mining assets include both owned and leased land in the states of Utah, Colorado, and Wyoming. All of the mining assets represent properties which have previously been mined, to different degrees, for uranium.

 

As the Company has not formally established proven or probable reserves on any of its properties, there is inherent uncertainty as to whether or not any mineralized material can be economically extracted as originally planned and anticipated.

 

The Company’s mineral properties and equipment and kinetic separation intellectual property are:

 

   As of
September 30,
2022
   As of
December 31,
2021
 
Mineral properties and equipment  $12,656,075   $11,780,142 
Kinetic separation intellectual property  $9,488,051   $9,488,051 

 

Oil and Gas Lease and Easement

 

The Company entered into an oil and gas lease that became effective with respect to minerals and mineral rights owned by the Company of approximately 160 surface acres of the Company’s property in Colorado. As consideration for entering into the lease, the lessee has agreed to pay the Company a royalty from the lessee’s revenue attributed to oil and gas produced, saved, and sold attributable to the net mineral interest. The Company has also received cash payments from the lessee related to the easement that the Company is recognizing incrementally over the eight year term of the easement.

 

On June 23, 2020, the same entity, as discussed above, elected to extend the oil and gas lease easement for three additional years, commencing on the date the lease would have previously expired. During 2021, the operator completed all well development stages, and each of the eight (8) wells commenced oil and gas production by mid-August 2021. On January 31, 2022, the operator of the Weld County Colorado oil and gas pooled trust issued the first cumulative royalty payment check in the amount of $207,552 for August 2021 through December 2021 sales which was recognized as income in the fourth quarter of 2021. Royalty receipts were received monthly as earned during each of the months in 2022.

 

During the three months ended September 30, 2022 and 2021, the Company recognized aggregate revenue of $108,547 and $16,155, respectively, and for the nine months ended September 30, 2022 and 2021, the Company recognized aggregate revenue of $387,810 and $48,465, respectively, under these oil and gas lease arrangements.

 

10

 

 

WESTERN URANIUM & VANADIUM CORP. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Stated in USD)

 

NOTE 4 – MINERAL ASSETS equipment, Kinetic separation INTELLECTUAL PROPERTY, AND OTHER PROPERTY, CONTINUED

 

Reclamation Liabilities

 

The Company’s mines are subject to certain asset retirement obligations, which the Company has recorded as reclamation liabilities. The reclamation liabilities of the United States mines are subject to legal and regulatory requirements, and estimates of the costs of reclamation are reviewed periodically by the applicable regulatory authorities. The reclamation liability represents the Company’s best estimate of the present value of future reclamation costs in connection with the mineral properties. The Company determined the gross reclamation liabilities of the mineral properties to be $751,405 and $740,446 as of September 30, 2022 and December 31, 2021, respectively. On March 2, 2020, the Colorado Mined Land Reclamation Board (“MLRB”) issued an order vacating the Van 4 Temporary Cessation, terminating mining operations and ordering commencement of final reclamation. The Company has begun the reclamation of the Van 4 Mine. The reclamation cost is fully covered by the reclamation bonds posted upon acquisition of the property. The Company adjusted the fair value of its reclamation obligation for the Van 4 Mine. The portion of the reclamation liability related to the Van 4 Mine and its related restricted cash are included in current liabilities and current assets, respectively, at a value of $75,057. The Company expects to begin incurring the reclamation liability after 2054 for all mines that are not in reclamation and accordingly, has discounted the gross liabilities over their remaining lives using a discount rate of 5.4%. The net discounted aggregated values as of September 30, 2022 and December 31, 2021 were $297,510 and $271,620, respectively. The gross reclamation liabilities as of September 30, 2022 and December 31, 2021 are secured by financial warranties in the amount of $751,405 and $740,446, respectively.

 

Reclamation liability activity for the nine months ended September 30, 2022 and 2021 consists of:

 

   For the Nine Months Ended
September 30,
 
   2022   2021 
Beginning balance at January 1  $271,620   $309,940 
Accretion   25,890    8,652 
Discontinuation of reclamation liability   -    (2,669)
Ending Balance at September 30  $297,510   $315,923 

 

11

 

 

WESTERN URANIUM & VANADIUM CORP. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Stated in USD)

 

NOTE 4 – MINERAL ASSETS equipment, Kinetic separation INTELLECTUAL PROPERTY, AND OTHER PROPERTY, CONTINUED

 

Sunday Mine Complex Permitting Status

 

On February 4, 2020, the Colorado DRMS sent a Notice of Hearing to Declare Termination of Mining Operations related to the status of the mining permits issued by the state of Colorado for the Sunday Mine Complex. At issue was the application of an unchallenged Colorado Court of Appeals Opinion for a separate mine (Van 4) with very different facts that are retroactively modifying DRMS rules and regulations. The Company maintains that it was timely in meeting existing rules and regulations. The hearing was scheduled to be held during several monthly MLRB Board meetings, but this matter was delayed several times. The permit hearing was held during the MLRB Board monthly meeting on July 22, 2020. At issue was the status of the five existing permits which comprise the Sunday Mine Complex. Due to COVID-19 restrictions, the hearing took place utilizing a virtual-only format. The Company prevailed in a 3 to 1 decision which acknowledged that the work completed at the Sunday Mine Complex under DRMS oversight was timely and sufficient for Western to maintain these permits. In a subsequent July 30, 2020 letter, the DRMS notified the Company that the status of the five permits (Sunday, West Sunday, St. Jude, Carnation, and Topaz) had been changed to “Active” status effective June 10, 2019, the original date on which the change of the status was approved. On August 23, 2020, the Company initiated a request for Temporary Cessation status for the Sunday Mine Complex as the mines had not been restarted within a 180-day window due to the direct and indirect impacts of the COVID-19 pandemic. Accordingly, a permit hearing was scheduled for October 21, 2020 to determine Temporary Cessation status. In a unanimous vote, the MLRB approved Temporary Cessation status for each of the five Sunday Mine Complex permits (Sunday, West Sunday, St. Jude, Carnation, and Topaz). On October 9, 2020, the MLRB issued a board order which finalized the findings of the July 22, 2020 permit hearing. On November 10, 2020, the MLRB issued a board order which finalized the findings of the October 21, 2020 permit hearing. On November 6, 2020, the MLRB signed an order placing the five Sunday Mine Complex mine permits into Temporary Cessation. On November 12, 2020, a coalition of environmental groups (the “Plaintiffs”) filed a complaint against the MLRB seeking a partial appeal of the July 22, 2020 decision by requesting termination of the Topaz Mine permit. On December 15, 2020, the same coalition of environmental groups amended their complaint against the MLRB seeking a partial appeal of the October 21, 2020 decision requesting termination of the Topaz Mine permit. The Company has joined with the MLRB in defense of their July 22, 2020 and October 21, 2020 decisions. On May 5, 2021, the Plaintiffs in the Topaz Appeal filed an opening brief with the Denver District Court seeking to overturn the July 22, 2020 and October 21, 2020 MLRB permit hearing decisions on the Topaz Mine permit. The MLRB and the Company were to respond with an answer brief within 35 days on or before June 9, 2021, but instead sought a settlement. The judicial review process was delayed as extensions were put in place until August 20, 2021. A settlement was not reached, and the MLRB and the Company submitted answer briefs on August 20, 2021. The Plaintiff submitted a reply brief on September 10, 2021. On March 1, 2022, the Denver District Court reversed the MLRB’s orders regarding the Topaz Mine and remanded the case back to MLRB for further proceedings consistent with its order. The Company and the MLRB had until April 19, 2022 to appeal the Denver District Court’s ruling. Neither the Company nor the MLRB appealed the Denver District Court ruling. Western anticipates receiving an MLRB board order of reclamation for the Topaz Mine. The Company is continuing to work toward the completion of an updated Topaz Mine Plan of Operations which is a separate federal requirement of the BLM for the conduct of mining activities on the federal land at the Topaz Mine.

 

12

 

 

WESTERN URANIUM & VANADIUM CORP. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Stated in USD)

 

NOTE 4 –MINERAL ASSETS equipment, Kinetic separation INTELLECTUAL PROPERTY, AND OTHER PROPERTY, CONTINUED

 

Kinetic Separation Intellectual Property

 

The Kinetic Separation intellectual property was acquired in Western’s acquisition of Black Range on September 16, 2015. Previously Black Range acquired its Kinetic Separation assets in the dissolution of a joint venture on March 17, 2015, through the acquisition of all the assets of the joint venture and received a 25-year license to utilize all of the patented and unpatented technology owned by the joint venture. The technology license agreement for patents and unpatented technology became effective as of March 17, 2015, for a period of 25 years, until March 16, 2040. There are no remaining license fee obligations, and there are no future royalties due under the agreement. The Company has the right to sub-license the technology to third parties. The Company may not sell or assign the Kinetic Separation license; however, the license could be transferred in the case of a sale of the Company. The Company has developed improvements to Kinetic Separation during the term of the license agreement and retains ownership of, and may obtain patent protection on, any such improvements developed by the Company.

 

The Kinetic Separation patent was filed on September 13, 2012 and granted on February 14, 2014 by the United States Patent Office. The patent is effective for a period of 20 years until September 13, 2032. This patent is supported by two provisional patent applications. The provisional patent applications expired after one year but were incorporated in the U.S. Patent by reference and claimed benefit prior to their expirations. The status of the patent and two provisional patent applications has not changed subsequent to the 2014 patent grant. The Company has the continued right to use any patented portion of the Kinetic Separation technology that enters the public domain subsequent to the patent expiration.

 

The Company anticipates Kinetic Separation will improve the efficiency of the mining and processing of the sandstone-hosted ore from Western’s conventional mines through the separation of waste from mineral bearing-ore, potentially reducing transportation, mill processing, and mill tailings costs. Kinetic Separation is not currently in use or being applied at any Company mines. The Company views Kinetic Separation as a cost saving technology, which it will seek to incorporate into ore production subsequent to commencing scaled production levels. There are also alternative applications, which the Company has explored.

 

Mining Equipment Purchases

 

During the nine months ended September 30, 2022 and 2021, Western purchased $895,400 and $65,000, respectively, in mining equipment and vehicles.

 

NOTE 5 – Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities consisted of:

 

   As of 
   September 30,
2022
   December 31,
2021
 
Trade accounts payable  $353,386   $510,831 
Accrued liabilities   219,544    188,762 
Total accounts payable and accrued liabilities  $572,930   $699,593 

 

13

 

 

WESTERN URANIUM & VANADIUM CORP. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Stated in USD)

 

NOTE 6 – COMMITMENTS AND CONTINGENCIES

  

Supply Contract

  

In December 2015, the Company signed a uranium concentrates supply agreement with a major United States utility company for delivery commencing in 2018 and continuing for a five-year period through 2022. On March 8, 2021, the Company entered into an agreement with a third party to complete the Year 4 (2021) uranium concentrate delivery. The Company paid $78,000 in April 2021 to the assignee for which the assignee made the delivery in May 2021. In April 2022, in satisfaction of the Year 5 delivery under its supply contract, the Company delivered 125,000 lbs of uranium concentrate from its prepaid uranium concentrate inventory. Accordingly, during the three and nine months ended September 30, 2022, the Company recorded revenue of $0 and $7,223,609 (at a price of approximately $57 per pound), respectively, and cost of revenue of $0 and $4,044,083, respectively, related to the delivery of the uranium. In May 2022, the Company received the cash proceeds from this sale.

 

Strategic Acquisition of Physical Uranium

 

In May 2021, the Company executed a binding agreement to purchase 125,000 pounds of natural uranium concentrate at approximately $32 per pound. In December 2021, the Company paid $4,044,083, in connection with its full prepayment of the purchase price for 125,000 pounds of natural uranium concentrate. This uranium concentrate was subsequently delivered under the terms of the aforementioned uranium concentrates supply agreement in April 2022.

 

NOTE 7 – SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS

 

Authorized Capital

 

The holders of the Company’s common shares are entitled to one vote per share. Holders of common shares are entitled to ratably receive such dividends, if any, as may be declared by the board of directors, out of legally available funds. Upon the liquidation, dissolution, or winding down of the Company, holders of common shares are entitled to share ratably in all assets of the Company that are legally available for distribution. As of September 30, 2022 and December 31, 2021, an unlimited number of common shares were authorized for issuance.

 

Private Placements

 

On January 20, 2022, the Company closed a non-brokered private placement of 2,495,575 units at a price of CAD $1.60 per unit. The aggregate gross proceeds raised in the private placement amounted to CAD $3,992,920 (USD $3,011,878 in net proceeds). Each unit consisted of one common share of Western (a “Share”) plus one common share purchase warrant of Western (a “Warrant”). Each Warrant entitled the holder to purchase one Share at a price of CAD $2.50 per Share for a period of three years following the closing date of the private placement. A total of 2,495,575 Shares and 2,495,575 Warrants were issued to investors and 98,985 Warrants were issued to broker dealers in connection with the private placement.

 

Warrant Exercises

 

During the nine months ended September 30, 2022, an aggregate of 2,020,351 warrants were exercised for total gross proceeds of $2,620,395.

 

Incentive Stock Option Plan

 

The Company maintains an Incentive Stock Option Plan (the “Plan”) that permits the granting of stock options as incentive compensation. Shareholders of the Company approved the Plan on June 30, 2008 and amendments to the Plan on June 20, 2013. The board of directors approved additional changes to the Plan on September 12, 2015 and as of October 1, 2021.

 

14

 

 

WESTERN URANIUM & VANADIUM CORP. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Stated in USD)

 

NOTE 7 – SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS CONTINUED

 

The purpose of the Plan is to attract, retain, and motivate directors, management, staff, and consultants by providing them with the opportunity, through stock options, to acquire a proprietary interest in the Company and benefit from its growth.

 

The Plan provides that the aggregate number of common shares for which stock options may be granted will not exceed 10% of the issued and outstanding common shares at the time stock options are granted. As of September 30, 2022, a total of 43,588,742 common shares were outstanding, and at that date the maximum number of stock options eligible for issue under the Plan was 4,358,874.

 

Stock Options

 

On February 10, 2022, the Company granted options under the Plan for the purchase of an aggregate of 900,000 common shares to five individuals consisting of directors and officers of the Company. The options have a five year term, an exercise price of CAD $1.76 (US $1.28 as of September 30, 2022) and vest equally in thirds commencing initially on the date of grant and thereafter on April 1, 2022, and July 1, 2022.

 

The Company utilized the Black-Scholes option pricing model to determine the fair value of these stock options, using the assumptions as outlined below.

 

   February 10,
2022
 
Stock Price  CAD$1.76 
Exercise Price  CAD$1.76 
Number of Options Granted   900,000 
Dividend Yield   0%
Expected Volatility   103.3%
Weighted Average Risk-Free Interest Rate   1.61%
Expected life (in years)   2.6 

 

   Number of
Shares
   Weighted
Average
Exercise Price
   Weighted
Average
Contractual
Life (Years)
   Weighted
Average
Grant Date
Fair Value
   Intrinsic
Value
 
Outstanding – January 1, 2022   2,324,670   $1.35    1.67   $0.39   $528,714 
Granted   900,000    1.28    -    0.84      
Expired   (116,670)   1.81    -    0.27    - 
Outstanding – September 30, 2022   3,108,000   $1.24    2.15   $0.52   $408,063 
Exercisable – September 30, 2022   3,108,000   $1.24    2.15   $0.52   $408,063 

 

The Company’s stock-based compensation expense related to stock options for the three months ended September 30, 2022 and 2021 was $0 and $0, respectively, and for the nine months ended September 30, 2022 and 2021 stock-based compensation expense was $753,219 and $0, respectively, which is included in general and administrative expenses on the Company’s condensed consolidated statements of operations and comprehensive loss. As of September 30, 2022, there was no unamortized stock option expense.

 

Warrants

 

   Number of
Shares
   Weighted
Average
Exercise Price
   Weighted
Average
Contractual
Life (Years)
   Intrinsic
Value
 
Outstanding - January 1, 2022   9,735,948   $1.09    1.49    3,799,606 
Issued   2,594,560    1.81    -    - 
Exercised   (2,020,351)   1.19    -    - 
Expired/Forfeited   (948,081)   1.97    -    - 
Outstanding – September 30, 2022   9,362,076   $1.17    2.11   $2,673,679 
Exercisable – September 30, 2022   9,362,076   $1.17    2.11   $2,673,679 

 

15

 

 

WESTERN URANIUM & VANADIUM CORP. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Stated in USD)

 

Note 8 – Mining Expenditures

 

   For the Three Months Ended
September 30,
   For the Nine Months Ended
September 30,
 
   2022   2021   2022   2021 
Permits  $29,946   $32,639   $86,103   $106,426 
Mining costs   172,421    300,988    524,336    312,534 
Royalties   2,153    1,401    5,707    3,961 
Total mining expenses  $204,520   $335,028   $616,146   $422,921 

 

NOTE 9 – Related Party Transactions AND BALANCES

 

The Company has transacted with related parties pursuant to service arrangements in the ordinary course of business, as follows:

 

Prior to the acquisition of Black Range, Mr. George Glasier, the Company’s CEO, who is also a director (“Seller”), transferred his interest in a former joint venture with Ablation Technologies, LLC to Black Range. In connection with the transfer, Black Range issued 25 million shares of Black Range common stock to Seller and committed to pay AUD $500,000 (USD $321,600 as of September 30, 2022) to Seller within 60 days of the first commercial application of the kinetic separation technology. Western assumed this contingent payment obligation in connection with the acquisition of Black Range. At the date of the acquisition of Black Range, this contingent obligation was determined to be probable. Since the deferred contingent consideration obligation is probable and the amount is estimable, the Company recorded the deferred contingent consideration as an assumed liability in the amount of $321,600 and $362,794 as of September 30, 2022 and December 31, 2021, respectively.

 

The Company also owed Mr. Glasier reimbursable expenses in the amount of $54,000 and $65,753 as of September 30, 2022 and December 31, 2021, respectively.

 

Note 10 – COVID-19  

 

The world has been, and continues to be, impacted by the COVID-19 pandemic. COVID-19, and measures to prevent its spread, impacted our business in a number of ways. The impact of these disruptions and the extent of their adverse impact on the Company’s financial and operating results will be dictated by the length of time that such disruptions continue, which will, in turn, depend on the currently unpredictable duration and severity of the impacts of COVID-19, and among other things, the impact of governmental actions imposed in response to COVID-19 and individuals’ and companies’ risk tolerance regarding health matters going forward and developing strain mutations. To date, COVID-19 has primarily caused Western delays in reporting, regulatory matters, and operations. Most notably, the Company initiated a request for Temporary Cessation status for the Sunday Mine Complex in August 2020 as the mines had not been restarted within the 180-day window due to the direct and indirect impacts of the COVID-19 pandemic. The Van 4 Mine reclamation process was delayed because of COVID-19 pandemic lockdowns. The need to observe quarantine periods also caused a limited loss of manpower and delay to the 2021/2022 Sunday Mine Complex project. The COVID-19 pandemic has limited Western’s participation in industry and investor conference events. The Company is continuing to monitor COVID-19 and its subvariants and the potential impact of the pandemic on the Company’s operations.

 

Note 11 – subsequent events

 

On October 31, 2022, the Board of Directors granted an aggregate of 1,665,000 options for the purchase of the Company’s common stock to the Company’s officers, directors and employees. Each of these options was granted under the Plan and had an exercise price of CAD $1.60 (US $1.16 as of September 30, 2022). The options vest equally in two installments beginning on the date of grant and thereafter on April 30, 2023.

 

16

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Forward-Looking Statements

 

The information disclosed in this quarterly report, and the information incorporated by reference herein, include “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements include, but are not limited to, statements regarding our or our management’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.

 

The forward-looking statements contained or incorporated by reference in this quarterly report are based on our current expectations and beliefs concerning future developments and their potential effects on us and speak only as of the date of each such statement. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described in this Item 2 of Part I and Item 1A of Part II of this quarterly report. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

 

The following discussion should be read in conjunction with our condensed consolidated interim financial statements and footnotes thereto contained in this quarterly report.

 

Overview

 

General

 

Western Uranium & Vanadium Corp. (“Western” or the “Company”, formerly Western Uranium Corporation) was incorporated in December 2006 under the Ontario Business Corporations Act. On November 20, 2014, the Company completed a listing process on the Canadian Securities Exchange (“CSE”). As part of that process, the Company acquired 100% of the members’ interests of Pinon Ridge Mining LLC (“PRM”), a Delaware limited liability company. The transaction constituted a reverse takeover (“RTO”) of Western by PRM. Subsequent to obtaining appropriate shareholder approvals, the Company reconstituted its board of directors and senior management team. Effective September 16, 2015, Western completed its acquisition of Black Range Minerals Limited (“Black Range”).

 

On August 18, 2014, the Company closed on the purchase of certain mining properties in Colorado and Utah from Energy Fuels Holding Corp. Assets purchased included both owned and leased lands in Utah and Colorado, and all represent properties that have been previously mined for uranium to varying degrees in the past. The acquisition included the purchase of the Sunday Mine Complex. The Sunday Mine Complex is located in western San Miguel County, Colorado. The complex consists of the following five individual mines: the Sunday mine, the Carnation mine, the Saint Jude mine, the West Sunday mine and the Topaz Mine. The operation of each of these mines requires a separate permit, and all such permits have been obtained by Western. In addition, each of the mines has good access to a paved highway, electric power to existing declines, office/storage/shop and change buildings, and an extensive underground haulage development with several vent shafts complete with exhaust fans. The Sunday Mine Complex is the Company’s core resource property and in July 2021 status was changed to “Active” when mining operations were restarted.

 

On September 16, 2015, Western completed its acquisition of Black Range, an Australian company that was listed on the Australian Securities Exchange until the acquisition was completed. The acquisition terms were pursuant to a definitive Merger Implementation Agreement entered into between Western and Black Range. Pursuant to the agreement, Western acquired all of the issued shares of Black Range by way of Scheme of Arrangement (“the Scheme”) under the Australian Corporation Act 2001 (Cth) (the “Black Range Transaction”), with Black Range shareholders being issued common shares of Western on a 1 for 750 basis. On August 25, 2015, the Scheme was approved by the shareholders of Black Range, and on September 4, 2015, Black Range received approval by the Federal Court of Australia. In addition, Western issued options to purchase Western common shares to certain employees, directors, and consultants. Such stock options were intended to replace Black Range stock options outstanding prior to the Black Range Transaction on the same 1 for 750 basis.

 

The Company has registered offices at 330 Bay Street, Suite 1400, Toronto, Ontario, Canada, M5H 2S8, and its common shares are listed on the CSE under the symbol “WUC” and are traded on the OTCQX Best Market under the symbol “WSTRF”. Its principal business activity is the acquisition and development of uranium and vanadium resource properties in the states of Utah and Colorado in the United States of America (“United States”).

 

17

 

 

Recent Developments

 

Sunday Mine Complex Project 2021/2022/2023

 

The SMC project entailed the development of multiple SMC ore bodies and involves a shift in the base of operations from the St. Jude Mine (2019) to the Sunday Mine (2021). Underground development began in August 2021 following mine ventilation, power upgrades, and increasing explosive capabilities. The first target was the extension of the drift (tunnel) 150 feet to reach the first surface exploration drill hole to access the GMG Ore Body (GMG). Early results were positive as drilling toward the GMG resulted in the location of ore-grade material within thirty feet of the existing mine workings. Notably, only limited exploration drilling has been done in this area due to the mountainous terrain on the surface above. As drifting proceeded, very high-grade ore continued to be intersected through the drift path and on both sides of the drift. As a result, the team shifted from development to mining. From December 2021 to March 2022, over 3,000 tons of high-grade uranium/vanadium ore was mined from the drift based upon on site scintillometer readings. At the end of March 2022, the mining contractor engaged by Western decided to retire from contract mining operations. As a result, Western scaled back operations to focus on building an in-house mining capability.

 

Subsequently, the Company has completed the build-out of its in-house mining capability.

 

Over $1,000,000 was spent on the acquisition, upgrading, and maintenance of a fleet of used/new mining equipment and vehicles. Additional employees have been hired for the first mining team and facilities have been upgraded. This first in-house mining team has been fully outfitted and readied for deployment. The initial project will focus on additional development of the GMG Ore body. This will involve ore production and stockpiling of high-grade ore and underground drilling /exploration to define additional production zones. The next project will be similar in scope and focus on the St. Jude Mine target areas defined during the 2019/2020 work project. Mining operations are targeted to restart in January 2023.

 

January 2022 Private Placement

 

On January 20, 2022, the Company closed on a non-brokered private placement of 2,495,575 units at a price of CAD $1.60 per unit. The aggregate gross proceeds raised in the private placement amounted to CAD $3,992,920. Each unit consisted of one common share of Western plus one common share purchase warrant of Western. Each warrant entitled the holder to purchase one common share at a price of CAD $2.50 per share for a period of three years following the closing date of the private placement. A total of 2,495,575 common shares and 2,495,575 warrants were issued to investors, and 98,985 warrants were issued to broker dealers in connection with the private placement.

 

Strategic Acquisition of Physical Uranium

 

In May 2021, the Company executed a binding agreement to purchase 125,000 pounds of natural uranium concentrate at approximately $32 per pound. In December 2021, the Company paid $4,044,083 in connection with its full prepayment of the purchase price for 125,000 pounds of natural uranium concentrate. This uranium concentrate was subsequently delivered and sold under the terms of the uranium supply agreement in the second quarter of 2022.

 

Uranium Supply Agreement Delivery

 

In the second quarter of 2022, in satisfaction of the Year 5 delivery under our supply contract, we delivered and sold 125,000 lbs of uranium concentrate from our prepaid uranium concentrate inventory. Accordingly, during the nine months ended September 30, 2022, we recorded revenue of $7,223,609 (at a price of approximately $57 per pound) and cost of revenue of $4,044,083 related to this uranium delivery.

 

Bullen Property (Weld County)

 

The Bullen Property is an oil and gas property located in Weld County Colorado. The Company acquired this non-core property in 2015 in the Black Range Minerals Limited acquisition, and Black Range purchased the property in 2008 for its Keota Uranium Project.

 

18

 

 

In 2017, the Company signed a three year oil and gas lease which in 2020 was extended for an additional three year term or until the end of continuous operations. The consideration was in the form of upfront bonus payments and a backend 3/16th production royalty payment. Additional right-of-way easement agreements were signed which allowed for the development of a pipeline. The lease agreement allows the Company to retain property rights to vanadium, uranium, and other mineral resources.

 

A 2019 lawsuit was filed in the Weld County District Court over the original Bullen Property deed language which was negotiated before the Company acquired Black Range by prior management and a bank representing the estate of the property owner. The Company settled with the plaintiffs by awarding the estate’s beneficiaries a non-participating royalty interest of 1/8th for all hydrocarbon and non-hydrocarbon substances that are produced and sold from the property.

 

In early 2020, the operator filed an application with the Colorado Oil & Gas Conservation Commission (“COGCC”) to update the permit to create a new pooled unit. Subsequently, during 2021, the operator advanced through the oil well production stages: drilling was completed in the first quarter, wellfield completion/fracking was completed during the second quarter, drill out was completed in July, and flowback was completed in August. By August 2021, each of the eight (8) wells had commenced oil and gas production. The first royalty payment was made in January 2022 and monthly royalty payments have been received subsequently.

 

Due to the success of the first 8 wells which were developed in 2021, the operator decided to develop a second set of 8 wells within Western’s royalty area during 2022. The 2022 well installation was on a timeline which ran slightly behind the 2021 wells. However, by August 2022, each of the eight (8) new wells had come online; September 2022 was the new well pad’s first full month of production. The first royalty payment will be made in the first quarter of 2023.

  

During the three months ended September 30, 2022 and 2021, we recognized aggregate revenue of $108,547 and $16,155, respectively, and for the nine months ended September 30, 2022 and 2021, we recognized aggregate revenue of $387,810 and $48,465, respectively, under these oil and gas lease arrangements. On January 31, 2022, the operator of the Weld County Colorado oil and gas pooled trust issued the first cumulative royalty payment in the amount of $207,552 for August 2021 through December 2021 sales, which was recognized as income in the fourth quarter of 2021.

 

19

 

 

Sunday Mine Complex Permitting Status

 

On February 4, 2020, the Colorado DRMS sent a Notice of Hearing to Declare Termination of Mining Operations related to the status of the mining permits issued by the state of Colorado for the Sunday Mine Complex. At issue was the application of an unchallenged Colorado Court of Appeals Opinion for a separate mine (Van 4) with very different facts that are retroactively modifying DRMS rules and regulations. The Company maintains that it was timely in meeting existing rules and regulations. The hearing was scheduled to be held during several monthly MLRB Board meetings, but this matter was delayed several times. The permit hearing was held during the MLRB Board monthly meeting on July 22, 2020. At issue was the status of the five existing permits which comprise the Sunday Mine Complex. Due to COVID-19 restrictions, the hearing took place utilizing a virtual-only format. The Company prevailed in a 3-to-1 decision which acknowledged that the work completed at the Sunday Mine Complex under DRMS oversight was timely and sufficient for Western to maintain these permits. In a subsequent July 30, 2020 letter, the DRMS notified the Company that the status of the five permits (Sunday, West Sunday, St. Jude, Carnation, and Topaz) had been changed to “Active” status effective June 10, 2019, the original date on which the change of the status was approved. On August 23, 2020, the Company initiated a request for Temporary Cessation status for the Sunday Mine Complex as the mines had not been restarted within a 180-day window due to the direct and indirect impacts of the COVID-19 pandemic. Accordingly, a permit hearing was scheduled for October 21, 2020 to determine Temporary Cessation status. In a unanimous vote, the MLRB approved Temporary Cessation status for each of the five Sunday Mine Complex permits (Sunday, West Sunday, St. Jude, Carnation, and Topaz). On October 9, 2020, the MLRB issued a board order which finalized the findings of the July 22, 2020 permit hearing. On November 12, 2020, a coalition of environmental groups filed a lawsuit against the MLRB seeking a partial appeal of the July 22, 2020 decision by requesting termination of the Topaz mine permit. On December 15, 2020, the same coalition of environmental groups amended their complaint against the MLRB seeking a partial appeal of the October 21, 2020 decision requesting termination of the Topaz mine permit. The Company has joined with the MLRB in defense of their July 22, 2020 and October 21, 2020 decisions. On May 5, 2021, the Plaintiff in the Topaz Appeal filed an opening brief with the Denver District Court seeking to overturn the July 22, 2020 and October 21, 2020 MLRB permit hearing decisions on the Topaz mine permit. The MLRB and the Company were to respond with an answer brief within 35 days on or before June 9, 2021, but instead sought a settlement. The judicial review process was delayed as extensions were put in place until August 20, 2021. A settlement was not reached and the MLRB and the Company submitted answer briefs on August 20, 2021. The Plaintiff submitted a reply brief on September 10, 2021. On March 1, 2022, the Denver District Court reversed the MLRB’s orders regarding the Topaz Mine and remanded the case back to MLRB for further proceedings consistent with its order. The Company and the MLRB had until April 19, 2022 to appeal the Denver District Court’s ruling. Neither the Company nor the MLRB appealed the Denver District Court ruling. Western anticipates receiving an MLRB board order of reclamation for the Topaz Mine. The Company is continuing to work toward the completion of an updated Topaz Mine Plan of Operations which is a separate federal requirement of the BLM for the conduct of mining activities on the federal land at the Topaz Mine.

 

Kinetic Separation Licensing

 

During 2016, the Company submitted documentation to the Colorado Department of Public Health and Environment (“CDPHE”) for a determination ruling regarding the type of license which may be required for the application of Kinetic Separation at the Sunday Mine Complex within the state of Colorado. During May and June of 2016, CDPHE held four public meetings in several cities in Colorado as part of the process. On July 22, 2016, CDPHE closed the comment period. In connection with this matter, the CDPHE consulted with the NRC. In response, the CDPHE received an advisory opinion, dated October 16, 2016, which did not contain support for the NRC’s opinion and with which the Company’s regulatory counsel does not agree. NRC’s advisory opinion recommended that Kinetic Separation should be regulated as a milling operation but did recognize that there may be exemptions to certain milling regulatory requirements because of the benign nature of the non-uranium bearing sands produced after Kinetic Separation is completed on uranium-bearing ores. On December 1, 2016, the CDPHE issued a determination that the proposed Kinetic Separation operations at the Sunday Mine Complex must be regulated by the CDPHE through a milling license. Beginning in 2017, the Company’s regulatory counsel prepared significant documentation in preparation for a prospective submission. On September 13, 2019, the Company’s regulatory counsel submitted a white paper to the NRC entitled “Recommendations on the Proper Legal and Policy Interpretation for Using Kinetic Separation Processes at Uranium Mine Sites.” On July 24, 2020, the NRC staff responded with a letter in support of the original conclusion. Western’s regulatory counsel has proposed alternatives. However, management has decided not to proceed at this time, given its present opportunity set.

 

20

 

 

Uranium Section 232 Investigation/Nuclear Fuel Working Group Process

 

An investigation under Section 232 of the Trade Expansion Act of 1962 was undertaken by the Department of Commerce in 2018 to assess the impact to national security of the importation of uranium utilized by civilian nuclear reactors within the United States. In response to the Section 232 report, the Trump White House formed the Nuclear Fuel Working Group (“NFWG”) to find solutions for reviving and expanding domestic nuclear fuel production and reinvigorating recommendations. In April 2020, the U.S. Department of Energy (DoE) released the NFWG report entitled “Restoring America’s Competitive Nuclear Energy Advantage – A strategy to assure U.S. national security.” The report outlines a strategy for the reestablishment of critical capabilities and direct support to the front end of the U.S. domestic nuclear fuel cycle. In July 2021, the uranium Section 232 report was publicly released. The report concluded that uranium imports were “weakening our internal economy” and “threaten to impair the national security” and recommended immediate actions to “enable U.S. producers to recapture and sustain a market share of U.S. uranium consumption”. A number of the initiatives have been subsequently implemented. Most recently, in December 2020, U.S. Congress passed the “COVID-Relief and Omnibus Spending Bill,” which included $75 million for the establishment of a strategic U.S. Uranium Reserve. In June 2022, the DoE released program guidelines to initiate purchases of $75 million of domestic uranium inventory which is already in storage at the Honeywell Metropolis Works uranium conversion facility in Illinois USA. RFP submissions were due by August 1, 2022, and awards were expected to be announced within 60 days, but have been delayed several times and not yet been made public. Western did not hold any qualifying inventory, so the Company didn’t submit an RFP.

 

Most notably the results of the Section 232 and NFWG processes provided an advance warning as to the national security risks of nuclear fuel cycle dependency upon Russia and its former Soviet republics. With Russia’s invasion of Ukraine, the actual risk level is now understood to be of a greater magnitude than reported. Further, the cumulative market distortions of competing against state-sponsored entities for decades has caused countries across the world to seek government remedies to level the playing field. Any actions taken to remove pricing distortions from uranium markets are a positive outcome for U.S. uranium miners.

 

 Vanadium Section 232 Investigation

 

In the United States, a petition for an investigation under Section 232 of the Trade Expansion Act of 1962 was requested by two domestic companies in November 2019. In June of 2020, the U.S. Secretary of Commerce, Wilbur Ross, initiated an investigation into whether the present quantities or circumstances of vanadium imports into the United States threaten to impair the national security. The Section 232 National Security Investigation of Imports of Vanadium was concluded, and a report was submitted to President Biden in February 2021. In July 2021, the report was made public. It concluded that vanadium imports “do not threaten to impair the national security as defined in Section 232,” but identified and recommended “several actions that would help to ensure reliable domestic sources of vanadium and lessen the potential for imports to threaten national security.” No action has been taken on these recommendations.

 

Biden-Harris Administration Initiatives

 

The positive momentum has continued for the nuclear and uranium mining sector due to the Biden-Harris Administration’s emphasis on climate change. Upon taking office, the Biden team immediately rejoined the Paris Agreement and continued its pursuit of campaign promises of investments in clean energy, creating jobs, producing clean electric power, and achieving carbon-free energy in electricity generation by 2035. Since taking office, President Biden has given all agencies climate change initiatives. The existing U.S. nuclear reactor fleet currently produces in excess of 50% of U.S. clean energy, and new, advanced nuclear technologies promise to generate additional clean energy. In an acknowledgement of the future growth potential of new nuclear technologies, the Biden-Harris Administration has increased U.S. government support of the industry to a level not seen in decades.

 

21

 

 

On August 16, 2022, President Biden signed into law the Inflation Reduction Act which provisions for $369 billion in climate and energy investments, a portion of which will significantly benefit the U.S. domestic nuclear industry. Notably, while protecting the climate, there is a leveling of the playing field with renewable energy which has long benefited from government support. We see the benefits to nuclear split across existing reactors, new advanced reactors, low enriched uranium and high-assay low enriched uranium nuclear fuels, and in multiple stages of the domestic nuclear fuel cycle. We believe that each of these benefits increase future aggregate demand for uranium.

 

The Harris-Biden Administration continues to prioritize climate change initiatives both in the United States and abroad. President Biden attended both the (COP26) and (COP27) United Nations Climate Change Conferences. At the most recent conference, Special Presidential Envoy for Climate John Kerry, proposed a new initiative for the U.S. to assist and accelerate a European transition from coal plants to SMRs. This program is ongoing as the Department of Energy is already advancing this initiative.

 

Financial Buyers of Uranium - Sprott Physical Uranium Trust and ANU Energy OEIC Ltd.

 

The Sprott Physical Uranium Trust (U.UN) (the “Trust”) took over the former Uranium Participation Corp. (U.TO) and launched an at-the-market program (ATM) on August 17, 2021 to raise capital for the closed-ended trust. Since the inception of the ATM program, the Trust has acquired significant quantities of uranium causing spot prices to increase. In the one year since the Trust initiated its ATM program in August 2021 it has purchased ~40 million pounds of uranium and grown the net asset value to ~ $3 billion.

 

Due to Sprott’s success a clone physical uranium fund was launched on May 2022. The ANU Energy OEIC Ltd fund raised over $75 million dollars in a private placement and has made its first uranium purchase. Kazatomprom, the world’s largest producer of uranium is a strategic investor and uranium supplier to ANU Energy. Subsequently, the fund announced that it was contemplating a $500 million IPO in 4Q2022 or 1Q2023.

 

These dedicated investment vehicles highlight the increasing impact of financial buyers on uranium markets. Physical uranium purchases by financial buyers are depleting material from the spot market and sequestering it away from utility buyers. This has forced a market tightening as inventory levels of the most mobile inventory have been significantly depleted, initiating a new round of long-term contracting by utilities.

 

Russia’s Invasion of Ukraine

 

In February, Russia invaded Ukraine commencing a war between the two countries. Russia is a major global energy supplier and both countries are top ten uranium producers, and Russia is a global leader in nuclear fuel services. On the day prior to the invasion, the spot price of uranium was less than $44/lbs and it increased to a decade high peak of over $63/lbs, before subsequently settling around the $50/lbs spot price level.

 

Russia’s invasion of Ukraine has called into question its role and future participation in the nuclear fuel cycle. However as of today, Rosatom, Russia’s national nuclear company has avoided sanctions due to dependencies that have been built-up in the industry over decades. However, a desire to stay away from bad actors and the threat of Russia weaponizing energy exports has elicited responses. Worldwide, utilities have accelerated their contracting of non-Russian conversion and enrichment services. New uranium supply agreements are being signed with Western producers. In the U.S., legislative and agency solutions are moving forward. This year multiple new nuclear funding programs have already been put in place and the language from the DoE has only gotten stronger. The Secretary of Energy recently declared: “The United States wants to be able to source its own fuel from ourselves and that’s why we are developing a uranium strategy.” It has become clear that the DoE is committed to creating nuclear fuel solutions to address the current dependence and promote a geopolitical realignment of the nuclear fuel cycle away from Russia.

 

As a result of these new realities, the U.S. Congress is considering both sanctions and multiple pieces of legislation focusing on prohibiting the importation of Russian uranium and nuclear fuel and supporting U.S. domestic miners and the U.S. nuclear fuel cycle. Most recently, in a show of bipartisan support, Senators Barrasso, Manchin and Risch merged their competing legislation, which has been positioned for post-election deliberations.

 

There remains a possibility that Russia might reverse-sanction the United States and not make nuclear fuel deliveries. Weaponizing of energy is a tactic that is already being deployed in the Russia/Ukraine war and is increasingly becoming a matter of concern from countries that utilize Russian energy. As the U.S. has the largest fleet of nuclear reactors, any action affecting this market will have the potential to cause a realignment of global uranium markets.

  

Nuclear Fuel and Uranium Markets

 

Western currently is observing positive catalysts across multiple levels of the nuclear fuel and uranium markets. At a micro-level the projected supply / demand imbalance is expanding. Demand is increasing with new reactors being built, next generation reactors being advanced, operating reactor life extensions, restarts of idle reactors, and nuclear phase-out plans being reversed. There are multiple data points pointing to a depletion of the secondary supply overhang, which was prevalent for the last decade. At a macro-level, the electrification transition and climate change initiatives have increased global support for nuclear. Further, Russia’s invasion of Ukraine and the ensuing global energy crisis has focused attention on security of supply and supply chain risks. As a result, Western continues to advance our operational strategy in anticipation of increasing uranium price levels which will reward the ability to quickly scale-up ore production.

 

22

 

  

COVID-19

 

The world has been, and continues to be, impacted by the novel coronavirus (“COVID-19”) pandemic. COVID-19, and measures to prevent its spread, impacted our business in a number of ways. The impact of these disruptions and the extent of their adverse impact on the Company’s financial and operating results will be dictated by the length of time that such disruptions continue, which will, in turn, depend on the currently unpredictable duration and severity of the impacts of COVID-19, and among other things, the impact of governmental actions imposed in response to COVID-19 and individuals’ and companies’ risk tolerance regarding health matters going forward and developing strain mutations. To date, COVID-19 has primarily caused Western delays in reporting, regulatory matters, and operations. Most notably, the Company initiated a request for Temporary Cessation status for the Sunday Mine Complex in August 2020 as the mines had not been restarted within the 180-day window due to the direct and indirect impacts of the COVID-19 pandemic. The Van 4 Mine reclamation process was delayed because of COVID-19 pandemic lockdowns. The need to observe quarantine periods also caused a limited loss of manpower and delay to the 2021 / 2022 Sunday Mine Complex project. The COVID-19 pandemic has limited Western’s participation in industry and investor conference events. The Company is continuing to monitor COVID-19 and its subvariants, and the potential impact of the pandemic on the Company’s operations.

 

Results of Operations

 

   For the Three Months Ended
September 30,
   For the Nine Months Ended
September 30,
 
   2022   2021   2022   2021 
Revenue  $108,547   $16,155   $7,611,419   $48,465 
Cost of revenues   -    -    4,044,083    - 
Gross profit   108,547    16,155    3,567,336    48,465 
                     
Expenses                    
Mining expenditures   204,520    335,028    616,146    422,921 
Professional fees   97,077    136,174    445,596    287,042 
General and administrative   351,928    361,301    1,870,747    835,281 
Consulting fees   18,346    12,801    78,165    16,810 
Total operating expenses   671,871    845,304    3,010,654    1,562,054 
                     
Operating profit/(loss)   (563,324)   (829,149)   556,682    (1,513,589)
                     
Interest expense, net   (35,799)   1,344    (17,740)   4,687 
Other (income)/expense   -    -    (4,000)   - 
Settlement expense   -    -    -    78,441 
                     
Net income/(loss)   (527,525)   (830,493)   578,422    (1,596,717)
                     
Other Comprehensive income/(loss)                    
Foreign exchange gain/(loss)   (148,365)   (46,363)   (312,492)   23,531 
                     
Comprehensive income/(loss)  $(675,890)  $(876,856)  $265,930   $(1,573,186)

 

Three Months Ended September 30, 2022 as Compared to the Three Months Ended September 30, 2021

 

Summary:

 

Our consolidated net loss for the three months ended September 30, 2022 and 2021 was $527,525 or $0.01 per share and $830,493 or $0.02 per share, respectively. The principal components of these year over year changes are discussed below.

 

Our comprehensive loss for the three months ended September 30, 2022 and 2021 was $675,890 and $876,856, respectively.

 

23

 

 

Revenue

 

Our revenue for the three months ended September 30, 2022 and 2021 was $108,547 and $16,155, respectively. The increase in revenue of $92,392 was primarily related to oil and gas royalties that were paid each month during the current quarter; payment of production royalties had not yet commenced in the corresponding quarter in the prior year.

 

Mining Expenditures

 

Mining expenditures for the three months ended September 30, 2022 were $204,520 as compared to $335,028 for the three months ended September 30, 2021. The decrease in mining expenditures of $130,508, or 39% was principally attributable to a reduction in mining operations during the current quarter while focusing on building an in-house mining capability; there were active mining operations during the full corresponding quarter in the prior year.

 

Professional Fees

 

Professional fees for the three months ended September 30, 2022 were $97,077 as compared to $136,174 for the three months ended September 30, 2021. The decrease in professional fees of $39,097 or 29% was primarily due to a decrease in legal fees as Securities and Exchange Commission share registration expenditures were concentrated in the prior period.

 

General and Administrative

 

General and administrative expenses for the three months ended September 30, 2022 were $351,928 as compared to $361,301 for the three months ended September 30, 2021. The decrease in general and administrative expense of $9,373 or 3% is primarily due to a $14,198 decrease in utility bills due to limited mining operations in the current quarter versus full mining operations during the corresponding quarter in the prior period.

 

Consulting Fees

 

Consulting fees for the three months ended September 30, 2022 were $18,346 as compared to $12,801 for the three months ended September 30, 2021. The increase in consulting fees of $5,545 or 43% was principally due to our reduced utilization of consultants during 2021 due to COVID-19.

 

Accretion and Interest

 

Accretion and interest for the three months ended September 30, 2022 produced income of $35,799 as compared to expense of $1,344 for the three months ended September 30, 2021. Due to increased capital balances, the Company was afforded access to a cash program paying higher interest rates which benefitted from both higher market interest rates and larger cash balances.

 

Foreign Exchange

 

Foreign exchange loss for the three months ended September 30, 2022 was $148,365 as compared to a loss of $46,363 for the three months ended September 30, 2021. The foreign exchange loss is primarily due to the strengthening of the U.S. dollar relative to the Canadian dollar.

 

24

 

 

Nine Months Ended September 30, 2022 as Compared to the Nine Months Ended September 30, 2021

 

Summary:

 

Our consolidated net income for the nine months ended September 30, 2022 was $578,422 or $0.01 per share and consolidated net loss was $1,596,717 or $0.04 per share for the nine months ended September 30, 2021. The principal components of these year over year changes are discussed below.

 

Our comprehensive income for the nine months ended September 30, 2022 was $265,930 and comprehensive loss was $1,573,186 for the nine months ended September 30, 2021.

 

Revenue

 

Our revenue for the nine months ended September 30, 2022 and 2021 was $7,611,419 and $48,465, respectively. The increase in revenue of $7,562,954 was primarily related to the revenue recognized upon the satisfaction of the uranium concentrate delivery under our supply contract whereby we delivered 125,000 lbs of uranium concentrate from our prepaid uranium concentrate inventory. Further, oil and gas royalties were recognized during every month during 2022, but $0 of oil and gas royalties and $48,465 of lease revenue were recognized during the corresponding nine-month period in the prior year.

 

Cost of Revenue

 

Cost of revenue was $4,044,083 for the nine months ended September 30, 2022 as compared to $0 for the nine months ended September 30, 2021. This increase was a result of recording the cost of the uranium concentrate that was sold and delivered during the second quarter of 2022.

 

Mining Expenditures

 

Mining expenditures for the nine months ended September 30, 2022 were $616,146 as compared to $422,921 for the nine months ended September 30, 2021. The increase in mining expenditures of $193,225, or 46% was principally attributable to increases in the utilization of contract labor, hydrology expenditures, and mining costs. The Company’s Sunday Mine Complex was active more months during the current period versus the prior period and costs of building an in-house mining capability were concentrated in the second and third quarters.

 

Professional Fees

 

Professional fees for the nine months ended September 30, 2022 were $445,596 as compared to $287,042 for the nine months ended September 30, 2021. The increase in professional fees of $158,554 or 55% was primarily due to an increase in legal expenditures and the reduced utilization of consultants during the prior year period due to COVID-19.

 

General and Administrative

 

General and administrative expenses for the nine months ended September 30, 2022 were $1,870,747 as compared to $835,281 for the nine months ended September 30, 2021. The increase in general and administrative expense of $1,035,446, or 124% is primarily due to a $744,327 increase in stock-based compensation expense as the 2021 stock option awards were granted and vested entirely during 2022. There was also a $122,036 increase in payroll expenses due to an increase in staff and compensation. Investor relations expenditures increased by $37,190 as investor initiatives were re-initiated in 2022.

 

25

 

 

Consulting Fees

 

Consulting fees for the nine months ended September 30, 2022 were $78,165 as compared to $16,810 for the nine months ended September 30, 2021. The increase in consulting fees of $61,355 was principally due to our reduced utilization of consultants during 2021 due to COVID-19.

 

Accretion and Interest

 

Accretion and interest for the nine months ended September 30, 2022 produced income of $17,740 as compared to expense of $4,687 for the nine months ended September 30, 2021. Due to increased capital balances, the Company was afforded access to a cash program paying higher interest rates which benefitted from both higher market interest rates and larger cash balances.

 

Foreign Exchange

 

Foreign exchange loss for the nine months ended September 30, 2022 was $312,492 as compared to a gain of $23,531 for the nine months ended September 30, 2021. The foreign exchange loss is primarily due to the strengthening of the U.S. dollar relative to the Canadian dollar.

 

Liquidity and Capital Resources

 

The Company’s cash and restricted cash balance as of September 30, 2022 was $11,220,194. The Company’s cash position is highly dependent on its ability to raise capital through the issuance of debt and equity and its management of expenditures for mining development and for fulfillment of its public company reporting responsibilities. Management believes that in order to finance the development of the mining properties and Kinetic Separation, the Company will be required to raise additional capital by way of debt and/or equity. Western could potentially require additional capital if the scope of Company’s projects expands. This outlook is based on the Company’s current financial position and is subject to change if opportunities become available based on current exploration program results and/or external opportunities.

 

Net cash provided by (used in) operating activities

 

Net cash provided by operating activities was $5,174,546 for the nine months ended September 30, 2022, as compared with $1,576,627 used in operating activities for the nine months ended September 30, 2021. Of the $5,174,546 in net cash provided by operating activities for the nine months ended September 30, 2022, $578,422 is derived from our net income before non-cash adjustments. After non-cash adjustments the cash income increased to $1,378,191. Changes in our operating assets and liabilities for the period primarily includes a $4,085,723 decrease in prepaid uranium concentrate inventory and a decrease of $146,177 in subscription payable.

 

Net cash used in investing activities

 

Net cash used in investing activities was $895,400 for the nine months ended September 30, 2022, as compared with $65,000 for the nine months ended September 30, 2021. This net cash used consists of purchases of equipment and vehicles to build Western’s in-house mining capability.

 

Net cash provided by financing activities

 

Net cash provided by financing activities for the nine months ended September 30, 2022 and 2021 were $5,632,273 and $5,519,337, respectively. During the nine months ended September 30, 2022 we completed a private placement representing aggregate net proceeds of $3,011,878 and received $2,620,395 from the exercise of warrants.

 

26

 

 

Reclamation Liability

 

The Company’s mines are subject to certain asset retirement obligations, which the Company has recorded as reclamation liabilities. The reclamation liabilities of the United States mines are subject to legal and regulatory requirements, and estimates of the costs of reclamation are reviewed periodically by the applicable regulatory authorities. The reclamation liability represents the Company’s best estimate of the present value of future reclamation costs in connection with the mineral properties. The Company determined the gross reclamation liabilities of the mineral properties to be $751,405 and $740,446 as of September 30, 2022 and December 31, 2021, respectively. The Company expects to begin incurring the reclamation liability after 2054 for all mines that are not in reclamation and accordingly, has discounted the gross liabilities over their remaining lives using a discount rate of 5.4%. The net discounted aggregated values as of September 30, 2022 and December 31, 2021 were $297,510 and $271,620, respectively. The gross reclamation liabilities as of September 30, 2022 and December 31, 2021 are secured by financial warranties in the amount of $751,405 and $740,446, respectively.

 

On March 2, 2020, the Colorado Mined Land Reclamation Board (“MLRB”) issued an order vacating the Van 4 Temporary Cessation, terminating mining operations and ordering commencement of final reclamation. The Company has begun the reclamation of the Van 4 Mine. The reclamation cost is fully covered by the reclamation bonds posted upon acquisition of the property. The Company adjusted the fair value of its reclamation obligation for the Van 4 Mine. Reclamation at the Van 4 Mine has continued using company employees and equipment. The headframe and ore bins have been dissembled and placed into storage. This phase followed building removal; hence cement pads are the only structures remaining onsite. The portion of the reclamation liability related to the Van 4 Mine and its related restricted cash are included in current liabilities and current assets, respectively, at a value of $75,057.

 

Oil and Gas Lease and Easement

 

The Company entered into an oil and gas lease that became effective with respect to minerals and mineral rights owned by the Company of approximately 160 surface acres of the Company’s property in Colorado. As consideration for entering into the lease, the lessee has agreed to pay the Company a royalty from the lessee’s revenue attributed to oil and gas produced, saved, and sold attributable to the net mineral interest. The Company has also received cash payments from the lessee related to the easement that the Company is recognizing incrementally over the eight year term of the easement.

 

On June 23, 2020, the same entity as discussed above elected to extend the oil and gas lease easement for three additional years, commencing on the date the lease would have previously expired. During 2021, the operator completed all well development stages and each of the eight (8) Blue Teal Fed wells commenced oil and gas production by mid-August 2021.

 

During the three months ended September 30, 2022 and 2021, the Company recognized aggregate revenue of $108,547 and $16,155, respectively, and for the nine months ended September 30, 2022 and 2021, the Company recognized aggregate revenue of $387,810 and $48,465, respectively, under these oil and gas lease arrangements. On January 31, 2022, the operator of the Weld County Colorado oil and gas pooled trust issued the first cumulative royalty payment check in the amount of $207,552 for August 2021 through December 2021 sales which was recognized as income in the fourth quarter of 2021. Subsequently, in 2022, monthly royalty checks were received for sales during each of the months in the first quarter.

 

27

 

 

Related Party Transactions

 

The Company has transacted with related parties pursuant to service arrangements in the ordinary course of business, as follows:

 

Prior to the acquisition of Black Range, Mr. George Glasier, the Company’s CEO, who is also a director of the Company (“Seller”), transferred his interest in a former joint venture with Ablation Technologies, LLC to Black Range. In connection with the transfer, Black Range issued 25 million shares of Black Range common stock to Seller and committed to pay AUD $500,000 (USD $321,600 as of September 30, 2022) to Seller within 60 days of the first commercial application of the Kinetic Separation technology. Western assumed this contingent payment obligation in connection with the acquisition of Black Range. At the date of the acquisition of Black Range, this contingent obligation was determined to be probable. Since the deferred contingent consideration obligation is probable and the amount is estimable, the Company recorded the deferred contingent consideration as an assumed liability in the amount of $321,600 and $362,794 as of September 30, 2022 and December 31, 2021, respectively.

 

The Company also owed Mr. Glasier reimbursable expenses in the amount of $54,000 and $65,753 as of September 30, 2022 and December 31, 2021, respectively.

 

Going Concern

 

With the exception of the quarter ending June 30, 2022, we had incurred losses from our operations. During the three months ended September 30, 2022, we generated a net loss of $527,525. We expect to generate operating losses for the foreseeable future as we incur expenses to bring our mining operations online. As of September 30, 2022, we had an accumulated deficit of $12,583,074 and working capital of $10,181,380.

 

Since inception, the Company has met its liquidity requirements principally through the issuance of notes and the sale of its common shares. On January 20, 2022, the Company closed on a non-brokered private placement of 2,495,575 units at a price of CAD $1.60 per unit. The aggregate gross proceeds raised in the private placement amounted to CAD $3,992,920 (USD $3,011,878 in net proceeds). During the nine months ended September 30, 2022, the Company received $2,620,395 in proceeds from the exercise of warrants.

 

The Company’s ability to continue its operations and to pay its obligations when they become due is contingent upon the Company obtaining additional financing. Management’s plans include seeking to procure additional funds through debt and equity financings, to secure regulatory approval to fully utilize its Kinetic Separation and to initiate the processing of ore to generate operating cash flows.

 

There are no assurances that the Company will be able to raise capital on terms acceptable to the Company or at all, or that cash flows generated from its operations will be sufficient to meet its current operating costs and required debt service. If the Company is unable to obtain sufficient amounts of additional capital, it may be required to reduce the scope of its planned product development, which could harm its financial condition and operating results, or it may not be able to continue to fund its ongoing operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern to sustain operations for at least one year from the issuance of the accompanying financial statements. The accompanying condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

28

 

 

Off Balance Sheet Arrangements

 

As of September 30, 2022, there were no off-balance sheet transactions. The Company has not entered into any specialized financial agreements to minimize its investment risk, currency risk or commodity risk.

 

Critical Accounting Estimates and Policies

 

The preparation of these condensed consolidated financial statements requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed consolidated financial statements and reported amounts of expenses during the reporting period.

 

Significant assumptions about the future and other sources of estimation uncertainty that management has made at the end of the reporting period, that could result in a material adjustment to the carrying amounts of assets and liabilities, in the event that actual results differ from assumptions made, include, but are not limited to, the following: fair value of transactions involving common shares, assessment of the useful life and evaluation for impairment of intangible assets, valuation and impairment assessments on mineral properties, deferred contingent consideration, the reclamation liability, valuation of stock-based compensation, valuation of available-for-sale securities and valuation of long-term debt, HST and asset retirement obligations. Other areas requiring estimates include allocations of expenditures, depletion and amortization of mineral rights and properties

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Not applicable.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

As of the end of the period covered by this report, our principal executive officer and principal financial officer evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on their evaluation of our disclosure controls and procedures, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective as of September 30, 2022 to ensure that information required to be disclosed by the Company in the reports that we file or submit under the Exchange Act is (a) recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and (b) accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate to allow for timely decisions regarding required disclosures.

 

Description of Material Weakness

 

Management has concluded that the Company’s disclosure controls and procedures were not effective as of September 30, 2022 due to the lack of segregation of duties and the failure to report disclosures on a timely basis.

 

Remediation of Material Weakness

 

Management has developed a plan and related timeline for the Company to design a set of control procedures and the related required documentation thereof in order to address this material weakness. However, its implementation was delayed as a decline in commodity prices caused the Company to pursue aggressive cost cutting and de-staffing which has increasingly concentrated duties on the remaining staff. Until the Company has the proper staff in place, it likely will not be able to remediate its material weaknesses.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rules 13a-15 or 15d-15 under the Exchange Act that occurred during the current fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

29

 

 

PART II . OTHER INFORMATION

 

Item 1. Legal Proceedings

 

In the opinion of management, we are not involved in any claims, legal actions or regulatory proceedings as of September 30, 2022, the ultimate disposition of which would have a material adverse effect on our condensed consolidated financial position, results of operations, or cash flows.

 

Item 1A. Risk Factors

 

Risks Related to Our Business

 

Our business activities are subject to significant risks, including those described below. Every investor or potential investor in our securities should carefully consider these risks. If any of the described risks actually occurs, our business, financial position and results of operations could be materially adversely affected. Such risks are not the only ones we face and additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business.

 

Our ability to become a successful operating mining company is contingent on whether we can continue to access adequate operating capital and can ultimately mine our properties at a profit sufficient to finance further mining activities and to acquire and finance additional reserves, all in spite of potentially significant fluctuations in the market prices of uranium and vanadium.

 

With the exception of the quarter ending June 30, 2022, we had incurred losses from our operations. During the three months ended September 30, 2022, we generated a net loss of $527,525. We expect to generate operating losses for the foreseeable future as we incur expenses to bring our mining operations online. As of September 30, 2022, we had an accumulated deficit of $12,583,074 and working capital of $10,181,380.

 

The Company’s ability to continue its planned operations and to pay its obligations when they become due is contingent upon the Company obtaining additional financing. Management’s plans include seeking to procure additional funds through debt and equity financings, to secure regulatory approval to fully utilize its Kinetic Separation technology and to initiate the processing of ore to generate operating cash flows.

 

If we cannot access additional sources of private or public capital, partner with another company that has cash resources and/or find other means of generating revenue other than uranium or vanadium sales, we may not be able to fully realize our planned operations.

 

Until we can produce and sell sufficient amounts of uranium and/or vanadium, we will have no way to generate adequate cash inflows except by monetizing certain of our assets, partnering with third parties that are better financed or obtaining additional financing of our own. We can provide no assurance that our properties will produce saleable production or that we will be able to continue to find, develop, acquire and finance additional mineral resources. If we cannot monetize certain existing assets, partner with another company that has cash resources, find other means of generating revenue other than uranium or vanadium production and/or access additional sources of private or public capital, we may not be able to remain in business and our shareholders may lose their entire investment.

 

30

 

 

Our ability to function as an operating mining company will be dependent on our ability to mine our properties at a profit sufficient to finance further mining activities and for the acquisition and development of additional properties. The volatility of uranium prices makes long-range planning uncertain and raising capital difficult.

 

Our ability to operate on a positive cash flow basis will be dependent on mining sufficient quantities of uranium or vanadium at a profit sufficient to finance our operations and for the acquisition and development of additional mining properties. Any profit will necessarily be dependent upon, and affected by, the long and short term market prices of uranium and vanadium, which are subject to significant fluctuation. Uranium prices have been and will continue to be affected by numerous factors beyond our control. These factors include the demand for nuclear power, political and economic conditions in uranium producing and consuming countries, uranium supply from secondary sources and uranium production levels and costs of production. A significant, sustained drop in uranium prices may make it impossible to operate our business at a level that will permit us to cover our fixed costs or to remain in operation.

 

Evaluating our future performance may be difficult since we have a limited financial and operating history, with significant negative cash flow and an accumulated deficit to date. Furthermore, there is no assurance that we will be successful in securing additional sources of capital sufficient to support our planned operations. As such, substantial doubt exists as to whether our cash resources and working capital will be sufficient to fund our planned operations over the next twelve months. Our long-term success will depend ultimately on our ability to raise additional capital, to achieve and maintain operational profitability and to develop positive cash flows from our mining activities.

 

As more fully described within this quarterly report, we acquired our first mineral properties in November of 2014. To date, we have been acquiring additional mineral properties and raising capital. We hold uranium projects in various stages of exploration in the states of Colorado and Utah.

 

As more fully described under “Liquidity and Capital Resources” of Item 2. “Management’s Discussion and Analysis of Financial Condition and Result of Operations”, we have a history of significant negative cash flows and net losses, with an accumulated deficit balance of $12.6 million and $13.2 million at September 30, 2022 and December 31, 2021, respectively. We have been reliant on royalty revenues and equity financings from the sale of our common shares in order to fund our operations. We do not expect to achieve profitability or develop positive cash flows from operations in the near term. As a result of our limited financial and operating history, including our significant negative cash flows and net losses to date, it may be difficult to evaluate our future performance.

 

At September 30, 2022 and December 31, 2021, we had working capital of $10,181,380 and $4,492,169, respectively. The continuation of the Company as a going concern is dependent upon our ability to obtain adequate additional financing. However, there is no assurance that we will be successful in securing any form of additional financing in the future; therefore, substantial doubt exists as to whether our cash resources and working capital will be sufficient to enable the Company to continue its operations over the next twelve months. The condensed consolidated financial statements for the nine months ended September 30, 2022 were prepared assuming that the Company would continue as a going concern. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Our reliance on equity and debt financings is expected to continue for the foreseeable future. The availability of such funds whenever such additional financing is required, will be dependent on many factors beyond our control, including, but not limited to, the market price of uranium, the continuing public support of nuclear power as a viable source of electricity generation, the volatility in the global financial markets affecting our stock price and the status of the worldwide economy, any one of which may cause significant challenges in our ability to access additional financing, including access to the equity and credit markets. We may also be required to seek other forms of financing, such as asset divestitures or joint venture arrangements to continue advancing our uranium projects, which would depend entirely on finding a suitable third party willing to enter into such an arrangement, typically involving an assignment of a percentage interest in the mineral project.

 

31

 

 

Our long-term success, including the recoverability of the carrying values of our assets and our ability to acquire additional uranium projects and continue with exploration and pre-extraction activities and mining activities on our existing uranium projects, will depend ultimately on our ability to achieve and maintain profitability and positive cash flow from our operations by establishing ore bodies that contain commercially recoverable uranium and to develop these into profitable mining activities. The economic viability of our mining activities has many risks and uncertainties. These include, but are not limited to: (i) a significant, prolonged decrease in the market price of uranium; (ii) difficulty in marketing and/or selling uranium concentrates; (iii) significantly higher than expected capital costs to construct the mine and/or processing plant; (iv) significantly higher than expected extraction costs; (v) significantly lower than expected uranium extraction; (vi) significant delays, reductions or stoppages of uranium extraction activities; and (vi) the introduction of significantly more stringent regulatory laws and regulations. Our mining activities may change as a result of any one or more of these risks and uncertainties and there is no assurance that any ore body that we extract mineralized materials from will result in achieving and maintaining profitability and developing positive cash flow.

 

Our operations are capital intensive, and we will require significant additional financing to continue production at the Sunday Mine Complex, continue exploration and begin pre-extraction activities on our other existing uranium/vanadium projects, and acquire additional uranium/vanadium projects.

 

Our operations are capital intensive and future capital expenditures are expected to be substantial. We will require significant additional financing to fund our operations, including continuing production at the Sunday Mine Complex, continuing exploration on our other existing projects and beginning pre-extraction activities on those projects, which include assaying, drilling, geological and geochemical analysis and mine construction costs, and acquiring additional uranium/vanadium projects. In the absence of such additional financing, we would not be able to fund our operations, which may result in delays, curtailment or abandonment of any one or all of our uranium projects.

 

Uranium/vanadium exploration and pre-extraction programs and mining activities are inherently subject to numerous significant risks and uncertainties, and actual results may differ significantly from expectations or anticipated amounts. Furthermore, exploration programs conducted on our uranium/vanadium projects may not result in the establishment of ore bodies that contain commercially recoverable uranium/vanadium.

 

Uranium/vanadium exploration and pre-extraction programs and mining activities are inherently subject to numerous significant risks and uncertainties, many beyond our control, including, but not limited to: (i) unanticipated ground and water conditions and adverse claims to water rights; (ii) unusual or unexpected geological formations; (iii) metallurgical and other processing problems; (iv) the occurrence of unusual weather or operating conditions and other force majeure events; (v) lower than expected ore grades; (vi) industrial accidents; (vii) delays in the receipt of or failure to receive necessary government permits; (viii) delays in transportation; (ix) availability of contractors and labor; (x) government permit restrictions and regulation restrictions; (xi) unavailability of materials, equipment and milling facilities; and (xii) the failure of equipment or processes to operate in accordance with specifications or expectations. These risks and uncertainties could result in delays, reductions or stoppages in our mining activities; increased capital and/or extraction costs; damage to, or destruction of, our mineral projects, extraction facilities or other properties; personal injuries; environmental damage; monetary losses; and legal claims.

 

32

 

 

Success in uranium/vanadium exploration is dependent on many factors, including, without limitation, the experience and capabilities of a company’s management, the availability of geological expertise and the availability of sufficient funds to conduct the exploration program. Even if an exploration program is successful and commercially recoverable uranium/vanadium is established, it may take a number of years from the initial phases of drilling and identification of the mineralization until extraction is possible, during which time the economic feasibility of extraction may change such that the uranium ceases to be economically recoverable. Uranium/vanadium exploration is frequently non-productive due, for example, to poor exploration results or the inability to establish ore bodies that contain commercially recoverable uranium, in which case the uranium project may be abandoned and written-off. Furthermore, we will not be able to benefit from our exploration efforts and recover the expenditures that we incur on our exploration programs if we do not establish ore bodies that contain commercially recoverable uranium/vanadium and develop these uranium/vanadium projects into profitable mining activities, and there is no assurance that we will be successful in doing so for any of our uranium/vanadium projects.

 

Whether an ore body contains commercially recoverable uranium/vanadium depends on many factors including, without limitation: (i) the particular attributes, including material changes to those attributes, of the ore body such as size, grade, recovery rates and proximity to infrastructure; (ii) the market price of uranium, which may be volatile; and (iii) government regulations and regulatory requirements including, without limitation, those relating to environmental protection, permitting and land use, taxes, land tenure and transportation.

 

We have established the existence of mineralized materials on our uranium properties. However, we have not established any measured, indicated or inferred mineral resources or any proven or probable reserves through the completion of a feasibility study for any of our uranium properties and we have no current plans to seek to do so, as it would not serve a business purpose at the present time. Furthermore, we have no current plans to establish proven or probable reserves for any of our uranium properties as it doesn’t serve a business purpose at the present time.

 

Because the number of mills permitted for processing of uranium and vanadium is very limited, it may be difficult for us to gain access to a mill on favorable terms, or at all, and this could negatively affect our ability to do business.

 

In the event that there is not a buying program in place for uranium/vanadium ore, the Company would need to arrange with a third party for conventional milling services. Because the number of mills permitted for processing of uranium and vanadium is very limited, it may be difficult for us to gain access to a mill on favorable terms, or at all. This could result in increased costs and/or significant delays in, interruption of, or cessation of the Company’s business activities. The practice of selling uranium/vanadium ore without first processing into yellowcake (U3O8) or Vanadium Pentoxide (V2O5) would likely generate lower revenues.

 

Our ability to realize anticipated benefits of the Kinetic Separation process is subject to uncertainties associated with that process. 

 

In order to utilize Kinetic Separation to process uranium/vanadium bearing ore, there are uncertainties that must be addressed. Currently, to utilize Kinetic Separation the Company would need to either apply for its own milling license for a processing facility or arrange to utilize a third party’s mill, either of which would entail delays and associated costs. The Company and its regulatory counsel are continuing to seek an alternative path forward that would allow the Company to use Kinetic Separation either inside a uranium mine or on the surface outside of the underground workings to further reduce transportation costs. There is no assurance that such an alternative approach will be approved.

 

In addition, although the Company has conducted initial tests of its Kinetic Separation technology with what appear to be positive results, those results have not been validated by a qualified person.

 

33

 

 

We do not insure against all of the risks we face in our operations.

 

In general, where coverage is available and not prohibitively expensive relative to the perceived risk, we will maintain insurance against such risk, subject to exclusions and limitations. We currently maintain insurance against certain risks including securities and general commercial liability claims and certain physical assets used in our operations, subject to exclusions and limitations; however, we do not maintain insurance to cover all of the potential risks and hazards associated with our operations. We may be subject to liability for environmental, pollution or other hazards associated with our exploration, pre-extraction and extraction activities, which we may not be insured against, which may exceed the limits of our insurance coverage or which we may elect not to insure against because of high premiums or other reasons. Furthermore, we cannot provide assurance that any insurance coverage we currently have will continue to be available at reasonable premiums or that such insurance will adequately cover any resulting liability.

 

Our inability to obtain financial surety would threaten our ability to continue in business.

 

Future financial surety requirements to comply with federal and state environmental and remediation requirements and to secure necessary licenses and approvals may increase significantly as future development and production occurs at certain of our sites in the United States. The amount of the financial surety for each producing property is subject to annual review and revision by regulators. We expect that the issuer of the financial surety instruments will require us to provide cash collateral for a significant amount of the face amount of the bond to secure the obligation. In the event we are not able to raise, secure or generate sufficient funds necessary to satisfy these requirements, we will be unable to develop our sites and bring them into production, which inability will have a material adverse impact on our business and may negatively affect our ability to continue to operate.

 

Acquisitions that we may make from time to time could have an adverse impact on us.

 

From time to time, we examine opportunities to acquire additional mining assets and businesses. Any acquisition that we may choose to complete may be of a significant size, may change the scale of our business and operations, and may expose us to new geographic, political, operating, financial and geological risks. Our success in our acquisition activities depends on our ability to identify suitable acquisition candidates, negotiate acceptable terms for any such acquisition, and integrate the acquired operations successfully with those of our Company. Any acquisitions would be accompanied by risks which could have a material adverse effect on our business. For example, there may be a significant change in commodity prices after we have committed to complete the transaction and established the purchase price or exchange ratio; a material ore body may prove to be below expectations; we may have difficulty integrating and assimilating the operations and personnel of any acquired companies, realizing anticipated synergies and maximizing the financial and strategic position of the combined enterprise, and maintaining uniform standards, policies and controls across the organization; the integration of the acquired business or assets may disrupt our ongoing business and our relationships with employees, customers, suppliers and contractors; and the acquired business or assets may have unknown liabilities which may be significant. In the event that we choose to raise debt capital to finance any such acquisition, our leverage will be increased. If we choose to use equity as consideration for such acquisition, existing shareholders may suffer dilution. Alternatively, we may choose to finance any such acquisition with our existing resources. There can be no assurance that we would be successful in overcoming these risks or any other problems encountered in connection with such acquisitions.

 

34

 

 

The uranium industry is subject to numerous stringent laws, regulations and standards, including environmental protection laws and regulations. If any changes occur that would make these laws, regulations and standards more stringent, it may require capital outlays in excess of those anticipated or cause substantial delays, which would have a material adverse effect on our operations.

 

Uranium exploration and pre-extraction programs and mining activities are subject to numerous stringent laws, regulations and standards at the federal, state, and local levels governing permitting, pre-extraction, extraction, exports, taxes, labor standards, occupational health, waste disposal, protection and reclamation of the environment, protection of endangered and protected species, mine safety, hazardous substances and other matters. Our compliance with these requirements requires significant financial and personnel resources.

 

The laws, regulations, policies or current administrative practices of any government body, organization or regulatory agency in the United States or any other applicable jurisdiction, may change or be applied or interpreted in a manner which may also have a material adverse effect on our operations. The actions, policies or regulations, or changes thereto, of any government body or regulatory agency or special interest group, may also have a material adverse effect on our operations.

 

Uranium exploration and pre-extraction programs and mining activities are subject to stringent environmental protection laws and regulations at the federal, state, and local levels. These laws and regulations, which include permitting and reclamation requirements, regulate emissions, water storage and discharges and disposal of hazardous wastes. Uranium mining activities are also subject to laws and regulations which seek to maintain health and safety standards by regulating the design and use of mining methods. Various permits from governmental and regulatory bodies are required for mining to commence or continue, and no assurance can be provided that required permits will be received in a timely manner.

 

Our compliance costs, including the posting of surety bonds associated with environmental protection laws and regulations and health and safety standards, have been significant to date and are expected to increase in scale and scope as we expand our operations in the future. Furthermore, environmental protection laws and regulations may become more stringent in the future, and compliance with such changes may require capital outlays in excess of those anticipated or cause substantial delays, which would have a material adverse effect on our operations.

 

To the best of our knowledge, our operations are in compliance, in all material respects, with all applicable laws, regulations and standards. We may not be able or may elect not to insure against the risk of liability for violations of such laws, regulations and standards, due to high insurance premiums or other reasons. Where coverage is available and not prohibitively expensive relative to the perceived risk, we will maintain insurance against such risk, subject to exclusions and limitations. However, we cannot provide any assurance that such insurance will continue to be available at reasonable premiums or that such insurance will be adequate to cover any resulting liability.

 

We may not be able to obtain, maintain or amend rights, authorizations, licenses, permits or consents required for our operations.

 

Our exploration and mining activities are dependent upon the grant of appropriate rights, authorizations, licenses, permits and consents, as well as continuation and amendment of these rights, authorizations, licenses, permits and consents already granted, which may be granted for a defined period of time, or may not be granted or may be withdrawn or made subject to limitations. There can be no assurance that all necessary rights, authorizations, licenses, permits and consents will be granted to us, or that authorizations, licenses, permits and consents already granted will not be withdrawn or made subject to limitations.

 

35

 

 

Closure and remediation costs for environmental liabilities may exceed the provisions we have made.

 

Natural resource companies are required to close their operations and rehabilitate the lands in accordance with a variety of environmental laws and regulations. Estimates of the total ultimate closure and rehabilitation costs for uranium operations are significant and based principally on current legal and regulatory requirements and closure plans that may change materially. Any underestimated or unanticipated rehabilitation costs could materially affect our financial position, results of operations and cash flows. Environmental liabilities are accrued when they become known, are probable and can be reasonably estimated. Whenever a previously unrecognized remediation liability becomes known, or a previously estimated reclamation cost is increased, the amount of that liability and additional cost will be recorded at that time and could materially reduce our consolidated net income in the related period.

 

The laws and regulations governing closure and remediation in a particular jurisdiction are subject to review at any time and may be amended to impose additional requirements and conditions which may cause our provisions for environmental liabilities to be underestimated and could materially affect our financial position or results of operations.

 

Major nuclear incidents may have adverse effects on the nuclear and uranium industries.

 

The nuclear incident that occurred in Japan in March 2011 had significant and adverse effects on both the nuclear and uranium industries. If another nuclear incident were to occur, it may have further adverse effects for both industries. Public opinion of nuclear power as a source of electricity generation may be adversely affected, which may cause governments of certain countries to further increase regulation for the nuclear industry, reduce or abandon current reliance on nuclear power or reduce or abandon existing plans for nuclear power expansion. Any one of these occurrences has the potential to reduce current and/or future demand for nuclear power, resulting in lower demand for uranium and lower market prices for uranium, adversely affecting the Company’s operations and prospects. Furthermore, the growth of the nuclear and uranium industries is dependent on continuing and growing public support of nuclear power as a viable source of electricity generation.

 

The marketability of uranium concentrates will be affected by numerous factors beyond our control which may result in our inability to receive an adequate return on our invested capital.

 

The marketability of uranium concentrates extracted by us will be affected by numerous factors beyond our control. These factors include macroeconomic factors, fluctuations in the market price of uranium, governmental regulations, land tenure and use, regulations concerning the importing and exporting of uranium and environmental protection regulations. The future effects of these factors cannot be accurately predicted, but any one or a combination of these factors may result in our inability to receive an adequate return on our invested capital.

 

The only significant market for uranium is nuclear power plants world-wide, and there are a limited number of customers.

 

We are dependent on a limited number of electric utilities that buy uranium for nuclear power plants. Because of the limited market for uranium, a reduction in purchases of newly produced uranium by electric utilities for any reason (such as plant closings) would adversely affect the viability of our business.

 

36

 

 

The price of alternative energy sources affects the demand for and price of uranium.

 

The attractiveness of uranium as an alternative fuel to generate electricity may be dependent on the relative prices of oil, gas, wind, solar, coal and hydro-electricity and the possibility of developing other low-cost sources of energy. If the prices of alternative energy sources decrease or new low-cost alternative energy sources are developed, the demand for uranium could decrease, which may result in a decrease in the price of uranium.

 

The title to our mineral property interests may be challenged.

 

Although we have taken reasonable measures to ensure proper title to our interests in mineral properties and other assets, there is no guarantee that the title to any of such interests will not be challenged. No assurance can be given that we will be able to secure the grant or the renewal of existing mineral rights and tenures on terms satisfactory to us, or that governments in the jurisdictions in which we operate will not revoke or significantly alter such rights or tenures or that such rights or tenures will not be challenged or impugned by third parties, including local governments, aboriginal peoples or other claimants. Our mineral properties may be subject to prior unregistered agreements, transfers or claims, and title may be affected by, among other things, undetected defects. A successful challenge to the precise area and location of our claims could result in us being unable to operate on our properties as permitted or being unable to enforce our rights with respect to our properties.

 

Due to the nature of our business, we may be subject to legal proceedings which may divert management’s time and attention from our business and result in substantial damage awards.

 

Due to the nature of our business, we may be subject to numerous regulatory investigations, securities claims, civil claims, lawsuits and other proceedings in the ordinary course of our business. The outcome of these lawsuits is uncertain and subject to inherent uncertainties, and the actual costs to be incurred will depend upon many unknown factors. We may be forced to expend significant resources in the defense of these suits, and we may not prevail. Defending against these and other lawsuits in the future may not only require us to incur significant legal fees and expenses, but may become time-consuming for us and detract from our ability to fully focus our internal resources on our business activities. The results of any legal proceeding cannot be predicted with certainty due to the uncertainty inherent in litigation, the difficulty of predicting decisions of regulators, judges and juries and the possibility that decisions may be reversed on appeal. There can be no assurances that these matters will not have a material adverse effect on our business, financial position or operating results.

 

Competition from better-capitalized companies affects prices and our ability to acquire both properties and personnel.

 

There is global competition for uranium/vanadium properties, ore processing mills, capital, customers and the employment and retention of qualified personnel. In the production and marketing of uranium and vanadium, there are a number of producing entities, some of which are government controlled and all of which are significantly larger and better capitalized than we are. Many of these organizations also have substantially greater financial, technical, manufacturing and distribution resources than we have.

 

Our uranium production also competes with uranium recovered from the de-enrichment of highly enriched uranium obtained from the dismantling of United States and Russian nuclear weapons and imports to the United States of uranium from the former Soviet Union and from the sale of uranium inventory held by the DoE. In addition, there are numerous entities in the market that compete with us for properties and mills and are attempting to become licensed to operate ISR and/or underground mining facilities. If we are unable to successfully compete for properties, mills, capital, customers or employees or with alternative uranium sources, it could have a materially adverse effect on our results of operations.

 

37

 

 

Because we have limited capital, inherent mining risks pose a significant threat to us compared with our larger competitors.

 

Because we have limited capital, we may be unable to withstand significant losses that can result from inherent risks associated with mining, including environmental hazards, industrial accidents, flooding, earthquake, interruptions due to weather conditions and other acts of nature which larger competitors could withstand. Such risks could result in damage to or destruction of our infrastructure and production facilities, as well as to adjacent properties, personal injury, environmental damage and processing and production delays, causing monetary losses and possible legal liability. Our business could be harmed if we lose the services of our key personnel.

 

Our business and mineral exploration programs depend upon our ability to employ the services of geologists, engineers and other experts. In operating our business and in order to continue our programs, we compete for the services of professionals with other mineral exploration companies and businesses. Our ability to maintain and expand our business and continue our exploration programs may be impaired if we are unable to continue to employ or engage those parties currently providing services and expertise to us or identify and engage other qualified personnel to do so in their place. To retain key personnel, we may face increased compensation costs, including potential new stock incentive grants and there can be no assurance that the incentive measures we implement will be successful in helping us retain our key personnel.

   

If we fail to maintain proper and effective internal controls, our ability to produce accurate and timely condensed consolidated financial statements could be impaired, which could harm our operating results, our ability to operate our business and investors’ views of us.

 

Ensuring that we have adequate internal financial and accounting controls and procedures in place so that we can produce accurate condensed consolidated financial statements on a timely basis is a costly and time-consuming effort that will need to be evaluated frequently. Section 404 of the Sarbanes-Oxley Act requires public companies to conduct an annual review and evaluation of their internal controls, which the Company does each year. Our failure to maintain the effectiveness of our internal controls in accordance with the requirements of the Sarbanes-Oxley Act could have a material adverse effect on our business. We could lose investor confidence in the accuracy and completeness of our financial reports, which could have an adverse effect on the price of our common shares.

 

38

 

 

Our business, financial condition and results of operations may be negatively affected by economic and other consequences from Russia’s military action against Ukraine and the international sanctions imposed in response to that action.

 

In late February 2022, Russia launched a large-scale military attack on Ukraine. The invasion significantly amplified already existing geopolitical tensions among Russia, Ukraine, Europe, NATO and the West, including the United States. In response to the military action by Russia, various countries, including the United States, the United Kingdom and European Union issued broad-ranging economic sanctions against Russia. Such sanctions included, among other things, a prohibition on doing business with certain Russian companies, large financial institutions, officials and oligarchs; a commitment by certain countries and the European Union to remove selected Russian banks from the Society for Worldwide Interbank Financial Telecommunications, or SWIFT, the electronic banking network that connects banks globally; a ban of oil imports from Russia to the United States; and restrictive measures to prevent the Russian Central Bank from undermining the impact of the sanctions. Additional sanctions have been and may be imposed in the future. Such sanctions (and any future sanctions) and other actions against Russia may adversely impact, among other things, the Russian economy and various sectors of the economy, including but not limited to, financial, energy, metals and mining, engineering and defense and defense-related materials sectors; result in a decline in the value and liquidity of Russian securities; result in boycotts, tariffs, and purchasing and financing restrictions on Russia’s government, companies and certain individuals; weaken the value of the ruble; downgrade the country’s credit rating; freeze Russian securities and/or funds invested in prohibited assets and impair the ability to trade in Russian securities and/or other assets; and have other adverse consequences on the Russian government, economy, companies and region. Further, several large corporations and U.S. states have announced plans to divest interests or otherwise curtail business dealings with certain Russian businesses.

 

The ramifications of the hostilities and sanctions may not be limited to Russia, Ukraine and Russian and Ukrainian companies and may spill over to and negatively impact other regional and global economic markets (including Europe and the United States), companies in other countries (particularly those that have done business with Russia and Ukraine) and on various sectors, industries and markets for securities and commodities globally, such as oil and natural gas. Accordingly, the actions discussed above and the potential for a wider conflict could increase financial market volatility and cause severe negative effects on regional and global economic markets, industries, and companies. In addition, Russia may take retaliatory actions and other countermeasures, including cyberattacks and espionage against other countries and companies around the world, which may negatively impact such countries and companies.

 

The extent and duration of the military action or future escalation of such hostilities, the extent and impact of existing and future sanctions, market disruptions and volatility, and the result of any diplomatic negotiations cannot be predicted.

 

While we expect any direct impacts to our business to be limited, the indirect impacts on the economy and on the mining industry and other industries in general could negatively affect our business and may make it more difficult for us to raise equity or debt financing.

 

In addition, the impact of other current macro-economic factors on our business, which may be exacerbated by the war in Ukraine – including inflation, supply chain constraints and geopolitical events – is uncertain.

 

39

 

 

The COVID-19 coronavirus could adversely impact our business, including our mine development plans.

 

In December 2019, a novel strain of coronavirus, COVID-19, was reported to have surfaced in Wuhan, China. Since then, the COVID-19 coronavirus has spread to multiple countries, including the United States. As the COVID-19 coronavirus continues to spread in the United States, we may experience disruptions that could severely impact our business, including:

 

interruption of key mining activities due to limitations on travel, gathering, or business operations imposed or recommended by federal or state governments, employers and others.

 

limitations in employee resources, including because of sickness of employees or their families or the desire of employees to avoid contact with large groups of people.

 

delays in financial reporting and filings due to the impact of mitigation efforts on staff and service providers

 

changes in local regulations as part of a response to the COVID-19 coronavirus outbreak which may require us to change the ways in which mining is conducted, which may result in unexpected costs.

 

delays in necessary interactions with regulators and other important agencies and contractors due to limitations in employee resources or new procedures due to limitations imposed by COVID-19.

 

reduction in the global demand for uranium and/or vanadium due to reduced primary applications of uranium (nuclear power generation) and vanadium (steelmaking).

 

COVID-19 restrictions could cause a decline in energy consumption or indirectly reduced oil prices could lessen the demand for nuclear power.

 

COVID-19 previously caused uranium mine closures that have taken substantial uranium supply offline and increased the spot price of uranium to date during this crisis, there is no guarantee that this relationship will continue as the COVID-19 crisis is ongoing and the dynamic of the mine closure/spot price relationship may change.

 

The global outbreak of the COVID-19 coronavirus continues to evolve. The extent to which the COVID-19 coronavirus and its subvariants may impact our business will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the ultimate geographic spread of the disease, the duration of the outbreak, travel restrictions and social distancing in the United States and other countries, business closures or business disruptions and the effectiveness of actions taken in the United States and other countries to contain and treat the disease.

 

40

 

 

Risks Related to Our Stock

 

If we are unable to raise additional capital, our business may fail and shareholders may lose their entire investment.

 

We had $10,468,789 and $880,821 in cash at September 30, 2022 and December 31, 2021, respectively. There can be no assurance that we will be able to obtain additional capital after we exhaust our current cash. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the issuance of such securities would likely result in substantial dilution to existing shareholders. If we borrow money, we will have to pay interest and may also have to agree to restrictions that limit our operating flexibility.

 

If additional capital is not available in sufficient amounts or on a timely basis, we will experience liquidity problems, and we could face the need to significantly curtail current operations, change our planned business strategies and pursue other remedial measures. Any curtailment of business operations would have a material negative effect on operating results, the value of our outstanding stock is likely to fall, and our business may fail, causing our shareholders to lose their entire investment.

 

Shareholders could be diluted if we were to use common shares to raise capital.

 

We may need to seek additional capital to carry our business plan. This financing could involve one or more types of securities including common shares, convertible debt or warrants to acquire common shares. These securities could be issued at or below the then prevailing market price for our common shares. Any issuance of additional common shares could be dilutive to existing shareholders and could adversely affect the market price of our common shares.

 

The Company’s common shares may at times be traded in low volumes, which may negatively affect your ability to sell shares.

 

The Company’s common shares may trade at times in low volumes on both the CSE and OTCQX, meaning that the number of persons interested in purchasing our common shares at or near bid prices at any given time may be relatively small. This situation may be attributable to a number of factors, including the fact that we are a small company that is relatively unknown to stock analysts, stock brokers, institutional investors and others in the investment community who can generate or influence sales volume, and that even if we came to the attention of such institutionally oriented persons, they tend to be risk-averse in this environment and would be reluctant to follow an early stage company such as ours or purchase or recommend the purchase of our shares until such time as we became more advanced and viable. As a consequence, there may be periods of several days or more when trading activity in the Company’s shares is minimal, as compared to a seasoned issuer which has a large and steady volume of trading activity that will generally support continuous sales without an adverse effect on share price. The Company cannot give you any assurance that a broader or more active public trading market for our common shares will develop or be sustained. Due to these conditions, we can give you no assurance that you will be able to sell your shares at or near bid prices or at all if you need money or otherwise desire to liquidate your shares.  Further, certain institutional and other investors may have investment guidelines that restrict or prohibit investing in securities traded in the over-the-counter market.  These factors may have an adverse impact on the trading and price of our securities and could result in the loss by investors of all or part of their investment.

 

41

 

 

The Company’s common share price may be volatile.

 

The future trading price of the Company’s common shares may be volatile and may fluctuate substantially. The price of the common shares may be higher or lower than the price you pay for your shares, depending on many factors, some of which are beyond the Company’s control and may not be directly related to its operating performance. These factors include the following:

 

price and volume fluctuations in the overall stock market from time to time;

 

significant volatility in the market price and trading volume of securities of mineral exploration and mining companies;

  

changes in government regulations or regulatory policies with respect to mineral exploration and mining companies or in the status of our regulatory approvals;

 

actual or anticipated changes in earnings or fluctuations in operating results;

 

announcements by us or by our competitors of acquisitions or of new products, commercial relationships or capital commitments;

 

disruption to our operations or those of other contractors critical to our operations;

 

the emergence of new competitors;

 

commencement of, or our involvement in, litigation;

 

dilutive issuances of our common shares or the incurrence of additional debt;

 

adoption of new or different accounting standards;

 

general economic conditions and trends and slow or negative growth of related markets;

 

loss of a major funding source; or

 

departures of key personnel.

 

Due to the continued potential volatility of its stock price, the Company may be the target of securities litigation in the future. Securities litigation could result in substantial costs and divert management’s attention and resources from the business.

 

42

 

 

The sale of shares by our directors and officers may adversely affect the market price for our shares.

 

Sales of significant amounts of common shares held by our officers and directors, or the prospect of these sales, could adversely affect the market price of our common shares. Management’s stock ownership may discourage a potential acquirer from making a tender offer or otherwise attempting to obtain control of us, which in turn could reduce our stock price or prevent our shareholders from realizing a premium over our stock price.

 

We have never paid or declared any dividends on our common shares.

 

We have never paid or declared any dividends on our common shares. Likewise, we do not anticipate paying dividends or distributions on our common shares. Any future dividends on common shares will be declared, if at all, at the discretion of our board of directors and will depend, among other things, on our earnings, our financial requirements for future operations and growth, and other facts as we may then deem appropriate.

 

Our Chief Executive Officer is our largest shareholder, and as a result he may be able to exert control over us and may have actual or potential interests that may diverge from yours.

 

George Glasier, our CEO, beneficially owns, in the aggregate, about 12.2% of our common shares. As a result, Mr. Glasier might be able to influence many matters requiring shareholder approval, including the election of directors and approval of mergers and other significant corporate transactions. This concentration of ownership may have the effect of delaying, preventing or deterring a change in control, and could deprive our shareholders of an opportunity to receive a premium for their common shares as part of a sale of our company and may affect the market price of our stock.

 

Furthermore, Mr. Glasier may have interests that diverge from those of other holders of our common shares. As a result, Mr. Glasier may vote the shares he owns or controls or otherwise cause us to take actions that may conflict with your best interests as a shareholder, which could adversely affect our results of operations and the trading price of our common shares. Through this control, Mr. Glasier can exert influence over our management, affairs and all matters requiring shareholder approval, including the approval of significant corporate transactions, a sale of our company, decisions about our capital structure and the composition of our board of directors.

 

Risks Related to Our Regulatory Environment

 

The SEC’s adoption of the “Modernization of Property Disclosures for Mining Registrants,” as codified in S-K 1300, has created new disclosure requirements for mineral reserves and mineral resources that create some ambiguity for issuers required to comply with both the requirements of S-K 1300 and NI 43-101 and may result in increased compliance costs.

 

SEC Industry Guide 7 has been rescinded and replaced by S-K 1300, which requires that we disclose specific information related to our material mining operations, including with particularity any mineral resources and mineral reserves. Although we have established the existence of mineralized materials on our uranium properties, we have not established any measured mineral resources or any proven or probable reserves through the completion of a feasibility study for any of our uranium properties and we have no current plans to seek to do so, as it would not serve a business purpose at the present time. Nevertheless, if in the future we were to seek to identify any measured mineral resources or to establish any proven or probable reserves, we would be required to provide disclosure in that regard under both S-K 1300 and NI 43-101. While S-K 1300 is substantively similar to NI 43-101 (with the primary difference being NI 43-101’s required format, a matter on which S-K 1300 is silent), S-K 1300 is potentially subject to unknown interpretations, which could require the Company to incur substantial costs associated with compliance. We cannot predict the nature of any future enforcement, interpretation, or application of S-K 1300. Any further revisions to, or interpretations of, S-K 1300 or NI 43-101 could result our company incurring unforeseen costs associated with compliance with both of those disclosure regimes.

 

43

 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

The Company made no unregistered sales of securities during the quarter covered by this report.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

For Western, safety is a core value, and we strive for superior performance. Our health and safety management system, which includes detailed standards and procedures for safe production, addresses topics such as employee training, risk management, workplace inspection, emergency response, accident investigation, and program auditing. In addition to strong leadership and involvement from all levels of the organization, these programs and procedures form the cornerstone of safety at Western, ensuring that employees are provided a safe and healthy environment and are intended to reduce workplace accidents, incidents and losses, comply with all mining-related regulations, and provide support for both regulators and the industry to improve mine safety.

 

The operation of our U.S. based mine is subject to regulation by the Federal Mine Safety and Health Administration (“MSHA”) under the “Federal Mine Safety and Health Act of 1977” (the “Mine Act”). MSHA inspects our mine on a regular basis and issues various citations and orders when it believes a violation has occurred under the Mine Act. Following passage of “The Mine Improvement and New Emergency Response Act of 2006,” MSHA significantly increased the number of citations and orders charged against mining operations. The dollar penalties assessed for citations issued has also increased in recent years.

 

Pursuant to Section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd-Frank Act”), issuers that are operators, or that have a subsidiary that is an operator, of a coal or other mine in the United States, and that is subject to regulation by the Federal Mine Safety and Health Administration under the Mine Safety and Health Act of 1977 (“Mine Safety Act”), are required to disclose in their periodic reports filed with the SEC information regarding specified health and safety violations, orders and citations, related assessments and legal actions, and mining-related fatalities. Western went into active mining operations at the Sunday Mine Complex during 2021. During the quarter ended September 30, 2022, Mine Safety and Health Administration (MSHA) mine inspections have not yielded any disclosures required by Section 1503(a) of the Dodd-Frank Act.”

 

Item 5. Other Information

 

None.

 

44

 

 

Item 6. Exhibits

 

Exhibit No.   Description
     
3.1 *   Certificate of Incorporation, as amended
3.2 *   Amended and Restated Bylaws
31.1   Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2   Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32

 

Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS   Inline XBRL Instance Document.
101.SCH   Inline XBRL Taxonomy Extension Schema Document.
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

*Previously filed as an exhibit to the Company’s Form 10 registration statement filed on April 29, 2016 and incorporated herein by reference.

 

45

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  WESTERN URANIUM &VANADIUM CORP.
     
Date: November 17, 2022 By: /s/ George Glasier
    George Glasier
   

Chief Executive Officer

(Principal executive officer)

   
Date: November 17, 2022 By: /s/ Robert Klein
    Robert Klein
   

Chief Financial Officer

(Principal financial and accounting officer)

 

 

46

 

 

 

 

Unlimited Unlimited false --12-31 Q3 0001621906 0001621906 2022-01-01 2022-09-30 0001621906 2022-11-15 0001621906 2022-09-30 0001621906 2021-12-31 0001621906 2021-01-01 2021-12-31 0001621906 2022-07-01 2022-09-30 0001621906 2021-07-01 2021-09-30 0001621906 2021-01-01 2021-09-30 0001621906 us-gaap:CommonStockMember 2021-12-31 0001621906 us-gaap:TreasuryStockMember 2021-12-31 0001621906 us-gaap:RetainedEarningsMember 2021-12-31 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001621906 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001621906 us-gaap:TreasuryStockMember 2022-01-01 2022-03-31 0001621906 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001621906 2022-01-01 2022-03-31 0001621906 us-gaap:CommonStockMember 2022-03-31 0001621906 us-gaap:TreasuryStockMember 2022-03-31 0001621906 us-gaap:RetainedEarningsMember 2022-03-31 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001621906 2022-03-31 0001621906 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001621906 us-gaap:TreasuryStockMember 2022-04-01 2022-06-30 0001621906 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001621906 2022-04-01 2022-06-30 0001621906 us-gaap:CommonStockMember 2022-06-30 0001621906 us-gaap:TreasuryStockMember 2022-06-30 0001621906 us-gaap:RetainedEarningsMember 2022-06-30 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001621906 2022-06-30 0001621906 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001621906 us-gaap:TreasuryStockMember 2022-07-01 2022-09-30 0001621906 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001621906 us-gaap:CommonStockMember 2022-09-30 0001621906 us-gaap:TreasuryStockMember 2022-09-30 0001621906 us-gaap:RetainedEarningsMember 2022-09-30 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001621906 us-gaap:CommonStockMember 2020-12-31 0001621906 us-gaap:TreasuryStockMember 2020-12-31 0001621906 us-gaap:RetainedEarningsMember 2020-12-31 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001621906 2020-12-31 0001621906 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001621906 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0001621906 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001621906 2021-01-01 2021-03-31 0001621906 us-gaap:CommonStockMember 2021-03-31 0001621906 us-gaap:TreasuryStockMember 2021-03-31 0001621906 us-gaap:RetainedEarningsMember 2021-03-31 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001621906 2021-03-31 0001621906 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001621906 us-gaap:TreasuryStockMember 2021-04-01 2021-06-30 0001621906 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001621906 2021-04-01 2021-06-30 0001621906 us-gaap:CommonStockMember 2021-06-30 0001621906 us-gaap:TreasuryStockMember 2021-06-30 0001621906 us-gaap:RetainedEarningsMember 2021-06-30 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001621906 2021-06-30 0001621906 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001621906 us-gaap:TreasuryStockMember 2021-07-01 2021-09-30 0001621906 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001621906 us-gaap:CommonStockMember 2021-09-30 0001621906 us-gaap:TreasuryStockMember 2021-09-30 0001621906 us-gaap:RetainedEarningsMember 2021-09-30 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001621906 2021-09-30 0001621906 wstrf:PinonRidgeMiningLLCMember 2014-11-20 0001621906 us-gaap:PrivatePlacementMember 2022-01-01 2022-01-20 0001621906 us-gaap:PrivatePlacementMember 2022-01-20 0001621906 us-gaap:PrivatePlacementMember 2022-01-01 2022-09-30 0001621906 wstrf:WarrantsMember 2022-01-01 2022-09-30 0001621906 us-gaap:FairValueInputsLevel1Member 2022-09-30 0001621906 us-gaap:FairValueInputsLevel2Member 2022-09-30 0001621906 us-gaap:FairValueInputsLevel3Member 2022-09-30 0001621906 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001621906 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001621906 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001621906 us-gaap:WarrantMember 2022-07-01 2022-09-30 0001621906 us-gaap:WarrantMember 2021-07-01 2021-09-30 0001621906 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001621906 us-gaap:WarrantMember 2021-01-01 2021-09-30 0001621906 wstrf:OptionsToPurchaseCommonSharesMember 2022-07-01 2022-09-30 0001621906 wstrf:OptionsToPurchaseCommonSharesMember 2021-07-01 2021-09-30 0001621906 wstrf:OptionsToPurchaseCommonSharesMember 2022-01-01 2022-09-30 0001621906 wstrf:OptionsToPurchaseCommonSharesMember 2021-01-01 2021-09-30 0001621906 2020-06-01 2020-06-23 0001621906 2022-01-01 2022-01-31 0001621906 2021-04-30 0001621906 2022-04-01 2022-04-30 0001621906 2021-05-01 2021-05-31 0001621906 2022-01-01 2022-01-20 0001621906 wstrf:IncentiveStockOptionPlanMember 2022-01-01 2022-09-30 0001621906 wstrf:IncentiveStockOptionPlanMember 2022-09-30 0001621906 us-gaap:CommonStockMember 2022-02-01 2022-02-10 0001621906 2022-02-01 2022-02-10 0001621906 2022-02-10 0001621906 2021-05-11 2022-02-10 0001621906 us-gaap:StockOptionMember 2021-12-31 0001621906 us-gaap:StockOptionMember 2022-01-01 2022-09-30 0001621906 us-gaap:StockOptionMember 2022-09-30 0001621906 us-gaap:WarrantMember 2021-12-31 0001621906 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001621906 us-gaap:WarrantMember 2022-09-30 0001621906 wstrf:BlackRangeMember 2022-01-01 2022-09-30 0001621906 us-gaap:SubsequentEventMember 2022-10-31 2022-10-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure iso4217:CAD xbrli:shares iso4217:CAD utr:acre
EX-31.1 2 f10q0922ex31-1_western.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION

PURSUANT TO RULE 13a-14 AND 15d-14

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, George Glasier, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Western Uranium & Vanadium Corp.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 17, 2022

 

  By: /s/ George Glasier
  Name:  George Glasier
  Title: Chief Executive Officer and President (Principal Executive Officer)

 

EX-31.2 3 f10q0922ex31-2_western.htm CERTIFICATION

Exhibit 31.2

 

CERTIFICATION

PURSUANT TO RULE 13a-14 AND 15d-14

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

 

I, Robert Klein, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Western Uranium & Vanadium Corp.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 17, 2022

 

  By: /s/ Robert Klein
  Name:  Robert Klein
  Title: Chief Financial Officer (Principal Financial and Accounting Officer)

 

EX-32 4 f10q0922ex32_western.htm CERTIFICATION

Exhibit 32

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Western Uranium & Vanadium Corp. (the “Company”) for the quarter ended September 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 17, 2022

 

  By: /s/ George Glasier
  Name:  George Glasier
  Title: Chief Executive Officer and President
    (Principal Executive Officer)

 

Date: November 17, 2022

 

  By: /s/ Robert Klein
  Name:  Robert Klein
  Title: Chief Financial Officer
    (Principal Financial and Accounting Officer)
     

 

 

 

 

 

EX-101.SCH 5 wstrf-20220930.xsd XBRL SCHEMA FILE 001 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss)(Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Business link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Liquidity and Going Concern link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Accounts Payable and Accrued Liabilities link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Share Capital and Other Equity Instruments link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Mining Expenditures link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Related Party Transactions and Balances link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Covid-19 link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Share Capital and Other Equity Instruments (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Mining Expenditures (Tables) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Business (Details) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Liquidity and Going Concern (Details) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of fair values of financial instruments link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of computations of net income (loss) per share link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details) - Schedule of mineral properties and equipment and kinetic separation intellectual property link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details) - Schedule of reclamation liability activity link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Accounts Payable and Accrued Liabilities (Details) - Schedule of accounts payable and accrued liabilities link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Share Capital and Other Equity Instruments (Details) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Share Capital and Other Equity Instruments (Details) - Schedule of black-scholes option pricing model link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Share Capital and Other Equity Instruments (Details) - Schedule of stock options link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Share Capital and Other Equity Instruments (Details) - Schedule of warrants link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Mining Expenditures (Details) - Schedule of mining expenditures link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Related Party Transactions and Balances (Details) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 6 wstrf-20220930_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 wstrf-20220930_def.xml XBRL DEFINITION FILE EX-101.LAB 8 wstrf-20220930_lab.xml XBRL LABEL FILE EX-101.PRE 9 wstrf-20220930_pre.xml XBRL PRESENTATION FILE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2022
Nov. 15, 2022
Document Information Line Items    
Entity Registrant Name WESTERN URANIUM & VANADIUM CORP.  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   43,589,048
Amendment Flag false  
Entity Central Index Key 0001621906  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Sep. 30, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Shell Company false  
Entity Ex Transition Period false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 000-55626  
Entity Incorporation, State or Country Code A6  
Entity Tax Identification Number 98-1271843  
Entity Address, Address Line One 330 Bay Street  
Entity Address, Address Line Two Suite 1400  
Entity Address, City or Town Toronto  
Entity Address, Country CA  
Entity Address, Postal Zip Code M5H 2S8  
City Area Code (970)  
Local Phone Number 864-2125  
Entity Interactive Data Current Yes  
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash $ 10,468,789 $ 880,821
Restricted cash, current portion 75,057 75,057
Prepaid uranium concentrate inventory 4,085,723
Prepaid expenses 299,357 153,701
Marketable securities 928 2,120
Other current assets 45,251 264,039
Total current assets 10,889,382 5,461,461
Restricted cash, net of current portion 676,348 665,389
Mineral properties and equipment, net 12,656,075 11,780,142
Kinetic separation intellectual property 9,488,051 9,488,051
Total assets 33,709,856 27,395,043
Current liabilities:    
Accounts payable and accrued liabilities 572,930 699,593
Reclamation liability, current portion 75,057 75,057
Subscription payable 146,177
Deferred revenue, current portion 60,015 48,465
Total current liabilities 708,002 969,292
Reclamation liability, net of current portion 222,453 196,563
Deferred tax liability 2,708,887 2,708,887
Deferred contingent consideration 321,600 362,794
Deferred revenue, net of current portion 60,015
Total liabilities 3,960,942 4,297,551
Commitments and Contingencies (Note 6)
Shareholders’ Equity    
Common shares, no par value, unlimited authorized shares, 43,589,048 and 39,073,428 shares issued as of September 30, 2022 and December 31, 2021, respectively, and 43,588,742 and 39,073,122 shares outstanding as of September 30, 2022 and December 31, 2021, respectively 42,581,002 36,195,510
Treasury shares, 306 shares held in treasury as of September 30, 2022 and December 31, 2021
Accumulated deficit (12,583,074) (13,161,496)
Accumulated other comprehensive (loss) income (249,014) 63,478
Total shareholders’ equity 29,748,914 23,097,492
Total liabilities and shareholders’ equity $ 33,709,856 $ 27,395,043
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Common shares, par value (in Dollars per share)
Common shares, shares authorized Unlimited Unlimited
Common shares, shares issued 43,589,048 39,073,428
Common shares, shares outstanding 43,588,742 39,073,122
Treasury shares held in treasury 306 306
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss)(Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenues $ 108,547 $ 16,155 $ 7,611,419 $ 48,465
Cost of revenues 4,044,083
Gross profit 108,547 16,155 3,567,336 48,465
Expenses        
Mining expenditures 204,520 335,028 616,146 422,921
Professional fees 97,077 136,174 445,596 287,042
General and administrative 351,928 361,301 1,870,747 835,281
Consulting fees 18,346 12,801 78,165 16,810
Total operating expenses 671,871 845,304 3,010,654 1,562,054
Operating profit/ (loss) (563,324) (829,149) 556,682 (1,513,589)
Accretion and interest (35,799) 1,344 (17,740) 4,687
Other (income)/expense (4,000)
Settlement expense 78,441
Net income/(loss) (527,525) (830,493) 578,422 (1,596,717)
Other comprehensive income/(loss)        
Foreign exchange gain/(loss) (148,365) (46,363) (312,492) 23,531
Comprehensive income/(loss) $ (675,890) $ (876,856) $ 265,930 $ (1,573,186)
Net income/(loss) per share - basic (in Dollars per share) $ (0.01) $ (0.02) $ 0.01 $ (0.04)
Net income/(loss) per share - diluted (in Dollars per share) $ (0.01) $ (0.02) $ 0.01 $ (0.04)
Weighted average shares outstanding - basic (in Shares) 43,514,832 38,203,075 42,536,893 36,243,124
Weighted average shares outstanding - diluted (in Shares) 43,514,832 38,203,075 43,547,377 36,243,124
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
Common Shares
Treasury Shares
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Total
Balance at Dec. 31, 2020 $ 29,886,367 $ (11,087,459) $ (25,542) $ 18,773,366
Balance (in Shares) at Dec. 31, 2020 30,083,747 306      
Foreign exchange gain (loss) 44,964 44,964
Net income (loss) (291,614) (291,614)
Balance at Mar. 31, 2021 $ 33,755,673 (11,379,073) 19,422 22,396,022
Balance (in Shares) at Mar. 31, 2021 36,458,747 306      
Private placement - February 16, 2021 $ 1,950,509 1,950,509
Private placement - February 16, 2021 (in Shares) 3,250,000      
Private placement - March 1, 2021 $ 1,918,797 1,918,797
Private placement - March 1, 2021 (in Shares) 3,125,000      
Balance at Dec. 31, 2020 $ 29,886,367 (11,087,459) (25,542) 18,773,366
Balance (in Shares) at Dec. 31, 2020 30,083,747 306      
Net income (loss)         (1,596,717)
Balance at Sep. 30, 2021 $ 35,405,704 (12,684,176) (2,011) 22,719,517
Balance (in Shares) at Sep. 30, 2021 38,221,317 306      
Balance at Mar. 31, 2021 $ 33,755,673 (11,379,073) 19,422 22,396,022
Balance (in Shares) at Mar. 31, 2021 36,458,747 306      
Proceeds from the exercise of warrants $ 1,597,416 1,597,416
Proceeds from the exercise of warrants (in Shares) 1,722,570        
Foreign exchange gain (loss) 24,930 24,930
Net income (loss) (474,610) (474,610)
Balance at Jun. 30, 2021 $ 35,353,089 (11,853,683) 44,352 23,543,758
Balance (in Shares) at Jun. 30, 2021 38,181,317 306      
Proceeds from the exercise of warrants $ 52,615 52,615
Proceeds from the exercise of warrants (in Shares) 40,000        
Foreign exchange gain (loss) (46,363) (46,363)
Net income (loss) (830,493) (830,493)
Balance at Sep. 30, 2021 $ 35,405,704 (12,684,176) (2,011) 22,719,517
Balance (in Shares) at Sep. 30, 2021 38,221,317 306      
Balance at Dec. 31, 2021 $ 36,195,510 (13,161,496) 63,478 23,097,492
Balance (in Shares) at Dec. 31, 2021 39,073,122 306      
Private placement - January 20, 2022 $ 3,011,878 3,011,878
Private placement - January 20, 2022 (in Shares) 2,495,575      
Stock based compensation - stock options $ 502,145 502,145
Proceeds from the exercise of warrants $ 341,850 341,850
Proceeds from the exercise of warrants (in Shares) 268,204        
Foreign exchange gain (loss) 56,661 56,661
Net income (loss) (1,173,603) (1,173,603)
Balance at Mar. 31, 2022 $ 40,051,383 (14,335,099) 120,139 25,836,423
Balance (in Shares) at Mar. 31, 2022 41,836,901 306      
Balance at Dec. 31, 2021 $ 36,195,510 (13,161,496) 63,478 23,097,492
Balance (in Shares) at Dec. 31, 2021 39,073,122 306      
Net income (loss)         578,422
Balance at Sep. 30, 2022 $ 42,581,002 (12,583,074) (249,014) 29,748,914
Balance (in Shares) at Sep. 30, 2022 43,589,048 306      
Balance at Mar. 31, 2022 $ 40,051,383 (14,335,099) 120,139 25,836,423
Balance (in Shares) at Mar. 31, 2022 41,836,901 306      
Stock based compensation - stock options $ 251,074 251,074
Proceeds from the exercise of warrants $ 1,989,427 1,989,427
Proceeds from the exercise of warrants (in Shares) 1,477,743        
Foreign exchange gain (loss) (220,788) (220,788)
Net income (loss) 2,279,550 2,279,550
Balance at Jun. 30, 2022 $ 42,291,884 (12,055,549) (100,649) 30,135,686
Balance (in Shares) at Jun. 30, 2022 43,314,644 306      
Proceeds from the exercise of warrants $ 289,118 289,118
Proceeds from the exercise of warrants (in Shares) 274,404        
Foreign exchange gain (loss) (148,365) (148,365)
Net income (loss) (527,525) (527,525)
Balance at Sep. 30, 2022 $ 42,581,002 $ (12,583,074) $ (249,014) $ 29,748,914
Balance (in Shares) at Sep. 30, 2022 43,589,048 306      
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash Flows From Operating Activities:    
Net income/(loss) $ 578,422 $ (1,596,717)
Reconciliation of net income (loss) to cash provided by (used in) operating activities:    
Depreciation 19,468 8,564
Accretion of reclamation liability 25,890 5,983
Stock based compensation 753,219
Change in marketable securities 1,192 542
Change in operating assets and liabilities:    
Prepaid uranium concentrate inventory 4,085,723
Prepaid expenses and other current assets 73,132 (80,454)
Accounts payable and accrued liabilities (126,664) 133,920
Subscription payable (146,177)
Deferred revenue (48,465) (48,465)
Contingent consideration (41,194)
Net cash provided by (used in) operating activities 5,174,546 (1,576,627)
Cash Flows Used In Investing Activities    
Purchase of property and equipment (895,400) (65,000)
Net cash used in investing activities (895,400) (65,000)
Cash Flows From Financing Activities    
Proceeds from Private Placement - January 20, 2022 3,011,878
Proceeds from warrant exercises 2,620,395 1,650,031
Issuances of common shares, net of offering costs 3,869,306
Net cash provided by financing activities 5,632,273 5,519,337
Effect of foreign exchange rate on cash (312,492) (7,835)
Net increase in cash and restricted cash 9,598,927 3,869,875
Cash and restricted cash - beginning 1,621,267 1,472,061
Cash and restricted cash - ending 11,220,194 5,341,936
Cash 10,468,789 4,445,103
Restricted cash, current portion 75,057 75,057
Restricted cash, noncurrent 676,348 821,776
Total 11,220,194 5,341,936
Cash paid during the period for:    
Interest
Income taxes
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Business
9 Months Ended
Sep. 30, 2022
Business [Abstract]  
BUSINESS

NOTE 1 – BUSINESS

 

Nature of operations

 

Western Uranium & Vanadium Corp. (“Western” or the “Company”) was incorporated in December 2006 under the Ontario Business Corporations Act. On November 20, 2014, the Company completed a listing process on the Canadian Securities Exchange (“CSE”). As part of that process, the Company acquired 100% of the members’ interests of Pinon Ridge Mining LLC (“PRM”), a Delaware limited liability company. The transaction constituted a reverse takeover (“RTO”) of Western by PRM. Subsequent to obtaining appropriate shareholder approvals, the Company reconstituted its Board of Directors and senior management team. Effective September 16, 2015, Western completed its acquisition of Black Range Minerals Limited (“Black Range”).

 

The Company’s registered office is located at 330 Bay Street, Suite 1400, Toronto, Ontario, Canada, M5H 2S8, and its common shares are listed on the CSE under the symbol “WUC.” On April 22, 2016, the Company’s common shares began trading on the OTC Pink Open Market, and on May 23, 2016, the Company’s common shares were approved for trading on the OTCQX Best Market. The Company’s principal business activity is the acquisition and development of uranium and vanadium resource properties in the states of Utah and Colorado in the United States of America (“United States”).

 

On June 28, 2016, the Company’s registration statement became effective and Western became a United States reporting issuer. Thereafter, the Company was approved for Depository Trust Company eligibility through the Depository Trust and Clearing Corporation, which facilitates electronic book-entry delivery, settlement, and depository services for shares in the United States.

XML 17 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Liquidity and Going Concern
9 Months Ended
Sep. 30, 2022
Liquidity and Going Concern [Abstract]  
LIQUIDITY AND GOING CONCERN

Note 2 – Liquidity and going concern

 

With the exception of the quarter ending June 30, 2022, the Company had incurred losses from our operations. During the three months ended September 30, 2022, the Company generated a net loss of $527,525. The Company expects to generate operating losses for the foreseeable future as it incurs expenses to bring its mining operations online. As of September 30, 2022, the Company had an accumulated deficit of $12,583,074 and working capital of $10,181,380.

 

Since inception, the Company has met its liquidity requirements principally through the issuance of notes and the sale of its common shares. On January 20, 2022, the Company closed a non-brokered private placement of 2,495,575 units at a price of CAD $1.60 per unit. The aggregate gross proceeds raised in the private placement amounted to CAD $3,992,920 (USD $3,011,878 in net proceeds). During the nine months ended September 30, 2022, the Company received $2,620,395 in proceeds from the exercise of warrants.

 

The Company’s ability to continue its planned operations and to pay its obligations when they become due is contingent upon the Company obtaining additional financing. Management’s plans include seeking to procure additional funds through debt and equity financing, to secure regulatory approval to fully utilize its kinetic separation (“Kinetic Separation”) technology, and to initiate the processing of ore to generate operating cash flows.

 

There are no assurances that the Company will be able to raise capital on terms acceptable to the Company or at all, or that cash flows generated from its operations will be sufficient to meet its current operating costs. If the Company is unable to obtain sufficient amounts of additional capital, it may be required to reduce the scope of its planned product development, which could harm its financial condition and operating results, or it may not be able to continue to fund its ongoing operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern to sustain operations for at least one year from the issuance of these condensed consolidated financial statements. The accompanying condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

XML 18 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Note 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Principles of Consolidation

 

The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10 of Regulation S–X. Accordingly, they do not include all of the information and notes required U.S. GAAP. However, in the opinion of management of the Company, all adjustments necessary for a fair presentation of the financial position and operating results have been included in these condensed consolidated financial statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10–K for the fiscal year ended December 31, 2021, as filed with the SEC on April 15, 2022. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for any subsequent quarters or for the year ending December 31, 2022.

 

The accompanying condensed consolidated financial statements include the accounts of Western and its wholly-owned subsidiaries, Western Uranium Corp. (Utah), PRM, Black Range, Black Range Copper Inc., Ranger Resources Inc., Black Range Minerals Inc., Black Range Minerals Colorado LLC, Black Range Minerals Wyoming LLC, Haggerty Resources LLC, Ranger Alaska LLC, Black Range Minerals Utah LLC, Black Range Minerals Ablation Holdings Inc., and Black Range Development Utah LLC. All inter-company transactions and balances have been eliminated upon consolidation.

 

The Company has established the existence of mineralized materials for certain uranium projects. The Company has not established proven or probable reserves, as defined by the United States Securities and Exchange Commission (the “SEC”), through the completion of a “final” or “bankable” feasibility study for any of its uranium projects.

 

Exploration Stage and Mineral Properties

 

In accordance with U.S. GAAP, expenditures relating to the acquisition of mineral rights are initially capitalized as incurred while exploration and pre-extraction expenditures are expensed as incurred until such time the Company exits the exploration stage by establishing proven or probable reserves. Expenditures relating to exploration activities, such as drill programs to search for additional mineralized materials, are expensed as incurred. Expenditures relating to pre-extraction activities, such as the construction of mine wellfields, ion exchange facilities, disposal wells, and mine development, are expensed as incurred until such time proven or probable reserves are established for that uranium project, after which subsequent expenditures relating to development activities for that particular project are capitalized as incurred. Expenditures relating to mining and ore production while the Company is in the exploration stage and while the ore is stockpiled underground are expensed as incurred.

 

Production stage issuers, as defined in subpart 1300 of Regulation S-K, having engaged in material extraction of established mineral reserves on at least one material property, typically capitalize expenditures relating to ongoing development activities, with corresponding depletion calculated over proven and probable reserves using the units-of-production method and allocated to future reporting periods to inventory and, as that inventory is sold, to cost of goods sold. The Company is an exploration stage issuer, which has resulted in the Company reporting larger losses than if it had been in the production stage due to the expensing, instead of capitalizing, of expenditures relating to ongoing mine development and extraction activities. Additionally, there would be no corresponding amortization allocated to future reporting periods of the Company since those costs would have been expensed previously, resulting in both lower inventory costs and cost of goods sold and results of operations with higher gross profits and lower losses than if the Company had been in the production stage. Any capitalized costs, such as expenditures relating to the acquisition of mineral rights, are depleted over the estimated extraction life using the straight-line method. As a result, the Company’s condensed consolidated financial statements may not be directly comparable to the financial statements of companies in the production stage. Western will not be eligible to become a production stage issuer, and will remain an exploration stage issuer, until such time as mineral reserves are established on at least one material property.

 

Use of Estimates

 

The preparation of these condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and revenues and expenses during the periods reported. By their nature, these estimates are subject to measurement uncertainty, and the effects on the condensed consolidated financial statements of changes in such estimates in future periods could be significant. Significant areas requiring management’s estimates and assumptions include the determination of the fair value of transactions involving common shares, assessment of the useful life and evaluation for impairment of Kinetic Separation intellectual property, valuation and impairment assessments of mineral properties and equipment, valuation of deferred contingent consideration, valuation of the reclamation liability, valuation of stock-based compensation, and valuation of available-for-sale securities. Other areas requiring estimates include allocations of expenditures, depletion, and amortization of mineral rights and properties. Actual results could differ from those estimates.

 

Foreign Currency Translation

 

The reporting currency of the Company, including its subsidiaries, is the United States dollar. The financial statements of subsidiaries located outside of the U.S. are measured in their functional currency, which is the local currency. The functional currency of the parent (Western Uranium & Vanadium Corp. (Ontario)) is the Canadian dollar. Monetary assets and liabilities of these subsidiaries are translated at the exchange rates at the balance sheet date. Transactions denominated in currencies other than the functional currency are recorded based on the exchange rates at the time of the transaction. Income and expense items are translated using average monthly exchange rates. Non-monetary assets are translated at their historical exchange rates. Translation adjustments are included in “Accumulated other comprehensive income” in the condensed consolidated balance sheets.

 

Revenue Recognition

 

The Company purchased prepaid uranium concentrate contracts for future delivery of uranium concentrate pursuant to a supply agreement. The Company recognizes revenue upon the delivery of the uranium contract to the counterparty and charges to cost of revenues the purchase cost of the uranium concentrate contract upon such delivery. 

 

The Company leases certain of its mineral properties for the exploration and production of oil and gas reserves. The Company accounts for lease revenue in accordance with the FASB ASC 842, Leases. Lease payments received in advance are deferred and recognized on a straight-line basis over the related lease term associated with the prepayment. Royalty payments are recognized as revenues based upon production.

 

Fair Values of Financial Instruments

 

The carrying amounts of cash, restricted cash, accounts payable, subscription payable, reclamation liability, contingent consideration and accrued liabilities approximate their fair value due to the short-term nature of these instruments. Marketable securities are adjusted to fair value at each balance sheet date based on quoted prices which are considered level 1 inputs. The Company’s operating and financing activities are conducted primarily in United States dollars, and as a result, the Company is not subject to significant exposure to market risks from changes in foreign currency rates. The Company is exposed to credit risk through its cash and restricted cash but mitigates this risk by keeping these deposits at major financial institutions.

 

The FASB ASC 820, Fair Value Measurements and Disclosures, provides the framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements).

 

Fair value is defined as an exit price, representing the amount that would be received upon the sale of an asset or payment to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows:

 

Level 1 - Quoted prices in active markets for identical assets or liabilities.

 

Level 2 - Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly.

 

Level 3 - Significant unobservable inputs that cannot be corroborated by market data and inputs that are derived principally from or corroborated by observable market data or correlation by other means.

 

The fair value of the Company’s financial instruments are as follows:

 

   Quoted Prices
in Active
Markets for
Identical
Assets or
Liabilities
(Level 1)
   Quoted Prices
for Similar
Assets or
Liabilities in
Active
Markets
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Marketable securities as of September 30, 2022  $928   $       -   $        - 
                
Marketable securities as of December 31, 2021  $2,120   $-   $- 

 

Stock-Based Compensation

 

The Company follows the FASB ASC 718, Compensation - Stock Compensation, which addresses the accounting for stock-based payment transactions, requiring such transactions to be accounted for using the fair value method. Awards of shares for property or services are recorded at the fair value of the stock or the fair value of the service, whichever is more readily measurable. The Company uses the Black-Scholes option-pricing model to determine the grant date fair value of stock-based awards under ASC 718. The fair value is charged to earnings depending on the terms and conditions of the award, and the nature of the relationship of the recipient of the award to the Company. The Company records the grant date fair value in line with the period over which it was earned. For employees and consultants, this is typically considered to be the vesting period of the award. The Company recognizes forfeitures at the time forfeitures occur.

 

Net Income (Loss) per Share

 

Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share are computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and warrants (using the treasury stock method). The following is a reconciliation of the numerator and denominator used to calculate basic earnings per share and diluted earnings per share for the three and nine months ended September 30, 2022 and 2021. The computation of net income (loss) per share for each of the three and nine months ended September 30, 2021 is the same for both basic and fully diluted.

 

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2022   2021   2022   2021 
Numerator:                
Net (loss) income  $(527,525)  $(830,493)  $578,422   $(1,596,717)
                     
Denominator:                    
Weighted average shares outstanding, basic   43,514,832    38,203,075    42,536,893    36,243,124 
                     
Dilutive effect of options and warrants   -    -    1,010,484    - 
                     
Weighted average shares outstanding, diluted   43,514,832    38,203,075    43,547,377    36,243,124 
                     
Net (loss) income per share, basic  $(0.01)  $(0.02)  $0.01   $(0.04)
                     
Net (loss) income per share, diluted  $(0.01)  $(0.02)  $0.01   $(0.04)

 

Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net income (loss) per share because the effect of their inclusion would have been anti-dilutive.

 

   For the Three Months
Ended September 30,
   For the Nine Months
Ended September 30,
 
   2022   2021   2022   2021 
Warrants to purchase common shares   9,362,076    10,715,873    2,970,826    10,715,873 
Options to purchase common shares   3,108,000    2,808,000    983,000    2,808,000 
Total potentially dilutive securities   12,470,076    13,523,873    3,953,826    13,523,873 

 

Recent Accounting Standards

 

Management does not believe that any recently issued, but not yet effective accounting standards, when adopted, will have a material effect on the accompanying condensed consolidated financial statements.

XML 19 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property
9 Months Ended
Sep. 30, 2022
Mineral Assets Equipment, and Kinetic Separation Intellectual Property and Other Property [Abstract]  
MINERAL ASSETS EQUIPMENT, KINETIC SEPARATION INTELLECTUAL PROPERTY, AND OTHER PROPERTY

NOTE 4 – MINERAL ASSETS equipment, Kinetic separation INTELLECTUAL PROPERTY, AND OTHER PROPERTY 

 

The Company’s mining properties acquired on August 18, 2014 that the Company retains as of September 30, 2022 include: The San Rafael Uranium Project located in Emery County, Utah; The Sunday Mine Complex located in western San Miguel County, Colorado; The Van 4 Mine located in western Montrose County, Colorado; The Sage Mine located in San Juan County, Utah, and San Miguel County, Colorado. These mining properties include leased land in the states of Colorado and Utah. None of these mining properties were operational at the date of acquisition.

 

The Company’s mining properties acquired on September 16, 2015 that the Company retains as of September 30, 2022 include Hansen, North Hansen and Hansen Picnic Tree located in Fremont and Teller Counties, Colorado. The Company also acquired the Keota project located in Weld County, Colorado and the Ferris Haggerty project located in Carbon County Wyoming. These mining assets include both owned and leased land in the states of Utah, Colorado, and Wyoming. All of the mining assets represent properties which have previously been mined, to different degrees, for uranium.

 

As the Company has not formally established proven or probable reserves on any of its properties, there is inherent uncertainty as to whether or not any mineralized material can be economically extracted as originally planned and anticipated.

 

The Company’s mineral properties and equipment and kinetic separation intellectual property are:

 

   As of
September 30,
2022
   As of
December 31,
2021
 
Mineral properties and equipment  $12,656,075   $11,780,142 
Kinetic separation intellectual property  $9,488,051   $9,488,051 

 

Oil and Gas Lease and Easement

 

The Company entered into an oil and gas lease that became effective with respect to minerals and mineral rights owned by the Company of approximately 160 surface acres of the Company’s property in Colorado. As consideration for entering into the lease, the lessee has agreed to pay the Company a royalty from the lessee’s revenue attributed to oil and gas produced, saved, and sold attributable to the net mineral interest. The Company has also received cash payments from the lessee related to the easement that the Company is recognizing incrementally over the eight year term of the easement.

 

On June 23, 2020, the same entity, as discussed above, elected to extend the oil and gas lease easement for three additional years, commencing on the date the lease would have previously expired. During 2021, the operator completed all well development stages, and each of the eight (8) wells commenced oil and gas production by mid-August 2021. On January 31, 2022, the operator of the Weld County Colorado oil and gas pooled trust issued the first cumulative royalty payment check in the amount of $207,552 for August 2021 through December 2021 sales which was recognized as income in the fourth quarter of 2021. Royalty receipts were received monthly as earned during each of the months in 2022.

 

During the three months ended September 30, 2022 and 2021, the Company recognized aggregate revenue of $108,547 and $16,155, respectively, and for the nine months ended September 30, 2022 and 2021, the Company recognized aggregate revenue of $387,810 and $48,465, respectively, under these oil and gas lease arrangements.

 

Reclamation Liabilities

 

The Company’s mines are subject to certain asset retirement obligations, which the Company has recorded as reclamation liabilities. The reclamation liabilities of the United States mines are subject to legal and regulatory requirements, and estimates of the costs of reclamation are reviewed periodically by the applicable regulatory authorities. The reclamation liability represents the Company’s best estimate of the present value of future reclamation costs in connection with the mineral properties. The Company determined the gross reclamation liabilities of the mineral properties to be $751,405 and $740,446 as of September 30, 2022 and December 31, 2021, respectively. On March 2, 2020, the Colorado Mined Land Reclamation Board (“MLRB”) issued an order vacating the Van 4 Temporary Cessation, terminating mining operations and ordering commencement of final reclamation. The Company has begun the reclamation of the Van 4 Mine. The reclamation cost is fully covered by the reclamation bonds posted upon acquisition of the property. The Company adjusted the fair value of its reclamation obligation for the Van 4 Mine. The portion of the reclamation liability related to the Van 4 Mine and its related restricted cash are included in current liabilities and current assets, respectively, at a value of $75,057. The Company expects to begin incurring the reclamation liability after 2054 for all mines that are not in reclamation and accordingly, has discounted the gross liabilities over their remaining lives using a discount rate of 5.4%. The net discounted aggregated values as of September 30, 2022 and December 31, 2021 were $297,510 and $271,620, respectively. The gross reclamation liabilities as of September 30, 2022 and December 31, 2021 are secured by financial warranties in the amount of $751,405 and $740,446, respectively.

 

Reclamation liability activity for the nine months ended September 30, 2022 and 2021 consists of:

 

   For the Nine Months Ended
September 30,
 
   2022   2021 
Beginning balance at January 1  $271,620   $309,940 
Accretion   25,890    8,652 
Discontinuation of reclamation liability   -    (2,669)
Ending Balance at September 30  $297,510   $315,923 

 

Sunday Mine Complex Permitting Status

 

On February 4, 2020, the Colorado DRMS sent a Notice of Hearing to Declare Termination of Mining Operations related to the status of the mining permits issued by the state of Colorado for the Sunday Mine Complex. At issue was the application of an unchallenged Colorado Court of Appeals Opinion for a separate mine (Van 4) with very different facts that are retroactively modifying DRMS rules and regulations. The Company maintains that it was timely in meeting existing rules and regulations. The hearing was scheduled to be held during several monthly MLRB Board meetings, but this matter was delayed several times. The permit hearing was held during the MLRB Board monthly meeting on July 22, 2020. At issue was the status of the five existing permits which comprise the Sunday Mine Complex. Due to COVID-19 restrictions, the hearing took place utilizing a virtual-only format. The Company prevailed in a 3 to 1 decision which acknowledged that the work completed at the Sunday Mine Complex under DRMS oversight was timely and sufficient for Western to maintain these permits. In a subsequent July 30, 2020 letter, the DRMS notified the Company that the status of the five permits (Sunday, West Sunday, St. Jude, Carnation, and Topaz) had been changed to “Active” status effective June 10, 2019, the original date on which the change of the status was approved. On August 23, 2020, the Company initiated a request for Temporary Cessation status for the Sunday Mine Complex as the mines had not been restarted within a 180-day window due to the direct and indirect impacts of the COVID-19 pandemic. Accordingly, a permit hearing was scheduled for October 21, 2020 to determine Temporary Cessation status. In a unanimous vote, the MLRB approved Temporary Cessation status for each of the five Sunday Mine Complex permits (Sunday, West Sunday, St. Jude, Carnation, and Topaz). On October 9, 2020, the MLRB issued a board order which finalized the findings of the July 22, 2020 permit hearing. On November 10, 2020, the MLRB issued a board order which finalized the findings of the October 21, 2020 permit hearing. On November 6, 2020, the MLRB signed an order placing the five Sunday Mine Complex mine permits into Temporary Cessation. On November 12, 2020, a coalition of environmental groups (the “Plaintiffs”) filed a complaint against the MLRB seeking a partial appeal of the July 22, 2020 decision by requesting termination of the Topaz Mine permit. On December 15, 2020, the same coalition of environmental groups amended their complaint against the MLRB seeking a partial appeal of the October 21, 2020 decision requesting termination of the Topaz Mine permit. The Company has joined with the MLRB in defense of their July 22, 2020 and October 21, 2020 decisions. On May 5, 2021, the Plaintiffs in the Topaz Appeal filed an opening brief with the Denver District Court seeking to overturn the July 22, 2020 and October 21, 2020 MLRB permit hearing decisions on the Topaz Mine permit. The MLRB and the Company were to respond with an answer brief within 35 days on or before June 9, 2021, but instead sought a settlement. The judicial review process was delayed as extensions were put in place until August 20, 2021. A settlement was not reached, and the MLRB and the Company submitted answer briefs on August 20, 2021. The Plaintiff submitted a reply brief on September 10, 2021. On March 1, 2022, the Denver District Court reversed the MLRB’s orders regarding the Topaz Mine and remanded the case back to MLRB for further proceedings consistent with its order. The Company and the MLRB had until April 19, 2022 to appeal the Denver District Court’s ruling. Neither the Company nor the MLRB appealed the Denver District Court ruling. Western anticipates receiving an MLRB board order of reclamation for the Topaz Mine. The Company is continuing to work toward the completion of an updated Topaz Mine Plan of Operations which is a separate federal requirement of the BLM for the conduct of mining activities on the federal land at the Topaz Mine.

 

Kinetic Separation Intellectual Property

 

The Kinetic Separation intellectual property was acquired in Western’s acquisition of Black Range on September 16, 2015. Previously Black Range acquired its Kinetic Separation assets in the dissolution of a joint venture on March 17, 2015, through the acquisition of all the assets of the joint venture and received a 25-year license to utilize all of the patented and unpatented technology owned by the joint venture. The technology license agreement for patents and unpatented technology became effective as of March 17, 2015, for a period of 25 years, until March 16, 2040. There are no remaining license fee obligations, and there are no future royalties due under the agreement. The Company has the right to sub-license the technology to third parties. The Company may not sell or assign the Kinetic Separation license; however, the license could be transferred in the case of a sale of the Company. The Company has developed improvements to Kinetic Separation during the term of the license agreement and retains ownership of, and may obtain patent protection on, any such improvements developed by the Company.

 

The Kinetic Separation patent was filed on September 13, 2012 and granted on February 14, 2014 by the United States Patent Office. The patent is effective for a period of 20 years until September 13, 2032. This patent is supported by two provisional patent applications. The provisional patent applications expired after one year but were incorporated in the U.S. Patent by reference and claimed benefit prior to their expirations. The status of the patent and two provisional patent applications has not changed subsequent to the 2014 patent grant. The Company has the continued right to use any patented portion of the Kinetic Separation technology that enters the public domain subsequent to the patent expiration.

 

The Company anticipates Kinetic Separation will improve the efficiency of the mining and processing of the sandstone-hosted ore from Western’s conventional mines through the separation of waste from mineral bearing-ore, potentially reducing transportation, mill processing, and mill tailings costs. Kinetic Separation is not currently in use or being applied at any Company mines. The Company views Kinetic Separation as a cost saving technology, which it will seek to incorporate into ore production subsequent to commencing scaled production levels. There are also alternative applications, which the Company has explored.

 

Mining Equipment Purchases

 

During the nine months ended September 30, 2022 and 2021, Western purchased $895,400 and $65,000, respectively, in mining equipment and vehicles.

XML 20 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accounts Payable and Accrued Liabilities
9 Months Ended
Sep. 30, 2022
Payables and Accruals [Abstract]  
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

NOTE 5 – Accounts Payable and Accrued Liabilities

 

Accounts payable and accrued liabilities consisted of:

 

   As of 
   September 30,
2022
   December 31,
2021
 
Trade accounts payable  $353,386   $510,831 
Accrued liabilities   219,544    188,762 
Total accounts payable and accrued liabilities  $572,930   $699,593 
XML 21 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies
9 Months Ended
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 6 – COMMITMENTS AND CONTINGENCIES

  

Supply Contract

  

In December 2015, the Company signed a uranium concentrates supply agreement with a major United States utility company for delivery commencing in 2018 and continuing for a five-year period through 2022. On March 8, 2021, the Company entered into an agreement with a third party to complete the Year 4 (2021) uranium concentrate delivery. The Company paid $78,000 in April 2021 to the assignee for which the assignee made the delivery in May 2021. In April 2022, in satisfaction of the Year 5 delivery under its supply contract, the Company delivered 125,000 lbs of uranium concentrate from its prepaid uranium concentrate inventory. Accordingly, during the three and nine months ended September 30, 2022, the Company recorded revenue of $0 and $7,223,609 (at a price of approximately $57 per pound), respectively, and cost of revenue of $0 and $4,044,083, respectively, related to the delivery of the uranium. In May 2022, the Company received the cash proceeds from this sale.

 

Strategic Acquisition of Physical Uranium

 

In May 2021, the Company executed a binding agreement to purchase 125,000 pounds of natural uranium concentrate at approximately $32 per pound. In December 2021, the Company paid $4,044,083, in connection with its full prepayment of the purchase price for 125,000 pounds of natural uranium concentrate. This uranium concentrate was subsequently delivered under the terms of the aforementioned uranium concentrates supply agreement in April 2022.

XML 22 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share Capital and Other Equity Instruments
9 Months Ended
Sep. 30, 2022
Share Capital and Other Equity Instruments [Abstract]  
SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS

NOTE 7 – SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS

 

Authorized Capital

 

The holders of the Company’s common shares are entitled to one vote per share. Holders of common shares are entitled to ratably receive such dividends, if any, as may be declared by the board of directors, out of legally available funds. Upon the liquidation, dissolution, or winding down of the Company, holders of common shares are entitled to share ratably in all assets of the Company that are legally available for distribution. As of September 30, 2022 and December 31, 2021, an unlimited number of common shares were authorized for issuance.

 

Private Placements

 

On January 20, 2022, the Company closed a non-brokered private placement of 2,495,575 units at a price of CAD $1.60 per unit. The aggregate gross proceeds raised in the private placement amounted to CAD $3,992,920 (USD $3,011,878 in net proceeds). Each unit consisted of one common share of Western (a “Share”) plus one common share purchase warrant of Western (a “Warrant”). Each Warrant entitled the holder to purchase one Share at a price of CAD $2.50 per Share for a period of three years following the closing date of the private placement. A total of 2,495,575 Shares and 2,495,575 Warrants were issued to investors and 98,985 Warrants were issued to broker dealers in connection with the private placement.

 

Warrant Exercises

 

During the nine months ended September 30, 2022, an aggregate of 2,020,351 warrants were exercised for total gross proceeds of $2,620,395.

 

Incentive Stock Option Plan

 

The Company maintains an Incentive Stock Option Plan (the “Plan”) that permits the granting of stock options as incentive compensation. Shareholders of the Company approved the Plan on June 30, 2008 and amendments to the Plan on June 20, 2013. The board of directors approved additional changes to the Plan on September 12, 2015 and as of October 1, 2021.

 

The purpose of the Plan is to attract, retain, and motivate directors, management, staff, and consultants by providing them with the opportunity, through stock options, to acquire a proprietary interest in the Company and benefit from its growth.

 

The Plan provides that the aggregate number of common shares for which stock options may be granted will not exceed 10% of the issued and outstanding common shares at the time stock options are granted. As of September 30, 2022, a total of 43,588,742 common shares were outstanding, and at that date the maximum number of stock options eligible for issue under the Plan was 4,358,874.

 

Stock Options

 

On February 10, 2022, the Company granted options under the Plan for the purchase of an aggregate of 900,000 common shares to five individuals consisting of directors and officers of the Company. The options have a five year term, an exercise price of CAD $1.76 (US $1.28 as of September 30, 2022) and vest equally in thirds commencing initially on the date of grant and thereafter on April 1, 2022, and July 1, 2022.

 

The Company utilized the Black-Scholes option pricing model to determine the fair value of these stock options, using the assumptions as outlined below.

 

   February 10,
2022
 
Stock Price  CAD$1.76 
Exercise Price  CAD$1.76 
Number of Options Granted   900,000 
Dividend Yield   0%
Expected Volatility   103.3%
Weighted Average Risk-Free Interest Rate   1.61%
Expected life (in years)   2.6 

 

   Number of
Shares
   Weighted
Average
Exercise Price
   Weighted
Average
Contractual
Life (Years)
   Weighted
Average
Grant Date
Fair Value
   Intrinsic
Value
 
Outstanding – January 1, 2022   2,324,670   $1.35    1.67   $0.39   $528,714 
Granted   900,000    1.28    -    0.84      
Expired   (116,670)   1.81    -    0.27    - 
Outstanding – September 30, 2022   3,108,000   $1.24    2.15   $0.52   $408,063 
Exercisable – September 30, 2022   3,108,000   $1.24    2.15   $0.52   $408,063 

 

The Company’s stock-based compensation expense related to stock options for the three months ended September 30, 2022 and 2021 was $0 and $0, respectively, and for the nine months ended September 30, 2022 and 2021 stock-based compensation expense was $753,219 and $0, respectively, which is included in general and administrative expenses on the Company’s condensed consolidated statements of operations and comprehensive loss. As of September 30, 2022, there was no unamortized stock option expense.

 

Warrants

 

   Number of
Shares
   Weighted
Average
Exercise Price
   Weighted
Average
Contractual
Life (Years)
   Intrinsic
Value
 
Outstanding - January 1, 2022   9,735,948   $1.09    1.49    3,799,606 
Issued   2,594,560    1.81    -    - 
Exercised   (2,020,351)   1.19    -    - 
Expired/Forfeited   (948,081)   1.97    -    - 
Outstanding – September 30, 2022   9,362,076   $1.17    2.11   $2,673,679 
Exercisable – September 30, 2022   9,362,076   $1.17    2.11   $2,673,679 
XML 23 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
Mining Expenditures
9 Months Ended
Sep. 30, 2022
Mining Expenditures [Abstract]  
MINING EXPENDITURES

Note 8 – Mining Expenditures

 

   For the Three Months Ended
September 30,
   For the Nine Months Ended
September 30,
 
   2022   2021   2022   2021 
Permits  $29,946   $32,639   $86,103   $106,426 
Mining costs   172,421    300,988    524,336    312,534 
Royalties   2,153    1,401    5,707    3,961 
Total mining expenses  $204,520   $335,028   $616,146   $422,921 
XML 24 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
Related Party Transactions and Balances
9 Months Ended
Sep. 30, 2022
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS AND BALANCES

NOTE 9 – Related Party Transactions AND BALANCES

 

The Company has transacted with related parties pursuant to service arrangements in the ordinary course of business, as follows:

 

Prior to the acquisition of Black Range, Mr. George Glasier, the Company’s CEO, who is also a director (“Seller”), transferred his interest in a former joint venture with Ablation Technologies, LLC to Black Range. In connection with the transfer, Black Range issued 25 million shares of Black Range common stock to Seller and committed to pay AUD $500,000 (USD $321,600 as of September 30, 2022) to Seller within 60 days of the first commercial application of the kinetic separation technology. Western assumed this contingent payment obligation in connection with the acquisition of Black Range. At the date of the acquisition of Black Range, this contingent obligation was determined to be probable. Since the deferred contingent consideration obligation is probable and the amount is estimable, the Company recorded the deferred contingent consideration as an assumed liability in the amount of $321,600 and $362,794 as of September 30, 2022 and December 31, 2021, respectively.

 

The Company also owed Mr. Glasier reimbursable expenses in the amount of $54,000 and $65,753 as of September 30, 2022 and December 31, 2021, respectively.

XML 25 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
Covid-19
9 Months Ended
Sep. 30, 2022
Covid-19 [Abstract]  
COVID-19

Note 10 – COVID-19  

 

The world has been, and continues to be, impacted by the COVID-19 pandemic. COVID-19, and measures to prevent its spread, impacted our business in a number of ways. The impact of these disruptions and the extent of their adverse impact on the Company’s financial and operating results will be dictated by the length of time that such disruptions continue, which will, in turn, depend on the currently unpredictable duration and severity of the impacts of COVID-19, and among other things, the impact of governmental actions imposed in response to COVID-19 and individuals’ and companies’ risk tolerance regarding health matters going forward and developing strain mutations. To date, COVID-19 has primarily caused Western delays in reporting, regulatory matters, and operations. Most notably, the Company initiated a request for Temporary Cessation status for the Sunday Mine Complex in August 2020 as the mines had not been restarted within the 180-day window due to the direct and indirect impacts of the COVID-19 pandemic. The Van 4 Mine reclamation process was delayed because of COVID-19 pandemic lockdowns. The need to observe quarantine periods also caused a limited loss of manpower and delay to the 2021/2022 Sunday Mine Complex project. The COVID-19 pandemic has limited Western’s participation in industry and investor conference events. The Company is continuing to monitor COVID-19 and its subvariants and the potential impact of the pandemic on the Company’s operations.

XML 26 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
Subsequent Events
9 Months Ended
Sep. 30, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

Note 11 – subsequent events

 

On October 31, 2022, the Board of Directors granted an aggregate of 1,665,000 options for the purchase of the Company’s common stock to the Company’s officers, directors and employees. Each of these options was granted under the Plan and had an exercise price of CAD $1.60 (US $1.16 as of September 30, 2022). The options vest equally in two installments beginning on the date of grant and thereafter on April 30, 2023.

XML 27 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accounting Policies, by Policy (Policies)
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Basis of Presentation and Principles of Consolidation

Basis of Presentation and Principles of Consolidation

 

The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10 of Regulation S–X. Accordingly, they do not include all of the information and notes required U.S. GAAP. However, in the opinion of management of the Company, all adjustments necessary for a fair presentation of the financial position and operating results have been included in these condensed consolidated financial statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10–K for the fiscal year ended December 31, 2021, as filed with the SEC on April 15, 2022. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for any subsequent quarters or for the year ending December 31, 2022.

 

The accompanying condensed consolidated financial statements include the accounts of Western and its wholly-owned subsidiaries, Western Uranium Corp. (Utah), PRM, Black Range, Black Range Copper Inc., Ranger Resources Inc., Black Range Minerals Inc., Black Range Minerals Colorado LLC, Black Range Minerals Wyoming LLC, Haggerty Resources LLC, Ranger Alaska LLC, Black Range Minerals Utah LLC, Black Range Minerals Ablation Holdings Inc., and Black Range Development Utah LLC. All inter-company transactions and balances have been eliminated upon consolidation.

 

The Company has established the existence of mineralized materials for certain uranium projects. The Company has not established proven or probable reserves, as defined by the United States Securities and Exchange Commission (the “SEC”), through the completion of a “final” or “bankable” feasibility study for any of its uranium projects.

 

Exploration Stage and Mineral Properties

Exploration Stage and Mineral Properties

 

In accordance with U.S. GAAP, expenditures relating to the acquisition of mineral rights are initially capitalized as incurred while exploration and pre-extraction expenditures are expensed as incurred until such time the Company exits the exploration stage by establishing proven or probable reserves. Expenditures relating to exploration activities, such as drill programs to search for additional mineralized materials, are expensed as incurred. Expenditures relating to pre-extraction activities, such as the construction of mine wellfields, ion exchange facilities, disposal wells, and mine development, are expensed as incurred until such time proven or probable reserves are established for that uranium project, after which subsequent expenditures relating to development activities for that particular project are capitalized as incurred. Expenditures relating to mining and ore production while the Company is in the exploration stage and while the ore is stockpiled underground are expensed as incurred.

 

Production stage issuers, as defined in subpart 1300 of Regulation S-K, having engaged in material extraction of established mineral reserves on at least one material property, typically capitalize expenditures relating to ongoing development activities, with corresponding depletion calculated over proven and probable reserves using the units-of-production method and allocated to future reporting periods to inventory and, as that inventory is sold, to cost of goods sold. The Company is an exploration stage issuer, which has resulted in the Company reporting larger losses than if it had been in the production stage due to the expensing, instead of capitalizing, of expenditures relating to ongoing mine development and extraction activities. Additionally, there would be no corresponding amortization allocated to future reporting periods of the Company since those costs would have been expensed previously, resulting in both lower inventory costs and cost of goods sold and results of operations with higher gross profits and lower losses than if the Company had been in the production stage. Any capitalized costs, such as expenditures relating to the acquisition of mineral rights, are depleted over the estimated extraction life using the straight-line method. As a result, the Company’s condensed consolidated financial statements may not be directly comparable to the financial statements of companies in the production stage. Western will not be eligible to become a production stage issuer, and will remain an exploration stage issuer, until such time as mineral reserves are established on at least one material property.

 

Use of Estimates

Use of Estimates

 

The preparation of these condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and revenues and expenses during the periods reported. By their nature, these estimates are subject to measurement uncertainty, and the effects on the condensed consolidated financial statements of changes in such estimates in future periods could be significant. Significant areas requiring management’s estimates and assumptions include the determination of the fair value of transactions involving common shares, assessment of the useful life and evaluation for impairment of Kinetic Separation intellectual property, valuation and impairment assessments of mineral properties and equipment, valuation of deferred contingent consideration, valuation of the reclamation liability, valuation of stock-based compensation, and valuation of available-for-sale securities. Other areas requiring estimates include allocations of expenditures, depletion, and amortization of mineral rights and properties. Actual results could differ from those estimates.

 

Foreign Currency Translation

Foreign Currency Translation

 

The reporting currency of the Company, including its subsidiaries, is the United States dollar. The financial statements of subsidiaries located outside of the U.S. are measured in their functional currency, which is the local currency. The functional currency of the parent (Western Uranium & Vanadium Corp. (Ontario)) is the Canadian dollar. Monetary assets and liabilities of these subsidiaries are translated at the exchange rates at the balance sheet date. Transactions denominated in currencies other than the functional currency are recorded based on the exchange rates at the time of the transaction. Income and expense items are translated using average monthly exchange rates. Non-monetary assets are translated at their historical exchange rates. Translation adjustments are included in “Accumulated other comprehensive income” in the condensed consolidated balance sheets.

 

Revenue Recognition

Revenue Recognition

 

The Company purchased prepaid uranium concentrate contracts for future delivery of uranium concentrate pursuant to a supply agreement. The Company recognizes revenue upon the delivery of the uranium contract to the counterparty and charges to cost of revenues the purchase cost of the uranium concentrate contract upon such delivery. 

 

The Company leases certain of its mineral properties for the exploration and production of oil and gas reserves. The Company accounts for lease revenue in accordance with the FASB ASC 842, Leases. Lease payments received in advance are deferred and recognized on a straight-line basis over the related lease term associated with the prepayment. Royalty payments are recognized as revenues based upon production.

 

Fair Values of Financial Instruments

Fair Values of Financial Instruments

 

The carrying amounts of cash, restricted cash, accounts payable, subscription payable, reclamation liability, contingent consideration and accrued liabilities approximate their fair value due to the short-term nature of these instruments. Marketable securities are adjusted to fair value at each balance sheet date based on quoted prices which are considered level 1 inputs. The Company’s operating and financing activities are conducted primarily in United States dollars, and as a result, the Company is not subject to significant exposure to market risks from changes in foreign currency rates. The Company is exposed to credit risk through its cash and restricted cash but mitigates this risk by keeping these deposits at major financial institutions.

 

The FASB ASC 820, Fair Value Measurements and Disclosures, provides the framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements).

 

Fair value is defined as an exit price, representing the amount that would be received upon the sale of an asset or payment to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows:

 

Level 1 - Quoted prices in active markets for identical assets or liabilities.

 

Level 2 - Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly.

 

Level 3 - Significant unobservable inputs that cannot be corroborated by market data and inputs that are derived principally from or corroborated by observable market data or correlation by other means.

 

The fair value of the Company’s financial instruments are as follows:

 

   Quoted Prices
in Active
Markets for
Identical
Assets or
Liabilities
(Level 1)
   Quoted Prices
for Similar
Assets or
Liabilities in
Active
Markets
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Marketable securities as of September 30, 2022  $928   $       -   $        - 
                
Marketable securities as of December 31, 2021  $2,120   $-   $- 

 

Stock-Based Compensation

Stock-Based Compensation

 

The Company follows the FASB ASC 718, Compensation - Stock Compensation, which addresses the accounting for stock-based payment transactions, requiring such transactions to be accounted for using the fair value method. Awards of shares for property or services are recorded at the fair value of the stock or the fair value of the service, whichever is more readily measurable. The Company uses the Black-Scholes option-pricing model to determine the grant date fair value of stock-based awards under ASC 718. The fair value is charged to earnings depending on the terms and conditions of the award, and the nature of the relationship of the recipient of the award to the Company. The Company records the grant date fair value in line with the period over which it was earned. For employees and consultants, this is typically considered to be the vesting period of the award. The Company recognizes forfeitures at the time forfeitures occur.

 

Net Income (Loss) per Share

Net Income (Loss) per Share

 

Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share are computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and warrants (using the treasury stock method). The following is a reconciliation of the numerator and denominator used to calculate basic earnings per share and diluted earnings per share for the three and nine months ended September 30, 2022 and 2021. The computation of net income (loss) per share for each of the three and nine months ended September 30, 2021 is the same for both basic and fully diluted.

 

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2022   2021   2022   2021 
Numerator:                
Net (loss) income  $(527,525)  $(830,493)  $578,422   $(1,596,717)
                     
Denominator:                    
Weighted average shares outstanding, basic   43,514,832    38,203,075    42,536,893    36,243,124 
                     
Dilutive effect of options and warrants   -    -    1,010,484    - 
                     
Weighted average shares outstanding, diluted   43,514,832    38,203,075    43,547,377    36,243,124 
                     
Net (loss) income per share, basic  $(0.01)  $(0.02)  $0.01   $(0.04)
                     
Net (loss) income per share, diluted  $(0.01)  $(0.02)  $0.01   $(0.04)

 

Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net income (loss) per share because the effect of their inclusion would have been anti-dilutive.

 

Recent Accounting Standards

Recent Accounting Standards

 

Management does not believe that any recently issued, but not yet effective accounting standards, when adopted, will have a material effect on the accompanying condensed consolidated financial statements.

XML 28 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Schedule of fair values of financial instruments
   Quoted Prices
in Active
Markets for
Identical
Assets or
Liabilities
(Level 1)
   Quoted Prices
for Similar
Assets or
Liabilities in
Active
Markets
(Level 2)
   Significant
Unobservable
Inputs
(Level 3)
 
Marketable securities as of September 30, 2022  $928   $       -   $        - 
                
Marketable securities as of December 31, 2021  $2,120   $-   $- 

 

Schedule of computations of net income (loss) per share
   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2022   2021   2022   2021 
Numerator:                
Net (loss) income  $(527,525)  $(830,493)  $578,422   $(1,596,717)
                     
Denominator:                    
Weighted average shares outstanding, basic   43,514,832    38,203,075    42,536,893    36,243,124 
                     
Dilutive effect of options and warrants   -    -    1,010,484    - 
                     
Weighted average shares outstanding, diluted   43,514,832    38,203,075    43,547,377    36,243,124 
                     
Net (loss) income per share, basic  $(0.01)  $(0.02)  $0.01   $(0.04)
                     
Net (loss) income per share, diluted  $(0.01)  $(0.02)  $0.01   $(0.04)

 

   For the Three Months
Ended September 30,
   For the Nine Months
Ended September 30,
 
   2022   2021   2022   2021 
Warrants to purchase common shares   9,362,076    10,715,873    2,970,826    10,715,873 
Options to purchase common shares   3,108,000    2,808,000    983,000    2,808,000 
Total potentially dilutive securities   12,470,076    13,523,873    3,953,826    13,523,873 

 

XML 29 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Tables)
9 Months Ended
Sep. 30, 2022
Mineral Assets Equipment, and Kinetic Separation Intellectual Property and Other Property [Abstract]  
Schedule of mineral properties and equipment and kinetic separation intellectual property
   As of
September 30,
2022
   As of
December 31,
2021
 
Mineral properties and equipment  $12,656,075   $11,780,142 
Kinetic separation intellectual property  $9,488,051   $9,488,051 

 

Schedule of reclamation liability activity
   For the Nine Months Ended
September 30,
 
   2022   2021 
Beginning balance at January 1  $271,620   $309,940 
Accretion   25,890    8,652 
Discontinuation of reclamation liability   -    (2,669)
Ending Balance at September 30  $297,510   $315,923 

 

XML 30 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accounts Payable and Accrued Liabilities (Tables)
9 Months Ended
Sep. 30, 2022
Payables and Accruals [Abstract]  
Schedule of accounts payable and accrued liabilities
   As of 
   September 30,
2022
   December 31,
2021
 
Trade accounts payable  $353,386   $510,831 
Accrued liabilities   219,544    188,762 
Total accounts payable and accrued liabilities  $572,930   $699,593 
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share Capital and Other Equity Instruments (Tables)
9 Months Ended
Sep. 30, 2022
Share Capital and Other Equity Instruments [Abstract]  
Schedule of black-scholes option pricing model
   February 10,
2022
 
Stock Price  CAD$1.76 
Exercise Price  CAD$1.76 
Number of Options Granted   900,000 
Dividend Yield   0%
Expected Volatility   103.3%
Weighted Average Risk-Free Interest Rate   1.61%
Expected life (in years)   2.6 

 

Schedule of stock options
   Number of
Shares
   Weighted
Average
Exercise Price
   Weighted
Average
Contractual
Life (Years)
   Weighted
Average
Grant Date
Fair Value
   Intrinsic
Value
 
Outstanding – January 1, 2022   2,324,670   $1.35    1.67   $0.39   $528,714 
Granted   900,000    1.28    -    0.84      
Expired   (116,670)   1.81    -    0.27    - 
Outstanding – September 30, 2022   3,108,000   $1.24    2.15   $0.52   $408,063 
Exercisable – September 30, 2022   3,108,000   $1.24    2.15   $0.52   $408,063 

 

Schedule of warrants
   Number of
Shares
   Weighted
Average
Exercise Price
   Weighted
Average
Contractual
Life (Years)
   Intrinsic
Value
 
Outstanding - January 1, 2022   9,735,948   $1.09    1.49    3,799,606 
Issued   2,594,560    1.81    -    - 
Exercised   (2,020,351)   1.19    -    - 
Expired/Forfeited   (948,081)   1.97    -    - 
Outstanding – September 30, 2022   9,362,076   $1.17    2.11   $2,673,679 
Exercisable – September 30, 2022   9,362,076   $1.17    2.11   $2,673,679 
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
Mining Expenditures (Tables)
9 Months Ended
Sep. 30, 2022
Mining Expenditures [Abstract]  
Schedule of mining expenditures
   For the Three Months Ended
September 30,
   For the Nine Months Ended
September 30,
 
   2022   2021   2022   2021 
Permits  $29,946   $32,639   $86,103   $106,426 
Mining costs   172,421    300,988    524,336    312,534 
Royalties   2,153    1,401    5,707    3,961 
Total mining expenses  $204,520   $335,028   $616,146   $422,921 
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
Business (Details)
Nov. 20, 2014
Pinon Ridge Mining LLC [Member]  
Business (Details) [Line Items]  
Acquired interest percentage 100.00%
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Liquidity and Going Concern (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Jan. 20, 2022
$ / shares
shares
Sep. 30, 2022
USD ($)
Jun. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
Sep. 30, 2021
USD ($)
Jun. 30, 2021
USD ($)
Mar. 31, 2021
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2022
CAD ($)
Sep. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
Liquidity and Going Concern (Details) [Line Items]                      
Net loss   $ (527,525) $ 2,279,550 $ (1,173,603) $ (830,493) $ (474,610) $ (291,614) $ 578,422   $ (1,596,717)  
Accumulated deficit   $ (12,583,074)           (12,583,074)     $ (13,161,496)
Working capital deficit               10,181,380      
Net proceeds raised in the private placement               3,011,878    
Non-brokered Private Placement [Member]                      
Liquidity and Going Concern (Details) [Line Items]                      
Private placement shares (in Shares) | shares 2,495,575                    
Private placement per share (in Dollars per share) | $ / shares $ 1.6                    
Gross proceeds raised in the private placement (in Dollars)                 $ 3,992,920    
Warrants [Member]                      
Liquidity and Going Concern (Details) [Line Items]                      
Proceeds from the exercise of warrants               $ 2,620,395      
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
Summary of Significant Accounting Policies (Details) - Schedule of fair values of financial instruments - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1) [Member]    
Summary of Significant Accounting Policies (Details) - Schedule of fair values of financial instruments [Line Items]    
Marketable securities $ 928 $ 2,120
Quoted Prices for Similar Assets or Liabilities in Active Markets (Level 2) [Member]    
Summary of Significant Accounting Policies (Details) - Schedule of fair values of financial instruments [Line Items]    
Marketable securities
Significant Unobservable Inputs (Level 3 [Member]    
Summary of Significant Accounting Policies (Details) - Schedule of fair values of financial instruments [Line Items]    
Marketable securities
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Summary of Significant Accounting Policies (Details) - Schedule of computations of net income (loss) per share - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Numerator:                
Net (loss) income (in Dollars) $ (527,525) $ 2,279,550 $ (1,173,603) $ (830,493) $ (474,610) $ (291,614) $ 578,422 $ (1,596,717)
Denominator:                
Weighted average shares outstanding, basic 43,514,832     38,203,075     42,536,893 36,243,124
Dilutive effect of options and warrants (in Dollars)         $ 1,010,484
Weighted average shares outstanding, diluted 43,514,832     38,203,075     43,547,377 36,243,124
Net (loss) income per share, basic (in Dollars per share) $ (0.01)     $ (0.02)     $ 0.01 $ (0.04)
Net (loss) income per share, diluted (in Dollars per share) $ (0.01)     $ (0.02)     $ 0.01 $ (0.04)
Total potentially dilutive securities 12,470,076     13,523,873     3,953,826 13,523,873
Warrants to purchase common shares [Member]                
Denominator:                
Total potentially dilutive securities 9,362,076     10,715,873     2,970,826 10,715,873
Options to purchase common shares [Member]                
Denominator:                
Total potentially dilutive securities 3,108,000     2,808,000     983,000 2,808,000
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Jan. 31, 2022
USD ($)
Jun. 23, 2020
Sep. 30, 2022
USD ($)
a
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
a
Sep. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
Mineral Assets Equipment, and Kinetic Separation Intellectual Property and Other Property [Abstract]              
Oil and gas lease permit area in acres (in Acres) | a     160   160    
Production revenue percentage of lease, description         As consideration for entering into the lease, the lessee has agreed to pay the Company a royalty from the lessee’s revenue attributed to oil and gas produced, saved, and sold attributable to the net mineral interest.    
Initial term of lease     8 years   8 years    
Additional term of lease   3 years          
Royalty payment $ 207,552            
Aggregate revenue     $ 108,547 $ 16,155 $ 387,810 $ 48,465  
Reclamation liability mineral properties     751,405   751,405   $ 740,446
Reclamation liability     75,057   $ 75,057    
Reclamation liability, description         The Company expects to begin incurring the reclamation liability after 2054 for all mines that are not in reclamation and accordingly, has discounted the gross liabilities over their remaining lives using a discount rate of 5.4%. The net discounted aggregated values as of September 30, 2022 and December 31, 2021 were $297,510 and $271,620, respectively.    
Gross reclamation liabilities     $ 751,405   $ 751,405   $ 740,446
Kinetic separation intellectual property, description         The Kinetic Separation intellectual property was acquired in Western’s acquisition of Black Range on September 16, 2015. Previously Black Range acquired its Kinetic Separation assets in the dissolution of a joint venture on March 17, 2015, through the acquisition of all the assets of the joint venture and received a 25-year license to utilize all of the patented and unpatented technology owned by the joint venture. The technology license agreement for patents and unpatented technology became effective as of March 17, 2015, for a period of 25 years, until March 16, 2040.    
Effective period         20 years    
Mining equipment purchases         $ 895,400 $ 65,000  
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details) - Schedule of mineral properties and equipment and kinetic separation intellectual property - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Schedule of mineral properties and equipment and kinetic separation intellectual property [Abstract]    
Mineral properties and equipment $ 12,656,075 $ 11,780,142
Kinetic separation intellectual property $ 9,488,051 $ 9,488,051
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details) - Schedule of reclamation liability activity - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Schedule of Reclamation Liability Activity [Abstract]    
Beginning balance at January 1 $ 271,620 $ 309,940
Accretion 25,890 8,652
Discontinuation of reclamation liability (2,669)
Ending Balance at September 30 $ 297,510 $ 315,923
XML 40 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accounts Payable and Accrued Liabilities (Details) - Schedule of accounts payable and accrued liabilities - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Schedule of Accounts Payable and Accrued Liabilities [Abstract]    
Trade accounts payable $ 353,386 $ 510,831
Accrued liabilities 219,544 188,762
Total accounts payable and accrued liabilities $ 572,930 $ 699,593
XML 41 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies (Details) - USD ($)
1 Months Ended 12 Months Ended
Apr. 30, 2022
May 31, 2021
Dec. 31, 2021
Apr. 30, 2021
Commitments and Contingencies Disclosure [Abstract]        
Agreed to pay       $ 78,000
Supply contract, description In April 2022, in satisfaction of the Year 5 delivery under its supply contract, the Company delivered 125,000 lbs of uranium concentrate from its prepaid uranium concentrate inventory. Accordingly, during the three and nine months ended September 30, 2022, the Company recorded revenue of $0 and $7,223,609 (at a price of approximately $57 per pound), respectively, and cost of revenue of $0 and $4,044,083, respectively, related to the delivery of the uranium. In May 2022, the Company received the cash proceeds from this sale.      
Strategic acquisition of physical uranium   In May 2021, the Company executed a binding agreement to purchase 125,000 pounds of natural uranium concentrate at approximately $32 per pound.    
Physical uranium inventory purchase description     In December 2021, the Company paid $4,044,083, in connection with its full prepayment of the purchase price for 125,000 pounds of natural uranium concentrate.  
XML 42 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share Capital and Other Equity Instruments (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 10, 2022
$ / shares
shares
Jan. 20, 2022
USD ($)
shares
Jan. 20, 2022
CAD ($)
$ / shares
shares
Sep. 30, 2022
USD ($)
shares
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
shares
Feb. 10, 2022
$ / shares
shares
Sep. 30, 2021
USD ($)
Feb. 10, 2022
$ / shares
Dec. 31, 2021
shares
Share Capital and Other Equity Instruments (Details) [Line Items]                    
Gross proceeds | $           $ 2,620,395        
Exercisable price per share | (per share) $ 1.28           $ 1.28   $ 1.76  
Exercisable price expires term 5 years                  
Warrants issued   98,985 98,985              
Aggregate warrants were exercised           2,020,351        
Common stock, shares outstanding       43,588,742   43,588,742       39,073,122
Number of options granted             900,000      
Stock based compensation expense (in Dollars) | $       $ 0 $ 0 $ 753,219   $ 0    
Common Stock [Member]                    
Share Capital and Other Equity Instruments (Details) [Line Items]                    
Number of options granted 900,000                  
Incentive Stock Option Plan [Member]                    
Share Capital and Other Equity Instruments (Details) [Line Items]                    
Percentage of issued and outstanding of common shares           10.00%        
Common stock, shares outstanding       43,588,742   43,588,742        
Maximum number of shares eligible for issue, shares           4,358,874        
Private Placement [Member]                    
Share Capital and Other Equity Instruments (Details) [Line Items]                    
Private placement units   2,495,575 2,495,575              
Unit price per share (in Dollars per share) | $ / shares     $ 1.6              
Gross proceeds | $     $ 3,992,920              
Net proceeds (in Dollars) | $   $ 3,011,878                
Exercisable price per share | $ / shares     $ 2.5              
Exercisable price expires term   3 years 3 years              
Shares issued     2,495,575              
Warrants issued   2,495,575 2,495,575              
XML 43 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share Capital and Other Equity Instruments (Details) - Schedule of black-scholes option pricing model
9 Months Ended
Feb. 10, 2022
$ / shares
shares
Schedule of Black Scholes Option Pricing Model [Abstract]  
Stock Price (in Dollars per share) $ 1.76
Exercise Price (in Dollars per share) $ 1.76
Number of Options Granted (in Shares) | shares 900,000
Dividend Yield 0.00%
Expected Volatility 103.30%
Weighted Average Risk-Free Interest Rate 1.61%
Expected life (in years) 2 years 7 months 6 days
XML 44 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share Capital and Other Equity Instruments (Details) - Schedule of stock options - Stock Option [Member]
9 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
Share Capital and Other Equity Instruments (Details) - Schedule of stock options [Line Items]  
Number of Shares, Outstanding – beginning balance (in Shares) | shares 2,324,670
Weighted Average Exercise Price, Outstanding – beginning balance $ 1.35
Weighted Average Contractual Life (years), Outstanding – beginning balance 1 year 8 months 1 day
Weighted Average Grant Date Fair Value, Outstanding – beginning balance $ 0.39
Intrinsic Value, Outstanding – beginning balance (in Dollars) | $ $ 528,714
Number of Shares, Granted (in Shares) | shares 900,000
Weighted Average Exercise Price, Granted $ 1.28
Weighted Average Grant Date Fair Value, Granted $ 0.84
Number of Shares, Expired, forfeited, or cancelled (in Shares) | shares (116,670)
Weighted Average Exercise Price, Expired, forfeited, or cancelled $ 1.81
Weighted Average Grant Date Fair Value, Expired, forfeited, or cancelled $ 0.27
Number of Shares, Outstanding – ending balance (in Shares) | shares 3,108,000
Weighted Average Exercise Price, Outstanding – ending balance $ 1.24
Weighted Average Contractual Life (years), Outstanding – ending balance 2 years 1 month 24 days
Weighted Average Grant Date Fair Value, Outstanding – ending balance $ 0.52
Intrinsic Value, Outstanding – ending balance (in Dollars) | $ $ 408,063
Number of Shares, Exercisable (in Shares) | shares 3,108,000
Weighted Average Exercise Price, Exercisable $ 1.24
Weighted Average Contractual Life (years), Exercisable 2 years 1 month 24 days
Weighted Average Grant Date Fair Value, Exercisable $ 0.52
Intrinsic Value, Exercisable (in Dollars) | $ $ 408,063
XML 45 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share Capital and Other Equity Instruments (Details) - Schedule of warrants - Warrant [Member]
9 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
Class of Warrant or Right [Line Items]  
Number of Shares Outstanding - beginning | shares 9,735,948
Weighted Average Exercise Price Outstanding - beginning | $ / shares $ 1.09
Weighted Average Contractual Life (years) - beginning 1 year 5 months 26 days
Intrinsic Value- beginning | $ $ 3,799,606
Number of Shares, Issued | shares 2,594,560
Weighted Average Exercise Price, Issued | $ / shares $ 1.81
Weighted Average Contractual Life (years), Issued
Intrinsic Value (USD), Issued | $
Number of Shares, Exercised | shares (2,020,351)
Weighted Average Exercise Price, Exercised | $ / shares $ 1.19
Weighted Average Contractual Life (years), Exercised
Intrinsic Value (USD) , Exercised | $
Number of Shares, Expired | shares (948,081)
Weighted Average Exercise Price, Expired | $ / shares $ 1.97
Weighted Average Contractual Life (years), Expired
Intrinsic Value (USD), Expired | $
Number of Shares Outstanding - ending | shares 9,362,076
Weighted Average Exercise Price Outstanding - ending | $ / shares $ 1.17
Weighted Average Contractual Life (years) Outstanding - ending 2 years 1 month 9 days
Intrinsic Value Outstanding - ending | $ $ 2,673,679
Number of Shares, Exercisable | shares 9,362,076
Weighted Average Exercise Price, Exercisable | $ / shares $ 1.17
Weighted Average Contractual Life (years), Exercisable 2 years 1 month 9 days
Intrinsic Value, Exercisable | $ $ 2,673,679
XML 46 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
Mining Expenditures (Details) - Schedule of mining expenditures - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Schedule of mining expenditures [Abstract]        
Permits $ 29,946 $ 32,639 $ 86,103 $ 106,426
Mining costs 172,421 300,988 524,336 312,534
Royalties 2,153 1,401 5,707 3,961
Total mining expenses $ 204,520 $ 335,028 $ 616,146 $ 422,921
XML 47 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
Related Party Transactions and Balances (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Related Party Transactions and Balances (Details) [Line Items]    
Deferred amount $ 321,600 $ 362,794
Reimbursable expenses $ 54,000 $ 65,753
Black Range [Member]    
Related Party Transactions and Balances (Details) [Line Items]    
Related party transaction, description In connection with the transfer, Black Range issued 25 million shares of Black Range common stock to Seller and committed to pay AUD $500,000 (USD $321,600 as of September 30, 2022) to Seller within 60 days of the first commercial application of the kinetic separation technology.  
XML 48 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
Subsequent Events (Details)
9 Months Ended
Oct. 31, 2022
shares
Feb. 10, 2022
shares
Sep. 30, 2022
$ / shares
Sep. 30, 2022
$ / shares
Subsequent Events (Details) [Line Items]        
Number of options granted   900,000    
Exercise price per share | (per share)     $ 1.16 $ 1.6
Subsequent Event [Member]        
Subsequent Events (Details) [Line Items]        
Number of options granted 1,665,000      
XML 49 f10q0922_westernuranium_htm.xml IDEA: XBRL DOCUMENT 0001621906 2022-01-01 2022-09-30 0001621906 2022-11-15 0001621906 2022-09-30 0001621906 2021-12-31 0001621906 2021-01-01 2021-12-31 0001621906 2022-07-01 2022-09-30 0001621906 2021-07-01 2021-09-30 0001621906 2021-01-01 2021-09-30 0001621906 us-gaap:CommonStockMember 2021-12-31 0001621906 us-gaap:TreasuryStockMember 2021-12-31 0001621906 us-gaap:RetainedEarningsMember 2021-12-31 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001621906 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001621906 us-gaap:TreasuryStockMember 2022-01-01 2022-03-31 0001621906 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001621906 2022-01-01 2022-03-31 0001621906 us-gaap:CommonStockMember 2022-03-31 0001621906 us-gaap:TreasuryStockMember 2022-03-31 0001621906 us-gaap:RetainedEarningsMember 2022-03-31 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001621906 2022-03-31 0001621906 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001621906 us-gaap:TreasuryStockMember 2022-04-01 2022-06-30 0001621906 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001621906 2022-04-01 2022-06-30 0001621906 us-gaap:CommonStockMember 2022-06-30 0001621906 us-gaap:TreasuryStockMember 2022-06-30 0001621906 us-gaap:RetainedEarningsMember 2022-06-30 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001621906 2022-06-30 0001621906 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001621906 us-gaap:TreasuryStockMember 2022-07-01 2022-09-30 0001621906 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001621906 us-gaap:CommonStockMember 2022-09-30 0001621906 us-gaap:TreasuryStockMember 2022-09-30 0001621906 us-gaap:RetainedEarningsMember 2022-09-30 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001621906 us-gaap:CommonStockMember 2020-12-31 0001621906 us-gaap:TreasuryStockMember 2020-12-31 0001621906 us-gaap:RetainedEarningsMember 2020-12-31 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001621906 2020-12-31 0001621906 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001621906 us-gaap:TreasuryStockMember 2021-01-01 2021-03-31 0001621906 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001621906 2021-01-01 2021-03-31 0001621906 us-gaap:CommonStockMember 2021-03-31 0001621906 us-gaap:TreasuryStockMember 2021-03-31 0001621906 us-gaap:RetainedEarningsMember 2021-03-31 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001621906 2021-03-31 0001621906 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001621906 us-gaap:TreasuryStockMember 2021-04-01 2021-06-30 0001621906 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001621906 2021-04-01 2021-06-30 0001621906 us-gaap:CommonStockMember 2021-06-30 0001621906 us-gaap:TreasuryStockMember 2021-06-30 0001621906 us-gaap:RetainedEarningsMember 2021-06-30 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001621906 2021-06-30 0001621906 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001621906 us-gaap:TreasuryStockMember 2021-07-01 2021-09-30 0001621906 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001621906 us-gaap:CommonStockMember 2021-09-30 0001621906 us-gaap:TreasuryStockMember 2021-09-30 0001621906 us-gaap:RetainedEarningsMember 2021-09-30 0001621906 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001621906 2021-09-30 0001621906 wstrf:PinonRidgeMiningLLCMember 2014-11-20 0001621906 us-gaap:PrivatePlacementMember 2022-01-01 2022-01-20 0001621906 us-gaap:PrivatePlacementMember 2022-01-20 0001621906 us-gaap:PrivatePlacementMember 2022-01-01 2022-09-30 0001621906 wstrf:WarrantsMember 2022-01-01 2022-09-30 0001621906 us-gaap:FairValueInputsLevel1Member 2022-09-30 0001621906 us-gaap:FairValueInputsLevel2Member 2022-09-30 0001621906 us-gaap:FairValueInputsLevel3Member 2022-09-30 0001621906 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001621906 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001621906 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001621906 us-gaap:WarrantMember 2022-07-01 2022-09-30 0001621906 us-gaap:WarrantMember 2021-07-01 2021-09-30 0001621906 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001621906 us-gaap:WarrantMember 2021-01-01 2021-09-30 0001621906 wstrf:OptionsToPurchaseCommonSharesMember 2022-07-01 2022-09-30 0001621906 wstrf:OptionsToPurchaseCommonSharesMember 2021-07-01 2021-09-30 0001621906 wstrf:OptionsToPurchaseCommonSharesMember 2022-01-01 2022-09-30 0001621906 wstrf:OptionsToPurchaseCommonSharesMember 2021-01-01 2021-09-30 0001621906 2020-06-01 2020-06-23 0001621906 2022-01-01 2022-01-31 0001621906 2021-04-30 0001621906 2022-04-01 2022-04-30 0001621906 2021-05-01 2021-05-31 0001621906 2022-01-01 2022-01-20 0001621906 wstrf:IncentiveStockOptionPlanMember 2022-01-01 2022-09-30 0001621906 wstrf:IncentiveStockOptionPlanMember 2022-09-30 0001621906 us-gaap:CommonStockMember 2022-02-01 2022-02-10 0001621906 2022-02-01 2022-02-10 0001621906 2022-02-10 0001621906 2021-05-11 2022-02-10 0001621906 us-gaap:StockOptionMember 2021-12-31 0001621906 us-gaap:StockOptionMember 2022-01-01 2022-09-30 0001621906 us-gaap:StockOptionMember 2022-09-30 0001621906 us-gaap:WarrantMember 2021-12-31 0001621906 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001621906 us-gaap:WarrantMember 2022-09-30 0001621906 wstrf:BlackRangeMember 2022-01-01 2022-09-30 0001621906 us-gaap:SubsequentEventMember 2022-10-31 2022-10-31 shares iso4217:USD iso4217:USD shares pure iso4217:CAD shares iso4217:CAD utr:acre 10-Q true 2022-09-30 2022 false 000-55626 WESTERN URANIUM & VANADIUM CORP. A6 98-1271843 330 Bay Street Suite 1400 Toronto CA M5H 2S8 (970) 864-2125 Yes Yes Non-accelerated Filer true true false false 43589048 10468789 880821 75057 75057 4085723 299357 153701 928 2120 45251 264039 10889382 5461461 676348 665389 12656075 11780142 9488051 9488051 33709856 27395043 572930 699593 75057 75057 146177 60015 48465 708002 969292 222453 196563 2708887 2708887 321600 362794 60015 3960942 4297551 43589048 39073428 43588742 39073122 42581002 36195510 306 306 -12583074 -13161496 -249014 63478 29748914 23097492 33709856 27395043 108547 16155 7611419 48465 4044083 108547 16155 3567336 48465 204520 335028 616146 422921 97077 136174 445596 287042 351928 361301 1870747 835281 18346 12801 78165 16810 671871 845304 3010654 1562054 -563324 -829149 556682 -1513589 35799 -1344 17740 -4687 4000 78441 -527525 -830493 578422 -1596717 -148365 -46363 -312492 23531 -675890 -876856 265930 -1573186 -0.01 -0.02 0.01 -0.04 -0.01 -0.02 0.01 -0.04 43514832 38203075 42536893 36243124 43514832 38203075 43547377 36243124 39073122 36195510 306 -13161496 63478 23097492 2495575 3011878 3011878 502145 502145 268204 341850 341850 56661 56661 -1173603 -1173603 41836901 40051383 306 -14335099 120139 25836423 1477743 1989427 1989427 251074 251074 -220788 -220788 2279550 2279550 43314644 42291884 306 -12055549 -100649 30135686 274404 289118 289118 -148365 -148365 -527525 -527525 43589048 42581002 306 -12583074 -249014 29748914 30083747 29886367 306 -11087459 -25542 18773366 3250000 1950509 1950509 3125000 1918797 1918797 44964 44964 -291614 -291614 36458747 33755673 306 -11379073 19422 22396022 1722570 1597416 1597416 24930 24930 -474610 -474610 38181317 35353089 306 -11853683 44352 23543758 40000 52615 52615 -46363 -46363 -830493 -830493 38221317 35405704 306 -12684176 -2011 22719517 578422 -1596717 19468 8564 25890 5983 753219 1192 542 -4085723 -73132 80454 -126664 133920 -146177 -48465 -48465 41194 5174546 -1576627 895400 65000 -895400 -65000 3011878 2620395 1650031 3869306 5632273 5519337 -312492 -7835 9598927 3869875 1621267 1472061 11220194 5341936 10468789 4445103 75057 75057 676348 821776 11220194 5341936 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 1 – BUSINESS</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Nature of operations</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Western Uranium &amp; Vanadium Corp. (“Western” or the “Company”) was incorporated in December 2006 under the Ontario Business Corporations Act. On November 20, 2014, the Company completed a listing process on the Canadian Securities Exchange (“CSE”). As part of that process, the Company acquired 100% of the members’ interests of Pinon Ridge Mining LLC (“PRM”), a Delaware limited liability company. The transaction constituted a reverse takeover (“RTO”) of Western by PRM. Subsequent to obtaining appropriate shareholder approvals, the Company reconstituted its Board of Directors and senior management team. Effective September 16, 2015, Western completed its acquisition of Black Range Minerals Limited (“Black Range”).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company’s registered office is located at 330 Bay Street, Suite 1400, Toronto, Ontario, Canada, M5H 2S8, and its common shares are listed on the CSE under the symbol “WUC.” On April 22, 2016, the Company’s common shares began trading on the OTC Pink Open Market, and on May 23, 2016, the Company’s common shares were approved for trading on the OTCQX Best Market. The Company’s principal business activity is the acquisition and development of uranium and vanadium resource properties in the states of Utah and Colorado in the United States of America (“United States”).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On June 28, 2016, the Company’s registration statement became effective and Western became a United States reporting issuer. Thereafter, the Company was approved for Depository Trust Company eligibility through the Depository Trust and Clearing Corporation, which facilitates electronic book-entry delivery, settlement, and depository services for shares in the United States.</span></p> 1 <p style="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.95pt; text-transform: uppercase; text-indent: -35.95pt"><span style="font-family: Times New Roman, Times, Serif">Note 2 – Liquidity and going concern</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.95pt; text-align: justify; text-indent: -35.95pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">With the exception of the quarter ending June 30, 2022, the Company had incurred losses from our operations. During the three months ended September 30, 2022, the Company generated a net loss of $527,525. The Company expects to generate operating losses for the foreseeable future as it incurs expenses to bring its mining operations online. As of September 30, 2022, the Company had an accumulated deficit of $12,583,074 and working capital of $10,181,380.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Since inception, the Company has met its liquidity requirements principally through the issuance of notes and the sale of its common shares. On January 20, 2022, the Company closed a non-brokered private placement of 2,495,575 units at a price of CAD $1.60 per unit. The aggregate gross proceeds raised in the private placement amounted to CAD $3,992,920 (USD $3,011,878 in net proceeds). During the nine months ended September 30, 2022, the Company received $2,620,395 in proceeds from the exercise of warrants.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company’s ability to continue its planned operations and to pay its obligations when they become due is contingent upon the Company obtaining additional financing. Management’s plans include seeking to procure additional funds through debt and equity financing, to secure regulatory approval to fully utilize its kinetic separation (“Kinetic Separation”) technology, and to initiate the processing of ore to generate operating cash flows.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.35pt; text-align: justify; text-indent: 104.65pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">There are no assurances that the Company will be able to raise capital on terms acceptable to the Company or at all, or that cash flows generated from its operations will be sufficient to meet its current operating costs. If the Company is unable to obtain sufficient amounts of additional capital, it may be required to reduce the scope of its planned product development, which could harm its financial condition and operating results, or it may not be able to continue to fund its ongoing operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern to sustain operations for at least one year from the issuance of these condensed consolidated financial statements. The accompanying condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.</span></p> -527525 -12583074 10181380 2495575 1.6 3992920 3011878 2620395 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><b>Note </b></span><b><span style="font-family: Times New Roman, Times, Serif">3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Basis of Presentation and Principles of Consolidation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10 of Regulation S–X. Accordingly, they do not include all of the information and notes required U.S. GAAP. However, in the opinion of management of the Company, all adjustments necessary for a fair presentation of the financial position and operating results have been included in these condensed consolidated financial statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10–K for the fiscal year ended December 31, 2021, as filed with the SEC on April 15, 2022. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for any subsequent quarters or for the year ending December 31, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The accompanying condensed consolidated financial statements include the accounts of Western and its wholly-owned subsidiaries, Western Uranium Corp. (Utah), PRM, Black Range, Black Range Copper Inc., Ranger Resources Inc., Black Range Minerals Inc., Black Range Minerals Colorado LLC, Black Range Minerals Wyoming LLC, Haggerty Resources LLC, Ranger Alaska LLC, Black Range Minerals Utah LLC, Black Range Minerals Ablation Holdings Inc., and Black Range Development Utah LLC. All inter-company transactions and balances have been eliminated upon consolidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company has established the existence of mineralized materials for certain uranium projects. The Company has not established proven or probable reserves, as defined by the United States Securities and Exchange Commission (the “SEC”), through the completion of a “final” or “bankable” feasibility study for any of its uranium projects.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Exploration Stage and Mineral Properties</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In accordance with U.S. GAAP, expenditures relating to the acquisition of mineral rights are initially capitalized as incurred while exploration and pre-extraction expenditures are expensed as incurred until such time the Company exits the exploration stage by establishing proven or probable reserves. Expenditures relating to exploration activities, such as drill programs to search for additional mineralized materials, are expensed as incurred. Expenditures relating to pre-extraction activities, such as the construction of mine wellfields, ion exchange facilities, disposal wells, and mine development, are expensed as incurred until such time proven or probable reserves are established for that uranium project, after which subsequent expenditures relating to development activities for that particular project are capitalized as incurred. Expenditures relating to mining and ore production while the Company is in the exploration stage and while the ore is stockpiled underground are expensed as incurred.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Production stage issuers, as defined in subpart 1300 of Regulation S-K, having engaged in material extraction of established mineral reserves on at least one material property, typically capitalize expenditures relating to ongoing development activities, with corresponding depletion calculated over proven and probable reserves using the units-of-production method and allocated to future reporting periods to inventory and, as that inventory is sold, to cost of goods sold. The Company is an exploration stage issuer, which has resulted in the Company reporting larger losses than if it had been in the production stage due to the expensing, instead of capitalizing, of expenditures relating to ongoing mine development and extraction activities. Additionally, there would be no corresponding amortization allocated to future reporting periods of the Company since those costs would have been expensed previously, resulting in both lower inventory costs and cost of goods sold and results of operations with higher gross profits and lower losses than if the Company had been in the production stage. Any capitalized costs, such as expenditures relating to the acquisition of mineral rights, are depleted over the estimated extraction life using the straight-line method. As a result, the Company’s condensed consolidated financial statements may not be directly comparable to the financial statements of companies in the production stage. Western will not be eligible to become a production stage issuer, and will remain an exploration stage issuer, until such time as mineral reserves are established on at least one material property.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The preparation of these condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and revenues and expenses during the periods reported. By their nature, these estimates are subject to measurement uncertainty, and the effects on the condensed consolidated financial statements of changes in such estimates in future periods could be significant. Significant areas requiring management’s estimates and assumptions include the determination of the fair value of transactions involving common shares, assessment of the useful life and evaluation for impairment of Kinetic Separation intellectual property, valuation and impairment assessments of mineral properties and equipment, valuation of deferred contingent consideration, valuation of the reclamation liability, valuation of stock-based compensation, and valuation of available-for-sale securities. Other areas requiring estimates include allocations of expenditures, depletion, and amortization of mineral rights and properties. Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Foreign Currency Translation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The reporting currency of the Company, including its subsidiaries, is the United States dollar. The financial statements of subsidiaries located outside of the U.S. are measured in their functional currency, which is the local currency. The functional currency of the parent (Western Uranium &amp; Vanadium Corp. (Ontario)) is the Canadian dollar. Monetary assets and liabilities of these subsidiaries are translated at the exchange rates at the balance sheet date. Transactions denominated in currencies other than the functional currency are recorded based on the exchange rates at the time of the transaction. Income and expense items are translated using average monthly exchange rates. Non-monetary assets are translated at their historical exchange rates. Translation adjustments are included in “Accumulated other comprehensive income” in the condensed consolidated balance sheets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Revenue Recognition</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company purchased prepaid uranium concentrate contracts for future delivery of uranium concentrate pursuant to a supply agreement. The Company recognizes revenue upon the delivery of the uranium contract to the counterparty and charges to cost of revenues the purchase cost of the uranium concentrate contract upon such delivery. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company leases certain of its mineral properties for the exploration and production of oil and gas reserves. The Company accounts for lease revenue in accordance with the FASB ASC 842, <i>Leases</i>. Lease payments received in advance are deferred and recognized on a straight-line basis over the related lease term associated with the prepayment. Royalty payments are recognized as revenues based upon production.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Fair Values of Financial Instruments</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying amounts of cash, restricted cash, accounts payable, subscription payable, reclamation liability, contingent consideration and accrued liabilities approximate their fair value due to the short-term nature of these instruments. Marketable securities are adjusted to fair value at each balance sheet date based on quoted prices which are considered level 1 inputs. The Company’s operating and financing activities are conducted primarily in United States dollars, and as a result, the Company is not subject to significant exposure to market risks from changes in foreign currency rates. The Company is exposed to credit risk through its cash and restricted cash but mitigates this risk by keeping these deposits at major financial institutions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The FASB ASC 820, <i>Fair Value Measurements and Disclosures</i>, provides the framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Fair value is defined as an exit price, representing the amount that would be received upon the sale of an asset or payment to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level 1 - Quoted prices in active markets for identical assets or liabilities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level 2 - Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level 3 - Significant unobservable inputs that cannot be corroborated by market data and inputs that are derived principally from or corroborated by observable market data or correlation by other means.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The fair value of the Company’s financial instruments are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Quoted Prices<br/> in Active<br/> Markets for<br/> Identical<br/> Assets or<br/> Liabilities<br/> (Level 1)</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Quoted Prices<br/> for Similar<br/> Assets or<br/> Liabilities in<br/> Active<br/> Markets<br/> (Level 2)</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Significant<br/> Unobservable<br/> Inputs<br/> (Level 3)</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Marketable securities as of September 30, 2022</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">928</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-107; font-family: Times New Roman, Times, Serif">       -</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-108; font-family: Times New Roman, Times, Serif">        -</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Marketable securities as of December 31, 2021</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,120</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-109; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-110; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Stock-Based Compensation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company follows the FASB ASC 718, <i>Compensation - Stock Compensation</i>, which addresses the accounting for stock-based payment transactions, requiring such transactions to be accounted for using the fair value method. Awards of shares for property or services are recorded at the fair value of the stock or the fair value of the service, whichever is more readily measurable. The Company uses the Black-Scholes option-pricing model to determine the grant date fair value of stock-based awards under ASC 718. The fair value is charged to earnings depending on the terms and conditions of the award, and the nature of the relationship of the recipient of the award to the Company. The Company records the grant date fair value in line with the period over which it was earned. For employees and consultants, this is typically considered to be the vesting period of the award. The Company recognizes forfeitures at the time forfeitures occur.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Net Income (Loss) per Share</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share are computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and warrants (using the treasury stock method). The following is a reconciliation of the numerator and denominator used to calculate basic earnings per share and diluted earnings per share for the three and nine months ended September 30, 2022 and 2021. The computation of net income (loss) per share for each of the three and nine months ended September 30, 2021 is the same for both basic and fully diluted.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three Months Ended<br/> September 30,</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Nine Months Ended<br/> September 30,</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Net (loss) income</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(527,525</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(830,493</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">578,422</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,596,717</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average shares outstanding, basic</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,514,832</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">38,203,075</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">42,536,893</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,243,124</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Dilutive effect of options and warrants</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-111; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-112; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,010,484</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-113; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average shares outstanding, diluted</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,514,832</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">38,203,075</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,547,377</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,243,124</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net (loss) income per share, basic</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.01</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.04</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Net (loss) income per share, diluted</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.01</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.04</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net income (loss) per share because the effect of their inclusion would have been anti-dilutive.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Three Months <br/>Ended September 30,</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Nine Months <br/>Ended September 30,</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrants to purchase common shares</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,362,076</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,715,873</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,970,826</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,715,873</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Options to purchase common shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,108,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,808,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">983,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,808,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 4pt; padding-left: 9.8pt"><span style="font-family: Times New Roman, Times, Serif">Total potentially dilutive securities</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,470,076</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,523,873</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,953,826</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,523,873</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Recent Accounting Standards</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Management does not believe that any recently issued, but not yet effective accounting standards, when adopted, will have a material effect on the accompanying condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Basis of Presentation and Principles of Consolidation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10 of Regulation S–X. Accordingly, they do not include all of the information and notes required U.S. GAAP. However, in the opinion of management of the Company, all adjustments necessary for a fair presentation of the financial position and operating results have been included in these condensed consolidated financial statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10–K for the fiscal year ended December 31, 2021, as filed with the SEC on April 15, 2022. Operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for any subsequent quarters or for the year ending December 31, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The accompanying condensed consolidated financial statements include the accounts of Western and its wholly-owned subsidiaries, Western Uranium Corp. (Utah), PRM, Black Range, Black Range Copper Inc., Ranger Resources Inc., Black Range Minerals Inc., Black Range Minerals Colorado LLC, Black Range Minerals Wyoming LLC, Haggerty Resources LLC, Ranger Alaska LLC, Black Range Minerals Utah LLC, Black Range Minerals Ablation Holdings Inc., and Black Range Development Utah LLC. All inter-company transactions and balances have been eliminated upon consolidation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company has established the existence of mineralized materials for certain uranium projects. The Company has not established proven or probable reserves, as defined by the United States Securities and Exchange Commission (the “SEC”), through the completion of a “final” or “bankable” feasibility study for any of its uranium projects.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Exploration Stage and Mineral Properties</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In accordance with U.S. GAAP, expenditures relating to the acquisition of mineral rights are initially capitalized as incurred while exploration and pre-extraction expenditures are expensed as incurred until such time the Company exits the exploration stage by establishing proven or probable reserves. Expenditures relating to exploration activities, such as drill programs to search for additional mineralized materials, are expensed as incurred. Expenditures relating to pre-extraction activities, such as the construction of mine wellfields, ion exchange facilities, disposal wells, and mine development, are expensed as incurred until such time proven or probable reserves are established for that uranium project, after which subsequent expenditures relating to development activities for that particular project are capitalized as incurred. Expenditures relating to mining and ore production while the Company is in the exploration stage and while the ore is stockpiled underground are expensed as incurred.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Production stage issuers, as defined in subpart 1300 of Regulation S-K, having engaged in material extraction of established mineral reserves on at least one material property, typically capitalize expenditures relating to ongoing development activities, with corresponding depletion calculated over proven and probable reserves using the units-of-production method and allocated to future reporting periods to inventory and, as that inventory is sold, to cost of goods sold. The Company is an exploration stage issuer, which has resulted in the Company reporting larger losses than if it had been in the production stage due to the expensing, instead of capitalizing, of expenditures relating to ongoing mine development and extraction activities. Additionally, there would be no corresponding amortization allocated to future reporting periods of the Company since those costs would have been expensed previously, resulting in both lower inventory costs and cost of goods sold and results of operations with higher gross profits and lower losses than if the Company had been in the production stage. Any capitalized costs, such as expenditures relating to the acquisition of mineral rights, are depleted over the estimated extraction life using the straight-line method. As a result, the Company’s condensed consolidated financial statements may not be directly comparable to the financial statements of companies in the production stage. Western will not be eligible to become a production stage issuer, and will remain an exploration stage issuer, until such time as mineral reserves are established on at least one material property.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The preparation of these condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and revenues and expenses during the periods reported. By their nature, these estimates are subject to measurement uncertainty, and the effects on the condensed consolidated financial statements of changes in such estimates in future periods could be significant. Significant areas requiring management’s estimates and assumptions include the determination of the fair value of transactions involving common shares, assessment of the useful life and evaluation for impairment of Kinetic Separation intellectual property, valuation and impairment assessments of mineral properties and equipment, valuation of deferred contingent consideration, valuation of the reclamation liability, valuation of stock-based compensation, and valuation of available-for-sale securities. Other areas requiring estimates include allocations of expenditures, depletion, and amortization of mineral rights and properties. Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Foreign Currency Translation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The reporting currency of the Company, including its subsidiaries, is the United States dollar. The financial statements of subsidiaries located outside of the U.S. are measured in their functional currency, which is the local currency. The functional currency of the parent (Western Uranium &amp; Vanadium Corp. (Ontario)) is the Canadian dollar. Monetary assets and liabilities of these subsidiaries are translated at the exchange rates at the balance sheet date. Transactions denominated in currencies other than the functional currency are recorded based on the exchange rates at the time of the transaction. Income and expense items are translated using average monthly exchange rates. Non-monetary assets are translated at their historical exchange rates. Translation adjustments are included in “Accumulated other comprehensive income” in the condensed consolidated balance sheets.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Revenue Recognition</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company purchased prepaid uranium concentrate contracts for future delivery of uranium concentrate pursuant to a supply agreement. The Company recognizes revenue upon the delivery of the uranium contract to the counterparty and charges to cost of revenues the purchase cost of the uranium concentrate contract upon such delivery. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company leases certain of its mineral properties for the exploration and production of oil and gas reserves. The Company accounts for lease revenue in accordance with the FASB ASC 842, <i>Leases</i>. Lease payments received in advance are deferred and recognized on a straight-line basis over the related lease term associated with the prepayment. Royalty payments are recognized as revenues based upon production.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Fair Values of Financial Instruments</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The carrying amounts of cash, restricted cash, accounts payable, subscription payable, reclamation liability, contingent consideration and accrued liabilities approximate their fair value due to the short-term nature of these instruments. Marketable securities are adjusted to fair value at each balance sheet date based on quoted prices which are considered level 1 inputs. The Company’s operating and financing activities are conducted primarily in United States dollars, and as a result, the Company is not subject to significant exposure to market risks from changes in foreign currency rates. The Company is exposed to credit risk through its cash and restricted cash but mitigates this risk by keeping these deposits at major financial institutions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The FASB ASC 820, <i>Fair Value Measurements and Disclosures</i>, provides the framework for measuring fair value. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Fair value is defined as an exit price, representing the amount that would be received upon the sale of an asset or payment to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level 1 - Quoted prices in active markets for identical assets or liabilities.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level 2 - Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Level 3 - Significant unobservable inputs that cannot be corroborated by market data and inputs that are derived principally from or corroborated by observable market data or correlation by other means.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The fair value of the Company’s financial instruments are as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Quoted Prices<br/> in Active<br/> Markets for<br/> Identical<br/> Assets or<br/> Liabilities<br/> (Level 1)</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Quoted Prices<br/> for Similar<br/> Assets or<br/> Liabilities in<br/> Active<br/> Markets<br/> (Level 2)</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Significant<br/> Unobservable<br/> Inputs<br/> (Level 3)</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Marketable securities as of September 30, 2022</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">928</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-107; font-family: Times New Roman, Times, Serif">       -</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-108; font-family: Times New Roman, Times, Serif">        -</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Marketable securities as of December 31, 2021</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,120</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-109; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-110; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Quoted Prices<br/> in Active<br/> Markets for<br/> Identical<br/> Assets or<br/> Liabilities<br/> (Level 1)</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Quoted Prices<br/> for Similar<br/> Assets or<br/> Liabilities in<br/> Active<br/> Markets<br/> (Level 2)</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Significant<br/> Unobservable<br/> Inputs<br/> (Level 3)</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Marketable securities as of September 30, 2022</span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">928</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-107; font-family: Times New Roman, Times, Serif">       -</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; width: 9%; text-align: right"><span style="-sec-ix-hidden: hidden-fact-108; font-family: Times New Roman, Times, Serif">        -</span></td><td style="width: 1%; padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Marketable securities as of December 31, 2021</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,120</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-109; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-sec-ix-hidden: hidden-fact-110; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p> 928 2120 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Stock-Based Compensation</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company follows the FASB ASC 718, <i>Compensation - Stock Compensation</i>, which addresses the accounting for stock-based payment transactions, requiring such transactions to be accounted for using the fair value method. Awards of shares for property or services are recorded at the fair value of the stock or the fair value of the service, whichever is more readily measurable. The Company uses the Black-Scholes option-pricing model to determine the grant date fair value of stock-based awards under ASC 718. The fair value is charged to earnings depending on the terms and conditions of the award, and the nature of the relationship of the recipient of the award to the Company. The Company records the grant date fair value in line with the period over which it was earned. For employees and consultants, this is typically considered to be the vesting period of the award. The Company recognizes forfeitures at the time forfeitures occur.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Net Income (Loss) per Share</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted earnings per share are computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options and warrants (using the treasury stock method). The following is a reconciliation of the numerator and denominator used to calculate basic earnings per share and diluted earnings per share for the three and nine months ended September 30, 2022 and 2021. The computation of net income (loss) per share for each of the three and nine months ended September 30, 2021 is the same for both basic and fully diluted.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three Months Ended<br/> September 30,</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Nine Months Ended<br/> September 30,</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Net (loss) income</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(527,525</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(830,493</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">578,422</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,596,717</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average shares outstanding, basic</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,514,832</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">38,203,075</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">42,536,893</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,243,124</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Dilutive effect of options and warrants</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-111; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-112; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,010,484</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-113; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average shares outstanding, diluted</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,514,832</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">38,203,075</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,547,377</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,243,124</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net (loss) income per share, basic</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.01</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.04</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Net (loss) income per share, diluted</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.01</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.04</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net income (loss) per share because the effect of their inclusion would have been anti-dilutive.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Three Months Ended<br/> September 30,</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Nine Months Ended<br/> September 30,</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Net (loss) income</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(527,525</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(830,493</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">578,422</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(1,596,717</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average shares outstanding, basic</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,514,832</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">38,203,075</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">42,536,893</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,243,124</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Dilutive effect of options and warrants</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-111; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-112; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,010,484</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-113; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average shares outstanding, diluted</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,514,832</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">38,203,075</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">43,547,377</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">36,243,124</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net (loss) income per share, basic</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.01</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.04</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Net (loss) income per share, diluted</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.01</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.02</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.01</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(0.04</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Three Months <br/>Ended September 30,</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Nine Months <br/>Ended September 30,</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Warrants to purchase common shares</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,362,076</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,715,873</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,970,826</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">10,715,873</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Options to purchase common shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,108,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,808,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">983,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,808,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 4pt; padding-left: 9.8pt"><span style="font-family: Times New Roman, Times, Serif">Total potentially dilutive securities</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,470,076</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,523,873</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,953,826</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,523,873</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p> -527525 -830493 578422 -1596717 43514832 38203075 42536893 36243124 1010484 43514832 38203075 43547377 36243124 -0.01 -0.02 0.01 -0.04 -0.01 -0.02 0.01 -0.04 9362076 10715873 2970826 10715873 3108000 2808000 983000 2808000 12470076 13523873 3953826 13523873 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Recent Accounting Standards</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Management does not believe that any recently issued, but not yet effective accounting standards, when adopted, will have a material effect on the accompanying condensed consolidated financial statements.</span></p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; text-transform: uppercase"><b>NOTE 4 – MINERAL ASSETS equipment, Kinetic separation INTELLECTUAL PROPERTY, AND OTHER PROPERTY </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; text-transform: uppercase"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company’s mining properties acquired on August 18, 2014 that the Company retains as of September 30, 2022 include: The San Rafael Uranium Project located in Emery County, Utah; The Sunday Mine Complex located in western San Miguel County, Colorado; The Van 4 Mine located in western Montrose County, Colorado; The Sage Mine located in San Juan County, Utah, and San Miguel County, Colorado. These mining properties include leased land in the states of Colorado and Utah. None of these mining properties were operational at the date of acquisition.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company’s mining properties acquired on September 16, 2015 that the Company retains as of September 30, 2022 include Hansen, North Hansen and Hansen Picnic Tree located in Fremont and Teller Counties, Colorado. The Company also acquired the Keota project located in Weld County, Colorado and the Ferris Haggerty project located in Carbon County Wyoming. These mining assets include both owned and leased land in the states of Utah, Colorado, and Wyoming. All of the mining assets represent properties which have previously been mined, to different degrees, for uranium.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">As the Company has not formally established proven or probable reserves on any of its properties, there is inherent uncertainty as to whether or not any mineralized material can be economically extracted as originally planned and anticipated.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company’s mineral properties and equipment and kinetic separation intellectual property are:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of <br/>September 30, <br/> 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of <br/>December 31, <br/> 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Mineral properties and equipment</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,656,075</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,780,142</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Kinetic separation intellectual property</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,488,051</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,488,051</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Oil and Gas Lease and Easement</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company entered into an oil and gas lease that became effective with respect to minerals and mineral rights owned by the Company of approximately 160 surface acres of the Company’s property in Colorado. As consideration for entering into the lease, the lessee has agreed to pay the Company a royalty from the lessee’s revenue attributed to oil and gas produced, saved, and sold attributable to the net mineral interest. The Company has also received cash payments from the lessee related to the easement that the Company is recognizing incrementally over the eight year term of the easement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">On June 23, 2020, the same entity, as discussed above, elected to extend the oil and gas lease easement for three additional years, commencing on the date the lease would have previously expired. During 2021, the operator completed all well development stages, and each of the eight (8) wells commenced oil and gas production by mid-August 2021. On January 31, 2022, the operator of the Weld County Colorado oil and gas pooled trust issued the first cumulative royalty payment check in the amount of $207,552 for August 2021 through December 2021 sales which was recognized as income in the fourth quarter of 2021. Royalty receipts were received monthly as earned during each of the months in 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">During the three months ended September 30, 2022 and 2021, the Company recognized aggregate revenue of $108,547 and $16,155, respectively, and for the nine months ended September 30, 2022 and 2021, the Company recognized aggregate revenue of $387,810 and $48,465, respectively, under these oil and gas lease arrangements.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Reclamation Liabilities</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company’s mines are subject to certain asset retirement obligations, which the Company has recorded as reclamation liabilities. The reclamation liabilities of the United States mines are subject to legal and regulatory requirements, and estimates of the costs of reclamation are reviewed periodically by the applicable regulatory authorities. The reclamation liability represents the Company’s best estimate of the present value of future reclamation costs in connection with the mineral properties. The Company determined the gross reclamation liabilities of the mineral properties to be $751,405 and $740,446 as of September 30, 2022 and December 31, 2021, respectively. On March 2, 2020, the Colorado Mined Land Reclamation Board (“MLRB”) issued an order vacating the Van 4 Temporary Cessation, terminating mining operations and ordering commencement of final reclamation. The Company has begun the reclamation of the Van 4 Mine. The reclamation cost is fully covered by the reclamation bonds posted upon acquisition of the property. The Company adjusted the fair value of its reclamation obligation for the Van 4 Mine. The portion of the reclamation liability related to the Van 4 Mine and its related restricted cash are included in current liabilities and current assets, respectively, at a value of $75,057. The Company expects to begin incurring the reclamation liability after 2054 for all mines that are not in reclamation and accordingly, has discounted the gross liabilities over their remaining lives using a discount rate of 5.4%. The net discounted aggregated values as of September 30, 2022 and December 31, 2021 were $297,510 and $271,620, respectively. The gross reclamation liabilities as of September 30, 2022 and December 31, 2021 are secured by financial warranties in the amount of $751,405 and $740,446, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">Reclamation liability activity for the nine months ended September 30, 2022 and 2021 consists of:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Nine Months Ended<br/> September 30,</span></td><td style="padding-bottom: 1.5pt; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Beginning balance at January 1</span></td><td style="width: 1%; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">271,620</span></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">309,940</span></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Accretion</span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,890</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,652</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Discontinuation of reclamation liability</span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: hidden-fact-114; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,669</span></td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Ending Balance at September 30</span></td><td style="font-weight: normal; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">297,510</span></td><td style="padding-bottom: 4pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">315,923</span></td><td style="padding-bottom: 4pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Sunday Mine Complex Permitting Status </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On February 4, 2020, the Colorado DRMS sent a Notice of Hearing to Declare Termination of Mining Operations related to the status of the mining permits issued by the state of Colorado for the Sunday Mine Complex. At issue was the application of an unchallenged Colorado Court of Appeals Opinion for a separate mine (Van 4) with very different facts that are retroactively modifying DRMS rules and regulations. The Company maintains that it was timely in meeting existing rules and regulations. The hearing was scheduled to be held during several monthly MLRB Board meetings, but this matter was delayed several times. The permit hearing was held during the MLRB Board monthly meeting on July 22, 2020. At issue was the status of the five existing permits which comprise the Sunday Mine Complex. Due to COVID-19 restrictions, the hearing took place utilizing a virtual-only format. The Company prevailed in a 3 to 1 decision which acknowledged that the work completed at the Sunday Mine Complex under DRMS oversight was timely and sufficient for Western to maintain these permits. In a subsequent July 30, 2020 letter, the DRMS notified the Company that the status of the five permits (Sunday, West Sunday, St. Jude, Carnation, and Topaz) had been changed to “Active” status effective June 10, 2019, the original date on which the change of the status was approved. On August 23, 2020, the Company initiated a request for Temporary Cessation status for the Sunday Mine Complex as the mines had not been restarted within a 180-day window due to the direct and indirect impacts of the COVID-19 pandemic. Accordingly, a permit hearing was scheduled for October 21, 2020 to determine Temporary Cessation status. In a unanimous vote, the MLRB approved Temporary Cessation status for each of the five Sunday Mine Complex permits (Sunday, West Sunday, St. Jude, Carnation, and Topaz). On October 9, 2020, the MLRB issued a board order which finalized the findings of the July 22, 2020 permit hearing. On November 10, 2020, the MLRB issued a board order which finalized the findings of the October 21, 2020 permit hearing. On November 6, 2020, the MLRB signed an order placing the five Sunday Mine Complex mine permits into Temporary Cessation. On November 12, 2020, a coalition of environmental groups (the “Plaintiffs”) filed a complaint against the MLRB seeking a partial appeal of the July 22, 2020 decision by requesting termination of the Topaz Mine permit. On December 15, 2020, the same coalition of environmental groups amended their complaint against the MLRB seeking a partial appeal of the October 21, 2020 decision requesting termination of the Topaz Mine permit. The Company has joined with the MLRB in defense of their July 22, 2020 and October 21, 2020 decisions. On May 5, 2021, the Plaintiffs in the Topaz Appeal filed an opening brief with the Denver District Court seeking to overturn the July 22, 2020 and October 21, 2020 MLRB permit hearing decisions on the Topaz Mine permit. The MLRB and the Company were to respond with an answer brief within 35 days on or before June 9, 2021, but instead sought a settlement. The judicial review process was delayed as extensions were put in place until August 20, 2021. A settlement was not reached, and the MLRB and the Company submitted answer briefs on August 20, 2021. The Plaintiff submitted a reply brief on September 10, 2021. On March 1, 2022, the Denver District Court reversed the MLRB’s orders regarding the Topaz Mine and remanded the case back to MLRB for further proceedings consistent with its order. The Company and the MLRB had until April 19, 2022 to appeal the Denver District Court’s ruling. Neither the Company nor the MLRB appealed the Denver District Court ruling. Western anticipates receiving an MLRB board order of reclamation for the Topaz Mine. The Company is continuing to work toward the completion of an updated Topaz Mine Plan of Operations which is a separate federal requirement of the BLM for the conduct of mining activities on the federal land at the Topaz Mine.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Kinetic Separation Intellectual Property</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Kinetic Separation intellectual property was acquired in Western’s acquisition of Black Range on September 16, 2015. Previously Black Range acquired its Kinetic Separation assets in the dissolution of a joint venture on March 17, 2015, through the acquisition of all the assets of the joint venture and received a 25-year license to utilize all of the patented and unpatented technology owned by the joint venture. The technology license agreement for patents and unpatented technology became effective as of March 17, 2015, for a period of 25 years, until March 16, 2040. There are no remaining license fee obligations, and there are no future royalties due under the agreement. The Company has the right to sub-license the technology to third parties. The Company may not sell or assign the Kinetic Separation license; however, the license could be transferred in the case of a sale of the Company. The Company has developed improvements to Kinetic Separation during the term of the license agreement and retains ownership of, and may obtain patent protection on, any such improvements developed by the Company.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The Kinetic Separation patent was filed on September 13, 2012 and granted on February 14, 2014 by the United States Patent Office. The patent is effective for a period of 20 years until September 13, 2032. This patent is supported by two provisional patent applications. The provisional patent applications expired after one year but were incorporated in the U.S. Patent by reference and claimed benefit prior to their expirations. The status of the patent and two provisional patent applications has not changed subsequent to the 2014 patent grant. The Company has the continued right to use any patented portion of the Kinetic Separation technology that enters the public domain subsequent to the patent expiration.</span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The Company anticipates Kinetic Separation will improve the efficiency of the mining and processing of the sandstone-hosted ore from Western’s conventional mines through the separation of waste from mineral bearing-ore, potentially reducing transportation, mill processing, and mill tailings costs. Kinetic Separation is not currently in use or being applied at any Company mines. The Company views Kinetic Separation as a cost saving technology, which it will seek to incorporate into ore production subsequent to commencing scaled production levels. There are also alternative applications, which the Company has explored.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b><i>Mining Equipment Purchases</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">During the nine months ended September 30, 2022 and 2021, Western purchased $895,400 and $65,000, respectively, in mining equipment and vehicles.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of <br/>September 30, <br/> 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of <br/>December 31, <br/> 2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Mineral properties and equipment</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">12,656,075</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">11,780,142</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif">Kinetic separation intellectual property</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,488,051</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,488,051</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p> 12656075 11780142 9488051 9488051 160 As consideration for entering into the lease, the lessee has agreed to pay the Company a royalty from the lessee’s revenue attributed to oil and gas produced, saved, and sold attributable to the net mineral interest. P8Y P3Y 207552 108547 16155 387810 48465 751405 740446 75057 The Company expects to begin incurring the reclamation liability after 2054 for all mines that are not in reclamation and accordingly, has discounted the gross liabilities over their remaining lives using a discount rate of 5.4%. The net discounted aggregated values as of September 30, 2022 and December 31, 2021 were $297,510 and $271,620, respectively. 751405 740446 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Nine Months Ended<br/> September 30,</span></td><td style="padding-bottom: 1.5pt; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Beginning balance at January 1</span></td><td style="width: 1%; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">271,620</span></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">309,940</span></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Accretion</span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">25,890</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">8,652</span></td><td style="font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Discontinuation of reclamation liability</span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right"><span style="-sec-ix-hidden: hidden-fact-114; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,669</span></td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Ending Balance at September 30</span></td><td style="font-weight: normal; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">297,510</span></td><td style="padding-bottom: 4pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">315,923</span></td><td style="padding-bottom: 4pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><b> </b></span></p> 271620 309940 25890 8652 2669 297510 315923 The Kinetic Separation intellectual property was acquired in Western’s acquisition of Black Range on September 16, 2015. Previously Black Range acquired its Kinetic Separation assets in the dissolution of a joint venture on March 17, 2015, through the acquisition of all the assets of the joint venture and received a 25-year license to utilize all of the patented and unpatented technology owned by the joint venture. The technology license agreement for patents and unpatented technology became effective as of March 17, 2015, for a period of 25 years, until March 16, 2040. P20Y 895400 65000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><b>NOTE 5 – Accounts Payable and Accrued Liabilities</b></span></p><p style="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-variant: normal; font-weight: normal; text-transform: none"> </span></p><p style="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-variant: normal; font-weight: normal; text-transform: none">Accounts payable and accrued liabilities consisted of:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><b> </b></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of</span></td><td style="padding-bottom: 1.5pt; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September 30, <br/> 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,<br/> 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Trade accounts payable</span></td><td style="width: 1%; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">353,386</span></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">510,831</span></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accrued liabilities</span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">219,544</span></td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">188,762</span></td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total accounts payable and accrued liabilities</span></td><td style="font-weight: normal; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">572,930</span></td><td style="padding-bottom: 4pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">699,593</span></td><td style="padding-bottom: 4pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif">As of</span></td><td style="padding-bottom: 1.5pt; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif">September 30, <br/> 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31,<br/> 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Trade accounts payable</span></td><td style="width: 1%; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">353,386</span></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%; font-weight: normal"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">510,831</span></td><td style="width: 1%; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Accrued liabilities</span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">219,544</span></td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">188,762</span></td><td style="padding-bottom: 1.5pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total accounts payable and accrued liabilities</span></td><td style="font-weight: normal; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">572,930</span></td><td style="padding-bottom: 4pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: normal; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; font-weight: normal; text-align: right"><span style="font-family: Times New Roman, Times, Serif">699,593</span></td><td style="padding-bottom: 4pt; font-weight: normal; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 353386 510831 219544 188762 572930 699593 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 6 – COMMITMENTS AND CONTINGENCIES</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b> </b> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Supply Contract</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">  </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In December 2015, the Company signed a uranium concentrates supply agreement with a major United States utility company for delivery commencing in 2018 and continuing for a five-year period through 2022. On March 8, 2021, the Company entered into an agreement with a third party to complete the Year 4 (2021) uranium concentrate delivery. The Company paid $78,000 in April 2021 to the assignee for which the assignee made the delivery in May 2021. In April 2022, in satisfaction of the Year 5 delivery under its supply contract, the Company delivered 125,000 lbs of uranium concentrate from its prepaid uranium concentrate inventory. Accordingly, during the three and nine months ended September 30, 2022, the Company recorded revenue of $0 and $7,223,609 (at a price of approximately $57 per pound), respectively, and cost of revenue of $0 and $4,044,083, respectively, related to the delivery of the uranium. In May 2022, the Company received the cash proceeds from this sale.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 64.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Strategic Acquisition of Physical Uranium</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In May 2021, the Company executed a binding agreement to purchase 125,000 pounds of natural uranium concentrate at approximately $32 per pound. In December 2021, the Company paid $4,044,083, in connection with its full prepayment of the purchase price for 125,000 pounds of natural uranium concentrate. This uranium concentrate was subsequently delivered under the terms of the aforementioned uranium concentrates supply agreement in April 2022.</span></p> 78000 In April 2022, in satisfaction of the Year 5 delivery under its supply contract, the Company delivered 125,000 lbs of uranium concentrate from its prepaid uranium concentrate inventory. Accordingly, during the three and nine months ended September 30, 2022, the Company recorded revenue of $0 and $7,223,609 (at a price of approximately $57 per pound), respectively, and cost of revenue of $0 and $4,044,083, respectively, related to the delivery of the uranium. In May 2022, the Company received the cash proceeds from this sale. In May 2021, the Company executed a binding agreement to purchase 125,000 pounds of natural uranium concentrate at approximately $32 per pound. In December 2021, the Company paid $4,044,083, in connection with its full prepayment of the purchase price for 125,000 pounds of natural uranium concentrate. <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>NOTE 7 – SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Authorized Capital</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The holders of the Company’s common shares are entitled to one vote per share. Holders of common shares are entitled to ratably receive such dividends, if any, as may be declared by the board of directors, out of legally available funds. Upon the liquidation, dissolution, or winding down of the Company, holders of common shares are entitled to share ratably in all assets of the Company that are legally available for distribution. As of September 30, 2022 and December 31, 2021, an unlimited number of common shares were authorized for issuance.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Private Placements</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On January 20, 2022, the Company closed a non-brokered private placement of 2,495,575 units at a price of CAD $1.60 per unit. The aggregate gross proceeds raised in the private placement amounted to CAD $3,992,920 (USD $3,011,878 in net proceeds). Each unit consisted of one common share of Western (a “Share”) plus one common share purchase warrant of Western (a “Warrant”). Each Warrant entitled the holder to purchase one Share at a price of CAD $2.50 per Share for a period of three years following the closing date of the private placement. A total of 2,495,575 Shares and 2,495,575 Warrants were issued to investors and 98,985 Warrants were issued to broker dealers in connection with the private placement.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Warrant Exercises</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the nine months ended September 30, 2022, an aggregate of 2,020,351 warrants were exercised for total gross proceeds of $2,620,395.</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Incentive Stock Option Plan</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company maintains an Incentive Stock Option Plan (the “Plan”) that permits the granting of stock options as incentive compensation. Shareholders of the Company approved the Plan on June 30, 2008 and amendments to the Plan on June 20, 2013. The board of directors approved additional changes to the Plan on September 12, 2015 and as of October 1, 2021.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The purpose of the Plan is to attract, retain, and motivate directors, management, staff, and consultants by providing them with the opportunity, through stock options, to acquire a proprietary interest in the Company and benefit from its growth.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Plan provides that the aggregate number of common shares for which stock options may be granted will not exceed 10% of the issued and outstanding common shares at the time stock options are granted. As of September 30, 2022, a total of 43,588,742 common shares were outstanding, and at that date the maximum number of stock options eligible for issue under the Plan was 4,358,874.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Stock Options</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i> </i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On February 10, 2022, the Company granted options under the Plan for the purchase of an aggregate of 900,000 common shares to five individuals consisting of directors and officers of the Company. The options have a five year term, an exercise price of CAD $1.76 (US $1.28 as of September 30, 2022) and vest equally in thirds commencing initially on the date of grant and thereafter on April 1, 2022, and July 1, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company utilized the Black-Scholes option pricing model to determine the fair value of these stock options, using the assumptions as outlined below.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">February 10,<br/> 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Stock Price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">CAD$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.76</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif">Exercise Price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">CAD$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.76</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Number of Options Granted</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">900,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Dividend Yield</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected Volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">103.3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif">Weighted Average Risk-Free Interest Rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.61</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life (in years)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of<br/> Shares</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> Average<br/> Exercise Price</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> Average<br/> Contractual<br/> Life (Years)</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> Average<br/> Grant Date<br/> Fair Value</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Intrinsic<br/> Value</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding – January 1, 2022</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,324,670</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.35</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.67</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.39</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">528,714</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">900,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.28</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.84</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(116,670</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.81</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.27</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding – September 30, 2022</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,108,000</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.24</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.15</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.52</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">408,063</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable – September 30, 2022</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,108,000</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.24</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.15</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.52</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">408,063</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The Company’s stock-based compensation expense related to stock options for the three months ended September 30, 2022 and 2021 was $0 and $0, respectively, and for the nine months ended September 30, 2022 and 2021 stock-based compensation expense was $753,219 and $0, respectively, which is included in general and administrative expenses on the Company’s condensed consolidated statements of operations and comprehensive loss. As of September 30, 2022, there was no unamortized stock option expense.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Warrants</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of<br/> Shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> Average<br/> Exercise Price</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> Average<br/> Contractual<br/> Life (Years)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Intrinsic<br/> Value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif">Outstanding - January 1, 2022</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,735,948</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.09</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.49</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,799,606</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,594,560</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.81</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-115; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-116; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,020,351</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.19</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-117; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-118; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired/Forfeited</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(948,081</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.97</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-119; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-120; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding – September 30, 2022</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,362,076</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.17</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.11</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,673,679</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable – September 30, 2022</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,362,076</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.17</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.11</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,673,679</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 2495575 1.6 3992920 3011878 2.5 P3Y 2495575 2495575 98985 2020351 2620395 0.10 43588742 4358874 900000 P5Y 1.76 1.28 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">February 10,<br/> 2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Stock Price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">CAD$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.76</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif">Exercise Price</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">CAD$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.76</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-family: Times New Roman, Times, Serif">Number of Options Granted</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">900,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Dividend Yield</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected Volatility</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">103.3</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif">Weighted Average Risk-Free Interest Rate</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.61</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Expected life (in years)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.6</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> 1.76 1.76 900000 0 1.033 0.0161 P2Y7M6D <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of<br/> Shares</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> Average<br/> Exercise Price</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> Average<br/> Contractual<br/> Life (Years)</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> Average<br/> Grant Date<br/> Fair Value</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Intrinsic<br/> Value</span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif">Outstanding – January 1, 2022</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,324,670</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.35</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.67</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.39</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">528,714</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">900,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.28</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.84</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(116,670</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.81</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.27</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding – September 30, 2022</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,108,000</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.24</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.15</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.52</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">408,063</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable – September 30, 2022</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,108,000</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.24</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.15</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.52</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">408,063</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> 2324670 1.35 P1Y8M1D 0.39 528714 900000 1.28 0.84 116670 1.81 0.27 3108000 1.24 P2Y1M24D 0.52 408063 3108000 1.24 P2Y1M24D 0.52 408063 0 0 753219 0 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Number of<br/> Shares</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> Average<br/> Exercise Price</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Weighted<br/> Average<br/> Contractual<br/> Life (Years)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Intrinsic<br/> Value</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif">Outstanding - January 1, 2022</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,735,948</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.09</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.49</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,799,606</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-family: Times New Roman, Times, Serif">Issued</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,594,560</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.81</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-115; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-116; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,020,351</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.19</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-117; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-118; font-family: Times New Roman, Times, Serif">-</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired/Forfeited</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(948,081</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.97</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-119; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-120; font-family: Times New Roman, Times, Serif">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding – September 30, 2022</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,362,076</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.17</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.11</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,673,679</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable – September 30, 2022</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">9,362,076</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1.17</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.11</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,673,679</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 9735948 1.09 P1Y5M26D 3799606 2594560 1.81 -2020351 1.19 -948081 1.97 9362076 1.17 P2Y1M9D 2673679 9362076 1.17 P2Y1M9D 2673679 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; text-transform: uppercase"><b>Note 8 – Mining Expenditures</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Three Months Ended <br/> September 30,</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Nine Months Ended<br/> September 30,</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif">Permits</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,946</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,639</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86,103</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">106,426</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mining costs</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">172,421</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">300,988</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">524,336</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">312,534</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Royalties</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,153</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,401</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,707</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,961</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total mining expenses</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">204,520</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">335,028</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">616,146</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">422,921</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Three Months Ended <br/> September 30,</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Nine Months Ended<br/> September 30,</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif">2022</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif">2021</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%"><span style="font-family: Times New Roman, Times, Serif">Permits</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">29,946</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">32,639</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86,103</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">106,426</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Mining costs</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">172,421</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">300,988</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">524,336</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">312,534</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Royalties</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2,153</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,401</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">5,707</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3,961</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left; padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif">Total mining expenses</span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">204,520</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">335,028</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">616,146</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 4pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 4pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">422,921</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 29946 32639 86103 106426 172421 300988 524336 312534 2153 1401 5707 3961 204520 335028 616146 422921 <p style="font: small-caps bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif">NOTE 9 – Related Party Transactions AND BALANCES</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company has transacted with related parties pursuant to service arrangements in the ordinary course of business, as follows:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Prior to the acquisition of Black Range, Mr. George Glasier, the Company’s CEO, who is also a director (“Seller”), transferred his interest in a former joint venture with Ablation Technologies, LLC to Black Range. In connection with the transfer, Black Range issued 25 million shares of Black Range common stock to Seller and committed to pay AUD $500,000 (USD $321,600 as of September 30, 2022) to Seller within 60 days of the first commercial application of the kinetic separation technology. Western assumed this contingent payment obligation in connection with the acquisition of Black Range. At the date of the acquisition of Black Range, this contingent obligation was determined to be probable. Since the deferred contingent consideration obligation is probable and the amount is estimable, the Company recorded the deferred contingent consideration as an assumed liability in the amount of $321,600 and $362,794 as of September 30, 2022 and December 31, 2021, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The Company also owed Mr. Glasier reimbursable expenses in the amount of $54,000 and $65,753 as of September 30, 2022 and December 31, 2021, respectively.</span></p> In connection with the transfer, Black Range issued 25 million shares of Black Range common stock to Seller and committed to pay AUD $500,000 (USD $321,600 as of September 30, 2022) to Seller within 60 days of the first commercial application of the kinetic separation technology. 321600 362794 54000 65753 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; text-transform: uppercase"><b>Note 10 – COVID-19 </b></span><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">The world has been, and continues to be, impacted by the COVID-19 pandemic. COVID-19, and measures to prevent its spread, impacted our business in a number of ways. The impact of these disruptions and the extent of their adverse impact on the Company’s financial and operating results will be dictated by the length of time that such disruptions continue, which will, in turn, depend on the currently unpredictable duration and severity of the impacts of COVID-19, and among other things, the impact of governmental actions imposed in response to COVID-19 and individuals’ and companies’ risk tolerance regarding health matters going forward and developing strain mutations. To date, COVID-19 has primarily caused Western delays in reporting, regulatory matters, and operations. Most notably, the Company initiated a request for Temporary Cessation status for the Sunday Mine Complex in August 2020 as the mines had not been restarted within the 180-day window due to the direct and indirect impacts of the COVID-19 pandemic. The Van 4 Mine reclamation process was delayed because of COVID-19 pandemic lockdowns. The need to observe quarantine periods also caused a limited loss of manpower and delay to the 2021/2022 Sunday Mine Complex project. The COVID-19 pandemic has limited Western’s participation in industry and investor conference events. The Company is continuing to monitor COVID-19 and its subvariants and the potential impact of the pandemic on the Company’s operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-variant: small-caps; text-transform: uppercase"><b>Note 11 – subsequent events</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">On October 31, 2022, the Board of Directors granted an aggregate of 1,665,000 options for the purchase of the Company’s common stock to the Company’s officers, directors and employees. Each of these options was granted under the Plan and had an exercise price of CAD $1.60 (US $1.16 as of September 30, 2022). The options vest equally in two installments beginning on the date of grant and thereafter on April 30, 2023.</p> 1665000 1.6 1.16 Unlimited Unlimited false --12-31 Q3 0001621906 EXCEL 50 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 51 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 52 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 53 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 113 238 1 false 17 0 false 7 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.westernuranium.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.westernuranium.com/role/ConsolidatedBalanceSheet Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Sheet http://www.westernuranium.com/role/ConsolidatedBalanceSheet_Parentheticals Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss)(Unaudited) Sheet http://www.westernuranium.com/role/ConsolidatedIncomeStatement Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss)(Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Changes in Shareholders??? Equity (Unaudited) Sheet http://www.westernuranium.com/role/ShareholdersEquityType2or3 Condensed Consolidated Statements of Changes in Shareholders??? Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.westernuranium.com/role/ConsolidatedCashFlow Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Business Sheet http://www.westernuranium.com/role/Business Business Notes 7 false false R8.htm 007 - Disclosure - Liquidity and Going Concern Sheet http://www.westernuranium.com/role/LiquidityandGoingConcern Liquidity and Going Concern Notes 8 false false R9.htm 008 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.westernuranium.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 009 - Disclosure - Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property Sheet http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherProperty Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property Notes 10 false false R11.htm 010 - Disclosure - Accounts Payable and Accrued Liabilities Sheet http://www.westernuranium.com/role/AccountsPayableandAccruedLiabilities Accounts Payable and Accrued Liabilities Notes 11 false false R12.htm 011 - Disclosure - Commitments and Contingencies Sheet http://www.westernuranium.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 12 false false R13.htm 012 - Disclosure - Share Capital and Other Equity Instruments Sheet http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstruments Share Capital and Other Equity Instruments Notes 13 false false R14.htm 013 - Disclosure - Mining Expenditures Sheet http://www.westernuranium.com/role/MiningExpenditures Mining Expenditures Notes 14 false false R15.htm 014 - Disclosure - Related Party Transactions and Balances Sheet http://www.westernuranium.com/role/RelatedPartyTransactionsandBalances Related Party Transactions and Balances Notes 15 false false R16.htm 015 - Disclosure - Covid-19 Sheet http://www.westernuranium.com/role/Covid19 Covid-19 Notes 16 false false R17.htm 016 - Disclosure - Subsequent Events Sheet http://www.westernuranium.com/role/SubsequentEvents Subsequent Events Notes 17 false false R18.htm 017 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.westernuranium.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://www.westernuranium.com/role/SummaryofSignificantAccountingPolicies 18 false false R19.htm 018 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.westernuranium.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.westernuranium.com/role/SummaryofSignificantAccountingPolicies 19 false false R20.htm 019 - Disclosure - Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Tables) Sheet http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyTables Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Tables) Tables http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherProperty 20 false false R21.htm 020 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) Sheet http://www.westernuranium.com/role/AccountsPayableandAccruedLiabilitiesTables Accounts Payable and Accrued Liabilities (Tables) Tables http://www.westernuranium.com/role/AccountsPayableandAccruedLiabilities 21 false false R22.htm 021 - Disclosure - Share Capital and Other Equity Instruments (Tables) Sheet http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsTables Share Capital and Other Equity Instruments (Tables) Tables http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstruments 22 false false R23.htm 022 - Disclosure - Mining Expenditures (Tables) Sheet http://www.westernuranium.com/role/MiningExpendituresTables Mining Expenditures (Tables) Tables http://www.westernuranium.com/role/MiningExpenditures 23 false false R24.htm 023 - Disclosure - Business (Details) Sheet http://www.westernuranium.com/role/BusinessDetails Business (Details) Details http://www.westernuranium.com/role/Business 24 false false R25.htm 024 - Disclosure - Liquidity and Going Concern (Details) Sheet http://www.westernuranium.com/role/LiquidityandGoingConcernDetails Liquidity and Going Concern (Details) Details http://www.westernuranium.com/role/LiquidityandGoingConcern 25 false false R26.htm 025 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of fair values of financial instruments Sheet http://www.westernuranium.com/role/ScheduleoffairvaluesoffinancialinstrumentsTable Summary of Significant Accounting Policies (Details) - Schedule of fair values of financial instruments Details http://www.westernuranium.com/role/SummaryofSignificantAccountingPoliciesTables 26 false false R27.htm 026 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of computations of net income (loss) per share Sheet http://www.westernuranium.com/role/ScheduleofcomputationsofnetincomelosspershareTable Summary of Significant Accounting Policies (Details) - Schedule of computations of net income (loss) per share Details http://www.westernuranium.com/role/SummaryofSignificantAccountingPoliciesTables 27 false false R28.htm 027 - Disclosure - Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details) Sheet http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetails Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details) Details http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyTables 28 false false R29.htm 028 - Disclosure - Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details) - Schedule of mineral properties and equipment and kinetic separation intellectual property Sheet http://www.westernuranium.com/role/ScheduleofmineralpropertiesandequipmentandkineticseparationintellectualpropertyTable Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details) - Schedule of mineral properties and equipment and kinetic separation intellectual property Details http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyTables 29 false false R30.htm 029 - Disclosure - Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details) - Schedule of reclamation liability activity Sheet http://www.westernuranium.com/role/ScheduleofreclamationliabilityactivityTable Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details) - Schedule of reclamation liability activity Details http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyTables 30 false false R31.htm 030 - Disclosure - Accounts Payable and Accrued Liabilities (Details) - Schedule of accounts payable and accrued liabilities Sheet http://www.westernuranium.com/role/ScheduleofaccountspayableandaccruedliabilitiesTable Accounts Payable and Accrued Liabilities (Details) - Schedule of accounts payable and accrued liabilities Details http://www.westernuranium.com/role/AccountsPayableandAccruedLiabilitiesTables 31 false false R32.htm 031 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.westernuranium.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.westernuranium.com/role/CommitmentsandContingencies 32 false false R33.htm 032 - Disclosure - Share Capital and Other Equity Instruments (Details) Sheet http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails Share Capital and Other Equity Instruments (Details) Details http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsTables 33 false false R34.htm 033 - Disclosure - Share Capital and Other Equity Instruments (Details) - Schedule of black-scholes option pricing model Sheet http://www.westernuranium.com/role/ScheduleofblackscholesoptionpricingmodelTable Share Capital and Other Equity Instruments (Details) - Schedule of black-scholes option pricing model Details http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsTables 34 false false R35.htm 034 - Disclosure - Share Capital and Other Equity Instruments (Details) - Schedule of stock options Sheet http://www.westernuranium.com/role/ScheduleofstockoptionsTable Share Capital and Other Equity Instruments (Details) - Schedule of stock options Details http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsTables 35 false false R36.htm 035 - Disclosure - Share Capital and Other Equity Instruments (Details) - Schedule of warrants Sheet http://www.westernuranium.com/role/ScheduleofwarrantsTable Share Capital and Other Equity Instruments (Details) - Schedule of warrants Details http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsTables 36 false false R37.htm 036 - Disclosure - Mining Expenditures (Details) - Schedule of mining expenditures Sheet http://www.westernuranium.com/role/ScheduleofminingexpendituresTable Mining Expenditures (Details) - Schedule of mining expenditures Details http://www.westernuranium.com/role/MiningExpendituresTables 37 false false R38.htm 037 - Disclosure - Related Party Transactions and Balances (Details) Sheet http://www.westernuranium.com/role/RelatedPartyTransactionsandBalancesDetails Related Party Transactions and Balances (Details) Details http://www.westernuranium.com/role/RelatedPartyTransactionsandBalances 38 false false R39.htm 038 - Disclosure - Subsequent Events (Details) Sheet http://www.westernuranium.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.westernuranium.com/role/SubsequentEvents 39 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Not-Referenced] WARN: 1 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:CommonStockSharesAuthorizedUnlimited - f10q0922_westernuranium.htm 5525 f10q0922_westernuranium.htm f10q0922ex31-1_western.htm f10q0922ex31-2_western.htm f10q0922ex32_western.htm wstrf-20220930.xsd wstrf-20220930_cal.xml wstrf-20220930_def.xml wstrf-20220930_lab.xml wstrf-20220930_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 56 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f10q0922_westernuranium.htm": { "axisCustom": 0, "axisStandard": 9, "contextCount": 113, "dts": { "calculationLink": { "local": [ "wstrf-20220930_cal.xml" ] }, "definitionLink": { "local": [ "wstrf-20220930_def.xml" ] }, "inline": { "local": [ "f10q0922_westernuranium.htm" ] }, "labelLink": { "local": [ "wstrf-20220930_lab.xml" ] }, "presentationLink": { "local": [ "wstrf-20220930_pre.xml" ] }, "schema": { "local": [ "wstrf-20220930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd" ] } }, "elementCount": 337, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 68, "http://www.westernuranium.com/20220930": 53, "http://xbrl.sec.gov/dei/2022": 4, "total": 125 }, "keyCustom": 58, "keyStandard": 180, "memberCustom": 5, "memberStandard": 11, "nsprefix": "wstrf", "nsuri": "http://www.westernuranium.com/20220930", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://www.westernuranium.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "wstrf:MineralAssetsEquipmentAndKineticSeparationIntellectualPropertyAndOtherProperty", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property", "role": "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherProperty", "shortName": "Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "wstrf:MineralAssetsEquipmentAndKineticSeparationIntellectualPropertyAndOtherProperty", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Accounts Payable and Accrued Liabilities", "role": "http://www.westernuranium.com/role/AccountsPayableandAccruedLiabilities", "shortName": "Accounts Payable and Accrued Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Commitments and Contingencies", "role": "http://www.westernuranium.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Share Capital and Other Equity Instruments", "role": "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstruments", "shortName": "Share Capital and Other Equity Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "wstrf:MiningExpendituresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Mining Expenditures", "role": "http://www.westernuranium.com/role/MiningExpenditures", "shortName": "Mining Expenditures", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "wstrf:MiningExpendituresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Related Party Transactions and Balances", "role": "http://www.westernuranium.com/role/RelatedPartyTransactionsandBalances", "shortName": "Related Party Transactions and Balances", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "wstrf:Covid19TextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Covid-19", "role": "http://www.westernuranium.com/role/Covid19", "shortName": "Covid-19", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "wstrf:Covid19TextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Subsequent Events", "role": "http://www.westernuranium.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Accounting Policies, by Policy (Policies)", "role": "http://www.westernuranium.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://www.westernuranium.com/role/SummaryofSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Condensed Consolidated Balance Sheets (Unaudited)", "role": "http://www.westernuranium.com/role/ConsolidatedBalanceSheet", "shortName": "Condensed Consolidated Balance Sheets (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "wstrf:ScheduleOfMiningAndMiningRelatedAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Tables)", "role": "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyTables", "shortName": "Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "wstrf:ScheduleOfMiningAndMiningRelatedAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)", "role": "http://www.westernuranium.com/role/AccountsPayableandAccruedLiabilitiesTables", "shortName": "Accounts Payable and Accrued Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Share Capital and Other Equity Instruments (Tables)", "role": "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsTables", "shortName": "Share Capital and Other Equity Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "wstrf:ScheduleOfMiningExpendituresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Mining Expenditures (Tables)", "role": "http://www.westernuranium.com/role/MiningExpendituresTables", "shortName": "Mining Expenditures (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "wstrf:ScheduleOfMiningExpendituresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c74", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Business (Details)", "role": "http://www.westernuranium.com/role/BusinessDetails", "shortName": "Business (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c74", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c5", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Liquidity and Going Concern (Details)", "role": "http://www.westernuranium.com/role/LiquidityandGoingConcernDetails", "shortName": "Liquidity and Going Concern (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": "0", "lang": null, "name": "wstrf:WorkingCapitalDeficit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c79", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:MarketableSecuritiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of fair values of financial instruments", "role": "http://www.westernuranium.com/role/ScheduleoffairvaluesoffinancialinstrumentsTable", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of fair values of financial instruments", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c79", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:MarketableSecuritiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c5", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Summary of Significant Accounting Policies (Details) - Schedule of computations of net income (loss) per share", "role": "http://www.westernuranium.com/role/ScheduleofcomputationsofnetincomelosspershareTable", "shortName": "Summary of Significant Accounting Policies (Details) - Schedule of computations of net income (loss) per share", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": "0", "lang": null, "name": "us-gaap:DilutiveSecurities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AreaOfLand", "reportCount": 1, "unitRef": "acre", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details)", "role": "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetails", "shortName": "Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "lang": "en-US", "name": "us-gaap:OperatingLeasesOfLessorContingentRentalsDescriptionOfVariableRateBasis", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "wstrf:ScheduleOfMiningAndMiningRelatedAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "wstrf:MineralPropertiesAndEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details) - Schedule of mineral properties and equipment and kinetic separation intellectual property", "role": "http://www.westernuranium.com/role/ScheduleofmineralpropertiesandequipmentandkineticseparationintellectualpropertyTable", "shortName": "Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details) - Schedule of mineral properties and equipment and kinetic separation intellectual property", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "wstrf:ScheduleOfMiningAndMiningRelatedAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "wstrf:MineralPropertiesAndEquipment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c2", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals)", "role": "http://www.westernuranium.com/role/ConsolidatedBalanceSheet_Parentheticals", "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c2", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "wstrf:ScheduleOfReclamationObligationsOfFairValueOfReclamationObligationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetRetirementObligationsNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details) - Schedule of reclamation liability activity", "role": "http://www.westernuranium.com/role/ScheduleofreclamationliabilityactivityTable", "shortName": "Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details) - Schedule of reclamation liability activity", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "wstrf:ScheduleOfReclamationObligationsOfFairValueOfReclamationObligationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetRetirementObligationsNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableTradeCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - Accounts Payable and Accrued Liabilities (Details) - Schedule of accounts payable and accrued liabilities", "role": "http://www.westernuranium.com/role/ScheduleofaccountspayableandaccruedliabilitiesTable", "shortName": "Accounts Payable and Accrued Liabilities (Details) - Schedule of accounts payable and accrued liabilities", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableTradeCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c95", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OtherCommitment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - Commitments and Contingencies (Details)", "role": "http://www.westernuranium.com/role/CommitmentsandContingenciesDetails", "shortName": "Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c95", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OtherCommitment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "wstrf:ProceedsFromIssuanceOfPrivatePlacements", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - Share Capital and Other Equity Instruments (Details)", "role": "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails", "shortName": "Share Capital and Other Equity Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "wstrf:ProceedsFromIssuanceOfPrivatePlacements", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c103", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unique": true, "unitRef": "cadPershares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - Share Capital and Other Equity Instruments (Details) - Schedule of black-scholes option pricing model", "role": "http://www.westernuranium.com/role/ScheduleofblackscholesoptionpricingmodelTable", "shortName": "Share Capital and Other Equity Instruments (Details) - Schedule of black-scholes option pricing model", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c103", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unique": true, "unitRef": "cadPershares", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c105", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - Share Capital and Other Equity Instruments (Details) - Schedule of stock options", "role": "http://www.westernuranium.com/role/ScheduleofstockoptionsTable", "shortName": "Share Capital and Other Equity Instruments (Details) - Schedule of stock options", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c105", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c108", "decimals": "INF", "first": true, "lang": null, "name": "wstrf:NumberOfSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - Share Capital and Other Equity Instruments (Details) - Schedule of warrants", "role": "http://www.westernuranium.com/role/ScheduleofwarrantsTable", "shortName": "Share Capital and Other Equity Instruments (Details) - Schedule of warrants", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c108", "decimals": "INF", "first": true, "lang": null, "name": "wstrf:NumberOfSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "wstrf:ScheduleOfMiningExpendituresTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c5", "decimals": "0", "first": true, "lang": null, "name": "wstrf:PaymentsToAcquireMiningPermits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - Mining Expenditures (Details) - Schedule of mining expenditures", "role": "http://www.westernuranium.com/role/ScheduleofminingexpendituresTable", "shortName": "Mining Expenditures (Details) - Schedule of mining expenditures", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "wstrf:ScheduleOfMiningExpendituresTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c5", "decimals": "0", "first": true, "lang": null, "name": "wstrf:PaymentsToAcquireMiningPermits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - Related Party Transactions and Balances (Details)", "role": "http://www.westernuranium.com/role/RelatedPartyTransactionsandBalancesDetails", "shortName": "Related Party Transactions and Balances (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": "0", "lang": null, "name": "us-gaap:CostsAndExpensesRelatedParty", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c104", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "038 - Disclosure - Subsequent Events (Details)", "role": "http://www.westernuranium.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c2", "decimals": "2", "lang": null, "name": "wstrf:ExercisePricePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c5", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss)(Unaudited)", "role": "http://www.westernuranium.com/role/ConsolidatedIncomeStatement", "shortName": "Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss)(Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c5", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c40", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Condensed Consolidated Statements of Changes in Shareholders\u2019 Equity (Unaudited)", "role": "http://www.westernuranium.com/role/ShareholdersEquityType2or3", "shortName": "Condensed Consolidated Statements of Changes in Shareholders\u2019 Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c48", "decimals": "0", "lang": null, "name": "wstrf:ForeignExchangeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://www.westernuranium.com/role/ConsolidatedCashFlow", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": "0", "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "006 - Disclosure - Business", "role": "http://www.westernuranium.com/role/Business", "shortName": "Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - Liquidity and Going Concern", "role": "http://www.westernuranium.com/role/LiquidityandGoingConcern", "shortName": "Liquidity and Going Concern", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - Summary of Significant Accounting Policies", "role": "http://www.westernuranium.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0922_westernuranium.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 17, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.westernuranium.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r89", "r94", "r144", "r192" ], "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofaccountspayableandaccruedliabilitiesTable", "http://www.westernuranium.com/role/ScheduleofmineralpropertiesandequipmentandkineticseparationintellectualpropertyTable", "http://www.westernuranium.com/role/ScheduleofreclamationliabilityactivityTable" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r132" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.westernuranium.com/role/BusinessDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r89", "r94", "r144", "r192", "r287" ], "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofaccountspayableandaccruedliabilitiesTable", "http://www.westernuranium.com/role/ScheduleofmineralpropertiesandequipmentandkineticseparationintellectualpropertyTable", "http://www.westernuranium.com/role/ScheduleofreclamationliabilityactivityTable" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r28" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r27" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "terseLabel": "ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/AccountsPayableandAccruedLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://www.westernuranium.com/role/ScheduleofaccountspayableandaccruedliabilitiesTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Accounts Payable and Other Accrued Liabilities, Current", "totalLabel": "Total accounts payable and accrued liabilities" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofaccountspayableandaccruedliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r9", "r26" ], "calculation": { "http://www.westernuranium.com/role/ScheduleofaccountspayableandaccruedliabilitiesTable": { "order": 1.0, "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "terseLabel": "Trade accounts payable" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofaccountspayableandaccruedliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r30" ], "calculation": { "http://www.westernuranium.com/role/ScheduleofaccountspayableandaccruedliabilitiesTable": { "order": 2.0, "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofaccountspayableandaccruedliabilitiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedReclamationCostsCurrent": { "auth_ref": [ "r30" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Current portion of reclamation reserve to restore a mining or drilling site to the condition agreed upon within the mining or drilling contract.", "label": "Accrued Reclamation Costs, Current", "terseLabel": "Reclamation liability, current portion" } } }, "localname": "AccruedReclamationCostsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r18", "r39", "r40", "r41", "r317", "r329", "r330" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive (loss) income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r38", "r41", "r47", "r48", "r49", "r81", "r82", "r83", "r243", "r274", "r325", "r326" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Reconciliation of net income (loss) to cash provided by (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Total potentially dilutive securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofcomputationsofnetincomelosspershareTable" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofcomputationsofnetincomelosspershareTable" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofcomputationsofnetincomelosspershareTable" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofcomputationsofnetincomelosspershareTable" ], "xbrltype": "domainItemType" }, "us-gaap_AreaOfLand": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of land held.", "label": "Area of Land", "terseLabel": "Oil and gas lease permit area in acres (in Acres)" } } }, "localname": "AreaOfLand", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetails" ], "xbrltype": "areaItemType" }, "us-gaap_AssetRetirementObligation": { "auth_ref": [ "r139", "r140" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.", "label": "Asset Retirement Obligation", "terseLabel": "Reclamation liability mineral properties" } } }, "localname": "AssetRetirementObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetRetirementObligationsNoncurrent": { "auth_ref": [ "r140" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Noncurrent portion of the carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.", "label": "Asset Retirement Obligations, Noncurrent", "periodEndLabel": "Ending Balance at September 30", "periodStartLabel": "Beginning balance at January 1" } } }, "localname": "AssetRetirementObligationsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofreclamationliabilityactivityTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r11", "r79", "r117", "r120", "r126", "r133", "r146", "r147", "r148", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r241", "r244", "r259", "r282", "r284", "r308", "r315" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r7", "r25", "r79", "r133", "r146", "r147", "r148", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r241", "r244", "r259", "r282", "r284" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r80" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "Basis of Presentation and Principles of Consolidation" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": { "auth_ref": [ "r236", "r237" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "terseLabel": "Deferred contingent consideration", "verboseLabel": "Deferred amount" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet", "http://www.westernuranium.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r235", "r238" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "BUSINESS" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/Business" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_Cash": { "auth_ref": [ "r10", "r284", "r331", "r332" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r4", "r10", "r70" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r63", "r70", "r74" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and restricted cash - ending", "periodStartLabel": "Cash and restricted cash - beginning" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r63", "r260" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase in cash and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r175" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercisable price per share" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r179", "r193" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r32", "r310", "r321" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and Contingencies (Note 6)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r141", "r142", "r143", "r145", "r336" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r81", "r82", "r252" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Shares", "verboseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails", "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common shares, par value (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorizedUnlimited": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the number of common shares permitted to be issued by an entity's charter and bylaws is unlimited. The acceptable value is \"Unlimited\".", "label": "Common Stock, Shares Authorized, Unlimited [Fixed List]", "terseLabel": "Common shares, shares authorized" } } }, "localname": "CommonStockSharesAuthorizedUnlimited", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "authorizedUnlimitedItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common shares, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r16", "r174" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common shares, shares outstanding", "verboseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r16", "r284" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common shares, no par value, unlimited authorized shares, 43,589,048 and 39,073,428 shares issued as of September 30, 2022 and December 31, 2021, respectively, and 43,588,742 and 39,073,122 shares outstanding as of September 30, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r43", "r45", "r46", "r52", "r312", "r323" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income/(loss)" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r55", "r79", "r133", "r146", "r147", "r148", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r259" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of revenues" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesRelatedParty": { "auth_ref": [ "r55" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs of sales and operating expenses for the period incurred from transactions with related parties.", "label": "Costs and Expenses, Related Party", "terseLabel": "Reimbursable expenses" } } }, "localname": "CostsAndExpensesRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1": { "auth_ref": [ "r72", "r73" ], "lang": { "en-us": { "role": { "documentation": "The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Converted Instrument, Warrants or Options Issued", "terseLabel": "Warrants issued" } } }, "localname": "DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Effective period" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r12" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenue, current portion" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueNoncurrent": { "auth_ref": [ "r14" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Deferred Revenue, Noncurrent", "terseLabel": "Deferred revenue, net of current portion" } } }, "localname": "DeferredRevenueNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r68", "r137" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r36", "r247", "r248", "r249", "r250" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "stringItemType" }, "us-gaap_DilutiveSecurities": { "auth_ref": [ "r103" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.", "label": "Dilutive Securities, Effect on Basic Earnings Per Share", "terseLabel": "Dilutive effect of options and warrants (in Dollars)" } } }, "localname": "DilutiveSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofcomputationsofnetincomelosspershareTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r53", "r86", "r87", "r88", "r89", "r90", "r95", "r97", "r99", "r100", "r101", "r105", "r106", "r253", "r254", "r313", "r324" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net income/(loss) per share - basic (in Dollars per share)", "verboseLabel": "Net (loss) income per share, basic (in Dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement", "http://www.westernuranium.com/role/ScheduleofcomputationsofnetincomelosspershareTable" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r53", "r86", "r87", "r88", "r89", "r90", "r97", "r99", "r100", "r101", "r105", "r106", "r253", "r254", "r313", "r324" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net income/(loss) per share - diluted (in Dollars per share)", "verboseLabel": "Net (loss) income per share, diluted (in Dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement", "http://www.westernuranium.com/role/ScheduleofcomputationsofnetincomelosspershareTable" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r102", "r104" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Income (Loss) per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r260" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Effect of foreign exchange rate on cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for employee benefit and equity-based compensation.", "label": "Employee Benefits and Share-Based Compensation", "terseLabel": "Stock based compensation expense (in Dollars)" } } }, "localname": "EmployeeBenefitsAndShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r47", "r48", "r49", "r81", "r82", "r83", "r85", "r91", "r93", "r107", "r134", "r174", "r176", "r228", "r229", "r230", "r233", "r234", "r252", "r261", "r262", "r263", "r264", "r265", "r266", "r274", "r325", "r326", "r327" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails", "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r132" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Acquired interest percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/BusinessDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ExploitationCostsPolicyPolicyTextBlock": { "auth_ref": [ "r293" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for exploitation costs.", "label": "Exploitation Costs, Policy [Policy Text Block]", "terseLabel": "Exploration Stage and Mineral Properties" } } }, "localname": "ExploitationCostsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ExtraordinaryAndUnusualItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Covid-19 [Abstract]" } } }, "localname": "ExtraordinaryAndUnusualItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r157", "r158", "r159", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r191", "r256", "r289", "r290", "r291" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleoffairvaluesoffinancialinstrumentsTable" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r157", "r183", "r184", "r189", "r191", "r256", "r289" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1) [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleoffairvaluesoffinancialinstrumentsTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r157", "r158", "r159", "r183", "r184", "r189", "r191", "r256", "r290" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Quoted Prices for Similar Assets or Liabilities in Active Markets (Level 2) [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleoffairvaluesoffinancialinstrumentsTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r157", "r158", "r159", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r191", "r256", "r291" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Significant Unobservable Inputs (Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleoffairvaluesoffinancialinstrumentsTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r255", "r256" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.", "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of fair values of financial instruments" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r257", "r258" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Values of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r68", "r160", "r161" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedLabel": "Accretion and interest" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r56" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r54", "r79", "r117", "r119", "r122", "r125", "r127", "r133", "r146", "r147", "r148", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r259" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r65", "r71" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Income taxes" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r67" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r67" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r67" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Prepaid uranium concentrate inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Change in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPayablesToCustomers": { "auth_ref": [ "r67" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The change during the period, either increase or decrease, in amounts payable to customers. The term customers generally excludes other broker-dealers; persons who are principal officers, directors, and stockholders; and persons whose securities or funds are part of the regulatory net capital of the broker-dealer. Another broker-dealer's account can be classified as a customer if the account is carried as an omnibus account in compliance with certain regulations. The accounts of principal officers, directors and stockholders may be combined in the customer captions if they are not material and the combination is disclosed in the oath that is required to accompany the annual audited FOCUS Report.", "label": "Increase (Decrease) in Payables to Customers", "terseLabel": "Subscription payable" } } }, "localname": "IncreaseDecreaseInPayablesToCustomers", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r67" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r62", "r64", "r71" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r5", "r22", "r284" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Prepaid uranium concentrate inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Initial term of lease" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetails" ], "xbrltype": "durationItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r29", "r79", "r121", "r133", "r146", "r147", "r148", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r242", "r244", "r245", "r259", "r282", "r283" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r21", "r79", "r133", "r259", "r284", "r309", "r319" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and shareholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r8", "r31", "r79", "r133", "r146", "r147", "r148", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r242", "r244", "r245", "r259", "r282", "r283", "r284" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermContractForPurchaseOfElectricPowerEstimatedAnnualCost": { "auth_ref": [ "r337" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Estimated annual cost to purchase electricity under a long-term contract from a production plant constructed and financed by a public utility district, cooperative, or other organization.", "label": "Long-Term Contract for Purchase of Electric Power, Estimated Annual Cost", "terseLabel": "Mining equipment purchases" } } }, "localname": "LongTermContractForPurchaseOfElectricPowerEstimatedAnnualCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesCurrent": { "auth_ref": [], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as current.", "label": "Marketable Securities, Current", "terseLabel": "Marketable securities" } } }, "localname": "MarketableSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet", "http://www.westernuranium.com/role/ScheduleoffairvaluesoffinancialinstrumentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_MineReclamationAndClosingLiabilityNoncurrent": { "auth_ref": [], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of a reclamation and mine closing liability that is associated with a legal obligation for the closure and reclamation of a mine including the removal of buildings, equipment, machinery and other physical remnants of mining, closure of tailings impoundments, leach pads and other mine features, and contouring, covering and revegetation of waste rock piles and other disturbed areas.", "label": "Mine Reclamation and Closing Liability, Noncurrent", "terseLabel": "Reclamation liability, net of current portion" } } }, "localname": "MineReclamationAndClosingLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_MineralPropertiesNet": { "auth_ref": [ "r138", "r306" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Mineral properties, net of adjustments.", "label": "Mineral Properties, Net", "terseLabel": "Mineral properties and equipment, net" } } }, "localname": "MineralPropertiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_MineralPropertiesNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mineral Assets Equipment, and Kinetic Separation Intellectual Property and Other Property [Abstract]" } } }, "localname": "MineralPropertiesNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r63" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows From Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r63" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows Used In Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r63", "r66", "r69" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows From Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r2", "r42", "r44", "r49", "r51", "r69", "r79", "r84", "r86", "r87", "r88", "r89", "r92", "r93", "r98", "r117", "r119", "r122", "r125", "r127", "r133", "r146", "r147", "r148", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r254", "r259", "r311", "r322" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.westernuranium.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "netLabel": "Net (loss) income (in Dollars)", "terseLabel": "Net income (loss)", "totalLabel": "Net income/(loss)", "verboseLabel": "Net income/(loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow", "http://www.westernuranium.com/role/ConsolidatedIncomeStatement", "http://www.westernuranium.com/role/LiquidityandGoingConcernDetails", "http://www.westernuranium.com/role/ScheduleofcomputationsofnetincomelosspershareTable", "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) [Abstract]", "terseLabel": "Cash paid during the period for:" } } }, "localname": "NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.westernuranium.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r117", "r119", "r122", "r125", "r127" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating profit/ (loss)" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesOfLessorContingentRentalsDescriptionOfVariableRateBasis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of reference rate for variable rate of lessor's operating lease.", "label": "Operating Leases of Lessor, Contingent Rentals, Description of Variable Rate Basis", "terseLabel": "Production revenue percentage of lease, description" } } }, "localname": "OperatingLeasesOfLessorContingentRentalsDescriptionOfVariableRateBasis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidity and Going Concern [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r24", "r284" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.", "label": "Other Commitment", "terseLabel": "Agreed to pay" } } }, "localname": "OtherCommitment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r37" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Foreign exchange gain/(loss)" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]", "terseLabel": "Other comprehensive income/(loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r57" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "negatedLabel": "Other (income)/expense" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r59" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireRoyaltyInterestsInMiningProperties": { "auth_ref": [ "r58" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from the purchase of royalty interests in mining properties is the amount of cash the mineral producer pays the owner of the mine or mineral resource.", "label": "Payments to Acquire Royalty Interests in Mining Properties", "terseLabel": "Royalty payment" } } }, "localname": "PaymentsToAcquireRoyaltyInterestsInMiningProperties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r194", "r195", "r196", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r208", "r209", "r210", "r211", "r212", "r213", "r215", "r216", "r218", "r219", "r222", "r223", "r224", "r225", "r226" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r194", "r195", "r196", "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r208", "r209", "r210", "r211", "r212", "r213", "r215", "r216", "r218", "r219", "r222", "r223", "r224", "r225", "r226" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r6", "r23", "r135", "r136" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Non-brokered Private Placement [Member]", "verboseLabel": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/LiquidityandGoingConcernDetails", "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "auth_ref": [ "r61" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.", "label": "Proceeds from Debt, Net of Issuance Costs", "terseLabel": "Net proceeds (in Dollars)" } } }, "localname": "ProceedsFromDebtNetOfIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r60" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Issuances of common shares, net of offering costs" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r60" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Proceeds from Private Placement - January 20, 2022", "verboseLabel": "Net proceeds raised in the private placement" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow", "http://www.westernuranium.com/role/LiquidityandGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r60" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Proceeds from warrant exercises" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r60" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from Warrant Exercises", "terseLabel": "Proceeds from the exercise of warrants" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/LiquidityandGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r333", "r334" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional Fees", "terseLabel": "Professional fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r190", "r277", "r278" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionDescriptionOfTransaction": { "auth_ref": [ "r13", "r269", "r271", "r272", "r273", "r276" ], "lang": { "en-us": { "role": { "documentation": "A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates.", "label": "Related Party Transaction, Description of Transaction", "terseLabel": "Related party transaction, description" } } }, "localname": "RelatedPartyTransactionDescriptionOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r190", "r277", "r279", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r275", "r276", "r278", "r280", "r281" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "RELATED PARTY TRANSACTIONS AND BALANCES" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/RelatedPartyTransactionsandBalances" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r10", "r74", "r307", "r316" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Restricted cash, noncurrent" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r10", "r70", "r74", "r307", "r316" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents", "terseLabel": "Total" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r10", "r70", "r74" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents, Current", "terseLabel": "Restricted cash, current portion" } } }, "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": { "auth_ref": [ "r70", "r74", "r335" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents, Noncurrent", "terseLabel": "Restricted cash, net of current portion" } } }, "localname": "RestrictedCashAndCashEquivalentsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashCurrent": { "auth_ref": [ "r10", "r74" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash, Current", "terseLabel": "Restricted cash, current portion" } } }, "localname": "RestrictedCashCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r17", "r176", "r284", "r318", "r328", "r330" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet", "http://www.westernuranium.com/role/LiquidityandGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r81", "r82", "r83", "r85", "r91", "r93", "r134", "r228", "r229", "r230", "r233", "r234", "r252", "r325", "r327" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r115", "r116", "r118", "r123", "r124", "r128", "r129", "r130", "r181", "r182", "r292" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue from Contract with Customer, Including Assessed Tax", "terseLabel": "Aggregate revenue" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r76", "r77" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r50", "r79", "r115", "r116", "r118", "r123", "r124", "r128", "r129", "r130", "r133", "r146", "r147", "r148", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r259", "r314" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/LiquidityandGoingConcernDetails", "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Private placement units" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Unit price per share (in Dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of accounts payable and accrued liabilities" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/AccountsPayableandAccruedLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofcomputationsofnetincomelosspershareTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r102" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of computations of net income (loss) per share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r198", "r214", "r217" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of stock options" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of black-scholes option pricing model" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r179", "r193" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "terseLabel": "Schedule of warrants" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r67" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r213" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value, Expired, forfeited, or cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Exercise Price, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r208", "r209" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted Average Grant Date Fair Value, Outstanding \u2013 ending balance", "periodStartLabel": "Weighted Average Grant Date Fair Value, Outstanding \u2013 beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r212" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price", "terseLabel": "Exercise Price (in Dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofblackscholesoptionpricingmodelTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend Yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofblackscholesoptionpricingmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofblackscholesoptionpricingmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Weighted Average Risk-Free Interest Rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofblackscholesoptionpricingmodelTable" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r207" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "terseLabel": "Number of Shares, Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "terseLabel": "Number of Shares, Exercisable (in Shares)", "verboseLabel": "Number of Shares, Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable", "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r201" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable", "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r202" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "negatedLabel": "Number of Shares, Expired, forfeited, or cancelled\t(in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r202" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Expired, forfeited, or cancelled", "verboseLabel": "Weighted Average Exercise Price, Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable", "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r205" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "terseLabel": "Number of Shares, Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r203" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures", "terseLabel": "Number of Options Granted (in Shares)", "verboseLabel": "Number of options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofblackscholesoptionpricingmodelTable", "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails", "http://www.westernuranium.com/role/SubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r203" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Number of Shares, Granted (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r227" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "periodEndLabel": "Intrinsic Value, Outstanding \u2013 ending balance (in Dollars)", "periodStartLabel": "Intrinsic Value, Outstanding \u2013 beginning balance (in Dollars)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r199", "r200" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Number of Shares, Outstanding \u2013 ending balance (in Shares)", "periodStartLabel": "Number of Shares, Outstanding \u2013 beginning balance (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period", "terseLabel": "Number of Shares, Issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r204" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r197", "r220", "r221", "r222", "r223", "r226", "r231", "r232" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-Based Payment Arrangement [Policy Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Stock Price (in Dollars per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofblackscholesoptionpricingmodelTable" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected life (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofblackscholesoptionpricingmodelTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r227" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "periodEndLabel": "Intrinsic Value Outstanding - ending", "periodStartLabel": "Intrinsic Value- beginning", "terseLabel": "Intrinsic Value, Exercisable (in Dollars)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable", "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Contractual Life (years), Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable", "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "terseLabel": "Weighted Average Grant Date Fair Value, Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Contractual Life (years), Outstanding \u2013 ending balance", "verboseLabel": "Weighted Average Contractual Life (years) Outstanding - ending" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable", "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Exercisable price expires term" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Contractual Life (years), Outstanding \u2013 beginning balance" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r174" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "terseLabel": "Shares issued" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r75", "r80" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SignificantSupplyCommitmentDescription": { "auth_ref": [ "r32", "r310", "r320" ], "lang": { "en-us": { "role": { "documentation": "Excluding long-term commitments, description of arrangements in which the entity must commit resources to supply goods or services to one or more customers, which may include identification of the goods or services to be furnished, identity of the buyer, pricing, effects on pricing (such as penalties) of failing to deliver minimum quantities required to be furnished, cancellation rights, and termination provisions.", "label": "Supply Commitment, Description", "terseLabel": "Supply contract, description" } } }, "localname": "SignificantSupplyCommitmentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r35", "r47", "r48", "r49", "r81", "r82", "r83", "r85", "r91", "r93", "r107", "r134", "r174", "r176", "r228", "r229", "r230", "r233", "r234", "r252", "r261", "r262", "r263", "r264", "r265", "r266", "r274", "r325", "r326", "r327" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable", "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails", "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r81", "r82", "r83", "r107", "r292" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r15", "r16", "r174", "r176" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Private placement - February 16, 2021 (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r15", "r16", "r174", "r176" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Private placement - February 16, 2021" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r15", "r16", "r176", "r215" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Stock based compensation - stock options" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]", "terseLabel": "Stock Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "domainItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r16", "r19", "r20", "r79", "r131", "r133", "r259", "r284" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r48", "r79", "r81", "r82", "r83", "r85", "r91", "r133", "r134", "r176", "r228", "r229", "r230", "r233", "r234", "r239", "r240", "r246", "r252", "r259", "r261", "r262", "r266", "r274", "r326", "r327" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Total shareholders\u2019 equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Capital and Other Equity Instruments [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r78", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r176", "r180", "r251" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r267", "r286" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r267", "r286" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r267", "r286" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r285", "r288" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/LiquidityandGoingConcernDetails", "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Substantial Doubt about Going Concern [Text Block]", "terseLabel": "LIQUIDITY AND GOING CONCERN" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/LiquidityandGoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r34", "r177" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Shares" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r34", "r177" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "terseLabel": "Treasury shares held in treasury" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r34", "r177", "r178" ], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury shares, 306 shares held in treasury as of September 30, 2022 and December 31, 2021" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r108", "r109", "r110", "r111", "r112", "r113", "r114" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrants to purchase common shares [Member]", "verboseLabel": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ScheduleofcomputationsofnetincomelosspershareTable", "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r96", "r101" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average shares outstanding - diluted (in Shares)", "verboseLabel": "Weighted average shares outstanding, diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement", "http://www.westernuranium.com/role/ScheduleofcomputationsofnetincomelosspershareTable" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r95", "r101" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average shares outstanding - basic (in Shares)", "verboseLabel": "Weighted average shares outstanding, basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement", "http://www.westernuranium.com/role/ScheduleofcomputationsofnetincomelosspershareTable" ], "xbrltype": "sharesItemType" }, "wstrf_AblationIntellectualProperty": { "auth_ref": [], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Ablation intellectual property.", "label": "Ablation Intellectual Property", "terseLabel": "Kinetic separation intellectual property" } } }, "localname": "AblationIntellectualProperty", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "wstrf_AccountsPayableandAccruedLiabilitiesDetailsScheduleofaccountspayableandaccruedliabilitiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Accounts Payable and Accrued Liabilities [Abstract]" } } }, "localname": "AccountsPayableandAccruedLiabilitiesDetailsScheduleofaccountspayableandaccruedliabilitiesLineItems", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofaccountspayableandaccruedliabilitiesTable" ], "xbrltype": "stringItemType" }, "wstrf_AccountsPayableandAccruedLiabilitiesDetailsScheduleofaccountspayableandaccruedliabilitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities (Details) - Schedule of accounts payable and accrued liabilities [Table]" } } }, "localname": "AccountsPayableandAccruedLiabilitiesDetailsScheduleofaccountspayableandaccruedliabilitiesTable", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofaccountspayableandaccruedliabilitiesTable" ], "xbrltype": "stringItemType" }, "wstrf_AccretionReclamationObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accretion of reclamation obligations.", "label": "Accretion Reclamation Obligation", "terseLabel": "Accretion" } } }, "localname": "AccretionReclamationObligation", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofreclamationliabilityactivityTable" ], "xbrltype": "monetaryItemType" }, "wstrf_AggregateWarrantWereExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aggregate warrants were exercised.", "label": "Aggregate Warrant Were Exercised", "terseLabel": "Aggregate warrants were exercised" } } }, "localname": "AggregateWarrantWereExercised", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "sharesItemType" }, "wstrf_BlackRangeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of stock issued during period sale of common stock value in private placement two.", "label": "Black Range Member", "terseLabel": "Black Range [Member]" } } }, "localname": "BlackRangeMember", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "domainItemType" }, "wstrf_BusinessDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business (Details) [Line Items]" } } }, "localname": "BusinessDetailsLineItems", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/BusinessDetails" ], "xbrltype": "stringItemType" }, "wstrf_BusinessDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business (Details) [Table]" } } }, "localname": "BusinessDetailsTable", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/BusinessDetails" ], "xbrltype": "stringItemType" }, "wstrf_ChangeInMarketableSecurities": { "auth_ref": [], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of change in marketable securities.", "label": "Change In Marketable Securities", "terseLabel": "Change in marketable securities" } } }, "localname": "ChangeInMarketableSecurities", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "wstrf_ConsultingFees": { "auth_ref": [], "calculation": { "http://www.westernuranium.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Consulting fees.", "label": "Consulting Fees", "terseLabel": "Consulting fees" } } }, "localname": "ConsultingFees", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "wstrf_Covid19TextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both.", "label": "Covid19 Text Block", "terseLabel": "COVID-19" } } }, "localname": "Covid19TextBlock", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/Covid19" ], "xbrltype": "textBlockItemType" }, "wstrf_DeferredTaxLiability": { "auth_ref": [], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of deferred tax liability.", "label": "Deferred Tax Liability", "terseLabel": "Deferred tax liability" } } }, "localname": "DeferredTaxLiability", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "wstrf_DenominatorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Denominator Abstract", "terseLabel": "Denominator:" } } }, "localname": "DenominatorAbstract", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofcomputationsofnetincomelosspershareTable" ], "xbrltype": "stringItemType" }, "wstrf_DiscontinuationOfReclamationLiability": { "auth_ref": [], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Discontinuation of reclamation liability.", "label": "Discontinuation Of Reclamation Liability", "terseLabel": "Accretion of reclamation liability" } } }, "localname": "DiscontinuationOfReclamationLiability", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "wstrf_DiscontinuationOfReclamationLiabilitys": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of discontinuation of reclamation liabilitys.", "label": "Discontinuation Of Reclamation Liabilitys", "negatedLabel": "Discontinuation of reclamation liability" } } }, "localname": "DiscontinuationOfReclamationLiabilitys", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofreclamationliabilityactivityTable" ], "xbrltype": "monetaryItemType" }, "wstrf_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.westernuranium.com/20220930", "xbrltype": "stringItemType" }, "wstrf_ExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price per share.", "label": "Exercise Price Per Share", "terseLabel": "Exercise price per share" } } }, "localname": "ExercisePricePerShare", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/SubsequentEventsDetails" ], "xbrltype": "perShareItemType" }, "wstrf_ForeignExchangeLoss": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A foreign exchange gain/loss occurs when a company buys and/or sells goods and services in a foreign currency, and that currency fluctuates relative to their home currency.", "label": "Foreign Exchange Loss", "terseLabel": "Foreign exchange gain (loss)" } } }, "localname": "ForeignExchangeLoss", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "wstrf_GrossProceedsFromIssuanceOfPrivatePlacements": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Gross Proceeds From Issuance Of Private Placements", "terseLabel": "Gross proceeds raised in the private placement (in Dollars)" } } }, "localname": "GrossProceedsFromIssuanceOfPrivatePlacements", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/LiquidityandGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "wstrf_GrossReclamationLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gross reclamation liabilities.", "label": "Gross Reclamation Liabilities", "terseLabel": "Gross reclamation liabilities" } } }, "localname": "GrossReclamationLiabilities", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetails" ], "xbrltype": "monetaryItemType" }, "wstrf_IncentiveStockOptionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Incentive Stock Option Plan Member", "terseLabel": "Incentive Stock Option Plan [Member]" } } }, "localname": "IncentiveStockOptionPlanMember", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "domainItemType" }, "wstrf_IncreaseDecreaseInReclamationLiabilities": { "auth_ref": [], "calculation": { "http://www.westernuranium.com/role/ConsolidatedCashFlow": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of reclamation liabilities.", "label": "Increase Decrease In Reclamation Liabilities", "negatedLabel": "Contingent consideration" } } }, "localname": "IncreaseDecreaseInReclamationLiabilities", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "wstrf_IntrinsicValueExercisableinDollars": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "ntrinsic value is the value any given option would have if it were exercised today basically, the intrinsic value.", "label": "Intrinsic Value Exercisablein Dollars", "terseLabel": "Intrinsic Value, Exercisable" } } }, "localname": "IntrinsicValueExercisableinDollars", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "monetaryItemType" }, "wstrf_IntrinsicValueUSDExercised": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of intrinsic value USD exercised.", "label": "Intrinsic Value USDExercised", "terseLabel": "Intrinsic Value (USD) , Exercised" } } }, "localname": "IntrinsicValueUSDExercised", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "monetaryItemType" }, "wstrf_IntrinsicValueUSDExpired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of intrinsic value USD expired.", "label": "Intrinsic Value USDExpired", "terseLabel": "Intrinsic Value (USD), Expired" } } }, "localname": "IntrinsicValueUSDExpired", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "monetaryItemType" }, "wstrf_IntrinsicValueUSDIssued": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of intrinsic value USD issued.", "label": "Intrinsic Value USDIssued", "terseLabel": "Intrinsic Value (USD), Issued" } } }, "localname": "IntrinsicValueUSDIssued", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "monetaryItemType" }, "wstrf_IssuedAndOutstandingCommonSharesPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of issued and outstanding common shares.", "label": "Issued And Outstanding Common Shares Percentage", "terseLabel": "Percentage of issued and outstanding of common shares" } } }, "localname": "IssuedAndOutstandingCommonSharesPercentage", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "percentItemType" }, "wstrf_KineticSeparationIntellectualProperty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of kinetic separation intellectual property.", "label": "Kinetic Separation Intellectual Property", "terseLabel": "Kinetic separation intellectual property" } } }, "localname": "KineticSeparationIntellectualProperty", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofmineralpropertiesandequipmentandkineticseparationintellectualpropertyTable" ], "xbrltype": "monetaryItemType" }, "wstrf_KineticSeparationIntellectualPropertyDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kinetic Separation Intellectual Property, Description.", "label": "Kinetic Separation Intellectual Property Description", "terseLabel": "Kinetic separation intellectual property, description" } } }, "localname": "KineticSeparationIntellectualPropertyDescription", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetails" ], "xbrltype": "stringItemType" }, "wstrf_LesseeOperatingLeaseTermOfContracts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee Operating Lease Term Of Contracts", "terseLabel": "Additional term of lease" } } }, "localname": "LesseeOperatingLeaseTermOfContracts", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetails" ], "xbrltype": "durationItemType" }, "wstrf_LiquidityandGoingConcernDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidity and Going Concern (Details) [Line Items]" } } }, "localname": "LiquidityandGoingConcernDetailsLineItems", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/LiquidityandGoingConcernDetails" ], "xbrltype": "stringItemType" }, "wstrf_LiquidityandGoingConcernDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidity and Going Concern (Details) [Table]" } } }, "localname": "LiquidityandGoingConcernDetailsTable", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/LiquidityandGoingConcernDetails" ], "xbrltype": "stringItemType" }, "wstrf_MineralAssetsEquipmentAndKineticSeparationIntellectualPropertyAndOtherProperty": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for mineral assets equipment, and kinetic separation intellectual property and other property.", "label": "Mineral Assets Equipment And Kinetic Separation Intellectual Property And Other Property", "terseLabel": "MINERAL ASSETS EQUIPMENT, KINETIC SEPARATION INTELLECTUAL PROPERTY, AND OTHER PROPERTY" } } }, "localname": "MineralAssetsEquipmentAndKineticSeparationIntellectualPropertyAndOtherProperty", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherProperty" ], "xbrltype": "textBlockItemType" }, "wstrf_MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetailsScheduleofmineralpropertiesandequipmentandkineticseparationintellectualpropertyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of mineral properties and equipment and kinetic separation intellectual property [Abstract]" } } }, "localname": "MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetailsScheduleofmineralpropertiesandequipmentandkineticseparationintellectualpropertyLineItems", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofmineralpropertiesandequipmentandkineticseparationintellectualpropertyTable" ], "xbrltype": "stringItemType" }, "wstrf_MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetailsScheduleofmineralpropertiesandequipmentandkineticseparationintellectualpropertyTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details) - Schedule of mineral properties and equipment and kinetic separation intellectual property [Table]" } } }, "localname": "MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetailsScheduleofmineralpropertiesandequipmentandkineticseparationintellectualpropertyTable", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofmineralpropertiesandequipmentandkineticseparationintellectualpropertyTable" ], "xbrltype": "stringItemType" }, "wstrf_MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetailsScheduleofreclamationliabilityactivityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Reclamation Liability Activity [Abstract]" } } }, "localname": "MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetailsScheduleofreclamationliabilityactivityLineItems", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofreclamationliabilityactivityTable" ], "xbrltype": "stringItemType" }, "wstrf_MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetailsScheduleofreclamationliabilityactivityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mineral Assets Equipment, Kinetic Separation Intellectual Property, and Other Property (Details) - Schedule of reclamation liability activity [Table]" } } }, "localname": "MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetailsScheduleofreclamationliabilityactivityTable", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofreclamationliabilityactivityTable" ], "xbrltype": "stringItemType" }, "wstrf_MineralPropertiesAndEquipment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Mineral properties and equipment.", "label": "Mineral Properties And Equipment", "terseLabel": "Mineral properties and equipment" } } }, "localname": "MineralPropertiesAndEquipment", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofmineralpropertiesandequipmentandkineticseparationintellectualpropertyTable" ], "xbrltype": "monetaryItemType" }, "wstrf_MiningCosts": { "auth_ref": [], "calculation": { "http://www.westernuranium.com/role/ScheduleofminingexpendituresTable": { "order": 2.0, "parentTag": "wstrf_MiningExpenditures", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of mining costs.", "label": "Mining Costs", "terseLabel": "Mining costs" } } }, "localname": "MiningCosts", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofminingexpendituresTable" ], "xbrltype": "monetaryItemType" }, "wstrf_MiningExpenditures": { "auth_ref": [], "calculation": { "http://www.westernuranium.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 }, "http://www.westernuranium.com/role/ScheduleofminingexpendituresTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Mining expenditures.", "label": "Mining Expenditures", "terseLabel": "Mining expenditures", "totalLabel": "Total mining expenses" } } }, "localname": "MiningExpenditures", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement", "http://www.westernuranium.com/role/ScheduleofminingexpendituresTable" ], "xbrltype": "monetaryItemType" }, "wstrf_MiningExpendituresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mining Expenditures [Abstract]" } } }, "localname": "MiningExpendituresAbstract", "nsuri": "http://www.westernuranium.com/20220930", "xbrltype": "stringItemType" }, "wstrf_MiningExpendituresTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents about the entire disclosures of mining expenditures.", "label": "Mining Expenditures Text Block", "terseLabel": "MINING EXPENDITURES" } } }, "localname": "MiningExpendituresTextBlock", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/MiningExpenditures" ], "xbrltype": "textBlockItemType" }, "wstrf_NumberOfSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Shares Outstanding.", "label": "Number Of Shares Outstanding", "periodEndLabel": "Number of Shares Outstanding - ending", "periodStartLabel": "Number of Shares Outstanding - beginning" } } }, "localname": "NumberOfSharesOutstanding", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "sharesItemType" }, "wstrf_NumeratorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Numerator Abstract", "terseLabel": "Numerator:" } } }, "localname": "NumeratorAbstract", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofcomputationsofnetincomelosspershareTable" ], "xbrltype": "stringItemType" }, "wstrf_OptionsToPurchaseCommonSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Options To Purchase Common Shares Member", "terseLabel": "Options to purchase common shares [Member]" } } }, "localname": "OptionsToPurchaseCommonSharesMember", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofcomputationsofnetincomelosspershareTable" ], "xbrltype": "domainItemType" }, "wstrf_PaymentsToAcquireMiningPermits": { "auth_ref": [], "calculation": { "http://www.westernuranium.com/role/ScheduleofminingexpendituresTable": { "order": 1.0, "parentTag": "wstrf_MiningExpenditures", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Payments to acquire mining permits.", "label": "Payments To Acquire Mining Permits", "terseLabel": "Permits" } } }, "localname": "PaymentsToAcquireMiningPermits", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofminingexpendituresTable" ], "xbrltype": "monetaryItemType" }, "wstrf_PhysicalUraniumInventoryPurchaseDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The description of the physical uranium inventory purchase.", "label": "Physical Uranium Inventory Purchase Description", "terseLabel": "Physical uranium inventory purchase description" } } }, "localname": "PhysicalUraniumInventoryPurchaseDescription", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "wstrf_PinonRidgeMiningLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Pinon Ridge Mining LLCMember", "terseLabel": "Pinon Ridge Mining LLC [Member]" } } }, "localname": "PinonRidgeMiningLLCMember", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/BusinessDetails" ], "xbrltype": "domainItemType" }, "wstrf_PrivatePlacementJanuaryTwentyThousandTwentyTwoShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of private placement shares issued during period.", "label": "Private Placement January Twenty Thousand Twenty Two Shares", "terseLabel": "Private placement - January 20, 2022 (in Shares)" } } }, "localname": "PrivatePlacementJanuaryTwentyThousandTwentyTwoShares", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "wstrf_PrivatePlacementJanuaryTwentyTwoThousandTwentyTwo": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued during period of the private placement .", "label": "Private Placement January Twenty Two Thousand Twenty Two", "terseLabel": "Private placement - January 20, 2022" } } }, "localname": "PrivatePlacementJanuaryTwentyTwoThousandTwentyTwo", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "wstrf_PrivatePlacementPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement per share.", "label": "Private Placement Per Share", "terseLabel": "Private placement per share (in Dollars per share)" } } }, "localname": "PrivatePlacementPerShare", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/LiquidityandGoingConcernDetails" ], "xbrltype": "perShareItemType" }, "wstrf_PrivatePlacementShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement Shares.", "label": "Private Placement Shares", "terseLabel": "Private placement shares (in Shares)" } } }, "localname": "PrivatePlacementShares", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/LiquidityandGoingConcernDetails" ], "xbrltype": "sharesItemType" }, "wstrf_ProceedsFromIssuanceOfPrivatePlacements": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds From Issuance Of Private Placements", "terseLabel": "Gross proceeds" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacements", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "wstrf_ReclamationLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reclamation liability.", "label": "Reclamation Liability", "terseLabel": "Reclamation liability" } } }, "localname": "ReclamationLiability", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetails" ], "xbrltype": "monetaryItemType" }, "wstrf_ReclamationLiabilityDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reclamation liability, description.", "label": "Reclamation Liability Description", "terseLabel": "Reclamation liability, description" } } }, "localname": "ReclamationLiabilityDescription", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyDetails" ], "xbrltype": "stringItemType" }, "wstrf_RelatedPartyTransactionsandBalancesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions and Balances (Details) [Line Items]" } } }, "localname": "RelatedPartyTransactionsandBalancesDetailsLineItems", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "stringItemType" }, "wstrf_RelatedPartyTransactionsandBalancesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions and Balances (Details) [Table]" } } }, "localname": "RelatedPartyTransactionsandBalancesDetailsTable", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/RelatedPartyTransactionsandBalancesDetails" ], "xbrltype": "stringItemType" }, "wstrf_Royalties": { "auth_ref": [], "calculation": { "http://www.westernuranium.com/role/ScheduleofminingexpendituresTable": { "order": 3.0, "parentTag": "wstrf_MiningExpenditures", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Royalties.", "label": "Royalties", "terseLabel": "Royalties" } } }, "localname": "Royalties", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofminingexpendituresTable" ], "xbrltype": "monetaryItemType" }, "wstrf_ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Accounts Payable And Accrued Liabilities Abstract" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesAbstract", "nsuri": "http://www.westernuranium.com/20220930", "xbrltype": "stringItemType" }, "wstrf_ScheduleOfBlackScholesOptionPricingModelAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Black Scholes Option Pricing Model [Abstract]" } } }, "localname": "ScheduleOfBlackScholesOptionPricingModelAbstract", "nsuri": "http://www.westernuranium.com/20220930", "xbrltype": "stringItemType" }, "wstrf_ScheduleOfComputationsOfNetIncomeLossPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Computations Of Net Income Loss Per Share Abstract" } } }, "localname": "ScheduleOfComputationsOfNetIncomeLossPerShareAbstract", "nsuri": "http://www.westernuranium.com/20220930", "xbrltype": "stringItemType" }, "wstrf_ScheduleOfFairValuesOfFinancialInstrumentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Fair Values Of Financial Instruments Abstract" } } }, "localname": "ScheduleOfFairValuesOfFinancialInstrumentsAbstract", "nsuri": "http://www.westernuranium.com/20220930", "xbrltype": "stringItemType" }, "wstrf_ScheduleOfMineralPropertiesAndEquipmentAndKineticSeparationIntellectualPropertyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Mineral Properties And Equipment And Kinetic Separation Intellectual Property Abstract" } } }, "localname": "ScheduleOfMineralPropertiesAndEquipmentAndKineticSeparationIntellectualPropertyAbstract", "nsuri": "http://www.westernuranium.com/20220930", "xbrltype": "stringItemType" }, "wstrf_ScheduleOfMiningAndMiningRelatedAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular of mining and mining related assets.", "label": "Schedule Of Mining And Mining Related Assets Table Text Block", "terseLabel": "Schedule of mineral properties and equipment and kinetic separation intellectual property" } } }, "localname": "ScheduleOfMiningAndMiningRelatedAssetsTableTextBlock", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyTables" ], "xbrltype": "textBlockItemType" }, "wstrf_ScheduleOfMiningExpendituresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of mining expenditures [Abstract]" } } }, "localname": "ScheduleOfMiningExpendituresAbstract", "nsuri": "http://www.westernuranium.com/20220930", "xbrltype": "stringItemType" }, "wstrf_ScheduleOfMiningExpendituresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "It represents about the entire tabular disclosures of mining expenditures.", "label": "Schedule Of Mining Expenditures Table Text Block", "terseLabel": "Schedule of mining expenditures" } } }, "localname": "ScheduleOfMiningExpendituresTableTextBlock", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/MiningExpendituresTables" ], "xbrltype": "textBlockItemType" }, "wstrf_ScheduleOfReclamationLiabilityActivityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Reclamation Liability Activity Abstract" } } }, "localname": "ScheduleOfReclamationLiabilityActivityAbstract", "nsuri": "http://www.westernuranium.com/20220930", "xbrltype": "stringItemType" }, "wstrf_ScheduleOfReclamationObligationsOfFairValueOfReclamationObligationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the aggregate benefit obligation and aggregate fair value of reclamation obligation.", "label": "Schedule Of Reclamation Obligations Of Fair Value Of Reclamation Obligation Table Text Block", "terseLabel": "Schedule of reclamation liability activity" } } }, "localname": "ScheduleOfReclamationObligationsOfFairValueOfReclamationObligationTableTextBlock", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/MineralAssetsEquipmentKineticSeparationIntellectualPropertyandOtherPropertyTables" ], "xbrltype": "textBlockItemType" }, "wstrf_ScheduleOfStockOptionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Stock Options Abstract" } } }, "localname": "ScheduleOfStockOptionsAbstract", "nsuri": "http://www.westernuranium.com/20220930", "xbrltype": "stringItemType" }, "wstrf_ScheduleOfWarrantsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Warrants Abstract" } } }, "localname": "ScheduleOfWarrantsAbstract", "nsuri": "http://www.westernuranium.com/20220930", "xbrltype": "stringItemType" }, "wstrf_SettlementExpense": { "auth_ref": [], "calculation": { "http://www.westernuranium.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Settlement expense.", "label": "Settlement Expense", "terseLabel": "Settlement expense" } } }, "localname": "SettlementExpense", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "wstrf_ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceS": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Exercise Price.", "label": "Share Based Compensation Arrangement By Shares Based Payment Award Options Outstanding Weighted Average Exercise Price S", "terseLabel": "Weighted Average Exercise Price Outstanding - ending" } } }, "localname": "ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceS", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "perShareItemType" }, "wstrf_ShareBasedCompensationArrangementBySharseBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceS": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average exercise price.", "label": "Share Based Compensation Arrangement By Sharse Based Payment Award Options Outstanding Weighted Average Exercise Price S", "terseLabel": "Weighted Average Exercise Price Outstanding - beginning" } } }, "localname": "ShareBasedCompensationArrangementBySharseBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceS", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "perShareItemType" }, "wstrf_ShareBasedCompensationWeightedAverageExercisePriceOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Change in the weighted average exercise price of options outstanding.", "label": "Share Based Compensation Weighted Average Exercise Price Outstanding", "periodEndLabel": "Weighted Average Exercise Price, Outstanding \u2013 ending balance", "periodStartLabel": "Weighted Average Exercise Price, Outstanding \u2013 beginning balance" } } }, "localname": "ShareBasedCompensationWeightedAverageExercisePriceOutstanding", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "perShareItemType" }, "wstrf_ShareCapitalandOtherEquityInstrumentsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Capital and Other Equity Instruments (Details) [Line Items]" } } }, "localname": "ShareCapitalandOtherEquityInstrumentsDetailsLineItems", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "stringItemType" }, "wstrf_ShareCapitalandOtherEquityInstrumentsDetailsScheduleofstockoptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Capital and Other Equity Instruments (Details) - Schedule of stock options [Line Items]" } } }, "localname": "ShareCapitalandOtherEquityInstrumentsDetailsScheduleofstockoptionsLineItems", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "stringItemType" }, "wstrf_ShareCapitalandOtherEquityInstrumentsDetailsScheduleofstockoptionsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Capital and Other Equity Instruments (Details) - Schedule of stock options [Table]" } } }, "localname": "ShareCapitalandOtherEquityInstrumentsDetailsScheduleofstockoptionsTable", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofstockoptionsTable" ], "xbrltype": "stringItemType" }, "wstrf_ShareCapitalandOtherEquityInstrumentsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Capital and Other Equity Instruments (Details) [Table]" } } }, "localname": "ShareCapitalandOtherEquityInstrumentsDetailsTable", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "stringItemType" }, "wstrf_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of share based compensation arrangement by sharebased payment award options outstanding weighted average remaining contractual term.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term", "terseLabel": "Weighted Average Contractual Life (years) - beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "durationItemType" }, "wstrf_SharebasedCompensationArrangementBySharebasedPaymentStockEligibleForIssue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sharebased compensation arrangement by sharebased payment Stock eligible for issue.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Stock Eligible For Issue", "terseLabel": "Maximum number of shares eligible for issue, shares" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentStockEligibleForIssue", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ShareCapitalandOtherEquityInstrumentsDetails" ], "xbrltype": "sharesItemType" }, "wstrf_StockIssuedDuringPeriodSaleOPrivatePlacement": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of sale of private placement.", "label": "Stock Issued During Period Sale OPrivate Placement", "terseLabel": "Private placement - March 1, 2021" } } }, "localname": "StockIssuedDuringPeriodSaleOPrivatePlacement", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "wstrf_StockIssuedDuringPeriodSaleOPrivatePlacementShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of sale of shares in private placement.", "label": "Stock Issued During Period Sale OPrivate Placement Shares", "terseLabel": "Private placement - March 1, 2021 (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSaleOPrivatePlacementShares", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "wstrf_StockIssuedDuringPeriodSharesWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants exercised issued during the period.", "label": "Stock Issued During Period Shares Warrants Exercised", "terseLabel": "Proceeds from the exercise of warrants (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesWarrantsExercised", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "wstrf_StockIssuedDuringPeriodValueWarrantsExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of warrants.", "label": "Stock Issued During Period Value Warrants Exercised", "terseLabel": "Proceeds from the exercise of warrants" } } }, "localname": "StockIssuedDuringPeriodValueWarrantsExercised", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "wstrf_StrategicAcquisitionOfPhysicalUranium": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Strategic acquisition of physical uranium.", "label": "Strategic Acquisition Of Physical Uranium", "terseLabel": "Strategic acquisition of physical uranium" } } }, "localname": "StrategicAcquisitionOfPhysicalUranium", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "wstrf_SubscriptionPayable": { "auth_ref": [], "calculation": { "http://www.westernuranium.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of subscription payable.", "label": "Subscription Payable", "terseLabel": "Subscription payable" } } }, "localname": "SubscriptionPayable", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "wstrf_SubsequentEventsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Line Items]" } } }, "localname": "SubsequentEventsDetailsLineItems", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "wstrf_SubsequentEventsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Table]" } } }, "localname": "SubsequentEventsDetailsTable", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "wstrf_SummaryofSignificantAccountingPoliciesDetailsScheduleoffairvaluesoffinancialinstrumentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) - Schedule of fair values of financial instruments [Line Items]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleoffairvaluesoffinancialinstrumentsLineItems", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleoffairvaluesoffinancialinstrumentsTable" ], "xbrltype": "stringItemType" }, "wstrf_SummaryofSignificantAccountingPoliciesDetailsScheduleoffairvaluesoffinancialinstrumentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) - Schedule of fair values of financial instruments [Table]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsScheduleoffairvaluesoffinancialinstrumentsTable", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleoffairvaluesoffinancialinstrumentsTable" ], "xbrltype": "stringItemType" }, "wstrf_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Member", "terseLabel": "Warrants [Member]" } } }, "localname": "WarrantsMember", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/LiquidityandGoingConcernDetails" ], "xbrltype": "domainItemType" }, "wstrf_WeightedAverageContractualLifeyearsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Duration of weighted average contractual life years exercised.", "label": "Weighted Average Contractual Lifeyears Exercised", "terseLabel": "Weighted Average Contractual Life (years), Exercised" } } }, "localname": "WeightedAverageContractualLifeyearsExercised", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "durationItemType" }, "wstrf_WeightedAverageContractualLifeyearsExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Weighted Average Contractual Lifeyears Expired", "terseLabel": "Weighted Average Contractual Life (years), Expired" } } }, "localname": "WeightedAverageContractualLifeyearsExpired", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "durationItemType" }, "wstrf_WeightedAverageContractualLifeyearsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of weighted average contractual life years issued.", "label": "Weighted Average Contractual Lifeyears Issued", "terseLabel": "Weighted Average Contractual Life (years), Issued" } } }, "localname": "WeightedAverageContractualLifeyearsIssued", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "durationItemType" }, "wstrf_WeightedAverageExercisePriceIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price Issued", "terseLabel": "Weighted Average Exercise Price, Issued" } } }, "localname": "WeightedAverageExercisePriceIssued", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/ScheduleofwarrantsTable" ], "xbrltype": "perShareItemType" }, "wstrf_WorkingCapitalDeficit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of working capital deficit.", "label": "Working Capital Deficit", "terseLabel": "Working capital deficit" } } }, "localname": "WorkingCapitalDeficit", "nsuri": "http://www.westernuranium.com/20220930", "presentation": [ "http://www.westernuranium.com/role/LiquidityandGoingConcernDetails" ], "xbrltype": "monetaryItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=116646717&loc=d3e6290-110844" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r143": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r145": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r232": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478" }, "r238": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r268": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123395306&loc=d3e36975-112693" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918703-209980" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919370-209981" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128295416&loc=SL77919784-209982" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r281": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r288": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "720", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=6473463&loc=d3e59303-107987" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r3": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=51888271" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "25", "SubTopic": "360", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=96866604&loc=d3e64895-109465" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a)(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 10.D)", "Topic": "980", "URI": "https://asc.fasb.org/extlink&oid=122136240&loc=d3e659339-123030" }, "r338": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r339": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r341": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r342": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r80": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" } }, "version": "2.1" } ZIP 57 0001213900-22-073520-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-22-073520-xbrl.zip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

LK'UJ//EL/#N+GO@QGO=/5BT0CYU]I%]-C" M!PKA S/CBP80M\1.RO#A!6.-GK0+>G3V1P<^LT:=;LT$=;#6I@]M M34GQ/NR^,L?,OS"@)[.S[-M\1$;L=#-N6E[H+-OKG)N[F&WLL$V-@YVOPZJ! ML_Q,Y@O&&/.+.S]VELDNWE7X #LPY_#81:?WIH?W(KCM?&D[BQAT/---\VS% M8O-^OHY\RZ&^OQ$[G5R_91$(D@#Z(W_\SFG>FG_.9DSQJ)??>"=7HH^=4![- M/3M0+9\+BZ5+!60U(1232:'8>IZG=')5$SBNXW)-<>0+R11F+A*JYV0:@G#+ M^K+?FSR!G)AJFM>5EM@ Z;>7P^+*B^D1,L["M, MI,F5=SYHH- K+PM1T"H*+RX:!P??^::/SI]PZ/^W2C@3!:X+6BN('=1KL..'$MTZ/.G M3B[+):52;RAJN1X1.QI?1.T([-Y,;!&<%2 C>>35L$>4[1H8 A$-DS?J4>*. M!R$_U]M3:)&491JUX?(RC7$9Q\.I0+8] ,TA+)O0!;SWYX@Z)B/#>';"9\I? M6$!P39]#\6J"D OC*9+)+XFE& ]]>#GN>M%0NAXU?A2[%/@3C'S(9Y(<7G7. MZ-B0U^\\B8=<%*-;C95T7;NW]R&O5#) \B#1J(">J(2WLZ#(? 6W9K'*C\VO MWUJ%NQN 1_NQU7[<;E%72>S_V2<#9!WR!4^PB?YZHL>#GC)E6IC59),<53Z M"$=7KM.CCD][?-3P%Y>CN6OJJV&S>PM(IT]IX)-/3XXQZEGPS>>4(/M@T:7$ MVSKL:_L0X@ME,4I!=T7U5-,KR7&$0YO^>"N(*F^ J#&;8C:7NR$564(^#\\0 MY4V8A'YK^2.O/D16\YP1RI K?#<=XX6"*\^C9D*\MWQSQJKU<)&LZAOWN6YR]C7'(@"KB)-@S#]0?V=," MG<2@U&J'P_8FB=Y(C=N2K+C]< I_9Q$T%C!"T [X8!D$X4,[_(PCV';]$7/1 M-KON*"#L0A(:D ?+_R$Q+/5&+IFE-M=H/1=T94E!]_$4V!6)GFO[,>#N/=>D M/8:Q@T.4G(Q.!ODNI95FJO[ U@>Q!JO8O_M$6\%],O:?W#W^WGK(B>^DI![. M[ILDW2KN%4DY_H=3^$9?0L\*9_4\%U1F7K\>VE)@*;,E+PE<$*UYNC(:LAP$ M$P/)C6$&KN=_-)!,HPGVR! R6[]R2$1]CS2$,3PYB0)B'<.F7/L4%EOA#AV7 M:F#BVI-/1<%-OI5W2_;R6E:V_7/Y#PWMTBN3'T_AFCX;S';!!_HT9'4"J&.Y M7@(_LO#\=8&4!X'B0Q.\_"KDAU/X;CG"7M$QGFGPGC13Y!UB^P?0A[;V&$ 5 M60'TX12X=UPH1(Y(G+!<)^_0R0-W2N\-J,H*K@^GT/K9M[J6U,%CY=PXD]!6 MM;&M*F?!P-J';HO.[6_MYN/30ZLC\Q:KSJ751)Z[!*'N6[[B>SS 98EKT_E- M^@6Y&W+7YSGK(,KOWGG2T_H7]28F%TWK@CR^#V%RW]PWZO$ENR"L_JN8?MME MT[,FDI>B-_G$CS;92MX,F7FHYC\,8O5^/8D2&SASRM6UU]Q=<$M.%^589,LI M=G\=]@>XF**A/I^&:X%F,[IPX5@[G1O%M%7^S7]&%Z+M9M5+N=PY:?(B2;-] M33I/7SNWU[?-A]M6RC0XR6=^==>^;K4[K>L"_-:Y^W9[W7QL79.OS6_ 05JD M\WNKE3;A3_*9BCM$>P7+(4^=Z\^',:=D".2<^>R#N\O)Q78C,$\,=;,$U(69 MI%,9IVE'^E$":G01Q =Z>JR!18DX69=KF]-U+/(R<7\[!H%8?ZZ>+-OZ*;20 M=0?7],,;)?:V&"D,$PB2*2/+CD'2H<. %QP2HRRI"K\E6<1AJ[J^/^P<*4&N MJ9FDAS9)#^U ]C(?RQL59CA6R"33[=WT?9HPNXNEVC9>,@:_Q,WE;?:RGD+A M30/$X' ]1XKA[%?"ZWJ>WE#6KU5_F07S@MSW33!N^/T%9U:D=/RR58]?_!*C3.K0,Y\D'(T52E7*TKM7IC41'(A33/E!I+I4>$ M638P*^T-9O6ZJM29Z"L9QM+SZ5DN/#VR7?#B!^H'GL6J=?/1F$ .A9BA$,)O M$$C$/FWQ&%ZP!-MB 'E@Q&/2;+A7:A5%K=32;I5MDP#ALQL&>Y#PV:X8O \& M?._1H6$)[COR#,<:#1@$F%6)75M#+.<5?G6]]R/<1NSRGZ+UL]BW>D"!ZHNFJ M'$C)5LR<&U:P"_8YSLLT)YRD^X\0"5O[* )D=_Z-U48B*W_F!!=Q&Q]NMW(% M#OK4DLLR#.^ / A-*:"YP9&P"C3U:EE12ZG=H7O!YG:%[46172O*WQN>'X]N M$%::6GI^H%2U&^Z> MQ@*SCZ=&,*_9$7*6@R;&X5D?YT;Z.#1@]?HPX$<&B>BCB(VVZY@?G8;56E4I M+;Z &SF:Q-#98K!/*NA4*R!FI]939>&_<.V6"IJ(E*@0Q# M5H:!LUO<(/OQ]0CZW,>D61HGHNE*M5)5U%I%CMV .-F9KV;-K;MOW)>Y[I5RO*RJZBA"E6SY1#A^E:.K,M0B%IDXDAB2^ MWVGV54XG16;F$%XID"C30H=I#V#HE/3<4=>F.TDF7FD,LLF'DP[$Q:=LB44[ M-Y1ZI;KN,5O>IRB(.-PE#C=V9"\)$*HII49%4^54G3,,W3-,;T5Z22>03EHL,X;GPMX34N1>$ M:3J]IB!+0E#[.)VKIBN-DB25$Q VNW"/9 &;:J.A5!I'6M=MX\P@TS;$-><3 MDM8[5@*6AK&R_9"@TY7KITB-E:ER*Z)EA_PT]V@Y.,FU,^KZIF<-8R8;2J]' MN$>65?75L*JO+&3:?^QT&R!?W MZ"MU1O0CD3#J!_,6I,A;V$#HC*C_( C_L0:F*JJ6.E\2TVH0GAM)N:O"LUQ7 MRE6YX2E!(/['9TJIEG45MMS;;.40LS9@]:L8VFIJ75%52?*=$2*[8K>K0*11 M;2AZ0Q*(8.A:KO&,KFPDQD$:!)0[,;ODVN0')R@.L%!&8&A;2:6PJ^^U:.B\AKN MD[T(IU]'($Q0W[]R!UW+"6,](@I=)0FTDL!1TC6EJF(,9A[1M(&TNBTT58%% M-\IRH.F0/?.I[ ;H 0YQH<,['S*0YZJ!+S\,1R[SF%& MC\_Q.!F0&!(18Q-)+56LR]K"6W8A,(M#7_ 8ENH8SB:X9HF.I#3@[&VDOT< MI4.$958!/4N")A6]45,J!U.''$5"E$*0&+DE1K:Q?"L)B5GL]2MW,+ "=A/8 MN#1E;& UV75AG]IN0$GU\Y% L&>]IC&HE;(;$_2(#&2WU"OGF7K[2-( M#S@DAD3$R+FT,:?H-1\E%KZ6&W9(#(F(L4/30C$LEYG.WKQ,XJI?D&5?UU;S M3S.MQ85^&3N!3U./HK+"B*LGEXX;+SS_!U;!(Z^&S0(;1HYM@>9$>\08!7W7 ML_X+O\8#2FVWO6W?K&0B$S/O!*[Y@S-3_];W1[0WUUPF1G-R62XIE7I#4>=< MP<[UO?3FO%V,M@0CK964LCYGM.(98O%6B.&ST)(.'09TT*4>*:D*T55=YY.Z MIF;XJ<8_A9_PZI!"2Z_4?E<^GGFV=+H;!7X ?<(F^IA8=:4VQ^R^:V*E'7)( M,4V?,^208NZXJ8W(AJ?27OQ%"6C\@[&_)=9Y'>"K839V3C&R@?,F/49*545K M5)2*)DDT;V9*U6KBTDKN>8\:_LA[WX&$$765. B6U8.D(FLTQ8;F"-O#R025/S0*>#2U=JFN9H,+*-((R.[]%G MR[2"(P3G*AU]VI8T^T #PW)HKV5X#E#93Y#G6E F>-X:= XC]6B:O[I!'T0UTQT,/=JG MCF^]4O+)=GW_,TA\\/%TA>.ED6(80;B%",*M\?8$%.X8"JZ2(+CEQ/\&0&C3 MX.[YT?B98K?JY8:B:JFY_/:C#:>9/Z+W4.)?-P#O5,Y422G79NWGQQ,@FY=D M"W_.+=!TGC,<-[E4FWR#$XI;LT*2B[@'V-GVB%'U7F1'-X/ L[JC@!67?W19 MCB1T[;FV#8_Y+?'TEI:8VE'HEM:UC,)T&Q2!U=$J%Y32HV*HI93%[/< T*C MH^6,GZ \S^&R4 BS#X;)3N"L@T-@>1<79&!X+Y;#SPNB\I^5T\VP_J4;C[L[ M7KCAYD--+JQ)F:P0#;\8N,/PR L_B"BR291RZ"'SK?]2,<#H ];0.7$8)NVI MV&GQ(9R5?5HP3&9X-)QW%NODN $[+#UV(S"Q8/ OGF&S,$)>%0ET?)\"' T0 ME5@D(6P&.,9]\1N7_Y@I@#Q;CN&8%KSH!_ !3]8ZC998.GKE"%H30SV9T^9? MBD5R8U&[=T[NC1=@A1V0;ZAC @Y*%^2.WP+FG[,..E3PLV(Q;((S>M%*(BDI M"5Q-GX/<*OOL(ZW@)#';];='8G+1M"[(X_L0)M?T@)N:%Z0-/%9,O>VRJ6G) ME\ZBM_BDV=K%TUTT_:Y'C1_%+@7&#NT.^9(F!UN=,UBV3,D))X@V9I4+.T^. ME\UC3* ,<9,1H]\%HOD/@UB]7T^,?ZLJ2X0[,RZG.YP'JE4'L1WNS+G!'ZW. M8^NA77AZ:+9OG[Z3OQJ#X07Y1[/=O&9_7MT]W)^29ON:=)Z^=FZO;YL/MZU. M.N8A^F@^WL(# M?!'N'G]O/<"B?+]_:/T.+]_^HT5NV_!WBWSZ=M?I?#Z(E?G4";C_SW+(4^?Z M0.;T%(D&*>"HO+/OWUI'JR;,NED'?6'=R- MZXDR^WU*'OL>I>0[O-WW20L6NO>EZYV)T4[$?>YMX9!*E+0M9Y)(1#HJI37T M'OVVU_<%*!:X?:R[>)^+/AT7CXN.2#_,1=\CTG-U_&P; 1(/%V>/LS_2V>^Z M_&6HNU?T7^96M3(BO#+5OW&<2\[\1"'O35^V:$ON+))DH:@ MT)+;"]6Z4BFGOIUK.ZN]5)Q"&&4#H^I68515M$KJJRD01;E%D;I-%-64JJ8I M9:V!0#IX(-6V":1R72E7Y6-'6Z]9N"#8-]LRR7X@4@N?H[O-\':,;82S+ZU> MH.$M9@B090#!:^X0(#((?>RXN'L.3^QE5YFH9?B_OG;D,0(S1\!9< MNS;VK90KE87T]YOG^N)ZC*'G/F/AGCW9]3@9[CD%,C/M8<4QB;"Q@;$N'396 MLMBJV?0Y;3/>TN0L!) S@D!A(#B8'$D)P8V=9J_KALF+9A M5>;O%BN1S4="V1G8LX*1A^?@CHWG;W[@/9\+6K029%A2$ GDIXHNR=T\")!M M6]!7!TBI5%'4.=?S(4#D!\@:=O35 5)ECI8RFM+S") U3.FK Z2LZTJ#I5#* M !#YKAO:5/)B[@SJ^["B8>769XIRUX[EKLB_E*3%#5VV*1HU1:UAX$(>\;%! MX$)Z?&CLWLR]7#>% -EC^$)Z@)3+%:6RETNE$"![C&!(#Q"]#D?,G(O%)1>[ MY!"J?J,.]4)YBE6_-WH#D'A!]#78U>2(_;U(5R%1FDZO.4&.T.FVQ(91T4 # M01M&'O&R29CHVGBI:DI)E41C1;SL+'9T7;QH2KVF*C4,1,\E8C:))UT7,?52 M1='KDG"87=O$UKZ*;U.I[LIU_)$=1([*.8:RJ%5,?I,B*W-M%^B8TA^86>I* M*;WO C,R$90;N%U3@U)7ZNFE3P0E@G(#5V]:4-;JBI8^*P9!B:#"ND/*E!OG103X89#[OLR@=Q$AHF2#);$Y-6::D$3- M1(3LRO"Y D+JY8I24M'/G$>$;&#J7 $A)4755*5:08SD$2,;&#=7P(BF5*JZ MHLJ"D5TG%6)>_?$DYB QD!A(#"2&Y,3(N=DAECT2A?C.R"?;]?W/"+JE'7W: MNMWAUC'= ?T&M$A*A#Z,_M>3XK1H6*F6E)*^#\$0@;()4+(P/ZP$E+K>4+1R MZGL1$"AR*)A9&"'FXV2*CU2J2K4N23@S8F0U9I*%%6(E9J(I%:VD5.K[9R=H MBSAPY*/&A<1 8B QD!B'DOS5-$V/,F$A3O^RV"73U,>[ /9D>OC-L!R?B7[4 MOW-:/YDX.++\_@ P0R&W"933*_,N R9:5:ER1E\/#*(MT%?>KQ@7RR MN.7H\UD8MWJ$.V;I;63E;&XCPV-PRW2J()UDH9,4X@KG<&W7<2]1>%K:LU[J9.X.#0*;,H%K7'5ZYG"/&L:$L*U=9EK+ M\66F") = *2. $& + -( P%R] #9?\[Q6)[X4(*NU95R6>X"#1AVDA-M(8?^ M7"0&$@.)@<20G!@Y3X%I4V'8$-Z+,\Q]V6< "A!CM:P7O:94]'U<(HX0V00B M&\2=K J1>DE5RHT20D0ZB&S+8;,0(5.\@ZF7.F:Z2(J.K66ZK,I -';_AU+3 M]A%"@CDN1X5Y5*F0&$@,) 82XT"-#>-H21! AA[M4\>W7BD:'_*!/B0&$@.) M@<20G!A'<]',C>O!X>V$@8EFWW!>*'DQ+&?^21IU@2$DNPHAV5Z1+"9(725E MJ+%-)T3%U?T9^P")1VC2X>WXT?J:Q!I7K M2DFF"QH0Y'*#?),"7_L">;D*&$_M,D&,'SO&-\VNV0?&2YJNE!NIW3\(\L,' M^=9JJVT=XU-7DI>42NE0XF;1487*+1(#B8'$0&+DB!B[CM58R945'?7EK _/ M"2'GP[#:11)(>1_R+71*>NZH:]-,99__746R730&:%Y(/!,;W'*&)TYX)EH<9*7<=;V MRSA37R6#]B94Y/*@R"$QD!A(#"2&Y,1 >Q.S-_4L>Q30'DJF,DJF&5J:$ )73YK0>0-'J=.P W975:0X^<\ WT>XD+_/,T.ZT'O-$RQ.J= >ETB$Q MD!A(#"2&Y,0X!LO3'[P[VN.C,V!^Q@L51B>?N*/ #PR']77$$4^KEY#8BPHU M88.Z;=^L)*=&*&@* +1'@R[U[IZYS.K?C6&PV*4?B:OEDE+1RDJ])(W&?[2J M54Z 6Y4#N(Q/JR5%K:U=?0V!>US 5>4 ;EE7*J6J4D]_"PT"][B!6Y,#N !: M'<0%39?&OH6EI%![1&(@,9 82(QC(08:N9)&KN,-L\J)[+H-,U?HE9T18='0 MA="5W-"U%G31U(70W;^I:VVN6ZXII5KJ^U(1NL<-W6T8N];CNGDR=YT%!I#I M\DO/>KTL%+Z&]6 Z7WXFZ"8F[\6B[X^4:+AI@ M0%Q MGTG0ISX%=!JCG@489IL%M#-?_,:O/3#8Q\^68SBF!2\"N /*K@;P3S]>>.F1 ML?X 9]K\2[%(;BQJ]\[)/3"'"WCQSQ%U3"!CF12+X=.<0XL7X$-'\4N!58,[0[YZB4'6YTS6+9,R0DGZ#-F90L[3XZ7S6-, M( DP/,6(IX'&?QC$ZOUZ8OQ;52L,C,9E?G@>WZ1_M#J/K8=VX>FAV;Y]^D[^ M:@R&%^0?S7;SFOUY=?=P?TJ:[6O2>?K:N;V^;3[M6N].Z M+L!OG;MOM]?-QQ;,\Q'^^=YJ/W;(W0VY^KW9_JW5(;=MTOF]^=#Z_>[;=>NA M\]?_J>M:[8*T_OYT^_BO@UB.3QUVH/0*ED.>.M>?#V-.3]%YFG(^:_(8_K-R MNID:D>[$Y (@K+5MAV(HEVK9W_""&?T]*>Z;KFT;0Q]8>O3;!7FS>D&?357] M)3W)3K+QN1;#2T 7W TZ*4PG835AH-Z%75]TOGO=<.%M5UL8$!L+X()]\.M) M91H[NQK7E3L8N.)2U[3_"3UO/U1$O.P9+X\@JOHC[QT1LY+G-4<3:YKF:#"R MC<5^OYQ.["@HUO7.+E?:F_R^Q-5?FRA:CSC)Z<1VV%-FD8,HQQG+"A4 M'!0YFP-WY 3'1D[/XJOYD9=V?.0C:-!7)6V MDM;ZZ=O$S;A#!"6",EM0/KJ!8>\18+M3L[>N4F-6S)H=88H2$@.)@<1 8B Q MD!A(#"2&7,3888[QAU)\&(]6JOV2K43_U; -QQ3:N>&S2/N_&<[(\-Z)IA!= MU?4%*Q^.1_UEJ]IP%(7WR^Y2@,(N:[_L,-FGOOZE]"LF\S04E=U"KZ?._MT? M!7()K45UP?.&JL U?_2!LU#/;_TYLH+W187I>8*8UJ@H%4U=$5/J[C&EY1%3 MTK&KQL[8E5I%/B4KGRKZU"Q:/XM]JPMQ@7O>>]6H$E QMP^2EN/@XBK&'45?GNA@1AJL80_35E=ST/JW$?$ M":GR^ :_OS_VW9%O.+WPKS=7&.Z76NMU4&TK2B5]>5;D9T< I#=W!DM+?(F* MJFE*/;W5#2&T.826.G*T;!PY2*W.O&1],U1 GHP9 ZOL%)7H06X6OB#MF?TX4+<,,@XY*1#IGK9A,> MZEO?']'>])';28=U547='*J-]+BB'\A XBSWG3X M$5:OLJ;4*ZDS!!$\J#D>"AV62KIUE'1S0:<&TBD/="IEE'>*=)))>%G;;7>( MPDLN'78WKD>A'3X>^M/L&\X+)2^&Y>"^0/XDXSF"86_2T GI( <=ENX7##_, M!YTP_% :.F4G'U?6E8]#L:P52F2LZ/X2QTE5J58U.81@1,B.-*C<(D0>S]JL M(C5^,+K+@%^JL,$"M*G(K;.!/@N6.^LN/]Y&JUT?L/I0-145S( M-BW++ZJJJ6BUDE)52VGE^NUC=%&!383GUOA71I'3R+]R#) ,^=<&L< 'Q[^P M]N9A6."P=!<2 XF!Q$!B(#&0&$@,)$9.B2&3ZY!/)7G5WZSOL+R1"CM[_]]W MPS/[I+3\^K]L![&F'@V=DIX[ZMITSVKTHH%LUZE?V]4U7"S\N515&FIJW_X< M>.S/RG-(V%QT;D[A M45<5K20-&)%7RHO('=T$JE>X ES69=8UT(^,ED\D!A(#B8'$0&(@,9 82 PD M!OJ1LZ[E$Y5[Y0/B)5^#/HW+OF+)UXQ46QE*OFI*N593:N74:B]RMT.&T*IU MTS2E46\H9;V&\)$3/EC>97MT6.HFQ+*O^: 3EGW-!9W*6/95&CIE)[[LN^RK M9.)++@N_XDV-**P=&!TRU[FV<Q(4L:YS/NB$]83S M02>L)RP-G?:J>!V\#'.@SKRY%W/,J2*+&P@9F10'3D:E5I%.N%\.A0Y+]PM> M39\/.N'5]-+0*;M4/GU;-W,LR.33=56IU>M[D)BG,_80)ROA9%OWO**! 9 9)C@$CAX#THUB634Y=/ M9;>5?O\VGUAJ)I^T@I0O!@OJBT>;T5+#B5#SIAP:E\T D+3DE#I\R$E[6SY ]1 M=LEEF5\L(X5BF6QT6'J,8!DI:>B$=)"##DOW"Y:1R@>=L(R4-'3*,!QOQV6D MM')=*54K>R\/A#A9#2='"A.9/6_;JS,U1[N*FL,T:ZPA@P#82B&&"E:90H @ M (X< $LY!%:90H!DJ/MMH\S4 H&^HM>4BIY:H-\^0M/F82$X,^->6&@* ;)7 MB\2!,J_=N77Y&'=;2*I#AP$==*F'U:3DSZ+=Y':O5:M)5>H-12VGCJS :AC' MF]R]Z:5SZ:M)5>J:HJHZ@A(99BID[JS\'E:3VC\H]U)-JHK5I(X4%1D:BC8I M>K=F-:E*O;3*#:U8MN. M4N>N8Z#A=@/(L%H%$@.)@<1 8B QD!A(#"1&3HFQ1W]RIJ[COQG.R/#>B<;] MQAH";GV-MKQ)U>X5'16*6B^!8EN3(V<^-T!99!;)!T96,WO4ZU6E5$6$Y)*5 M;%)J?5L^3T3(1CQDJ0,2RU3)0*+L?"[EK9FW%WD#-1 ):DJYDOH2#TP;E@ F MI5V[YMCU0ZE#KQ B^Q<8-\@_645@U.I*K58"@5$2<> @7&+WGO5J!)0,;<.D M ^B,CZ-(;FC7$UIW%=7NC7?(!DD.2ZLWPW#X5_.OV8X%:( 8J.-JZINV448[ M;/#PZH?+L2,XKM( X%34?0AL1PN6LS$[70*>N+*(3UOO-!YTR*AN(=-HRG3(JWH9TVC*=,BI3A722 M2;I90V4\8.E&'@_D]J\*>C$L![<.LC )CYI:1K4YD$ZX7PZ%#DOW"X:2YH-. MZ&V6AD[9B=!K% %*=07,5!&]LM*HXD7QN43(VDI6;A&ROQM5\?:?@ZY]C<7/ M#Q 2V6FC"*_$" Y!@@"X,@!L)1#9!1SB #),4 RS,_;H/;TJA=HZ U-J:Y? MIA!O_\D'.)=RKXPB<9%[Y1@@&7*O#6* #XQ[R>/,1>O;=JUO6* -B8'$0&(@ M,9 82 PD!A(CI\0XZ!L[169?:7YJWR(EZ9 N*%E=B=[++265W=5TK2KE2GV5 MFJYXV]C17IZS$2Q7J I6*BFU2D6IUDH(2F28J9 I8^5:!&7>..52+TE&2;>( MBKRA(CO72&4/]7E+M8:BRG.2XK6(4IZ?6ZL(/(7'AE+6\0YV!.2'@-Q1 6)= M5TJ-JJ)*#4IT(Z/A$ZW02 PD!A(#B8'$0&(@,9 84A-C?]FG&\SCWG--2GL^ M']"SYPY(T*>$_J2>:?F4.9#?#,\SG& Z"16!MXIJFWDY3^Z:^",D32LD5V^I M&T-3:J#Z5FI8$18A%!793H>@L&A:I5%3RIHDUS8A?-)ZGY .F]-AJ9<02[[F M@TY8\C4?=,*2K]+0*3OQ)>N2KSD77^3Q[V#-5PGV#O*P_9PU=:SY*@V=D YR MT&'I?L&:K_F@$]9\E89.V51@F-Q+E$R&YJOLJ$$*SYBA6/L*(C M F#SFFAUK/F* $$ '#D EG((K/F* ,DP-7"'-5_+M;)2U5++[%CS-9_@7,J] ML.8K B1#[K7#FJ^210TE)Q9*OJ77HO12\J>ZNY&M=T>J:4M*PY.N^L2E_'::-8+E*R=>* M4JJ4%+7>0% BPTR%3"SY>D2@W$O)USJ6?#U25&3G&:GNH>1K'4[2:AU+OAX[ M,I<#1K655459)$;<3/?O&S:L&TBJY4M0IB M1T[L8,&6[=%AJ7\0B[WF@TY8[#4?=,)BK]+0*3O9!447";TZ6.A5@GV#_&L_ MYTP#"[U*0R>D@QQT6+I?L-!K/NB$A5ZEH5.&$:3;JO2ZJ+Y&52E54P>/;C%. M%&&R$DR.$B58\17K'6$]1P3 YA71&ECQ%0&" #AR "SE$%CQ%0&2H<"^PXJO M]9*JE!MK9P1BQ==\@',I]\**KPB0O9H;#I1YR>/413OMP0:7(S&0&$@,) 82 M XF!Q$!B(#'RD:K'![K;@J\=.@SHH$L]K/JZBAZ]GYHW&]R;LG+55UW'JJ\R M8#,'I9@V@>5J55_+:D6IJ64$)3+,-,BL[:Y,-E9]W3LH]U+UM8%57X\4%=EY M1VJ;%*=>J^JKKE3K946K2<.TL.JKG,C<=3UB75$U#4%YY*!KN&B 287R:1 ;$](5:L,NABX0S[P^(.(#NH&^S.4[GSKOU0, M)OJ -71.'(8]._SLU? L@PUZXM/(GB<^/+E\[-."89KN ,;S#G"!+P+H'_0( M @.T8/(OGF&3H>$%S$ 7]*E/ 9K&J&<%M,?V @B?OOB-!W(8[.-GRS$.&E1\;Z YQI\R_%(KFQJ-T[)_?&"["L#OUS1!T3R%@AQ6+X M-.>]X@7X$0TC"3%-GX.Q*OOLHY";DP\@GP[(B7E$,[@@C^]#F$?3,[J6>4': MP/7$+-LNFUHI^=)9]!:?-%NF>+J+IM_UJ/&CV*7 :J'=(5^]Y&"K?)\;)YC FT 4367_.,6/8T)/D/@UB]7T^,?ZMJE<'6N,P/=^3; M^8]6Y['UT"X\/33;MT_?R5^-P?""_*/9;EZS/Z_N'NY/2;-]33I/7SNWU[?- MA]M6)^_G I_YU5W[NM7NM*X+\%OG[MOM=?.Q!?-\A'^^M]J/'7)W0ZZ:G=_) MS;>[/PYCSI\Z['SI%2R'/'6N/Q_&G)ZBXS7E?-8\E?C/RNEF^L+R W2+YR<7 M,8%\MAT*NEQH9G_#&,SH[TE]P71MVQCZ<&A$OUV0-ZL7]-F8U%_2H^ DE0MV MU@$[Y6F-)?+()YLI>]];\#$L+OOTUY/JR;(MET(^67=P-Z['1\,*PK8MAY+O M\'+?)RU8Y]Z7KG14\;_K''3?EA MG,U82Y^,I5F@TVB 19F($V53JT5E?*>NJ["[>SY$OW*V(I*[?H M[M(9-:72J"JU]$ZH[2S_ENHH[4=2>Z! 3=.R+8,M)!^@^TP<&H042ED2F.S:HOBAAR)#;IKP-/@^#7QB.+U8RT:O@\R&;B2&1,3(FTQU M[]&A8?7X4$:>X5BC 6/V+! 0^ $%UO *O[H>&MKVHPC>.J9'00^\IN+?6^4FBZ)\>0X@+-4-=A]+/$6)63F874NV:/E.@3Z\E"-=T>G>,:DU.K!1! M<)OC:DPOG0^#SL0R-=VZS8ZS7,$UO1"?T3-PJ&VR5 M3%EO1+5[03#8(TU!KF]C:J6J U55JGN)@<#;6_<3&;,YE*805"HI#5V2>('# M$XP[HZYO>M8P#K4).33N'EDX<;AM_$?W:N0#MJB7BO&6JXI62QW3CXQW>RI_ MX[!4?CGX5B3#\[%X])4Z(^19TO"LB#H/@C!I+)5UI5RM(+O*&6HR%11SBYI= MBX7+KA3<;@P.#^)\@0[X(%E]0*O'7<#SV+*T'4JDI5W[_5 M:,_9V]D7>\,-L69'R)T.FA@YK_,R59&/,5]RZQ 6I.=/%>5##,J*022&1,0X M&E/:_<@S^X9/H_H&H*B!T!:\\] 8^N?(&K(;-M!2<6A&M4AROS?>^14JCV[3 M!&I[]#X$P+UM.$'3Z;4B#"R)2&NP"TM3QT:@9>W8\;J!IID%7JL51947KGDV M\X66/9ZPXZ-A3PH.O\ V$RL'*]EF5F3UZ""7!#_9V_;6P\]JK%<"'HN&O5SN M!M3CD1B'9]CC5VWTJ-?<3('RWGDB$-=UW :$JUHBIJ29,#,$?C#HYHY$?^8-,=# //BL% M#(^QNX/@4_?Y&9X'%=1T_9E"->AMVWX<:?"*[LNT MF7JUH934U-'BF'2Q0=+%@TK*N81/-E[8U<$ M3T4#SEO:1X*%!!6MT1E[/!9_)(9$Q,C6&9M::\YRO[= \36#2#D&ODVA?T)_ MFKR./>'5JAFW!Q:-.H_4,:@;"' "!'?/K9#L#T#U.X<=R^Q_%H#Z"@>O$_@/ MU \\RPQHCWW1='J3'R2>3!$Z5=)TI9S^LA*,LCYVA&\@9>X'X36E7DKM(9 W M+!NE5!2,D!BY)<:NI-0L-G:;!L0*"R-%ERAQTQ_+WO-B5CQ/'D7$[<;:M]&A M>0]C\0PE#R>Q9&]V.C34"J-NM+82U4-9'E[M!C* D#A[ZG7)(D! M07GNP/<3RG-(C .Q.L9I('/$.E(D7?IB.0YTA@89F<,L2GLZPY=&V>F:HE=3 MRX08+X1 /C'+90F17*[IBEI-'2\J>3 1RIPHYB Q=$8MGHXZ_*=S2!BZNHFM??+^Q0R$;Z[A&]- M/BVIHI3*FM(HK1VHO@/XHF2)P@Q*ED= C&PERZQ%QGSB9M&IF!>9;8GHI2KE M:EVIU1MR.-T0$KN2@Y9<@Z64RQ5%4R5)'=JUY++=@)RQ>!FGX2G$''D>*\0S M=+TY-]3E9$?($0>Q :>@S&[!S'CSDLKMM:I2*J>N?X;N:L1EEL?!DBLP=$VIU0ZEE,4ZDO9B MH^=6"Q8]NH%AHR5?0DM^9L=!TT%?$R)4ZH-A%8@>ECL)G442:L?H+$)B')YM MM3,:#FU>(MNP^5AZEF_:KC_R**]4R4*3GFWWC5B.8.3 4\\1G+*"$XDA$3'R M5B(\CD\<&E:/]$:\&&W0IV3($Q:9)(=;7UJT(3$D(H:49J%-RUB#EL>BEE'M MSD[M7EZ0NK2=@M1HC);!!CWQ:70QJ?CPY/*Q3PN&"2< C.>=Z<>.&T#_ MAD>)P:YH#^B+9]APYGC\3A?0GGU*1HXQZED\U<]E)Y,O?N,^>X-]'%XD "_Z M 7S S''^Z<<++STRUA_@3)M_*1;)C47MWCFY-UZ :73HGR/JF$#&*BD6PZHE!UN=,UBV3,D) M)^@S9F4+.T^.E\UC3*"CQC#_81"K]^N)\6]5K;%GC,OY';*;D%?O=?+$$LC< M8*G^:'4>6P_MPM-#LWW[])W\U1@,+\@_FNWF-?OSZN[A_I0TV]>D\_2U.M>?9\:>ESTI7/OMT0!>,F>*2;*_ M+6=$>\W@UY-_?QWYED-]_\H==.%T97ZKZ]BU]0CO?;5=\T?15/_-WONW=D*H M;QI#QMN]$9V.3$C7VLF^UY"AF6B%O_Y/7=>T"_+UJ7/;;G4ZTXNZZ2 GX?F? MD1]8S^^;C?R+%0/ NIP>[]D$X>GPB_KSUEG#T\[G#V12]=P:-TGK0T"6$QA_4A]/%*3QYAF.-!M$9 M;SA&C_UYY7K#4_*)L11=O0@?YG\!@W$][A\,O[P26E'XY6?R9OBLD#(TX'I< MS8'SYYJ:=-"E'M%5M0J*$4CULL)?#CMF]VH.;T!Q_BB?%ZQ4AYHCC]_I1**" MJ_$LKSJM:!*GA::?T.:,(&IPLF?#_'-D>=#Q\MBXB1I?^FJW!T 'P?MW&O19 MZ=A7H /3$N_>'.KY?6MX3STF)H"L'0?)%?5$E-P0\,A25]69 +E?0CV5#/C2 M^OSPJ%UP79:Y>WSV_;T%KY 'JP>K]-UB91')MV]7\8+=/WR/%DR!M;^FMO$& M*G'!M@9<[;4MT&QL&#\)->=3 HHT"0!R_GBA@&#!2%#/HZ\P%'C"^$&!YE[< MT\/C78PO&%>(1W89'XSAE'1&79_K1P$)7.)V X,/MF ,@6Q#4/ #*JY=[8-< M!LWRSU^!')/D]&AR.!:LP5?7\'JLQVL@LQFXGL^K^/C4L6 3P+:"E1_P;JDQ M."6B;J_U2@%GPT!@5JLJ!'R#\8C&448;:9\ND MQ/()S(0S8F!CI9)*OAKOI!-XE ;0%+ 72K2R"ISUT?6@=U>)N+(BV*:AD.^5 MWXG>J2L<_ RT$U<9%Y@9C#%>UFG(;SNM!)?WWP>@$$7GQ1]/5Z?120+,O0G[ MTR:ZSCE[=6)#QK.:Z([5:(4% R["#+=1CW>/5P5@5S_(W9 ZY+OA_6#38^-U MV9_O1"^E[^&-,L,>9Q*4!\#,Z>WO_R1?84.'70G.-M5J :;FF-;0L$DW.N#" M*T/?&5U82\GMST;; Q9HNT/.5( =C,+CF7WU&AW.,$1W!(R?'4I#YDFC[,05 M2\U4/LZ[GP*#WUT $+'A1.VYT2-/#NOC9B[3#QPA/QE'?Y0EI _ MW#F%OXT<2O3Z,N0+CB%$KK$=&C:9"8((H?&)QA 8G[OB2V,*2Q[E:?FP32S? M'U&/;PJ/&L_PDE)(GK1,1IS87]?P*NP"UWLGCQ[,/'Z2PFI8H101]#UW]-+G MTYAY@8WORJ8&#U]+B)$*>>M;9I\\&R9KA0VT0&V8%# [RR1=U_U1A E#.SWH M"X2.=P7.]R 0X;%*N"GCSGSJO0);]?FH0W8Q;V.=KH!&V8 SNYW6ML#;]+/GTG.E.@BS[B@ZX*T)HJ1$GYLE+BRS02S).?N&TRAYT4$0,%S?9^Q0L\=$)!($O:E4W(] M#B0&ODU!T821]GW6!>T5QOK1_&Y>*%-]A%;HT(#WQ ;[OTLU[DVIZ+,7L$P(@K#00SAI?*:51C.*%@G6)EJ^T)["''4^I2PHH/ \ M8C8[PDPI@5AOGS?FL!>@M2Y?7":*#X1>/EYZD%%M$%U.29.OV$Q0T!RLH?+C>&^6E,B6=]EJ&Q\;O-\?]7XON4Q!!TY5*O:2HM=D4 M5-QA!.?OMC *UQ.=4;"$_/YW^(GJY$1W-F,%-,3*MK2JD^:Y@Y M(D%[8_Y<6I\_RVB3[]Z.CW^/<@LD#QTAL;II M3\K*3!HW6.P X#\,7('-P=5%@"?[=$:G/RV :OXW R@%,J\^EW$P74CP9]&9<;VH9)(RUVN7ET#:XM-MV]Z.L^ZJK#ASYWUXE9G5RR>W\K M2F7.S5G\69_92 PV";%:5\WK#SA&K;JZ<7?^Z.^IQRIY=F/DUA3=A5:(V&KC3T.>OQZ:GS MT>@WN(PPW&F:II2K\U6X&&D83)/1+'/$\(4G)8KRE(>-:G%%.T/*%G/ M9C'^,#Q0B8+63]"% &E+TO=UI0JLI=28LQEA"6+ DBR9?&)<<#2-3MQA!(?8Z$191S-H!@3.,\'1>3LGWV%D4 M#Y8-BOM*[5$/SF)*N;#*Q@30Y^)_HJ61T_/C4[U'N\+B1;E_<-R/4H#7?) MS2P3'AO:(2&P,@6_'_A5YWXJ]@/ M%U"S[[BV^_*N1&L)\P^8LZT@3A;N,>7*R3,!W6:!%A0GFV>[EX7M0C\MI;1= M:&KYM+H-V\5&9NBU=KF46]6CW$_DN*#4^LRMP8RHW+4^81BV;!LV'6%*,,,+ M%U;&^AML.>H-F!>%RZH]FP"NJX/)Q"Y?9X8 C"*D1.-3;"%9)-"OF*Z>2&QO\,I M*DS?'QB,\42R/=]9\,_(I$)F-V$ D= >\378;/! D'0?189OTQW9/5 ?/#'? M<= YBTKGW1>XFRR>%8B8(SOP^0*&HP&M(4F5F+5R=A+Z!%U'V"&31J!''@@? M=Q0*G[ :,:IY-@@L"L-U89Y_8AY'9]Z#2:LG^]H'F+*U3E#T6<#!IH8/= /! MZ9T:WEB@2"I&03Q4'JE?^#A27XC9R:R %>+\8=Y\52/NS\-)>FRGB:\Y<@-:P4/Y02B0:P!&SJS!-XB(Z'%-D M0//!JA@-L!A9 /(&"F. ?\8 M\"_1MEO)P0Q+9X%H!=)$$X[B$5?0[H%5@[#EK^Y<3M7:/@/^EWB=12X [/K5*L;^Y\_3]>_/A7^3NAG1N?VO?WMQ>-=N/I'EU=??4?KQM_T;N81M= M);E"-QLU+@?Y!2M",'8JKXK<%3-A#-_RF4$2)$0GX.-N.KULM\LF?>P]:P:P MP! M]#CK)YMM(Y]N-9/"OHJRVC=>*>E2RJSRS!(H_$>L.:_'%>@W*^B'UA5F713V M&>8=C%YR58@\3P$J4IA;.?#8%K M]8X/S,H4%H# )3?P&*Q_\>_\L8>13>$O9GYY$ 92UD G/.G^"7(NGQ6,V'Y7 MA!%X6E6W[2AN9GH,PKL:&V[BJ9R2W]TWEMR@1'XW=V@Y(@"GD$@C<")11>R=_XP<3KE"3,Z/&QJO?,#LC-P0/3&7&:-2TP%6 M8I,''K#*S(HA1D(4_%\4DU-XMICS2IB-N+=MG,I4TKBS#7X:S*IFTP0$.ZTK MUJJ(;6>Y'\PK=\IBTZ>6/XK]$2%2?"+3_KUQ!$\A\N\184D-8CP X"I]H!! M\5C=$ 11)\*6)(R*(B(IC+IE1B=_G#L31H'YS/ 7#2R:.1MT-/5".'4]]\ZW MO1V&Y?4.P])N#L-2EH>AC)$V&QV&T3D0A.;?T)H?1\='23)O?1?.PJ+[Q@ST M;)M9/0NV*AM&]&B8?5D(TRU9SL9GA>6T*%9C<\EG]W;<9YHK&SE4V^<)U(EHF:A /APJG/?KIF4^9'1K)Y%!3-.UGV?([PG\JK9_HISJZ'#@>7[ M/*0@D3,.\M$XZBU<76\+5U8T6+5^#FW7$EOZBCG6>=/OXN?*IJET MKE\O,=%)Z%Y#Y.\93,[O1QHL[> %M;#[#5#X7K%2$:V916 M1K9\I].M4YBV]L3-DIO0LEK+"K!^VT''#R)RI @?AT24J?HH2BB)LC-F- MPB@8?JZ),B(BT>BM#_HUZR;>*6R/##U:A%E&T:P3HV#MA@DSDTTQ%( X/S+A MP($I3D3NP!D;^.%I&W?%1'_8E'#LQ:=E6&$$CLN"R^PO4\?E*9Q_"Q8DV6Z8 M"LX5 CX>=LAZ+ 8)6GSQC &W7OF@@+/T57:0C<.%Y@H 2F'1K)>,:&H1YPTJ MLL)$5K6(C.2-VO8S<_'#PX("XM@OA,FVO)6>Y0]='\;,GO:%$,_?GHA52DVO M6$R977?1R%BD*3Q'(6!3YSYTQW*2PP"IA 5D(9"3:?GC)2)Q!ZQ6C&6.;,.+ M^N"#2>"YD(X<83H7-]9Y-(KK8HLK]L!4H%EHWYJ%*[>(QF^PIN!I/P ^,V2F MJ@*OSB!N(%BX]B@=I3@UZNL=-K5%"L[*9XQ\A\5]#-J" *,H!S"I1O"@R"ZO ML:255&:/)TE[?/'_%*:H(C3$&_H"LMICT9:#71CAFF6O,)1 MR,[$<3;-ST9^E/7!DY.*[G,QP1 &O"H4?Q7&'M9XX1&9@0C_CJHQB(M\?!&A M#;VQD'!V@"J"N1O!^&/.)5P;ON+QECYW2;RX[&WV\:06:3%E;P[O$>2.XD^9 MKBDLT3/V^,)XC, YF>4H3(F%0<%V8#H;ST_E!IHX82E> -%;;Q0' 0LFQL+@ MN1.(>17X;68A3?D7#"[S*%M(4';Z>!*A]O,.R5/2C _ET%\$2_\6.38<=PH( MQH#-][^A #!+M<(LU29]0L1G^8'PB-.RPZQ;ZL-1OU$M07C3&9LI^*TS0G7\: MV(^L8@IKI&AS=PW?B3SCV@B7:5&9H?1FYD3<=8]7'[/?"]R@Z27CWN>^RD#/ M>TY4!II9V-@(SPYY$N171?)C[8LR\6H@VN'"[VHS9#IC1:2DWF!;D#'^6 M5T\)<,R'MIQW2VV831.:L884DR(:NG[@T=!5C(;>90P1!D5C4#0&1-M^:EUOC27M^N#?GC6BL9XU MHKZBK^;)IW?/K5!.]M/Z9";?DM!P(>@&PV3:3SQ0=+RDCGM5UX-?8Y$Q;"'. MY,,.\]^+X%@C$8BY8DBDB(%D?)BYL"?=+%%8J3]1=]J%OWZ,=5:N=1=8AO5@ M& ; ,ON.PENSFCGSQ0H^GZT^'E4Z%7[+* MW8 :/[24B$)EA9G+I/VX^U,!XZ\\F,#R@%,P#5X)URPQ'8^G"W.+.D_&-E@! M5C[W<=IK5(&@'Q4LC0N_KY#/R[5F[K[PA7$2%-7Q.."3T*X6S<2,C#S^&.RG M$Z<9C-V(HH&Y66FF!$1A@FXD2;=DE%F/LK3WL QM3 L6^_MJV"-!G62(D^6\ MNO:KB&M+%'52.*5]/QEJ//+I\\@6Y@U..]:BZ(>'70^&T$WTPFPU"!YH9;-R MJJ,)B^JX%1X--VYE/ (_:9$95S(N1&4M0L?0N"5XO$>?*?<*)2IQ,,):/1I5 M>YUX7@#>M(TP1CNN2#_U''>,%+N&V*4#!E_17$$47DX\:KP:ELTL,$58GR(O MH.7'P2^GY(Y9 &),:+4EMJ4*Z;D:@M$MNR0*V<$M[8 M/6-&F)O.V1$8$O)PB&Q$+51 AB6$L272A2?(BH>1+T#2K?\8-*P:C9*MPNRB66-6G$8]$??M])(A-2R)&=I[X+;/+COA@V,(1Y5)%.'G1K^F#D("9MM]L)X)5$X7'VOKIG;I:V: MW'5C6-X_F*WZ[ODF4G%O>48!I[7@ ZEM5FD:DT%(9 ,M\)%R#38>+$F,5BJI M\8+P9U]!O38FPPOR)$^NF?^E?9P MAJ,(YER5?!O5:XT#<][#T.1H\H%K$(R M#Q$.@'*,0?,/"O&A RR9>3P4;GTQ/4O<'15_NL##LLA'(WP:I@D[>\KAR*J4 M_^1.BQY' XTH\;#7B^NW)Y**P57:ZB0X'4:&7PCP#8IA:92R(06:F-Q;DFW"F M)AR73$#A5UL*CS);-^)9_H_P]H6$7_19V'9CTU/KY_E,H/"4X> XPA5^=D#$8G==\95#N$!8!MES-W8%C6"Q(/1 M^P4CR0/[%C F4+O?P\1&SW(9X_QOV(_@:6Q;C[WB_"8(Z\\1SU@2>SYT04QU MGVS]Q7H-F^3)(WY0"+OBI=Y'3LRB)QFN%6;?T)!+"17+8B&*W'0=&KGAL^3) M\BEBR8GX$?]S'#3"LE3\>*[O!3X M\L4,7YZA),.6RE-MB)U"D)F%H8420>- M T\ZJ&'2P2XTC:45CC^XFAAS$S W(4>3E#TW0=I-NM/I1%75U\M>B*7=;2=5 MY27Y:_LF-?(I7O3/6Y_1KN[ V8I:MV:ZB%;/6*TKKZ76R5C&[V9LL;+&Q2Z, ML%*"%0@]AMG,PK+-48!\&([/E:ZW<6'DT#$3^UJC&WO9E=U,U>&%<(3'A)O' M. =C$"X@U8A:R470Z[SY M>JLU5D/'VFLAH;RR0B)S%&1>Q]FUV45QYT>ATVWE=HLU4X"T>3E F["4REHL M)8O+$\7/4[UB.5F3_ALS0!0T4B1_W]PJR0/( M]1F0,TC[%C1A> O,?#/;0)FR'D[NBA3M%:+])-+HPK+[HA-^0::(#8ZLHM%# M8]NA0JC%'XEJN/!;-9WH+]R#:^_!-;,6]'E9"YOLP=I:>[":ASU8@CV85'#G M&<7#*W:=L( 0*W?E=EU/!&^_1^)>SP@,D0HXM5- )N4";G@[#"_"QEV.K)9U MHJT"M)7H/-EL^"0- ]39@WS'@8SGX"&W_@9;]\*FCV]L6FVKU-?:8#4)E4/F M\YM*VYT3&C#IPXYL&CQL83L*RL$B>,W #&I;0]9P6#GY=<3%H['BN\.#3/Z>V7$A&XY MD\6:#'UZ3J+?+LB;U0OZK!7UEQ/F?_H2>%'[KRP.%F2M: \)O]9)Z*4*>HL= M>=F!,NA=+NWI@H0+-?:Z,6]CI@.(YPNKQC[]]42/:?"1PS-CIX,0JOF [KE4 M_*7KG8D!@OS M!Y /?##UJ2,TIK24!TPE'IT/KAETZ(@.6=&1.$K'9'M*Z 4)+L%%_1GBEB0C M[EG@I3JTX B$I14ET]DQZ'KGQ'OI?M+5LJ*7ZHI>J7R>/=C"L[%:_F5V,N6- MIK(@NI6YQ?@@XFL#271MX()UCX[OS$>X!,C+P N=DIX[@HF-18M?)F%LT^=- M!O:_"U8B[7 :4\/AA5@V<6T*8?,FJB\](6W6&B>@)9O6P+!]+KJ)*T=_/;%^ M!N?.:%#LN4$Q?&!:%!UC9'Q!DZC*$ # 8A3WB*K+LX[&_F]D\N&7H^"^:,1 M7:X%G4QIMI0M(X2W >$B\)6B];/8MWH@\)T3\2^,T R*FEH+PRE66LDT/XL( M-@3;%-CJVP*;S)!++YF,Y8Z,,;]-,.]JOV9Y4J?N:!L30F(@,9 8N];@=J:U M35PMST?!KI=?L*+221XRB!L[T\GJ^HYU,EW1=#6M5K97Z1B!N08PEPN_C=6$ MWT7"+,+BH&"AJ;F%171@GW$V*)^??KW,[#3%+W;@]%ZS;)->7K&D2X?5%/_* MXKRO$A6S[WBL=]/IW?+J7-8KO;<-9\4"+VLT+4.YEPZO(L['74@.7*H2+U*7 M(M;7K$>D5Q;%3VR&4OE84[(*61@+-%GNJZ;5>2F!Y'19&!_#)IE&950$&(X MCX9W--*HV!C/CF QLHGB^'&J2:)RKE(8%[H7U_LER^KRBP2C)MG5"]#B^![% M1#14?(GBF^&):R_%K07\C>AF 1ZS2[U7'LV;++K+2H#,N16!7]7(9A[689OS MM6@M7 G*"IA9/AFXO&VCQPJNB&01=E1-ECD910O&3_9BQ^R[-O4++@=7,46*J!UC^87$!;_C,CT"F:R;5W870GSEZL2,%E;! M!%0^T^BR^411Y^3GK@D*WG%$H*:H#Z&I!UX@HHX%(O*(U#@>&LS5TB>DFO+YIU&FFYB3*)D:CBHV,I02-TS=*H0 MZQDF UWP%-\A'!- 2G;7SRICO)__&K^%TAK?90#K)&IHS+1O^?Z(>XGCRA_T M)YQ>EC^V$1 WK*O!U%[053U>2^/3V+@2>-QP\1X^+@PLG[E&6Q"V(WY+E2@8 M"R,S+=LRDEQ1[[U4UQK=>.Y@ZLQNNZ>IWGSRB)']CUG=OZ45CQ_=$PW7-7OO8OD MH.J^DH,>.2_EF5V"C;88&^490).\=&^+=:R4:D;[Z:;/!V1MIT>=3\]TV927.>,#9X^R/=/8[ MJ3=0T>=D@(Z3&-E?YZ2Q$5=MTR"RK@E;VTE*<3C>IZ#6EHE?6* .0X>(OJA."@,H(4-7= :I> M4I5RHX2 RCF@EN))W0*>IOA2K:Z4F;*V3QBE*PZ!6-J,.=5VQYPTI=*H*C6M M)A-[PN(/F.*.Q$!B(#&0&+DAQG9L&^L/\7HW#_7RB90EEB MX,IFF$)=3VY=#XF!Q$!B(#$D)\8F)JG%T:$3#- VT0P,<( MX&V$VZS-@+]\]$<,^M M@@-/1W*E>JIJ\DB4BXIV(4CW#M+J?D$JD>4402JKMJYN$:.YX)_';%*2 Y\K MU+G;/1.5R':T;OT[-!NA/H;$0&(@,9 8TA-CNV:CS;+P/S0:K1;B=$@E 5:2 M)+=5#6!G)J/0';DKHU'6^?]IM7$$Z$X!FJ&Y:#V 2E/+"@$J8SV5#$U%<_"9 M [YYM 5_I,#FSLQ$ZS%/::K[S#<3G?%[J/-[V_KXXO)Y3^SH]O62NN;MZXV3 MV9&L=)-XZ40^TMV[ 87Y&+;]7HBN:2=^G'#,LC]LRZ$]4)9(T*=$W(3>I;;[ M1OK&*_N5.H2&U[F39\\=\.?,\:7NK/9%J%01![2O4.T*E3#0OH3F!2V9QLBG M!?;ZN&H&_&5Y[!U[Y+/&WMR1W4MT#=2SBM'(3Y,8W'2I=[ A]K,!M/4V0$E= MM $Z9I_V1C:]>V["5[V9M/56"(\;0,?5&!AWS],[9[93#?H4F#.I;8=LE[-S M]C>LKQG]O3*QPX//=&W;&/KTG$2_79#H[AM5_>5D9U>HRN+$VO]%[C>NL,@P M3O#8]RB-;G3GE[GS:]V))#>Z(X5(&\X'>0FTRTN0I<,'WC9^9(N^Q]O&CW?1 M$>G'A?3]76Z]28I_6'&0!"X9CCRS;_A<2QN $"\L( L6-,^7?2[=,?NX/;:^ M46[^AMI5<\!TO*7I=@VE5-45M5;%VV>/!) ;Y=IO'Y":JM2TBE*O[?E:;43D MSA"Y4>[Q]A&I*XV:JM1U9)'' LBZW("4F$7*G3]X%Q;D3DC$?!!II.(#3RK( M2YV*>D/NO5E2-+6NJ*HJ3P:"+%8$A/5B6#UC?:4H]N8-A\,,-QG!69$V=U MA/&HJ^_O_-U5O0/E7U?*-745BST&6!\WH&4W^)>4BEY:Q9J%@#YN0$NN*Y>4 M1J6TBK\ \7S<>);<_Y4+!BU[QLR7+F @'K@% ^Z.5T^R= %]S70!+<9YF/0S MP[8GQP6+E6C7W>.;D'$E[ >W^.*" 1!J^18C%\GHM/\1Z)!B*&_O^S]V;=;1O9O^@[ M/@5.KOLL>RU(YBPISLE:LB0GZK8E_24YN?UT%T@42<0@P&"0S#R)6?*)';P<\>QV_5['^P+X,^\S(L(EW9D/O1>/46+IL//6<+\ MY7=CX7[;ZPK0D^"]8]H^<[*=.9/%;3(7;)Q^?E@+!S?GB^O(#VA;!+@VJG+Z;F?NKOJN/ MT;V_^*&(W> X242:G/V=^6.4P<>A]Q_X(O5[-V+LQB1GS^$U00#R/7,#T)9@ M3ND$?G<)HCY6?S^DF=\G:=S_>;MC+A)>.MSS6^V8G>N/L\XO;L\^?STYNO\(EOKJ^O#J[ MOOVO0YSK$B[^M?YL/CV]FHLQ;7ZL:SOOZ)XH$WMGU[!\ELHMF 8G;!@0>1]\ M2.R1C\XH>\SS1_@)MP>;$(.% "=QG U@5+M^Z-B-6KW%]@P6(,O7@%V3NGX( M#R4('%&H/[:Q3(]1)#Q0$6%P^P;F?>WV71%87X&8_&QDP\;]A98+F'EDEH#8 M. ."F< (8 A-'/MKZ@X_\-,9&$03&P^,Q@_$=_.Q>Y& Y IID"_^(!.!?L<) M!JW!@.+W_ $_:-%KK#F/8U5U'"5BP<,WJ'G2%(QG<BQB^ MA[^(GL'TDZ>)%J$%S]'1)SY^N558C^< ORD9NVGNEMTT7@6[R?E'O4,'JZBFY01+EZ\#)_D=$J8NKG.)MUI]@O\XP AH+'_LDXMA/8(*# 9[NG!?8 M)V[@8=@92X>*"6V72[1VRX3*"+9UG%@F]QBZ[*"E\!XFAH'4=[N! MGPSA=@#QW@%U OW!O[J$@(1D'=_AW0C)CPOD[P/!YV3NX'4 J>KC?1LR*:,S M.T8N!3?4I5J7^Z' GUGP:AP=WS3B,_#_@8&U&[<'B^P*6\!VPIWK\0R_IQCL MP]L+TXA]V"OZ? PW6-UI1.3J^6-D$M6=V2Y1MW=[9UHEO#,+!#>3[UJ?-Y[8A"!YTY]=Y3<>Z]>FVV"J)>VVB]DOMS&<0"B?T* M<0P6X6T_!X1!H42IME)"82%&2D%N"+D-^I*J'3[CBU@W;I( DJXMHV M<36?FKCJSL%AS:FW5FYU\4+Q+G;.F:7ZS=V/'C"3IK9VEU?F">Y)^3GO2J;1 MXDMRY+0.#YU:>^6^&[OFNA7![)B;OBZ"V78"_XYS]7?3V6)'?I.#W;IE.F5( MH+_T PLMC-_*:7*L&%N:C(214W_OIT.,XXPQD@J/2D\V6\/*K4WR)9%1TNZD M$''&Q(@QZ&3??8S3!!-KV]J'+B2+A7O9_PSSFBLSW%XL0!7OS*)*V$D6]]T> MU@_$',H9\D?+&<*%LQ0-^42@2;H_+9X*R0*T DP8 MP)(0H$_/[KG)$(R,"95@3,\T[G8#U\H-B56>.]/OZ;8F&?F*J%[@O/YYE?;/7+*O]*% M36;)VR&43A%BS$U6FE'F8,ZJS4YA1LZ/^#[&S*A]^S0C_HZ.?X>/AB8%A]"C M?$Y*<@@"^QZ($*3HG0@B#BXGJ3M $B('MML;:LY!#.;MX3MZ)%$3Q&RR&99. M&]+%Q MO3^:UXD3V+20V%Q893VP,4B.E-STZ.9B1OY;E;A8&B*$#RB_'E M7.E'#_;]&#[H9:,,>#GJ)$I,2:YO]X:B]\V2V5@N%83CH&^6HV"UUEYO."V8*.X1G:$MIV^14!VG,M55BUC, MZ!L&E(T#M(TZGL>D:!(3_0@')!+8KZ30EC+A:[L50T\!%+U]"IRQ+Z#CU]FQ@S5%V)3"9 M8$+BR4*>1Y8!U@@\Q['72K)GS<,#Y[ ^QUA]^-@/2K*$UJ'3ZCQX[%8&QQO+ MHHM999.: WF%-B7C6FM*5M6J:9OO/)J>B#SJIQ^I][9TM<]5^7K5?EZ*6)C MN\!DV9*,>5GUV0Z2]NWYQ=>STQ>TQP\RS^NE2$">BUZ@3NBV5N? M?5 5 HDT77[XL,>CXY7-S;#K@OX75-&/J;ZQL).L^Y<,>LJ"-"[8Q!I:GX-# M=M2%N=!N$- 8^N"FZ^70'(T]]L;%.87;04[A^Q:&N!9\J?QK7\&V0C.8BTWG M3C, 6Y?M)[!ZT5D:Q6@.DX>2#"CI H9]&ZF257QU+THP>MNWS"FXY &\\\4] MUO;!AD6>+*F3 5YW/ [@$Z[ST\.Y63J,&,.3RWSG+6N2U[PF\X*M5A?FJ.>I MIJFJ9._<@"WY?I9F<7$$7HI/MR84;!Q3"%N6W4Y5814KD3V!<36LKB47EROCBO0#G$9@*@770P4H_CBQG Y&V9 3 &LP M[/\'[W,-R=)W*8/^Q&H8>!F@19439&-IN3WE)G_5)F_ MAPQ;A71(P("H>#=>!P+@6!A97-HP.G7:\Q=VX(N6]3NA3E!#GAZSWW9&6GG M42'7M6G\-US8'+);&E=]6J&WR407"+V9(R^O_?,2 ZL[QA2J;P-4:(,C,:UI M@[,B->$_U@JT<=HA&PM;12#XP4AOQT@R]>96< 8,"LIU]^2R_PF4MS]0O"WX MRX$G/:X+X)PU/$\)Y8]#8H^!3]@]B3T6R.()2*8ZLX?/[%'@ M%B6ZYMM%O-A<-?^(5C=9M5TW<#&M DQHF;%+LUBTT48-^JXW=PD$P8.TMGM< M@@>G4+;RV@<=L,E%%$K7U9*\9'8\K %9L.LS6PTDHR+;YR3;U@;I]9O1;;-V MY!RU7@C=;@M_8PM0G[T>!C:C<'5-9:>7Z5F9R//>G35RD-EVUVF;"=3D>$3M/5\"C(\=#ISZJ#*0X6[-0'F5G9NVQ0\Q6"5X>^,^C2- MN6&XDIJLVS-3G[P[[^.F-^]R8Q7LGO]];^A[GH#?\']AQKUTKUYOR;>NN("] MC4WL9V:%%=4]#=4]*@5\-S)EBG$50@\Z"V%9E:W3Z1RMV__YB2[ NZV9!MMM MBGX6XLOLC[G_R/3';W)AG[U9^W/9Z9M/K&P@@%MR.G'JRT:-VLLOIRJR+R?9 M'SR;L[59;SM'C>9+H_O2@!YNI\GBUBIVFZ^]8K=>5>R^V*K$GUY(,6E5$US5 M!+^*V[<*9EM5$_P".?'S9(_NN*=:O8Q-U?A8N(>Q5>AA?(4E52E55"&CR1*[ M_ 7##]W-%UY+O.,N:O5V"0GT,K0^B6Y,.(BMN56&I]=?;FPJ8'7MBPB63[5$ MOPN7BZ$BK,$)L+;I5A4)][7%P(91]A6+-(Y<61%CCR+X MX0172WL;9X%(+*/\&3>K6(2(!5[< )E>Z:>\,CC)@("=1T(0)Q'?_83^0>^T MY[YS*$\.WY#(I'F/Z]RL(6)=2I#$1-Q1A;!"4<1"4EE;*H<#*NIF"$?L)]C, M%&O?\*4>'/,$7JE>@-.48_/I%J9@#HG5R^8P'OABR'G7/0FJ8D M N>=R/=$D1;7NR/V:.PG8IJ*+$U%IQD!/I]<_G%^NE<_LE6Q)5?-I\96IE'T M#3NSPM7(4C\@*&8LH?1C9 Q[41A,I$NF>*R(ENKZ ==JNG83AZM;Z*A)J "< M)@JVMQS&BYY.&#REO70QW0+946T&CG'C2< XGK-L1JU^I$$A)7==QGV5I\+(1#0 MZ]7$Y =^JE/;-$ES -<)I[!G#IL-< 2WF?+ M>\!EI[@-6'%*6X'DB_BI'C$L(KCZ86T/WW#OAUYT#[=0(YQ[?@P;8G&W]-") V+JD&QA=@QDLV0%) M?EGHAOXH@AVYBU*)&$_L0^W^O&)VF>=/$U7U M^&#Q(L/CHGPB+XOJY@D-DF='L2R]^04^.+71-.8%K)\"7?7:(T:U"Z-:TZ/. MG->R@3LSXP+K"4WT >28JJ!Z>OL501/.?JX58(^ .84O M0F#)4Q#07A&OQ6]M=X"2.#76)<0W MYOB@'J18:^R2^C#_L#1[[T[4A:=-*&I/^!R1$%L-O &T3%WR7&_/P*0_O%KX M%55+Q%\1 5LH_!-6"8!A>:(OPD2Q6YA^ M<6/QUBV<54)[]P6HJZVP-G V^8&KHG">'^M_MCS\T )5GFL18E_T$<.I@[75IJ\59I?2!1\.L+MI!97UB4L529GT94 MDAV%;(3FX2B-:1VC/4]Y!.A(OM,3)4)5 M M3M. >SG01/[*/)]*[AF'!X$U>G!3"\HA8G(C6#\OC&8YIG M(^+WL3$8O0_%6XQ\7#7M2!?M!"@K:'#3>>9KI]7FPTA@\5N3-/(G+1318X02 MHFV#)_.$@KI^6*.V%&#EYY,*XOO&B :"N;FLAJ8M1') SDK#32&?F+N)J@2=B74, M:G-@UX]DC36VY>'+LG"5>1^6+" Q<2%\FI1Y/*%4:I0 AS?*A4V]TY([)]^E M=%6$=NCY8\*'8@1XXEXAO]"4=, ^S+Q!I4WE>UO)*8^?)5 >&+I%,"Y36B,JP2X&R]]@!GHPIP;C,ZOVZ48G[< MO@J'5N'0*ASZ8]S5%Q4\?=EATZ=&Q2U!J&K'G67KVV@MNYMC4:W4;PR"--NH MJ[54G6WH>KH9KS6>:O\T'2Q)XS/08)5?XQST_ Q,FT MN4O>NM2^ XI 4.-(.S\.>%A']W^C0&QATA8B9-+'/(0T=8MO9$>';.GFVHWV M'G8JM ._1\Y ,,@YYB8(;U-AN;KHWB!?#_HM])^IZ W#*(@&$]WUUYH9DNU_ MXZ=J+.I!JUM(\DN3)4/,="5F+,OI#<)PCRNQJJFY79N;,3K2"R9_3^?8JLW% MT,1](GC1 AHHS[HO1!'P6SIV\F<4(#6UTT,? D:"*&Y(FZ.7/>NJ)2Q4BBC" M.219=T\?2W$'*:SDQQY[R*L<<=B^'^& /HWMT MG\E6P7+@'C6C[,+HI 2)6%X?[2(CHL7N@U,=DV<7)WM1XO,C"B@1&+D%:YES M2_(0=J'+[2SI,#US-!]I,$Z&_AA^SN>"6Q%U*>+*%(4,(96(X!Q;0E=F;VB9 M^PTZZ&[46F$/0#DGI."UYDJM/E M+Z>BFYZ'(,\S/%1,84(4KQD62_Q8LN/IA3<;.&F8J]PE^%<"9E=$L79<\7V$ ME_B.@C@HX?EG1DX2LT/K@1^ICKH29CH*!4V+8C(40,&FJ3&&1M.7B)Q%&1 MR:N4#"-Y1"8=$(G(HRKR[=F4R^[T2K] UMO8O/06Q[,FD.[ M]S[H25+^$T4*F;[5FQC]/3C^Y:GP*V70R40E^#A)@8'L#;DE @9Z^W$TFC8R M+-@N5(KY5BLL^UR=-[Q"\&H0#ZE\CVHOTN48]AX,X,"EQ'OCN]BL ?A8QLD? MJ*;A=96Y,R-<6SYE;J]*'X)2%,CX98(I:/,L*\XR4%Q$M5+!_,S<<:8"(!,PV#,G,*" M^VWT)R^R&*/?.I5=>N9/ U3TN/..U-_=((G@__#87#8R#*Z[J+L/\*X@PN[L ME7ZX-I/:<7.SQC::F^W&!\>IW99>JWV5@84*QM5.FIZ5AJQV>MJ%1F-S!KQL^?HEB1XV7_#/ :+EW M H1(((J-K!^X22^LI'[ZXB^Q+(O2!7.>P2Y,KMP)8@G !4<8.?C6Z*&"($!! ME&1QWEX@UT7G-S70\ SKO7X+HF-G!X!!2*MMR]"CK59HRR42QCU/QP:V%;!76Q&/_"F!#0HU@DSTPHB'65I$W)6/7A MW/PZ_)@GJ_;-&ANWP)6WP&R'I9(WO=+TLED?PV0C16QSBEVGV8SBRWF[F57F M4;66*2$T8DE;RQPG-,.H_T(;2?PX=%.NWB/:'N.I@U'&,];-B*J&,B_O4%6Q MESS3NE,XSJK7S)8:JL>N)Z@)*QDB4@6K&G64N5'')E"?18V-3O_D0:3#=M-I M'LYV.RUE>XZ*6DM&K9L =*Y#K>UZS3ELUE\&M6ZYFT7VSR^D'DOV]<-#YZ"S:/OA[)*V#:(K(/G7!R2_/:-*)3JL MP1C:!PWGJ%GU4JBNP,L3@ENZ ITC4 F/7GQ;A4?V*7AA$N\6,4)^.P/BQFM;FMSQ C7L+O%N31)1^79K4]AS M[RVU11B/@XFE6AK65H%&&,B=$C?8SD!! M][,1;B.*HYCJXQ*B(J/ GB%.8<)_1?%4J3$A1:03@FS$-V--L2<"G]#[\[HK ME%$PC4,NDHTT^".7("-4,6-0R&)D51&'"38&_.>A"32KUD)2E,IS$3@SG)UV M#I,PL;@8C"#>Z27_Q4%;]EM\[;MYNZ$7,X4S[_H/U2PW>\G*S:EQL5E[ M<#BW# 'K#AA5%!>FJFP9!$)PX7=>Q:8^MD:8LT&().H ?0;X913697+ZJ#.3 MS@GO]/M^SPU3YDKY<@H(+N?&3!M4,($ U$E?;JFLKZ1S:N<38PA^A%>1Q-J3 M+*](&_+WH"/5&U2P80==JK:>=])49HFO',>"SG?>CWRJWHR0'@K8["98Q1 ( MD A]IL3'FBWQ*4XX%OA.+,06,$Y&B!IO&-GXS8'3:#2=3NW(?HO%EEA;SIU# M")S].]6NP$Z\:1_@-;+'Z"5_-UV0@K6?5&I)F*TS8[2<6@O^=]BI5#DH MXH-ILC"HXK*O:$*2!.D^2FI-J0K?12_CQB!=;L1@: O V51MI:VD!?%0$ABA MFV98?C]/)KCI- MN-I %6_3X++K4LB6WBBN>6MNYDCZJA'%:E!HZW_3B664Q M&+Q/#">42$@:M[R?$5P B,")B9:M]X;%#JH0Q5VREN_2/) MX/CS]I/:FN@" M_L 0XU+N*T@H#9SBHIMSQ+ *8J[@3JP9K=;4D1I/68BY>P:SMGOE)@5^,8P" M1,K'4NQT3R9*._*.@16@BT]SM)A%&,;'^O$'?NI M&Y3,M_)TO2(??X+-M<^^C)X51!62BYC".]1 HNCW0!":H0M&%$'*H&A*95= MA!G#]EIDI=%O]NW?\Q!=EY"P(== M--6HF:3&,92-._JR(UF$J)A11G(^$ ."$G*QAQYE*O51LN_;7\>R!T;@P[EY M+@,+&<"ECH4N!:E3>=%].+4UCCU<=87TL5XG=E4#?:0(9UIH=X>_EA.WC(FC M'XKZFW0S[F=U3(\OP-C0>E.SKGQ,U-(R\$?D[0HS^G9F\H02YVKF0,"CV S, M!<7C-78$V1&':*W-(4IAKE[%_AWHF-85-EHBJZQDTJ%^[3+:,!>AM:_ MW9!0.1MS?7JX&K(Y0?/:Z\;1-[)DQDPSW)Q+&5K+07 V<"C?N%A83QM^0:P, M_B .=DZ="\_#6\S4X5'G>IN9W_WT:\-I';6=]D%[UN>,OTWLHFORY/CT(6B? MCKFJQKJKNL(1KT1,JYJ[@I[K72$T,*^COM^9XS9'B8P/L+/?'0RP61A<[$$< M)8FM'9:QZR M',Z->X0BU2?U;M\^PXZD^'P!YP.5,,L4Y?B9@MAZZZKNE41-JG$E'#!"M8:B MH /DCI%[-T:(U?EO^I._5.^2\Y*?6KG^@SV0B2,6_%$X*,WE2:_720!JUV5? M3O(ROL;,Q[/O(NX!^=.%TU\F\MNDOL+=:^RW%]P]7N-C<(F1!N< $]]'L9>( M<(9AX/N[B)Z&S%F$W.N4.6%NXGU%)Q-QE4ORK&&KN:2P;H+YEY^@NLF_2_ZD MW%"0B]BF>R"N%7"\BL=G;H!09<(R(,)!G_&+]* BB>Q5-0NE!2C7W:[?F M7N_18=G6>W3H'!VNOEB+-1M8 M!+PQ3N9YE^>3;F4EK:K]=M;6F]MEL)*4L%.(=YO>R,.U;^0V MFG1MS.;.*3**'F1:@,V* 755+AE;+I<,/EK[V-=L3K/S6$;>,LH/N8>2BPT M)7G8,^1AOT6&+\U:_$#;Q^2.![-MA'X@_!&U')%=$A)Z3\3Z)X8G?#U$S[#% M]BVR$.8'6#C-0B61<0?PT/YW!K*'A4R-$TR!688>MW&2^6J%W[*;KMYD+\]L M/$0/8V$5H&S5P$U69EYHM*YI1U_)1O9/H.J:95H+KLGC>WQW M7GNU7:NJMJNJ[:IJNZK:[@>HMGNA659/U/EZA_Z#G>JE]=K:BNF:K;MVKIB. MLW@<);JI*&E'S=D]Q3'%A"J)4OASE%*V G- MEV,_5R)&60SW4GNH]AJ&BPJNO?CIU_ILA/!?BA/(F .6,D7Y&--I9;Q[*6SS MM.T9ZSU9G!7F8.'@2A&U>FV#5DMR8W!^O#O&IBUU5;::3AOAWEJS<&_S4M2, M?7(L,E!3IC **U)[0_>[/\I&!I$5=TT J?LJLXY.P$C&)]+%M/U'T-1C7)[S MX[;'Z))E]OYQDO_DB@L7:%//Y*P_13'1Y?(]=9KM0^?P8!8XLN+,J[/7#3*] M2Y'J3?.V9*"T9+[0,H>HZNNG>=?+F.=]&5IYN^VYB7VZ,;=DD5/\D$)#9N44 MENH^)@)6K]4W3-;X^##+_&BPS.-[-_8DY?]&X:[S\(K2<)9G"M1J\ZO0BX(( M5&4L]+ M9(X0;1:F",UD"&'M&T5351SR,1EA]5JS?"EA]?V#V48 F(/X,A:3)<7%-.:D M)E)(8 X P#O9$!),1?%W1O479#+Z0)UFYV*@$MGI6=9BR(PP9D/<-!Y;&*M> M]K*XL9X'WSW[WQD\7G>LF8K'LC'?DNDTZ]0 :$&1_X3-_U8_O.#3+EJ4G$M),D2U2>"%RX M;*1C@&B^!3Y6['9%$-U7%+DZ6:U?0U%O+2^Z7[E-WWSUP9")R1] %:QVY,=> M->Y;%8I]>\2Z<5NNK092E%9-4P+->OU^:EO=H1VAT&_0?HZ8*.DA4YNR2Y3K M+>(9@RZZ"++ZR<"G-U(0B'OYK%O9]"EAL[VAL-!3ASB-'&PDL+MN4C6QE/EYB M_\8NJ(>:D.U&E9@>Y7YH][N%5=66[G\JYT&\[L M5*)EV/_%_+F7*;"6WH[GNA+/*K(0JU)XZFROW71I>'GER['%,_O7$XJJ+4Y; M;:W]1Q2XC/9;W9FMW9GF\]^9_%P?NC6@HNZOW$*G!#=G&^:-BM?8,F!C7_O) MM[U/6+Y]KE*\<-^J.[&U.]%ZOCN!AXMGJX[VP1NQWUFY)7 )+D191$G@]X7] MU@\9 >'=#W)WEL:H6W-CU+@_JP6HER=#/2@$,.9[\@Z7AANHD7]!)&AEO^8>?23/\ M[SRUL#K<%W2XY*ZV3]$PUI^A_FF3 EJJC7WV"93H9,'NC?TP\7OYJ97PP)XD MS->J;1(V,^IX;%7LJF!B94IF%;1["L_2)J"Y&X;L#!I@=?0!\*EFH^5T#LH7 MMWL=M+DHP:,$9/F8\LKY1#E555!,8G^@I' Z>;TYBPM64>!S<\>EOL/.AK[# M-8M;#,)Z=''+VIM8W^\PK<-K:?O.HXK0_&BD_FPJJ3;NE]/G3K^W&H7-0GZV!?V[* M?-JP__S$RM<:F=P1X6^*-;^U=,G?$)MWFSF3NSZLBM#6)[2R* M%$MR&QC"W ML+BBT%)0Z%YU#J4XAY?(*?X@FV*;G**V?[BR!E=1Z--2Z,H#O;3ZJ&U'?LZ^ MC_UX87'3$\;EUHK%[9(<'S>330GV;7G5_$]1W!=^FJ'[,O2(8%SN<+1*H52] MWGE,P&4NQ6WUT!>E/%2T_E2T7D+U85527Q8#6LFX.%PYE7WW-Z$L&#YI3!*;=C2S4.*L98W8OR,L9-"NNG)]S:B&#FI;W-0AZN MN'>;365-VH5!;2_*NH%X9M)=-)$=<_2#4@0K5\B7:SKUVN%C8C9SR.OY./-K MHNU%T?;2DG6Y\NT:*WMJ*PI^,=QYI_EZ*]3ZSK+4)\C-:^S7VROFYE6D7#'C MG45RJENKYH;V$*-N[,R!- S4/;31C@WNRU&J#.OG M)N4?@7%O<"$J\[DB^)>G@&]' A3-YX4MXEZ2_;PM_,2G:<-5&E#%@_5!%3L_ M&;L]9],^V$\/86DTBB,'Q<&'Q*;>;GMT*[ ]H;XYMOB._Q9V+ (705[3R"ZV MD%8-4=,AHB>/8![#Q!:A![^==7M0OT+X1QW[2EO+NT!N4&![-AH'T42(CR(4 M?3_%U,KY)LSB2SVG\2G.??F4-\B9WLF4'3BV!*%@_3L13+A;I#JO$%O]K7Q< M#](']@E?OCD;-%3?PN8C_T>T/;3VP_[ 49 MGJ0?V@,8,78#.D'7&X'MDJ286GPGU)$EJN7H-"^ Q7OX SSID+*LZ.8G*?R' M@BS8\C0:"YFI3$,@3<1B"(_A", .DWW[F)K\SE*5PRU-B63"");KCJ(XI7:5 M)FM1\]QJ \FM"ZEG$TJ'ZPNE@Y]*T.]<]> M63/V[9[RNB=TN-PGLCH6\]RA MI]L?OU@(YI>?3.C]*MNSRZRLITEZQ67".V!QDX)TVJ$JC/)% / M7H) K0ZJ7C]\"0>U34RQ+0%!OY? ?A4D]+/#WY53OYK%?YSG_EFL5AVU#IU: MF5!P*SSHYR;T9]3FGAT/^JB"/?T1KL-R9>5H.\I*12&OE4(:M1=,(2\)+JC" MUGWA<$'UVM/GZ#4[#:=VL'(LORJF_X&+Z7>=XR>2)\GQJZ^MME;47EJ.O&&. MX(O%TZU7L#\5XWZ47E'^#,.&TSEHPO]6CAV5&D>T0@E]-4*F3&K_\^"$5@9# M6:C[Q'*0$3B[8Z[GC1.X8<)@PP6/^V<[&8S@V MX%>$KZ0VH0BKM.U5S;SS?^WMV9]\$7@_VU? #-&D^3L384_ ^P_LO3WY<[K' M&CU)S8/?OI=&8_AU ZE"?J(HI8.?/13W^FD!WB)#2.AWTBBU.8/4B&D9"U%+ M^&#?3L:PD./8[?J]#_8%7"!>YD6$2ZNWS:?>J\=HU00CE:-%S5]_-Q;NM[VN M@/.$%X]I_\S9=N;,%O?)7+%Q0OE-6#BX.5]<2'Y"%>D_EO2GWMF- F]37-7- MH6K.;F[/KB^LK]?'%^=?O]C_VQV-/]A_'%\GMU8MY?V[>]GL)Z+T[.+F[-3_-?-Y>?ST^-;^./3 M^<7QQ(T);/"&W9 M@%HT_?X_*C1<*8[I C&QS5,JW2&M&L%ZE5?YV> #'Q&+>W47\SDWO5YM>D7I MS[#I\QQ'*SB>7B:EOP DTBL1C_QT$1KU2T8V*Q,>Y!H-5]@.DA&RY#8Z[OV= M^;%@VI+8P9%SU"H?(EE%6=NFK#7ZXFQ&6<=K-5#LIX6E2!31U]U]'$#5+_&5NXO6;L MC.?7QO3Y+DO-K;?7[DI>0;G\B.2XM@JX CG6G5:M1"AL%3F6GQS7UCM7(,>V MT4K-W-7)L-1K.T>K1 MQ*JT?*-JJ[7K[JY%@ 6*5VZ<3FZQ%(V/*3GUDUX0)7#&*]?A*82.1[QRMC(O MKX_;K(!S7EF=_,H//8%#U?QPP_)5ZTB7Y\E%V[1JVUPV5>E^//Y\?'%2K-#= ME("*]^.O+$G]_J0D-7R;$UGC)RX$7(] R[>[MT-A(6*-&T[LH9O8J5P+T,R] MGP[M6!+0&!;JPXO&69QD;IC::60G(K[S>\)VCLKRJ13D&.Q3\!0EWWC\Y]^/2?B"@6K3S0[W!VU,L><#6P-=J:U&FT; MSBC !QC+;&K3X8VC$7Z9 A7ABGC?;#?TZ"L_108 GX_=B7W\]=1^TZ[5G%JM M9K_]>@-_-1MUIP-_N?3B6):D%]941=(G%_GS]_;Q=2Z;Q^G]!,/#E'-;IBQI$2_@XZ3)CB*,G@& MOH(M F4:OBM<,0MN$=H$WHK#P<3=?)\#W^WZ@0_*AA0$C@NT_T;$_,R7Y6L[N(PEX&ZPK391G_1-&LM7.6IZ,E/Z_0I_#_PCS%>D3L1X+5[:7KCNB)];6G<7$\:S]F+ M[6D[IM)'PC.ZAZM+HI=E+IRR/^J"XD:<0X4X'GNE-X";IBPN;E=%0YL[OR0 MVT*QM,Z%;3WU5#MMYV!.*LW"ZVC/OX[6PNM85C=!::!]3J([WZL?/1+/9_JI M%PSB4Z]I-\')Y1_GIWOU(]O,A(N2D%XPC@5:4K:? M)G8"?[B>\<(HBRWE$V 3+"3@<62 ]V =[-LP2?ESJ5TGH)#Z29PQ9JY6:6&C M1*A^XX/EXMT)=#JH9\-Y)J35!_4J9',#WA.-2:T*!ZCA9 %,^!Z,)M3"/;]' M:&EJ!P(1#L VP-%@2^$C-[63K#(8 M#^#O!Q&\*D3[QPTLY0^$KZ,$5@ES1*$"'PD\0GW>^&H_!/+WO0S$I-Q&927" MSH)1K#Z,_00M2;#X7+1;8C%P8^I'-A1N 'L'LA5,G00F A]:P*$0"9E>Y<$J M@VB,OP5^Z\)D1EE*FX#T$)&IY>230N(=QR"68R!ZN^=FN )E^WD@B2<)+V@< MQ7BXJ+\.,A#043Q1LZ!=L^3YTSA?0*3;882',"G81O NL.R(&%QXT]\9>@]@ M^O:M@-V+T=]U M3,AY; O+.$OL97W&0AV+P(F,:O"\1WG-IQ-H"[C=*\9J'_ M#7Z))F "2_-P#G0W\4124"BD5T[J8?7#VAZ^\AZ.);H':J$#(ZN-7"'ZR.@/ M@UX6W&/D"7\ .VGQ).&IP!WQ6L"*[.$U93,5MA6O@Z#]-@E0O\Q&!@B3"N4M M#@4;M5$7G8;"_CL#(QYO"!BY IN0LA?'DB?H@ATYP@;.\)Z$I@PL; Q::BR) M!&:@UHIZT'M2D>;M,$S\+U@]SV)VFD@_/M7< MA*."LZ8 M]_4.?@]G"S<=3&0"9B5F)U>L*4;S J1IF#/<3A^?*UZL-+&2K"NE9L[9QA%R M-N11!3Z8+V ^;[,-:MZM4KA3(;7%@-)-!I2'^+GI&1W2H\-'"U]0.N&^J5I8 MUVIAHM:]I'4M]2 M4G:"R!H<2'?XI9.,15%QZ+#Z/3Q_C'7U,R\5"EQ/8:CJ2N9O= MP*N)"4YRL%K7+UTS$K,0V&33]%PP74.3C40 W7W'^-KI@'I/*N_,"/:@UP M^-I; W2JU@ SE$/_7]=5 "JA9J^^44;- ^1._^>2MN#^?[7:(5*J^VNI5P2: MWCGP1:L!EJX;NBRMM?3#8$:6),KMU%\@#3O0!RSP5T\$S$B[K'JC*D&;#6]TX.%;Z+7R>Q3ZE9AVS M>Z!^U&Q2BA6(# 25)(\?XK97["Z,,M*J8_C.:9548F.Q)[Z!C M#Z,QGG!7!+[H)PZE]X2LYT4Q>1-3@9D[ACN2DD\RS/39M\^!EWG,U'#+)L;1 ML(^7SI:]VN13XE%1@()>E-(@['2%G4%%%"CM'U>.WY?#2#L:?]OSXUXVPB[1 M/9$H.L%)H=>(K(=@@A1"F15C.1IN7'_A)K-R>P]*2Z+."9ULY,,2CB(P^0WM MT]W,Q]IQ/?-Y%GCJ0TM^R!DDL^_F@YG^E [$F_YTY$YF/L(T\^D/QV!&S7P6 M@:#"!):I>6FWVT,.:NF%$G.)A=6#3>PB^Z:<+P[P$%W.G0H-BQ/-\H!:.HP2^,@D?@VB4:T'@["T4Z+211ZO,]P M<'$4O,LYM\%K>7YXC3G*P8TW=7 0'@%-EQ0!&-'B?#UDA6!+HS/!\_MT\+ M M<3222Y8,0E+*: RGJ:**2Q>LMH362(=77*:2K=8BV"KQ?ZY)SI \&3NL, '(8,Y9M5=DQB'H+D M]6KU#^W\GX*%<>I^(Z(WLBOAT+,QWQC,F+I#GQ[.?K&.A]%@(2F-(H@X=UQM M"+S'T"N=676!"/0>AG" C'H"^)S+B^X*BD3ZL78ZRNQ9C" GN7H7N/?)[@3# M[K/W2CU=%A%8TH#TX^4FM"1J.B37DSG&?\%%R).,)2OR,'N,$C#(M>0RA2(A MC^P\5<'@@GA'^U&4PF47";LAT\C*I=$B@5-*[>#)VBQN,,'+.RQX$?Z2XWPA7$GF=E@?05MS<]&JFLG&-0>_GD"&NN^ MKIHQTB#0P)%Q-?FE$2J#+QU9- .L1>7O/DF\G'LPT_L"U &Y-,8::FWBFDZ/@WHAO*%Q9'=GA3%V"-/:=4CFJO. MCE)U1Z1U7_EA%%K7O@?#2D!J+"Q2,[BZ_I(7,+FP:R#&43\I- MZ5'9B*-QC$E17%XTC *IA(#&Y@93^X/%)?ET,"^PJX+9Q6 K6,-8,I9[?>!. MN*-]^XPMBCMA1/?J'2*"MJ-GG1, #K&X)H>2A8 9)?9GN:%J.XP?:1*H6-4Z M,R]C<Z$JMWQVQ++(UJ:$0LS,]:,L =;-%6>80)%)Y@T7 M'$TI4F7%(!9YZM7\JIY\G"K3F+%:Y-O5*GG?)^M1I:]RCN7/Y@3Q$TD$ M;LR%5\9G-VBUVO]&3W[^(7(;\W$=(KB-QNX_M+)]B_,-='&>]*UHXYB3/:4% MAT:A+'"DQ$A@23*G%XZ5W#'\86*<)+-B=B1(]C?ES!9YLHK.+<7VR.9 MF&+][!A>Z=E#?S"\=V&'10!\%A/K..\2?B*^2U'JB5Z [W%DJLQ[3(0$-OT> MK)TQ9P2S'.UF/A%[(E<16I2JG>!AD,AG3&.83Q9@2-CP';%M1$G/<%R410[B MI4_^-N;M_ OQ'1[&+%Q7Y9HNH*MY*> ]]%/ MH,)UA/JMJC\3CAMN!V87JI2 M>5&/X951,JN4%,23.XJWL\)WQ=6L;:@&2*P@(C!F! M@A4JW4KZ+"EG.$ES^6#\H_\0E=& Y$7BIFOC&%HLNH] M^?YI[1;YD:I#H"KS!:7EP). F5 LS>$ER$;,E($M;9%+)9^H90MPR0PMM

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end